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EPILEPSY 
Epilepsy affects 0.5-1% of the general population and is the second most common chronic neurological disease 
following cerebrovascular disorders. It is a central nervous system (CNS) disorder characterized by recurring 
epileptic seizures and by the neurobiological, cognitive and psycho-social consequences for individual patients. 
The definition of epilepsy requires the occurrence of at least two epileptic seizures. 
An epileptic seizure is defined as a transient occurrence of signs and symptoms due to excessive or abnormal 
synchronous neuronal activity in the brain (Fisher and others, 2005). The classification of epileptic seizures is 
based on clinical symptoms and electrical brain activity as proposed by the Commission of Classification and 
Terminology of the International League Against Epilepsy (ILAE) (Anonymous, 1981; Anonymous, 1985; 
Anonymous, 1989). Seizures can be classified as partial, when they are limited to a part of one cerebral 
hemisphere, or generalized, when both hemispheres are involved in seizure induction.  
Partial seizures are the most common form of epileptic seizures and can be subdivided on the basis of whether 
or not consciousness is impaired during the attack and whether or not progression to generalized convulsions 
occurs. Simple partial seizures (SPS) are seizures in which consciousness is not impaired. In complex partial 
seizures (CPS) consciousness is impaired. A partial seizure that does not terminate but instead progress to a 
generalized motor seizure is termed a partial seizure with secondary generalization (SG).  
Generalized seizures can be subdivided into absence seizures, myoclonic seizures, clonic seizures, tonic 
seizures, tonic-clonic seizures and atonic seizures.  
Epilepsy syndromes can also be classified according to the underlying etiology as idiopathic when they are not 
associated with a brain lesion or symptomatic when they result from a known or suspected disorder of the 
brain (Panayiotopoulos, 2005). 
TREATMENT OF EPILEPSY 
Chronic administration of antiepileptic drugs (AED) is the treatment of choice for epilepsy. Kwan and Brodie 
have shown that the first AED leads to seizure freedom in 47% of patients with newly diagnosed epilepsy. 
Thirteen percent are seizure free with the second AED, and only 1% after switching to a third AED (Kwan and 
Brodie, 2001). In general, about 30% to 40% of all epilepsy patients have uncontrolled seizures or unacceptable 
medication-related side effects despite adequate pharmacological treatment. These patients have ‘refractory 
epilepsy’ (Brodie and Kwan, 2002). It is however very important to provide seizure control in order to prevent 
cognitive deterioration (Boon and others, 1994; Jokeit and Ebner, 2002), ongoing neuronal damage (Sutula and 
others, 2003) or sudden unexpected death (Tomson and others, 2005). Therefore research towards alternative 
therapies to treat refractory seizures is ongoing.  
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The least invasive treatment option consists of including patients in trials with newly developed antiepileptic 
drugs. These result into seizure freedom in about 7% of patients with refractory epilepsy (Fisher, 1993).  
Epilepsy surgery is an invasive but often curative treatment option that aims at removing the ictal onset zone 
believed to be responsible for seizure occurrence
 
(Wiebe and others, 2001). Depending on the localization of 
the seizure focus, approximately 70% of the patients are rendered seizure free after resective epilepsy surgery 
(Engel, 1996a). However, a large number of patients, included for presurgical evaluation, are unsuitable surgery 
candidates due to the absence of a circumscribed ictal onset zone or the localisation of the onset zone in 
functional brain tissue (Boon and others, 1999; Clusmann and others, 2002).  
Gamma knife surgery (GKS) and radiofrequency ablation (RFA) are less invasive alternatives for resective 
surgery. GKS is based on the convergence of 201 gamma ray beams. Cortical structures can be targeted with 
GKS with a stereotactic precision, without opening the skull. RFA requires putting an electrode in the structure 
that needs to be lesioned, but is still less invasive than complete resection. Until now, no definite conclusions 
can be made concerning efficacy and safety of both approaches (Parrent and Blume, 1999; Regis and others, 
2004; Srikijvilaikul and others, 2004). 
The ketogenic diet consists of a high-fat, adequate protein and low-carbohydrate diet that mimics the 
biochemical changes associated with starvation, which creates ketosis. This treatment is sometimes associated 
with severe systemic side effects. Long-term prospective studies show a reduction of seizure frequency of more 
than 90% in one third of the patients who are able to continue the diet (Freeman and others, 1998; Freeman 
and others, 2006). 
Vagus nerve stimulation (VNS) has proven to be an efficacious and safe treatment during long-term follow-up 
(Vonck and others, 2004). Through an implanted device and an electrode wound around the left nervus vagus 
in the neck, electrical pulses are administered to the afferent nerve fibers. VNS is indicated in patients with 
refractory epilepsy who are unsuitable candidates for epilepsy surgery or who have had insufficient benefit 
from such a treatment (Ben-Menachem, 2002). 
Another method of neurostimulation involves direct stimulation of deep brain structures, termed deep brain 
stimulation (DBS). DBS requires insertion of stimulation electrodes into intracerebral targets. Although our 
group and others have demonstrated efficacy and safety of chronic DBS as an alternative treatment for 
refractory temporal lobe epilepsy (TLE) (Vonck and others, 2002; Velasco and others, 2005), this technique is 
still in an early stage of development.  
TEMPORAL LOBE EPILEPSY  
Temporal lobe epilepsy (TLE) comprises 30-35% of all epilepsies and is the most common form of refractory 
symptomatic epilepsy (Spencer, 2002). Patients suffering from TLE can have SPS, in which the patients remain 
conscious. The SPS can be divided into different subgroups: SPS with changes in muscle activity (simple partial 
motor seizures), changes in sensation (simple sensory seizures), autonomic changes and psychic changes. More 
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common are CPS in which the patients lose consciousness and have sensory, mental, visceral and somatomotor 
symptoms. A CPS is often preceded by an aura. Although temporal lobe seizures are always partial, they can 
become secondarily generalized and result into tonic-clonic seizures (Mathern and others, 1996; Engel, 1996b). 
TLE can be categorized in two groups: those with seizures originating in the mesial temporal lobe structures 
(mesial temporal lobe epilepsy, MTLE) and those with seizures beginning elsewhere in the temporal lobe [e.g., 
lateral temporal lobe epilepsy (LTLE)]. There is very little information about LTLE and distinguishing seizure 
characteristics do not exist (Walczak, 1995). Patients suffering from LTLE comprise less than 10% of patients 
with TLE. Unlike patients with MTLE, there are no reported large series of patients with well-documented 
lateral temporal lobe seizure origin. This partly explains why LTLE is not well described (Williamson and others, 
1999). Therefore, in this dissertation, we refer to MTLE when we describe TLE, unless otherwise stated.  
The hypothesis on TLE development covers three phases; (1) an initial precipitating insult of the brain such as 
head trauma, status epilepticus (SE), stroke, inflammation or febrile seizures initiates a cascade of events; (2) a 
period of epileptogenesis during which several processes (either molecular or structural) occur; (3) chronic 
epilepsy characterized by the occurrence of recurrent seizures.  
There is still a lot of debate about the mechanisms underlying development and intractability of TLE, but it is 
generally believed that limbic structures such as the hippocampus, the amygdala and the temporal neocortex 
play crucial roles. One of the reasons for this belief is the fact that surgical removal of these temporal lobe 
structures eliminates seizures in up to 80% of the cases (Lieb and others, 1987; Engel, Jr., 1992; Foldvary and 
others, 2000). Histological studies on tissue, obtained surgically from patients with intractable and unilateral 
TLE, reveal specific changes which could underlie hyperexcitability of the removed structures. Typical 
alterations that are described in temporal lobe regions involve neuronal loss (Lewis, 2005), gliosis, synaptic 
plasticity (Cavazos and Cross, 2006), neurogenesis (Parent, 2002), inflammation (Vezzani and others, 2002), and 
molecular reorganization in cellular membranes and extracellular matrix (Perosa and others, 2002; Avanzini 
and Franceschetti, 2003).  
Hippocampal sclerosis (HS) is the most common lesion observed in patients with refractory TLE and is found in 
60-70% of the cases referred for surgical evaluation (Lewis, 2005). HS is frequently the result of a previous 
status epilepticus, complicated febrile convulsions, encephalitis or an ischemic insult (French and others, 1993). 
However also the seizures themselves can cause or aggravate HS (Sutula and others, 2003). The hallmark of HS 
is extensive gliosis combined with a rather selective loss of neurons in the hilus of the dentate gyrus and areas 
CA1 and CA3 of the hippocampus proper (fig. 1). Granule cells of the dentate gyrus and pyramidal neurons of 
the area CA2 and the subiculum are relatively spared. Neuronal cell loss involves both glutamatergic excitatory 
neurons and GABAergic inhibitory interneurons in the dentate gyrus and the hippocampus proper. Sclerosis can 
extend to other mesiotemporal regions such as the amygdala, the entorhinal, perirhinal and temporopolar 
cortex (Yilmazer-Hanke and others, 2000; Jutila and others, 2001; Salmenpera and others, 2001; Hermann and 
others, 2002; Wieser, 2004).  
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There are several indications that hippocampal sclerosis plays an important contributing role in TLE. Firstly, 
from epilepsy surgery it is evident that best seizure control (up to 80%) in TLE is obtained when a large part of 
the hippocampus is included in the temporal lobe resective surgery (Mathern and others, 1995b; Engel, 1996a). 
Secondly, careful pathologic analysis of temporal lobe specimens, especially from patients with seizure control 
following resection, have found that most contain an area of focal pathology, usually hippocampal sclerosis or 
mass lesions (French and others, 1993). By contrast, in most surgical patients with poor seizure control, no 
hippocampal pathology or only mild damage can be demonstrated (e.g. amygdalar sclerosis) (Miller and others, 
1994; Mathern and others, 1995b). Thirdly, intracranial EEG seizure onsets correlate with the presence of 
hippocampal sclerosis. Severe neuron loss in the anterior hippocampus was associated with anterior focal EEG 
ictal onsets. Cell death in both the anterior and posterior hippocampal segments was associated with regional 
mesial temporal onsets (Babb and others, 1984).  
 
Fig 1 Hippocampal sclerosis in temporal lobe epilepsy. A) A coronal FLAIR (fluid attenuated inversion recovery) T2-weighted magnetic 
resonance imaging (MRI) image showing left hippocampal sclerosis (arrow). B) Nissl staining of normal (above) and sclerotic hippocampus 
(below). In the normal hippocampus different hippocampal subfields can be discriminated: the granule cell layer (GC) and hilus (H) of the 
dentate gyrus (DG); the CA1, CA2 and CA3 subfield of the hippocampus proper and the subiculum (SUB). In the sclerotic hippocampus 
there is extensive loss of neurons in the hilus, CA3 and CA1 regions. In the CA2 region and the subiculum cells are relatively spared. Granule 
cells also show damage and dispersion (arrowheads). C) Schematic illustration of normal hippocampal anatomy (above). Granule cell 
dendrites are located in the inner and outer molecular layers of the DG where they receive input of the entorhinal cortex through the 
perforant path. Activation of the granule cell axons, the mossy fibers (light-shaded gray area), can stimulate CA3 pyramidal neurons. In 
addition hilar mossy cells (rhomboid shaped) and inhibitory basket cells (solid triangles) are stimulated, thereby regulating granule cells by 
feedback mechanisms. The axons of the mossy cells are in the inner molecular layer. Axons of the CA3 neurons, the Schaffer collaterals, 
stimulate CA1 pyramidal neurons. Axons of CA1 neurons leave the hippocampus through the subiculum. D) In hippocampal sclerosis there 
is loss of hilar mossy cells, CA3 and CA1 neurons and other hippocampal cells. Mossy fibers sprout axon collaterals into the inner molecular 
layer (dark gray shade) and into regio superior (light shaded area). Figure modified from (Mathern and others, 1999) 
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Another frequently described phenomenon in both human and experimental TLE is aberrant sprouting of 
granule cell axon collaterals in regions they normally does not innervate (fig. 1). This process is called mossy 
fiber sprouting and is most probably the result of the loss of appropriate targets of the mossy fibers, e.g. hilar 
polymorphic neurons and CA3 neurons, during the epileptogenic process (Cavazos and Cross, 2006). The most 
prominent mossy fiber sprouting is seen in the inner molecular layer of the dentate gyrus (Sutula and others, 
1989; Babb and others, 1991; Isokawa and others, 1993). The aberrantly sprouted mossy fibers innervate 
preferentially glutamatergic granule cells, creating primarily a recurrent excitatory feedback circuitry. 
Therefore, mossy fiber sprouting is believed to be an excitatory phenomenon (Wuarin and Dudek, 1996; 
Buckmaster and others, 2002; Scharfman and others, 2003). Electrophysiological studies on human 
hippocampal slices and experimental studies in animal models for TLE confirmed this by showing that the 
extent of mossy fiber sprouting correlates with the excitability of the hippocampus (Cavazos and others, 1991; 
Franck and others, 1995). Next to the inner molecular layer mossy fiber sprouting was also reported in the CA3 
and CA1 regions of the hippocampus (Mathern and others, 1999; Cavazos and Cross, 2006).  
The degree of mossy fiber sprouting correlates with the degree of neuronal loss (Cavazos and Cross, 2006) and 
both pathological factors seem to contribute to the intensification of chronic seizures (Gorter and others, 2001; 
Zhang and others, 2002). Although HS and mossy fiber sprouting are very often associated with TLE, there are 
patient studies (Spencer and Spencer, 1994) and experimental studies (Longo and Mello, 1997; Longo and 
Mello, 1998; Zhang and others, 2002; Romcy-Pereira and Garcia-Cairasco, 2003; Brandt and others, 2004) 
showing that temporal lobe epileptogenesis can also occur without both processes taking place. So the role of 
both processes in the genesis of MTLE remains controversial.  
The dendritic tree of the granule cells of the dentate gyrus also exhibits morphological plasticity. In both human 
TLE patients (von Campe and others, 1997) and experimental animal models for TLE (Dashtipour and others, 
2003) the presence of persistent basal dendrites in the hilus are reported. In a normal situation basal dendrites 
are a transient morphological feature of newly born granule cells. In the epileptic hippocampus, hilar basal 
dendrites remain and receive synaptic input from sprouted mossy fibers (Ribak and others, 2000). Therefore, 
both hilar basal dendrites and apical dendrites of granule cells contribute to additional recurrent excitatory 
circuitry via sprouted mossy fibers in the epileptic brain.  
Dispersion of granule cells, or the widening of the granule cell layer, is another typical phenomenon in TLE and 
is correlated with the severity of hippocampal neuronal loss and the extent of mossy fiber sprouting. It remains 
an unresolved question whether
 
granule cell dispersion is a developmental defect or the result of epileptic 
seizure
 
activity. Granule cell dispersion is mainly observed in TLE patients who experienced
 
febrile convulsive 
seizures in early infancy, suggesting an
 
initial precipitating event as a trigger for the development
 
of granule cell 
dispersion (Houser, 1990; Lurton and others, 1998). The exact mechanism leading to the widening of the 
granule cell layer has not been elucidated and is still under debate. Possible contributing factors could be local 
deficits in reelin, a protein that controls neuronal migration (Heinrich and others, 2006) or migration of newly 
born neurons towards ectopic locations (Jessberger and others, 2005; Parent and others, 2006).  
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ANIMAL MODELS FOR EPILEPSY  
ACUTE AND CHRONIC EPILEPSY MODELS 
In order to better understand the mechanisms involved in seizure-initiation, epileptogenesis and spontaneous 
seizures, different experimental epilepsy models were developed. These models are valuable tools in the 
ongoing search for new treatments. In general, epilepsy models can be classified in two categories based on 
whether they display acutely provoked seizures or chronic epilepsy.  
In acute seizure models, seizures are evoked by specific stimuli (audiogenic, electrical, chemical). These models 
are preferably used as an initial screening test for anti-seizure capacities of new potential treatments. Two of 
the most frequently used acute models are the maximal electroshock (MES) model and the pentylenetetrazol 
(PTZ) model. The MES model is used to search for compounds with activity against generalized tonic-clonic 
seizures. Originally in the MES model, a current was delivered via scalp and mouth electrodes in cats (Merritt 
and Putnam, 1937). Nowadays bilateral transauricular or corneal electrodes are used in the MES model (Walker 
and others, 2002). The PTZ model involves systemic injection of the convulsant and is used to discover drugs 
with efficacy against non-convulsive absence or myoclonic seizures (Loscher, 2002).  
Chronic epilepsy models more closely resemble the epileptic state in which spontaneous and recurrent seizures 
occur (Mascott and others, 1994; Loscher, 2002). Many chronic epilepsy models were created specifically to 
reproduce specific types of human epilepsy, particularly the most common form: TLE (Wieser, 2004). There are 
chronic TLE models with a genetic predisposition to develop TLE (idiopathic), such as the Ihara epileptic rat 
displaying neuronal microdysgenesis and gliosis in the hippocampus (Arai and others, 2003). In genetically 
normal rodents spontaneous seizures, originating from the temporal lobe, can be provoked (symptomatic) by 
different types of insults such as brain infarction (Kelly and others, 2001; Kelly and others, 2006), traumatic 
brain damage (Kharatishvili and others, 2006), febrile seizures (Dube and others, 2006), kindling (Michael and 
others, 1998) or SE. In this study both the kindling and the SE model were used.  
THE KINDLING MODEL  
Since its discovery by Goddard, the kindling model has been extensively used as a chronic animal model for TLE 
(Goddard, 1967). The kindling phenomenon is based on the repetitive induction of a focal seizure discharge, 
which eventually produces a progressive, highly reliable and permanent increase in the epileptic response to 
the inducing agent. The inducing agent can be chemical (e.g. PTZ) or electrical stimulation, with the latter being 
most widely used. Electrical stimulation can be focussed to different brain structures such as the amygdala, the 
hippocampus or the pyriform cortex by using implanted electrodes (Morimoto and others, 2004). The initial 
seizure response is expressed as a brief focal epileptiform discharge, termed the afterdischarge (AD), evident at 
the stimulated site and recorded by an implanted electrode. As kindling continues, the AD alters dramatically 
with an increase in duration, amplitude, spike frequency and an alteration of spike morphology (Racine, 1972). 
 Chapter 1|Introduction on Temporal Lobe Epilepsy  17 
 
The intensification of the electrographic response to the stimulation is correlated with an increased severity of 
behavioural responses. A seizure severity scale called Racine’s scale has been developed to score the 
behavioural responses (Racine, 1972). Racine’s scale is widely used in kindling studies stimulating different 
limbic structures. Racine’s grading of convulsive seizures was based on amygdala stimulation: (stage I) 
immobility, eye closure, ear twitching, twitching of vibrissae, sniffing, facial clonus; (stage II) head nodding 
associated with more severe facial clonus; (stage III) clonus of one forelimb; (stage IV) bilateral clonus 
accompanied by rearing without falling; (stage V) generalized tonic-clonic seizures accompanied with rearing 
and falling. In hippocampal kindling behaviour in the early stages of kindling is different, and therefore a 
modified version of Racine’s scale is generally used: stage I and II seizures represent wet dog shakes, 
accompanied by head nodding (stage I) and chewing (stage II). Stage III, IV and V correspond to the same 
behaviour as seen in amygdala kindling. An animal is termed “fully kindled” when electrical stimulation 
reproducibly evokes generalized tonic-clonic seizures (stage 5 seizures). Once an animal is fully kindled it 
remains displaying stage 5 seizures in response to stimulation for months or years (Goddard and others, 1969). 
If kindling stimulation is continued in fully kindled animals they eventually develop spontaneous seizures 
(Michael and others, 1998).  
In the standard kindling protocol, animals receive a kindling stimulation once daily. This allows to fully kindle 
animals, e.g. rats, within 10 to 15 days dependent on the region which is stimulated. Next to this standard 
protocol there are also rapid kindling procedures which allow to kindle animals over a much shorter period. In 
our study, we used the alternate day rapid hippocampal kindling which allows to fully kindle rats with 48 
kindling stimulations, spread over four alternating days (Lothman and Williamson, 1994). There are however 
also rapid kindling protocols in which animals receive 40 kindling stimulations, all in one day (Bengzon and 
others, 1997; Smith and others, 2005).  
Even in rats that demonstrate spontaneous seizures after extensive kindling, gross morphological damage, as 
observed in patients with HS, are not or only moderately evident (Michael and others, 1998). This confirms that 
spontaneous seizures can develop without the presence of extensive HS. Based on the controlled induction of 
epileptogenesis, the kindling model is a very interesting tool to study the role of other events associated with 
epileptogenesis. However, this model is less appropriate to evaluate spontaneous seizures because it is very 
labour intensive as a huge number of stimulations have to be administrated before spontaneous seizures are 
evident.  
THE STATUS EPILEPTICUS MODEL 
The SE model is probably the best characterized chronic TLE model displaying spontaneous seizures. In this 
model, SE is the initial precipitating insult causing the process of epileptogenesis which eventually results in the 
occurrence of spontaneous seizures. Next to the occurrence of spontaneous seizures, SE models also display 
typical histopathological changes in different temporal lobe regions, which closely resemble the pathology seen 
in human TLE (Tauck and Nadler, 1985; Sutula and others, 1989; Mathern and others, 1993; Mello and others, 
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1993; Mathern and others, 1995a). Evoking a SE, which is severe enough to cause spontaneous seizures, can be 
done either by electrical or chemical (kainic acid, pilocarpine) stimulation of various brain regions.  
Electrical stimulation can be focussed on the perforant path (Gorter and others, 2001; Mazarati and others, 
2002), the ventral hippocampus (Lothman and others, 1989; Bertram and Cornett, 1994), or the amygdala 
(Nissinen and others, 2000; Brandt and others, 2003). At the beginning of the electrical stimulation the 
response of the stimulated structure is driven by electrical stimuli. Stimulus-independent epileptiform 
potentials appear within 15 min. By the end of the stimulation, animals show continuous stimulus-independent 
discharges called self sustaining status epilepticus (SSSE).  
Pilocarpine (PILO) is a muscarinic agonist which induces a SE after systemic injection (Leite and others, 1990; 
Cavalheiro and others, 1991; Lemos and Cavalheiro, 1995; Arida and others, 1999; Glien and others, 2001; 
Klitgaard and others, 2002). PILO can be administrated as one large dose (320-400 mg/kg) or as a smaller dose 
(30 mg/kg), when lithium (127 mg/kg) is given 24 hours before SE. Injection of several low-doses of PILO also 
efficiently produces SE with a lower mortality compared to higher dose injections of PILO (Glien and others, 
2001). Subcutaneous injection of methylscopolamine (1 mg/kg) is normally used to reduce the peripheral 
effects associated with the autonomic activation caused by PILO (Cavalheiro and others, 1991).  
Kainic acid (KA), a structural analogue of glutamic acid, is another frequently used chemoconvulsant and is 
isolated from the seaweed Digenea simplex. KA can be injected systemically as a single bolus or as repeated 
low doses for the induction of a SE. Systemic injection of a single bolus is often associated with a high mortality 
rate and a low percentage of rats displaying spontaneous seizures (Leite and others, 1990; Stafstrom and 
others, 1992). Intraperitoneal injection of repeated low-doses (5 mg/kg) of KA, results in a higher fraction of 
rats developing spontaneous seizures and less mortality (Hellier and others, 1998).  
Both in the systemic PILO and KA models high total doses of both neurotoxins are needed (respectively 20-50 
mg/kg and 20-40 mg/kg) with direct toxic effects on the whole brain. By injecting PILO or KA directly into 
specific brain regions, a SE can be evoked by using much lower doses and limiting direct toxic effects to small 
brain areas. In a study done by Furtado and coworkers, injection of PILO directly into the hilus of the 
hippocampus resulted in zero mortality with a high percentage of animals (71%) displaying spontaneous 
seizures (Furtado Mde and others, 2002). KA has also been directly injected in different brain areas such as in 
the amygdala (Ben-Ari and others, 1980; Tanaka and others, 1992; Mascott and others, 1994), the ventricle 
(Sater and Nadler, 1988), the entorhinal cortex (Miettinen and others, 1998) and in the hippocampus (French 
and others, 1982; Cavalheiro and others, 1983; Leite and others, 1996; Bragin and others, 1999; Bragin and 
others, 2004; Bragin and others, 2005). Various studies have demonstrated that intracerebral injection of KA 
and the following SE can provoke the same histopathological changes as seen in human TLE (Leite and others, 
1996; Miettinen and others, 1998; Bragin and others, 2004). Other studies have shown that 
electrophysiological features of epileptogenesis and spontaneous seizures in the intrahippocampal kainic acid 
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model”resemble those of patients with medically refractory TLE (Bragin and others, 1999; Bragin and others, 
2004). 
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This manuscript provides a general introduction on different cell therapy strategies that have been 
implemented and tested in a preclinical and sometimes in a clinical setup. First, different cell types, that have 
been used or could be used, are critically evaluated. This is followed by an overview of several cell therapy 
options for different disease mechanisms. Three common neurodegenerative disorders are discussed. Fist, we 
show that clinical benefits have been observed in Parkinson’s disease, which is probably the most attractive 
neurodegenerative disease to be treated with cell therapy because of its localized loss of a single cell type. But 
we also highlight some important side effects of cell therapy in Parkinson’s disease. Next, we focus on stroke 
which involves loss of tissue in focal or diffuse brain regions and we discuss some possible cell therapy options. 
Finally, we also confer shortly to different cell therapy options for epilepsy. However, we will further elaborate 
on this in the next chapter of this dissertation.  
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SUMMARY  
Neurodegenerative diseases are characterized by the irreversible loss of neurons involved in networks, 
important for specific physiological functions. At present, several renewable cell sources stand in line to replace 
fetal brain cells as potential cell source for transplantation in the damaged brain. Recent developments raise 
the hope that selective populations of different neuronal phenotypes could be made “on demand”. However, 
for every potential cell source there are still a lot of questions and drawbacks, which need to be resolved 
before a cell source could become the standard for clinical neuronal transplantation. The recent finding that 
the brain responds to damage by increased endogenous neurogenesis could prelude new “neurotrophic 
therapies”, based on stimulating this endogenous repair. From preclinical studies it is evident that different 
disease mechanisms require different cell therapy approaches, depending on the underlying factor of the 
disease, the identity of neuronal systems that are involved and the complexity of networks that are affected. In 
this review the potential of different cell sources, including the endogenous progenitor cells, are discussed. 
Also results of preclinical and clinical transplantation studies in three different disease models are critically 
evaluated.  
INTRODUCTION 
Current therapies for neurodegenerative diseases provide effective symptomatic relief, particularly in early 
stages of the disease. However, there are too few therapies, if any, that affect the underlying disease 
processes. Therefore disease-modifying therapies that halt, slow down or reverse disease progression are 
sorely needed. Some of the possible treatment options would be: modification of immunological responses, 
neurotrophic or anti-apoptotic treatment, gene therapy and cell therapy. Replacement of the lost cells seems 
to be a vital step for functional repair of the brain damage, since in most cases the spared systems cannot 
replace the function of the lost cells. In contrast to other mammalian tissues the adult mammalian nervous 
system has weak capabilities for both endogenous cell replacement and pattern repair. The reason for this 
defective self repair is that adult neuronal cells cannot regenerate after being damaged and that endogenous 
neural stem cells have only a very limited potential to generate new neuronal cells to replace degenerated 
neurons. Therefore there is great interest in restoring the damaged nervous system by stimulating endogenous 
repair or by transplanting new cells into the damaged brain. These cells can be selected on the base of their 
phenotype, the neurotransmitter they release or by the way they are genetically engineered. Before cell 
therapy can be a routinely done practice in the clinic, a lot of questions will have to be answered by preclinical 
research. At this moment different cell sources are tested for their potential to mediate functional repair of 
brain damage. The goal of this review is to critically evaluate the potential of different candidate cell sources 
for transplantation. The possibility of stimulating endogenous self repair will be discussed. Three selected 
neurodegenerative diseases will be presented and the progress and possibilities of cell therapy will be 
discussed.  
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CELL SOURCES 
FETAL BRAIN TISSUE 
Most studies in neurodegenerative diseases have used fetal brain tissue for implantation. Cells are isolated at a 
time point on which the cells, that have to be implanted, are already fully differentiated in the appropriate cell 
type. There is a critical time window for the isolation of the population of neurons for implantation. If the 
relevant neurons are too young, they are not yet differentiated. If they are too old, they have developed 
extensive connections so that dissection involves axotomy and trauma. This optimal time window, however, 
varies between different neuronal populations (Dunnett and Bjorklund, 1992). This implies that a lot of fetal 
brains are necessary to obtain sufficient tissue to be implanted and mostly only one neuronal phenotype can 
be isolated from one single fetus.  
STEM CELLS 
The ethical and practical problems around fetal tissue transplantation have led to the search for alternative cell 
sources. Stem cells seem to be ideal candidates for transplantation. Stem cells are broadly defined as 
progenitor cells which produce differentiated progeny and are capable to self-renew (Morrison and others, 
1997). Stem cells could become an almost unlimited source for the generation of specific neurons. The cell 
preparations could be standardized and quality-controlled with respect to viability and purity. Different types 
of stem cells could be used for neuronal transplantation. 
NEURAL STEM CELLS 
Neural stem cells (NSC) can be isolated from different regions of the embryonic central nervous system (CNS) 
or from restricted areas in the adult brain. Technical advances in recent years, including the use of 
bromodeoxyuridine (BrdU) and retroviral reporter mitotic labelling, have shown that the hippocampal dentate 
gyrus and the forebrain subventricular zone (SVZ), with a rostral migratory stream (RMS) of neuroblasts 
towards the olfactory bulbs, are germinative regions in which neurogenesis is ongoing throughout life 
(Cameron and others, 1993; Lois and Alvarez-Buylla, 1994; Lois and others, 1996; van Praag and others, 2002). 
It is presumed that this ongoing neurogenesis is an integral part of ongoing plasticity in the adult mammalian 
brain. NSC have been isolated from rodent central nervous system (Palmer and others, 1995; Reynolds and 
Weiss, 1996; Weiss and others, 1996; Palmer and others, 1997; Shihabuddin and others, 1997; Gritti and 
others, 1999; Palmer and others, 1999; Temple and Alvarez-Buylla, 1999; Weiss, 1999; Seaberg and van der 
Kooy, 2002; Galli and others, 2003; Gobbel and others, 2003; Kim and others, 2003) and human brain (Flax and 
others, 1998; Fricker and others, 1999; Svendsen and others, 1999; Vescovi and others, 1999; Svendsen and 
Caldwell, 2000; Akiyama and others, 2001; Nunes and others, 2003). NSC are defined by three main 
characteristics: they can self-renew, give rise to all of the major neural cells types, i.e. neurons, 
oligodendrocytes and astrocytes (Song and others, 2002) and when transplanted into the brain they are able to 
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survive, migrate and integrate in a functionally active way (Gage and others, 1995; Flax and others, 1998; 
Auerbach and others, 2000; Englund and others, 2002). When NSC are transplanted into the damaged brain, 
they migrate preferentially towards the damaged areas, where they also seem to integrate and replace the lost 
cells (Flax and others, 1998; Barker and Dunnett, 1999; Yandava and others, 1999; Bjorklund and others, 2002; 
Dziewczapolski and others, 2003; Pluchino and others, 2003). However, precursors isolated from adult 
telencephalon and propagated as neurospheres generate disappointingly few neurons, both in transplantation 
paradigms as well as in differentiating conditions in vitro (Fricker and others, 1999; Song and others, 2002). 
Also the kind of differentiated cell types that they can generate is limited depending upon the developmental 
stage and region from which they are isolated and the in vitro conditions in which they are grown thereafter 
(Parmar and others, 2002; Hack and others, 2004; Horiguchi and others, 2004).  
EMBRYONIC STEM CELLS 
Embryonic stem cells are also an attractive cell source for transplantation into the damaged brain. These cells 
are truly pluripotent and have an unlimited capacity for in vitro expansion. The cells can easily be genetically 
manipulated. Several differentiation protocols have already been developed for differentiation of embryonic 
stem cells towards neurons and neuronal-restricted precursors (Strubing and others, 1995; Okabe and others, 
1996; Li and others, 1998; Mujtaba and others, 1999; Carpenter and others, 2001; Gokhan and Mehler, 2001; 
O'Shea, 2001; Temple, 2001; Westmoreland and others, 2001; Kim and others, 2002; Wichterle and others, 
2002). ES cell-derived neural precursors incorporate into the CNS and differentiate into neurons and glia 
(Brustle and others, 1997; McDonald and others, 1999; Zhang and others, 2001). Electrophysiological studies 
have demonstrated that transplanted embryonic stem cell-derived neurons (ESNs) display electrophysiological 
properties similar to endogenous cells (Kim and others, 2002). Embryonic stem cell-derived glial precursors 
(ESGPs), have been used successfully for myelin repair (Brustle and others, 1999; Liu and others, 2000) and dye 
coupling studies showed that the ESGP-derived astrocytes formed gap junctions with each other but also with 
host astrocytes after transplantation in hippocampal slices (Scheffler and others, 2003).  
Although embryonic stem cells seem to have an unrestricted potential to differentiate towards 
neuroectodermal phenotypes, embryonic stem cells cannot be readily transplanted into the brain. Because of 
the enormous random in vitro differentiation potential of embryonic stem cells, any remaining non-neural 
(Tabar and Studer, 2002) pluripotent embryonic stem cell could give rise to teratomas upon transplantation, 
resulting in significant concerns as to the clinical safety of this approach. When ES cells are transplanted into 
the striatum of an animal model for PD, they differentiate into a significant number of dopamine neurons but 
the incidence of ES-mediated tumor formation in this study was high (20%) (Bjorklund and others, 2002). 
ADULT NON-NEURONAL SOMATIC STEM CELLS  
Several recent reports suggest that adult somatic stem cells isolated from non-neuronal tissues may 
“transdifferentiate” across tissue lineage boundaries, thus offering an accessible source for therapeutic 
applications and even for neural tissue repair. Human and animal bone marrow (BM) transplantation studies 
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have shown that donor-derived neurons and glial cells can be found in the brain of the host (Eglitis and Mezey, 
1997; Brazelton and others, 2000; Mezey and others, 2000; Mezey and others, 2003). However, the number of 
these “transdifferentiated” cells is extremely low and recent works have demonstrated that donor BM cells 
contribute to adult Purkinje neurons through cell fusion (Alvarez-Dolado and others, 2003; Weimann and 
others, 2003). This is in contrast to another study which demonstrated that human hematopoietic cells could 
contribute to long term adult human neuropoiesis without fusing (Cogle and others, 2004). It seems that fusion 
as well as transdifferentiation can explain the presence of donor-derived cells in the brain of the recipient. Also 
purified mesenchymal stem cells, isolated from the bone marrow, seem to be capable of differentiating in vitro 
(Sanchez-Ramos and others, 2000; Woodbury and others, 2000; Black and Woodbury, 2001; Deng and others, 
2001; Kohyama and others, 2001; Sanchez-Ramos, 2002; Woodbury and others, 2002; Rismanchi and others, 
2003; Dezawa and others, 2004) and in vivo (Kopen and others, 1999; Chopp and Li, 2002) towards cells 
expressing neuronal and glial markers. Expression of neuronal and glial markers, on the contrary, cannot be 
seen as an absolute proof of neuronal differentiation since it has been demonstrated that undifferentiated 
mesenchymal stem cells also express markers for neural lineage (Woodbury and others, 2002). Moreover only 
one study has been able to demonstrate that MSC can differentiate towards neurons displaying appropriate 
electrophysiological characteristics (Kohyama and others, 2001). In addition to hematopoietic and MSC stem 
cells, rare pluripotent stem cell subsets have been isolated from BM. Rare cell types, called multipotent adult 
progenitor cells (MAPC), has been co-isolated with mesenchymal stem cells and is able to differentiate towards 
cells from the endodermal, mesodermal and ectodermal phenotypes (Jiang and others, 2002). The MAPC is 
capable of differentiating toward cells with morphological and electrophysiological properties of midbrain 
neurons (Jiang and others, 2003). Recently a new pluripotent, CD45 negative population from human cord 
blood, termed unrestricted somatic stem cells (USSCs), has been described (Kogler and others, 2004). It has 
been demonstrated that these cells can be differentiated towards neuronal cell types. Implantation of these 
cells in rat brain revealed that human tau-positive neurons persisted in the rat brain for up to 3 months. In this 
study, though, no electrophysiological experiments were done to confirm that the cells were indeed 
functionally active neurons. Other cells that display a presumed neurogenic potential are adipose-derived stem 
cells (Safford and others, 2002) and stem cells derived from the dermis of mammalian skin (Toma and others, 
2001). 
BIO-ENGINEERED CELLS 
Cells can be genetically engineered to overcome problems such as senescence or to induce cells to release 
neurotrophic or neuromodulating factors. For example, neuroepithelial precursor cells, derived from defined 
regions and prior to their terminal mitosis, have been infected with a retrovirus carrying a temperature 
sensitive immortalizing oncogene. When transplanted into the intact brain, most of these cell lines will 
differentiate towards neurons, astrocytes and oligodendrocytes. They even seem to respond to local 
microenvironmental cues, since the cells differentiate with morphologies indistinguishable from those of local 
endogenous neurons (Martinez-Serrano and Bjorklund, 1997; Whittemore and Onifer, 2000). These 
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immortalized cell lines have been utilized in a variety of ex vivo gene therapy experiments, in which they have 
been genetically modified in order to release different disease modifying molecules. As an example NGF-
secreting cells from the HiB5 cell line have been implanted into the adult rat striatum. One week after 
transplantation a stroke was induced by middle cerebral artery occlusion. The graft prevented striatal 
degeneration of both projection neurons and cholinergic interneurons (Andsberg and others, 1998). Different 
other growth factor-, neurotransmitter- or metabolite-releasing immortalized cell lines have been created by 
genetic engineering. For example, cell lines releasing brain-derived neurotrophic factor (BDNF) (Rubio and 
others, 1999); neurotrophin 3 (Liu and others, 1999); neurotransmitters, such as GABA (Eaton and others, 
1999); or metabolites, such as -glucuronidase (Snyder and others, 1995) have been developed. Next to these 
immortalized cell lines other cell sources have been engineered to release disease-modifying substances. 
Commonly used cell types are fibroblasts (Blesch and others, 2001; Liu and others, 2002; Tobias and others, 
2003; Pizzo and others, 2004) and stem cells (Arnhold and others, 2003; Behrstock and Svendsen, 2004; Zhao 
and others, 2004). 
STIMULATING ENDOGENOUS REPAIR 
The finding that there is ongoing neurogenesis in the dentate gyrus of the hippocampus and the forebrain SVZ, 
has led to the idea that stimulation of neurogenesis could enhance endogenous brain repair. There is some 
suggestion that neurogenesis also exists in other brain regions such as the neocortex (Magavi and others, 2000; 
Gould and others, 2001), the amygdala (Bernier and others, 2002) and the substantia nigra (Zhao and others, 
2003). But these findings are controversial (Kornack and Rakic, 2001; Koketsu and others, 2003). If 
neurogenesis exists in these regions it is probably at much lower degree or may only be induced after insults 
(Mohapel and Brundin, 2004). Evidence from in vivo studies suggests that specific growth and neurotrophic 
factors influence neural precursor proliferation in the adult rodent dentate gyrus and SVZ, and in some cases in 
other brain regions such as striatum, thalamus, hypothalamus, septum and parenchymal regions lining the 
ventricles. These factors include basic fibroblast growth factor (bFGF), insulin growth factor-1 (IGF-1), 
epidermal growth factor (EGF), vascular endothelial growth factor (VEGF) and glial-derived neurotrophic factor 
(GDNF) (Kuhn and others, 1997; Wagner and others, 1999b; Aberg and others, 2000; Benraiss and others, 2001; 
Emsley and Hagg, 2003; Schanzer and others, 2004). Several lines of evidence suggest that astrocytes play 
important roles in the migration, differentiation, integration and survival of neuroblasts derived from the SVZ 
and the dentate gyrus (Doetsch and others, 1999; Lim and Alvarez-Buylla, 1999; Song and others, 2002; Galli 
and others, 2003). Because astrocytes are activated by most brain insults, they are most likely also involved in 
injury-induced neurogenesis.  
A lot of work has been done on damaged induced neurogenesis in several models of stroke. Two recent reports 
indicate that forebrain SVZ neurogenesis increases ipsilateral to the infarct after adult rat transient middle 
cerebral artery occlusion (Arvidsson and others, 2002; Parent and others, 2002). The neuroblasts generated 
after stroke form chains closely apposed to astrocytes that extend from the SVZ to the injured striatum 
although it seems that only a small portion of the newly formed striatal neurons survive. When selective 
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damage is induced to the hippocampal CA1 region, by inducing transient four vessel ischemia in rats, and 
subsequently bFGF and EGF are infused for three days in the first week after stroke, 40 % of the CA1 pyramidal 
neurons are regenerated. The source for the newly generated neurons is demonstrated to be the SVZ in the 
posterior periventricular region (Nakatomi and others, 2002). Transient global ischemia in young adult 
macaque monkeys also induces a significant postischemic increase of the number of newly formed cells in the 
hippocampal dentate gyrus, the subventricular zone of the temporal horn of the lateral ventricle and the 
temporal neocortex (Tonchev and others, 2003).  
CELL THERAPY FOR DIFFERENT NEURONAL DISEASE MECHANISMS 
It seems that the potential of cell therapy to restore neuronal damage mostly depends on the complexity of the 
disease. This ranges from focal cell death of only one neuronal or glial phenotype to more extensive cell death 
of different neuronal phenotypes throughout the brain. In the next chapter three different disease models with 
an increasing complexity are presented and the possibilities for developing a cell therapy are evaluated.  
REPLACING SINGLE NEURONAL PHENOTYPES: PARKINSON’S DISEASE (PD) 
CNS diseases affecting specific neuronal cell populations are Parkinson’s disease (PD, loss of striatal 
dopaminergic neurons), Huntington’s disease (HD; loss of GABAergic striatal spiny projection neurons) and 
amyotrophic lateral sclerosis (ALS, loss of cholinergic motor neurons). These neurodegenerative diseases are 
the most attractive ones to be treated with cell therapy and therefore a considerable amount of research has 
been done to investigate the possibilities of repair by cell transplantation. The reader is referred to excellent 
reviews of these studies (Bjorklund and Lindvall, 2000; Isacson, 2003; Lindvall and others, 2004). In this review 
only progress in cell therapy for PD will be discussed. In PD there is specific loss of the majority of midbrain 
dopaminergic neurons projecting towards the striatum. Clinical trials for transplantation of human embryonic 
mesencephalic tissue into the striatum of patients with severe Parkinson’s disease have shown that neuronal 
replacement can work in the human brain. The grafted neurons survive and reïnnervate the striatum for as 
long as 10 years despite an ongoing disease process (Kordower and others, 1995; Piccini and others, 1999). 
These open trials have shown that after transplantation dopamine release is elevated and clinical benefit 
becomes evident (Piccini and others, 2000). A systematic review of 11 studies reporting 95 graft studies was 
made by (Polgar and others, 2003). Two double blind sham surgery-controlled trials, however, showed no 
statistically significant improvement in behavioural score. It seems that the outcome of transplantation is 
dependent on the age of the donor, the severity of the disease (Olanow and others, 2003) and the variation in 
composition of the graft (Freed and others, 2001). Several studies reported the occurrence of dyskinesias as an 
important side effect of transplantation, which became troublesome in 7-15% of the grafted patients (Freed 
and others, 2001; Hagell and others, 2002; Olanow and others, 2003). These rather disappointing results and 
the occurrence of dyskinesias, next to the limited tissue availability and the wide variation in functional 
outcome, impelled the search for alternative sources from which large numbers of dopaminergic neurons can 
be generated. Several recent publications provide a good review of the different studies in which dopaminergic 
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differentiation of several types of stem cells was investigated (Bjorklund and Lindvall, 2000; Brundin and Hagell, 
2001; Lindvall and Hagell, 2002; Lindvall, 2003; Lindvall and McKay, 2003). Functionally active dopaminergic 
neurons can be generated from mouse (Kim and others, 2002; Morizane and others, 2002) and monkey 
embryonic stem cells (Kawasaki and others, 2002) and from neural stem cells (NSC) derived from the fetal 
rodent (Wagner and others, 1999a; Carvey and others, 2001; Yan and others, 2001) and human brain (Storch 
and others, 2001), using different neuronal differentiation protocols. However, up to now there is only one 
report describing differentiation of adult neural stem cells towards dopaminergic neurons (Daadi and Weiss, 
1999). Also there is little evidence that functional dopaminergic neurons can be obtained from non-neural stem 
cells. One study described differentiation of mesenchymal stem cells towards functionally active dopaminergic 
neurons but when these cells where transplanted into the diseased brain they did not differentiate towards 
neurons (Zhao and others, 2002; Jiang and others, 2003). Dopaminergic neurons derived from stem cells have 
been transplanted into Parkinson’s models and in some cases clear behavioural recovery could be 
demonstrated (Lindvall, 2003).  
CELL THERAPY FOR DISEASES AFFECTING MULTIPLE BRAIN REGIONS AND NEURONAL 
PHENOTYPES  
Probably the most difficult to treat are diseases where transplanted cells should be able to generate multiple 
phenotypes and reform long distance connections such as in the case of cerebral ischemic insults (Rossi and 
Cattaneo, 2002) and epilepsy (Grisolia, 2001).  
CEREBRAL ISCHEMIC INSULTS 
There are two main types of ischemic insults that affect the brain in a specific way. First, cardiac arrest or 
coronary artery occlusion causes an abrupt and near-total interruption of total cerebral blood flow. This global 
ischemia causes selective neuronal death of certain vulnerable neuronal populations such as the pyramidal 
neurons of CA1 hippocampal subregion. In the case of global ischemia, fetal hippocampal CA1 tissue and 
conditionally immortalized neuroepithelial MHP36 cells have been transplanted into the damaged CA1 region. 
In the case of transplantation of fetal CA1 tissue behavioural recovery is dependent on the establishment of 
some afferent and efferent connections. In the case of MHP36 cells there was also a behavioural improvement 
but only a small portion of the grafted cells displayed neuronal or glial markers. So it remains unclear whether 
behavioural recovery was caused by restoration of functional connectivity or by secretion of trophic substances 
(Sinden and others, 1995; Sinden and others, 1997; Virley and others, 1999). 
The second type of ischemic insult, stroke, is caused by occlusion of a cerebral artery and leads to irreversible 
damage in a core region, which is surrounded by a zone of partially reversible injury, the penumbra zone. The 
majority of cases with stroke in humans are caused by occlusion of the middle cerebral artery, which leads to 
infarction in the cerebral cortex, basal ganglia and internal capsule. In the only reported clinical trial, neurons 
generated from the human teratocarcinoma cell line NT-2 have been implanted in the infarcted area of 
patients, who had experienced a stroke in the basal ganglia. Behavioural improvements were seen in some 
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patients (Kondziolka and others, 2000) and autopsy in one patient revealed the presence of grafted cell 
expressing neuronal markers 2 years after grafting (Nelson and others, 2002). Next to this human trial, cells 
from different origins (fetal cortical and striatal tissue, neural precursor cells, cell lines with neurogenic 
potential, bone marrow stromal cells) have been transplanted in several stroke models and this in different 
affected brain regions (cortex, striatum), in the ventricles or intravenously (Savitz and others, 2002; Lindvall 
and others, 2004). In most cases the transplanted cells survived and a partial behavioural recovery could be 
seen. However, in few studies there is evidence for a functional integration of these cells into the damaged 
networks. It is possible that transplantation may enrich the local neural environment through region-specific 
synaptic connections and trophic factors. Alternatively, grafts may upregulate endogenous recovery 
mechanisms and induce surviving cells to establish new circuits.  
EPILEPSY 
Epilepsy has many etiologies, all leading to an imbalance between excitation and inhibition. Unlike in the two 
other disease mechanisms presented sofar, there is no identifiable defect to be restored by cell therapy. 
Nevertheless, in temporal lobe epilepsy (TLE) there is a common lesion: hippocampal sclerosis (Liu and others, 
1995; Blumcke and others, 1999). Hippocampal sclerosis is characterized by a selective loss of hippocampal 
neurons, axonal sprouting and dense gliosis. However, it is still unproven whether seizures are a cause or an 
effect of hippocampal sclerosis. Grafting of fetal hippocampal tissue for repair of hippocampal networks in the 
intracerebral kainic acid model for TLE led to the partial reversal of some of the characteristic 
anatomopathological changes of hippocampal sclerosis, such as mossy fiber sprouting and loss of GABAergic 
interneurons. (Shetty and Turner, 1996; Shetty and Turner, 1997a; Shetty and Turner, 1997b; Shetty and 
others, 2000; Shetty and Turner, 2000; Zaman and others, 2000; Zaman and Shetty, 2001; Zaman and Shetty, 
2003). A major caveat in these studies is that the authors have not investigated the influence of transplantation 
on the occurrence of epileptic seizures (personal communication, Ashok Shetty, 2002). Another transplantation 
strategy consists of grafting neurotransmitter-releasing cells to modulate network excitability. When GABA-rich 
fetal striatal tissue is transplanted into the substantia nigra (SNr) of fully amygdala kindled rats this leads to a 
significant increase in the threshold to electrically evoke focal discharges (after discharge threshold [ADT]) and 
a significant reduction of seizure severity (Loscher and others, 1998). However, this seizure-suppressing effect 
was only transient and disappeared over the weeks after transplantation. Noradrenaline-rich locus coeruleus 
(LC) tissue has been transplanted in the damaged hippocampus of status epilepticus models (Bortolotto and 
others, 1990). Grafting led to a reduction of the number of spontaneous seizures. But if the transplanted rats 
were subjected to kindling stimulations approximately eight months after transplantation, no difference in ADT 
and kindling rate could be demonstrated (Holmes and others, 1991). Next to neurotransmitter rich fetal brain 
tissue, cells have been engineered to release agents for the inhibition of in vivo seizure activity. Thompson et 
al. engineered conditionally immortalized mouse neurons to deliver GABA by driving GAD65 expression under 
the control of a tetracycline regulatable promoter (Thompson and others, 2000). This cell line has been 
transplanted into the SNr (Thompson and others, 2000) or the pyriform cortex (Gernert and others, 2002) of 
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rats prior to kindling. In both cases the transplantation had only weak effects on ADT and kindling rate. These 
GABA-releasing cells have also been transplanted in the lithium pilocarpine status epilepticus model for TLE, 
which displays spontaneous seizures. The animals were transplanted into the anterior SNr 45-65 days after SE 
(Thompson and Suchomelova, 2004). Seven to 10 days after transplantation a robust suppression of seizures 
and the reduction in epileptiform spikes emerged in the group that was transplanted with GABA releasing cells. 
The evaluation of the seizure suppressant effect of GABA releasing transplants was ended 13 days after 
transplantation, while it would have been interesting to investigate whether this anticonvulsant effect was long 
lasting.  
Adenosine and its analogues also have powerful antiseizure and neuroprotective activities (Lee and others, 
1984; Fredholm, 1997). Therefore baby hamster kidney cells have been engineered to release adenosine in the 
environment by inactivating the adenosine metabolizing enzyme adenosine kinase (ADK). These adenosine-
releasing cells have been encapsulated and transplanted into the ventricles of the rat kindling model (Huber 
and others, 2001). After transplantation of the cells, behavioural seizure activity was almost completely 
suppressed during four days after transplantation. This strong protection lasted for three weeks after 
transplantation after which there was a significant loss of the transplanted cells and the seizure suppressant 
effect. Embryonic stem cell-derived glial cells have been engineered for adenosine delivery (Fedele and others, 
2004). These cells still have to be transplanted into an epilepsy model but it is expected that the survival of 
these glial cells will be greater compared to the kidney and fibroblast cells, which will probably lead to a more 
long term seizure suppressant effect.  
CONCLUSION 
From the evaluation of different cell sources for transplantation it is evident that grafting of fetal cells will not 
become the standard to treat neurodegenerative diseases because of ethical and practical problems and the 
high diversity in functional outcome after transplantation. Embryonic and neural stem cells are good 
alternatives for fetal tissue, given that we learn more about the mechanisms involved in control of cell 
proliferation and differentiation, neuronal integration and survival. Genetic engineering provides a tool to 
modify the cells in favour of their survival, integration and their capacity to modify underlying disease 
mechanisms. Other strategies for reconstruction of damaged networks could be based on the stimulation of 
endogenous neurogenesis and repair, by means of modulating neurotrophic mechanisms controlling both. 
Another option could be to combine cell therapy with neurotrophic treatment in order to maximize the 
recruitment of newborn but also transplanted cells. The cell therapy strategy for a given disease highly depends 
on the complexity of the disorder. In a disease such as PD, where there is selective loss of dopaminergic 
neurons, the ultimate goal is to replace the lost cells, repair connectivity and normalize neurotransmitter 
release. That is why lots of efforts are made to selectively generate dopaminergic cells from different cells 
sources. In more complex disorders, such as stroke and epilepsy, reconstructive therapy seems to be much 
further away and therefore other strategies seem to be appropriate in first instance. In stroke, partial recovery 
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after transplantation sometimes occurs without functional integration of transplanted cells. Therefore 
neurotrophic responses of both donor and host cells, evoked by the transplantation itself, may play an 
important role. Transplantation of cells, engineered to secrete neurotrophic factors, could be a first option in 
the treatment of stroke. In epilepsy most successes can be expected by transplanting cells, which secrete 
seizure suppressant agents or neurotransmitters, in brain structures that are presumed to play key roles in the 
generation or spread of epileptic seizures.  
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WHY AN ADDENDUM 
This addendum is added to the introductory review in order to update the reader with more recent and 
complete information concerning the isolation, neuronal differentiation and therapeutic potential of different 
stem cell types (embryonic stem cells, neural stem cells and bone marrow stem cells). First in this addendum a 
list of criteria is presented which can be used to evaluate the potential of stem cells to differentiate towards 
neuronal cells. Specific caveats and pitfalls are considered which can lead to false positive results. Next, the 
latest progress (and criticisms) concerning the differentiation of three stem cell types [embryonic stem cells 
(ESC), neural stem cells (NSC) and bone marrow (BM)-derived stem cells] is given. Finally, some of the most 
recent information concerning cell replacement in PD and cerebral ischemic insults are presented. This 
addendum does not contain additional information concerning cell therapy application for epilepsy as we 
discuss this more thoroughly in the review, presented in the following chapter, and in the remaining of this 
dissertation.  
CRITERIA FOR NEURONAL DIFFERENTIATION 
From the review, presented in the previous chapter, it should be evident that different stem/progenitor cell 
populations are believed to have the potential to produce different neuronal cell types and to become an 
extremely important cell source for transplantation in different neurological diseases. Indeed, in the past few 
years, a huge number of studies have shown that stem or progenitor cells (even of non-neural origin) can be 
induced to express mature neuronal markers in culture or upon transplantation in the CNS.  
When evaluating these studies, one needs to be aware that expression of neuronal markers alone is not 
sufficient as proof for neuronal differentiation. Mature neuronal genes, for example, are expressed in 
undifferentiated bone marrow-derived stem cells. This expression is random and non-specific rather than a 
proof for a neuronal phenotype (Tondreau and others, 2004; Lu and others, 2004). In figure 1, a number of 
criteria are given which allow demonstrating that cells have the capacity to adopt a neuronal phenotype. The 
criteria are ordered according to their increasing evidence value.  
Expression of neuronal markers can be used to indicate the potential for neuronal differentiation but it is 
important to verify that this expression occurs in regulated and physiologically relevant manner. First of all, 
expression of neuronal markers should be detectable both at the gene (mRNA) and protein level. It is thereby 
also important to verify that the markers are expressed in the proper chronology. Expression of early neural 
markers (e.g. nestin,sox2) should precede the expression of late neural markers (tau, NF-200). For some 
neuronal proteins it is also important to verify that they are expressed at appropriate locations within the cell. 
For example channel-related proteins should be mainly expressed at height of the membrane.  
Even when all these criteria on marker expression are fulfilled, it can still not be proven that a cell has the 
ability to function as a neuron. In order to do so, electrophysiological techniques (e.g. patch clamp studies) are 
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needed which allow identifying the presence of inward and outward currents, the ability to generate action 
potentials and the formation of active synapses.  
The ultimate, but most difficult to demonstrate, criterion for the ability of a cell type to generate functional 
neurons is showing that the cells are capable of expressing appropriate neuronal markers, display functional 
properties and integrate into existing neuronal networks in vivo. 
  
Fig 1.: Criteria which need to be fulfilled to conclude that stem cells are capable of of neuronal differentiation 
When the in vivo generation of neuronal cells is evaluated two important pitfalls need to be considered. The 
first pitfall concerns the manner of cell labelling. If membrane intercalating dyes or labelled oligonucleotides 
[5′-bromo-2′-deoxyuridine (BrdU) or tritiated thymidine] are used special care is warranted since those labels 
can be recycled from dying donor cells to endogenous neuronal cells (Yoon and others, 2005; Burns and others, 
2006). In those cases it is necessary to include an additional control group in which labelled dying cells are 
transplanted. The problem of label transfer can be overcome by genetically engineering the cells to induce the 
expression of fluorescent proteins or β-galactosidase under a ubiquitous or neural-specific promoter.  
Another pitfall that should be taken into account is the possibility of cell fusion. In two reports, transplanted 
bone marrow-derived cells were reported to spontaneously fuse with endogenous Purkinje neurons (Alvarez-
Dolado and others, 2003; Weimann and others, 2003). The product of cell fusion is a cell which has the 
morphology and properties of a Purkinje neuron and expresses the reported gene (GFP/β-galactosidase). The 
occurrence of cell fusion can be identified by performing a sex-mismatched transplantation and using in situ 
hybridization for the sex chromosomes or by using the Cre-lox recombinase system (Wang and others, 2003; 
Harris and others, 2004). In the latter approach cells, in which ubiquitous expression of reporter gene is 
inhibited by a floxed inhibitory sequence, are transplanted into mice which ubiquitously express the Cre 
enzyme. If cell fusion occurs the Cre enzyme excises the floxed inhibitory sequence resulting in the expression 
of the reporter gene (Harris and others, 2004).  
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NEURAL DIFFERENTIATION OF EMBRYONIC STEM CELLS 
Differentiation of embryonic stem cells (ESC) to neuroepithelial cells is the prerequisite step and gatekeeper 
toward the generation of different neuronal and glial subclasses. There are three main strategies to convert 
ESC to neuroepithelial cells in vitro: systems based on embryoid-body (EB) formation, neural induction on a 
stromal feeder layer and protocols based on default differentiation into neural fates.  
The first strategy to induce differentiation of ESC toward neuroepithelial cells consists of allowing ESC to 
aggregate as EBs in suspension culture. EBs contain by default derivatives of all three germ layers but 
modifications to the protocol have been developed to stimulate neural induction and to select and expand EB-
derived neural precursors. These neural progenitors can be further differentiated towards various functional 
neuronal or glial phenotypes by using patterning, survival or lineage-promoting factors (Bain and others, 1995; 
Okabe and others, 1996; Brustle and others, 1999; Lee and others, 2000).  
One of the standard protocols to stimulate neural differentiation of mouse ESC is based on the exposure of EBs 
to retinoic acid (RA) (Strubing and others, 1995; Bain and others, 1995). In an alternative EB-based protocol, 
undifferentiated EBs are exposed to serum-free medium containing insulin, transferrin and selenite (ITS 
medium). In these minimal growth conditions survival of ESC-derived, nestin expressing neural precursors is 
selectively favoured while other ESC-derived cells die. The mouse ESC-derived neuronal cells expressed inward 
and outward currents and action potentials (both evoked and spontaneous) approximately 1 week of 
differentiation (Strubing and others, 1995). When plated onto organotypic hippocampal slices mouse ESC-
derived neuronal precursors demonstrate ionic currents within the first 5 d of culture. ESC-derived neurons 
also develop action potentials and received synaptic input from host axons (Benninger and others, 2003). Upon 
transplantation in the developing rat brain the ESC-derived neural precursors migrate into different brain 
regions, adopt complex morphology, acquire an excitatory or inhibitory neuronal phenotype and form 
functional synapses with endogenous neurons (Wernig and others, 2004).  
To stimulate human EBs to differentiate towards neuroepithelial cells they can be exposed to FGF-2 and 
subsequently replated to allow the formation of neural tube like structures termed neural rosettes. These 
human neuroepithelial precursors can be enzymatically separated from the surrounding cell types and replated 
for further neuronal differentiation. Compared to mouse ESC, human ESC-derived neuronal precursors develop 
functional properties much more slowly, probably reflecting temporal differences in gestation duration 
between human and animals. Differentiated human neurons begin firing action potentials only at 7 weeks and 
repetitive trains of APs are not observed until 10 weeks in vitro (Johnson and others, 2007).  
The second strategy to promote neuroepithelial differentiation of ESC towards neural cells consist of culturing 
ESC on a stromal feeder layer. Several stromal cell lines (e.g. PA-6, MS5, S17) exhibit neural inducing properties 
in co-cultures with ES cells. The molecular nature of this stromal-derived inducing activity remains unknown. 
Human ESC-derived neural precursors, co-cultured with PA6 cells and transplanted in the developing mouse 
brain, generate neurons throughout the brain which form functional synapses with surrounding endogenous 
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neurons (Muotri and others, 2005). At present coculture with PA6 and MS5 cells is the most successful 
approach to differentiate mouse and human ESCs to dopaminergic neurons (Zhang, 2006). 
The third strategy to induce neuronal differentiation is based on the “default hypothesis” which states that in 
the absence of (BMP) signalling in primitive ectodermal cells will lead to neuronal differentiation. These 
protocols consist of plating the ESC at low density in minimal conditions without feeders, serum or addition of 
exogenous growth factors (Tropepe and others, 2001; Ying and others, 2003). When the neural precursors, 
derived according to this strategy, are exposed to FGF-2 and EGF pure cultures of self-renewing ESC-derived 
NSC can be obtained. These ESC-derived NSC can be expanded for over 100 passages while retaining the 
capacity of generating a large proportion of β3-tubulin expressing neuronal cell types. The expanded cells 
display a bipolar morphology and express Sox2, Pax6, nestin and RC2 suggestive of a radial glia-like phenotype. 
During development radial glia function as neural stem cells. In vitro these expanded ESC-derived NSC can be 
differentiated towards functional neuronal cells capable of firing action potentials. Upon transplantation into 
the developing embryonic brain and the adult mouse hippocampus the cells express both neural and glial 
markers (Conti and others, 2005).  
The first step towards the use of ESC for transplantation in neurological diseases is the production of highly 
enriched or even purified populations of specific subclasses of neural precursors. It is thereby extremely 
important that no undifferentiated ESC remain in the population of cells which will be transplanted. Because of 
the enormous random in vitro differentiation potential of embryonic stem cells, any remaining non-neural 
pluripotent embryonic stem cell could give rise to teratomas upon transplantation (Bjorklund and others, 2002; 
Tabar and Studer, 2002 ). So far, protocols to avoid this teratotoma formation are still lacking (Vogel, 2005). 
Strategies have been developed which use genetic lineage selection to specifically enrich for neural progenitor 
cells (Li and others, 1998). Also culture protocols (see higher) have been developed which allow the derivation 
of pure cultures of radial-glia like NSC without the necessity of genetic lineage selection (Conti and others, 
2005).  
In the standard EB-based neuronal differentiation protocol ESC mainly acquire GABAergic and glutamatergic 
phenotypes (Studer, 2006). However, in the light of possible therapeutic applications in neurodegenerative 
diseases great efforts are made to stimulate differentiation of ESC towards specific neuronal phenotypes. For 
example, there is much scientific interest in selecting/enriching for midbrain dopamine neurons for Parkinson’s 
disease patients and spinal motor neurons for amyotrophic lateral sclerosis (ALS) patients. One strategy to 
generate specific neuronal phenotypes is by developing protocols which induce directed differentiation 
towards the specific neuronal sublasses. These protocols are based on mimicking CNS patterning events during 
early embryo development. For example, exposure of EBs to RA (caudalizing factor) combined with SHH 
(ventralizing morphogen) has led to the successful generation of spinal cord motor neurons with high 
efficiency. These motor neurons develop appropriate transmitter
 
receptors, intrinsic properties which allow the 
repetitive firing of action potentials and even form functional synapses with muscle
 
fibers in culture (Wichterle 
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and others, 2002; Miles and others, 2004; Li and others, 2005). For the generation of dopaminergic neurons 
targeted differentiation relies on the use of FGF-8 and SHH (see further).  
An alternative (but possibly complementary) approach to direct in vitro differentiation consists of lineage 
selection based on surface markers or promoter-driven expression of selectable markers. For example lineage 
selection for Sox2 expressing EB-derived cells after treating EBs with RA has enabled the enrichment of neural 
progenitor cells (Li and others, 1998). Another example of genetic lineage selection involves the derivation of 
motor neurons by introducing a plasmid containing eGFP under control of a motor neuron specific promotor 
(Hb9) in ESC prior to their exposure to RA and SHH (Singh Roy and others, 2005).  
DIFFERENTIATION OF BRAIN-DERIVED NEURAL STEM CELLS 
As already indicated in the introductory review, NSC have been isolated from a variety of regions of both the 
developing and adult brain of different mammals, including humans. Two ways of culturing CNS-derived NSC 
were described. A first technique is to propagate them as neurospheres, which are free-floating spherical 
clusters containing NSC together with more differentiated neuronal and glial cells. A second technique consists 
of culturing NSC as monolayers on coated surfaces. There are indications that culturing NSC as neurospheres 
would favour a gliogenic fate while the monolayer culture would promote a more selective enrichment of NSC 
(Conti and others, 2005).  
In both protocols (neurosphere/monolayer culture) NSC are enriched by selective expansion in response to 
mitogens, which are in most cases basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF). 
This major disadvantage of this selective expansion technique is that it requires prolonged periods in vitro. In 
order to overcome this prolonged in vitro culture, surface antigen-based sorting has been used to selective 
isolate NSC (Uchida and others, 2000; Lee and others, 2005). Alternatively genetic lineage selection techniques 
in which selective makers are placed under the control of NSC-specific promoters (e.g. nestin, musashi1) have 
proven to be successful (Roy and others, 2000; Keyoung and others, 2001).  
In vitro, upon removal of mitogens, NSC are able to differentiate towards astrocytes, oligodendrocytes but also 
physiologically active neurons which are able to fire action potentials (Liu and others, 1999; Song and others, 
2002; Babu and others, 2007). It is still unclear which subclasses of neuronal cells can be derived from brain-
derived NSC. It seems that brain-derived NSC are influenced by early brain patterning since neurospheres 
isolated from different CNS regions express region-specific markers and generate region-specific progeny 
(Hitoshi and others, 2002; Babu and others, 2007). For example, functional mature dopaminergic neurons have 
only been generated from NSC isolated from the ventral midbrain (Richardson and others, 2004). However, the 
differentiation program of NSC can be influenced to some extend by exposing the cells to various growth 
factors or cytokines (Johe and others, 1996).  
NSC can also generate functional neurons in vivo but this is most prominent when the cells are transplanted in 
the developing brain or in neurogenic regions (hippocampus, olfactory bulbs) of the adult brain (Gage and 
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others, 1995; Flax and others, 1998; Auerbach and others, 2000; Englund and others, 2002). Thus, it seems that 
the presence of a neurogenic niche is crucial for appropriate neuronal differentiation. From these 
transplantation studies it is also evident that regional cues can alter the regional identity of brain-derived NSC. 
For example hippocampus-derived NSC differentiate towards hippocampal granule cells after homotopic 
transplantation in hippocampus and towards olfactory neurons after heterotopic transplantation in the 
olfactory bulbs (Suhonen and others, 1996). In non-neurogenic regions (including damaged brain regions) 
undifferentiated NSC mainly adopt glial cell fates upon transplantation (Gage and others, 1995; Dziewczapolski 
and others, 2003; Richardson and others, 2005; Conti and others, 2006; Martino and Pluchino, 2006).  
One strategy to overcome the inability of NSC to form specific neuronal phenotypes or to generate neurons 
upon transplantation in non-neurogenic brain regions is to isolate specific neuronal progenitor cells, prior to 
their terminal differentiation, from developing brain regions and to immortalize them. The latter is frequently 
done by introducing a temperature sensitive (ts) mutated allele (A58) of the simian virus 40 (SV40) large T-
antigen (T-ag) in the cells. Consequently the progenitor cells can be expanded in culture at temperatures below 
mammalian body temperature (for example 33°C), but upon implantation into a host brain, they stop dividing 
and differentiate towards mature neural cells (Martinez-Serrano and Bjorklund, 1997). For example the MHP36 
neural progenitor cell line was established by dissecting cells from the hippocampal proliferative-zone Anlage 
at E14, i.e. just before the cells migrate away from the ventricular zone to form the hippocampus (Sinden and 
others, 1997). MHP36 cells were able to generate site-specific neurons in the non-neurogenic regions of the 
hippocampus. Additionally MHP36 cells migrate towards lesioned brain areas where they adopt morphologies 
resembling endogenous neurons. 
NEURAL TRANSDIFFERENTIATION OF NON-NEURAL SOMATIC STEM CELLS  
As indicated in our review different types of non-neural somatic stem cells (e.g. mesenchymal stem cells, 
hematopoietic stem cells) are claimed to be capable of generating neural cell types. However, in contrast to 
neural differentiation of NSC and ESC, this neural “transdifferentiation” potential of non-neural somatic stem 
cells is subject of much scientific debate.  
Most studies claiming neural transdifferentiation have based their conclusions on the expression of neural 
markers and/or the adoption of neural morphologies. But a variety of studies have demonstrated that non-
neural stem cells can express neural markers prior to any differentiation (e.g. MSC, fibroblasts). Furthermore, 
recent evidence shows the adoption of a neural–like morphology and an upregulation of neural marker 
expression can be a stress-artefact rather than a true proof for neural differentiation (Neuhuber and others, 
2004; Lu and others, 2004; Bertani and others, 2005). Another study evaluated the distribution of neural 
antigens (e.g. ion channel subunits) in bone marrow cells after “neural transdifferentiation” and found that this 
was completely different from that seen in adult neurons which probably indicates that the cells cannot 
function as neurons (Jin and others, 2003). 
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Only very few studies examined the electrophysiological properties of the bone marrow-derived putative 
neurons (Kohyama and others, 2001; Hofstetter and others, 2002; Hung and others, 2002; Jiang and others, 
2003; Padovan and others, 2003; Dezawa and others, 2004; Wislet-Gendebien and others, 2005). Two reports 
could not show any electrophysiological evidence for neuronal differentiation despite the expression of neural 
markers (Hofstetter and others, 2002; Padovan and others, 2003). Two other studies found some voltage 
dependent currents but could not demonstrate action potentials in the neuron-like cells (Kohyama and others, 
2001; Hung and others, 2002).  
There have been in vitro studies demonstrating that bone marrow-derived stem cells are capable of 
differentiating towards functionally active neurons, able to fire action potentials. Wislet-Gendebien and 
colleagues co-cultured nestin-positive MSC with cerebellar granule neurons and found action potentials after 
15 days of co-culture. Similar results were obtained when MSC were co-cultured with formalin-fixed granule 
neurons in the presence of granule cell conditioned medium indicating that cell fusion was not the mechanism 
behind the neural differentiation (Wislet-Gendebien and others, 2005). Jiang and co-workers co-cultured 
MAPC, after their exposure to a three-step neuronal induction protocol, with astrocytes for 5 to 12 days and 
found electrophysiological evidence of neuronal differentiation was evident since action potentials were 
measured using patch clamp recording (Jiang and others, 2003). In both reports the bone marrow-derived stem 
cells were not able to fire trains of action potentials nor was there an indication of strong synaptic activity, 
indicating that the neuronal cells were still immature. Dezawa and colleagues genetically engineered MSC to 
induce expression of the intracellular Notch domain prior to exposing them to factors which stimulate 
dopaminergic differentiation. Upon differentiation cells were obtained which were able to generate action 
potentials, release dopamine in response to depolarization and improve rotational after transplantation in a rat 
model for Parkinson’s disease (Dezawa and others, 2004).  
Although several studies have shown that bone marrow-derived stem cells can express neural markers upon 
transplantation in the brain, none of these studies used electrophysiological techniques to demonstrate that 
the cells also function as neural cells. Also most of the studies based their conclusion solely on BrdU-labelling 
and did not perform control experiments where dead cells were transplanted to assure that BrdU was not 
transferred from dying transplanted cells to endogenously dividing neural precursors (Kopen and others, 1999; 
Li and others, 2000; Chen and others, 2001; Li and others, 2001; Munoz-Elias and others, 2004; Munoz and 
others, 2005; Coyne and others, 2006). Furthermore none of these transplantation studies did exclude that cell 
fusion between donor cells and endogenous neurons/glia was the mechanism behind the presumed neural 
differentiation.  
CELL TRANSPLANTATION FOR PARKINSON’S DISEASE  
In the past few years much efforts are made to generate cells which can replace lost midbrain dopaminergic 
neurons in models of PD. Grafting of poorly differentiated ESC in the striatum of 6-hydroxydopmaine (6-OHDA) 
treated rats gave rise to dopaminergic neurons at the transplant site, restoration of the hemodynamic 
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response to an amphetamine challenge and functional improvement in motor asymmetry. This indicated that 
ESC were capable of generating functional dopaminergic neurons capable of integrating in the host striatum. 
However, in this study it was not confirmed that the cells were donor-derived and also no electrophysiological 
analysis was done to confirm functional integration of the dopaminergic cells. Also, in 5 out of 25 transplanted 
rats teratoma-like structures were found at the transplant site (Bjorklund and others, 2002). So, although these 
results were promising they also indicated that in vitro purification of ESC-derived dopaminergic precursors will 
be of the greatest importance (see higher). Several strategies to induce directed differentiation of ESC towards 
dopaminergic neurons have been developed (for reviews see (Conti and others, 2006) and (Zhang, 2006)).  
One strategy consists of transducing mouse ESC with the nuclear cell receptor Nurr1, a transcription factor 
essential for the generation of dopaminergic midbrain neurons. When the Nurr1 mouse ESC were exposed to 
FGF-8 and SHH in culture, they generated tyrosine hydrolase (TH)-expressing, functionally active midbrain 
dopaminergic neurons. Transplantation of Nurr1-transduced cells in the striatum of 6-OHDA lesioned rats led 
to some degree of functional cell replacement with the transplanted neurons innervating the striatum by 
extending processes up to 2 mm and forming functional synapses. Behavioural studies showed significant 
reduction in motor assymemetry in the animals that had undergone transplantation. There was no evidence of 
teratoma formation and the grafts were negative for the proliferation marker Ki-67 (Kim and others, 2002). 
Recently a protocol has been published which allows the enrichment of dopaminergic neurons to up to 90%. In 
this protocol Nurr1 transduced ESC were co-cultured with stromal cell lines (PA6) and exposed to FGF-8 and 
SHH (Kim and others, 2006).  
It has been demonstrated that co-culture with stromal cells also stimulates differentiation of human and non-
human primate ESC towards midbrain dopaminergic neurons. Perrier and colleagues showed that co-culture of 
human ESC with MS5 stromal cells and subsequent exposure to SHH and FGF-8 resulted in a high fraction of 
TH-expressing dopaminergic neurons. Furthermore they found that TH+ neurons also expressed engrailed 1 
(En-1), a transcription factor which is expressed in midbrain dopamine neurons. The authors also demonstrated 
the presence of enzymes relating to dopamine metabolism such as aromatic amino acid decarboxylase and 
vesicular monoamine transporter 2. Furthermore the neurons formed synaptic connections and were capable 
of generating action potentials in culture (Perrier and others, 2004).  
Although the stromal cell-approach is elegant through its simplicity and efficiency, it has the disadvantage that 
target neural cells are contaminated with stromal cells. Currently major efforts are made to identify the 
molecular factors which are responsible for this dopaminergic specification and/or differentiation so that a 
more defined system can be created for the production of dopaminergic neurons. Alternatively, also other 
differentiation protocols are developed which are not based on the use of stromal cell co-culture systems.  
One successful alternative protocol to differentiate human ESC to dopaminergic neurons uses the EB 
differentiation protocol. After 4 days as free floating EBs, ESC are replated in the presence of FGF-2 to allow the 
formation neural rosettes. The neural rosettes are then exposed to FGF-8 and SHH to induce dopaminergic 
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differentiation. In this protocol it is crucial that FGF-8 and SHH are applied at early time points to obtain 
dopaminergic neurons which co-express the midbrain transcription factor En-1. If factors are applied too late 
dopaminergic neurons express transcription factors of the forebrain indicating that the ESC have differentiated 
towards olfactory bulb dopaminergic interneurons (Yan and others, 2005).  
It is demonstrated in vivo that astrocytes play a crucial in specifying and maintaining the phenotypes of 
midbrain dopaminergic neurons. In line with this evidence, a recent study induced dopaminergic differentiation 
of human ESC in co-culture with mesencephalic astrocytes. The yield of dopaminergic neurons by this approach 
was approximately 55% of total neurons. After transplantation a robust engraftment of the human ESC-derived 
dopaminergic neurons was seen and this was correlated which significant behavioural improvement. However, 
the authors did find continued mitotic activity of neuroepithelial-like tumour cells at the core of the transplant 
(Roy and others, 2006).  
An alternative cell source which could be used for the generation of midbrain dopaminergic neurons are brain-
derived NSC. However, up till now, this has been much less successful compared to embryonic stem cells. 
Human fetal NSC have been transplanted in the striatum of 6-OHDA-lesioned rats but this resulted in a very 
limited number of donor-derived, TH-expressing dopaminergic neurons 20 weeks after transplantation. A large 
part of the transplanted NSC had differentiated towards astrocytes (Svendsen and others, 1997). In line with 
this report several other studies have shown that brain-derived NSC which have been expanded in culture 
mainly generate glial cells when transplanted in non-neurogenic regions such as the striatum or substantia 
nigra (Dziewczapolski and others, 2003; Lie and others, 2004; Richardson and others, 2005).  
Sanchez-Pernaute and co-workers were more successful in obtaining TH-expressing dopaminergic neurons 
which were also able to survive after transplantation in the striatum of parkinsonian rats. The authors 
pretreated short-term expanded, human fetal mesencephalic neural precursors with dibutyryl cyclic adenosine 
monophosphate and ascorbic acid 2 days prior to transplantation (Sanchez-Pernaute and others, 2001). Six 
weeks after transplantation robust TH-expression was found in the grafted cells and a significant behavioural 
improvement. However it is unclear whether the cells would retain the same potential to generate 
dopaminergic neurons after a more extensive in vitro expansion. This is highly unlikely since it was 
demonstrated for rat fetal mesencephalic neural progenitors that the cells lose their dopaminergic potential 
after expansion in the presence of FGF-2 (Studer and others, 1998).  
Expanded neural precursors can be stimulated to generate functional dopaminergic cells by transduction with 
Nurr-1 (Kim and others, 2003). Though, these dopaminergic neurons are immature, secrete only minimal 
amounts of dopamine and do not survive after transplantation in the 6-OHDA lesioned striatum. A recent 
experiment showed that co-transducing neural precursor cells with Nurr-1 and the neurogenic factor Mash-1 
prior to their exposure to neurogenic factors (BDNF and NT-3) promotes the in vitro differentiation towards 
functional and mature dopaminergic neurons. Transplanting these cells in the striatum of parkinsonian rats 
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lead to the survival of a small fraction of the dopaminergic cells. As a result of the transplantation a significant 
behavioral improvement was demonstrated (Shim and others, 2007).  
One study succeeded in generating cells with characteristics of dopaminergic neurons starting from a non-
neuronal cell population. As indicated higher, Dezawa and coworkers transduced human and rat mesenchymal 
stem cells to induce the expression of the intracellular Notch domain. By exposing the cells to glial derived 
neurotrophic factor (GDNF) they could be enriched for cells co-expressing TH and midbrain transcription 
factors (En-1 and Nurr-1). After transplantation into the striatum of parkinsonian rats, cells expressing TH could 
be detected up to 10 weeks after grafting. As a result of the transplantation there was a higher release of 
dopamine together with a significant functional improvement (Dezawa and others, 2004). These promising 
results are not yet confirmed in other laboratories.  
Overall, several in vitro experiments have succeeded in generating high numbers of dopaminergic neurons 
(especially from ESC). However, the survival of dopaminergic neurons, transplanted in the brain of PD models, 
was in the majority of the cases rather disappointing. Also, up till now, none of the transplantation studies was 
able to demonstrate that stem-cell derived dopaminergic neurons could generate action potentials, form 
functional synapses and release dopamine in an activity dependant manner (Zhang and others, 2007). One of 
the possible explanations for these rather disappointing results is that the dopaminergic neurons that are 
generated in vitro may be not the correct type of dopamine neurons. The midbrain neurons that synapse with 
striatal neurons are located in the substantia nigra. Thus, if dopamine neurons do not possess the nigra 
dopamine neurons characteristics they may fail to form proper synapses with striatal neurons, which may lead 
to the death of the transplanted cells (Zhang and others, 2007). Therefore, setting up culture systems which 
allow the more specific generation nigra dopaminergic neurons could lead to much higher survival rates. Next 
to the demand for specific subclasses of dopaminergic neurons, the high risk for tumour formation by 
undifferentiated ESC urges the necessity for more defined differentiation protocols.  
Once the right type of dopaminergic progenitors can be generated in purity and abundance, a number of still 
unresolved issues need to be addressed before the cells can become clinically useful. These include the lack of 
afferent control of the dopaminergic cells when transplanted in the striatum, their uncontrolled dispersion and 
the lack of nigrostriatal reconstruction upon alternative transplantation in the substantia nigra. Each of these 
issues was already considered as problematic in fetal mesencephalic transplant studies.  
CELL TRANSPLANTATION FOR STROKE 
As already discussed in the review, presented in the previous chapter, cells from a variety of sources such as 
fetal brain, neuroepithelial cell lines, teratocarcinoma cell lines, bone marrow, umbilical cord, adipose tissue, 
have been transplanted in the brain of stroke models. For an overview of these studies (including the most 
recent ones) we refer to an excellent review (Bliss and others, 2007).  
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In most of the experimental studies on cell transplantation for stroke there was evidence of some behavioural 
improvement. Many studies showed that cells actively migrate towards the ischemic lesion upon 
transplantation, probably because of the presence of injury-induced chemoattractans at the lesion site such as 
stromal-derived factor 1 and monocyte attractant protein 1  (Hill and others, 2004; Newman and others, 2005; 
Muller and others, 2006; Shen and others, 2007). However only very few studies demonstrated that the 
transplanted cells had differentiated towards functionally active neurons which had integrated into the 
network. In their review, Bliss and co-workers, refer to only two studies which could demonstrate that 
transplanted human or rat NSC had formed synaptic-like structures upon transplantation in the ischemic brain 
(Toda and others, 2001; Ishibashi and others, 2004). There is also one study which transplanted monkey ESC-
derived neural precursor cells in the brain of mice after stroke and found that the cells re-established 
functional connections with target areas by injecting a retrograde tracer (fluorogold) (Hayashi and others, 
2006).  
In the majority of the studies survival of the transplanted cells is either too low or the differentiation towards 
neural cells too minimal to confer the functional improvement to active cell replacement. Instead, in those 
studies, it is more likely that cell transplantation induced trophic mechanisms which stimulate endogenous 
recovery and/or protection mechanisms. This hypothesis is further strengthened by the finding that grafting 
neural progenitor cells contralateral to the lesion can produce the same behavioural recovery as grafting 
ipsilateral to the lesion (Modo and others, 2002).  
Several potential mechanism have been suggested to underlie the trophic effects of cell transplantation in 
stroke. One frequently suggested hypothesis is that transplanted cells reduce death of endogenous neurons by 
secretion of trophic factors such as VEGF, FGF, GDNF and BDNF (Johnston and others, 2001; Borlongan and 
others, 2004; Kurozumi and others, 2005). Alternative mechanisms that could underlie the behavioural 
recovery could be the stimulation of endogenous neovascularization (Chen and others, 2003b; Taguchi and 
others, 2004; Jiang and others, 2005; Shyu and others, 2006) or neurogenesis (Chen and others, 2003a; Zhang 
and others, 2004) through the release of growth factors. Immunomodulation is an alternative mechanism 
through which cell transplantation could promote behavioural recovery in stroke. There are indications that 
transplanted NSC can induce apoptosis of T-lymphocytes possibly by the upregulation of membrane expression 
of certain death receptor ligands (such as FASL, TRAIL and APO3L) (Pluchino and others, 2005). Also NSC are 
believed to hamper infiltration of blood-born monocytes at the lesion border of ischemic areas where the NSC 
accumulate (Kelly and others, 2004).  
Despite the behavioural improvements described in animal models for stroke and the suggested trophic and 
immunomodulatory effects of cell transplantation, clinical trials were rather disappointing. In a phase II trial 
human teratocarcinoma cells (NT2 cell line) were transplanted in 18 chronic basal ganglia stroke patients which 
were randomized to stereotactic transplantation (n=14) or control (n=4). Only six of the 14 transplanted 
patients showed slight though non-significant improvement on the motor European Stroke Scale (Bliss and 
others, 2007). Fetal porcine neural progenitors were transplanted into 5 basal ganglia stroke patients. At 4 
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years of clinical follow-up only 1 of the 5 treated patients showed significant improvement on the National 
Institutes of Health Stroke Scale (Savitz and others, 2005).  
The disappointing results of these clinical transplantation studies indicate that probably more rational 
approaches than simply injecting cells into the damaged brain will be required to obtain more satisfactory 
outcomes. However, based on preclinical research it is very difficult to identify more optimal strategies since 
transplantation parameters such as delay between lesion and transplantation, cell source, number of 
transplanted cells, route of cell delivery and target for transplantation varied greatly among experimental 
studies.  
Most probably a cell therapy for stroke will only be of major clinical value when it succeeds to replace dead 
neurons, remyelinate axons and repair neural circuitries. Therefore a successful cell therapy for stroke will 
probably require much more complex transplantation paradigms than injecting bone marrow cells 
intravenously. It will probably be necessary to optimize in vitro differentiation strategies to enable the 
generation of specific neural precursor subtypes. Probably, multiple transplantations will be required at 
different locations and different time points. Additionally, it is likely that also the brain environment will need 
to be modified in order to create a niche which supports the integration of new neuronal cells and their 
sustained survival.  
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This manuscript is a comprehensive overview of published studies in which cells are transplanted in a model for 
TLE. First, a short introduction on TLE and the corresponding animal models is given. Further in the manuscript, 
two main approaches for cell transplantation in TLE are discussed: cell replacement for reconstruction of 
damaged networks and the use of cells for local delivery of antiepileptic substances. In the restorative 
approach, results of transplantation of fetal cells are discussed, followed by the evaluation of neuroprogenitor 
cell transplantation and the potency of these cells to replace lost brain cells. In the cell-based delivery 
approach, a distinction is made based on which neuromodulatory substances are secreted by the transplanted 
cells. Studies using cells which secrete noradrenaline, acetylcholine, GABA and adenosine are critically 
evaluated.  
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SUMMARY 
For patients with refractory epilepsy it is important to search for alternative treatments. One of these potential 
treatments could be introducing new cells or modulating endogenous neurogenesis to reconstruct damaged 
epileptic circuits or to bring neurotransmitter function back into balance. In this review the scientific basis of 
these cell therapy strategies is discussed and the results are critically evaluated. Research on cell 
transplantation strategies has mainly been performed in animal models for temporal lobe epilepsy, in which 
seizure foci or seizure propagation pathways are targeted. Promising results have been obtained, although 
there remains a lot of debate about the relevance of the animal models, the appropriate target for 
transplantation, the suitable cell source and the proper time point for transplantation. From the presented 
studies it should be evident that transplanted cells can survive and sometimes even integrate in an epileptic 
brain and in a brain that is subjected to epileptogenic interventions. There is evidence that transplanted cells 
can partially restore damaged structures and/or release substances that modulate existent or induced 
hyperexcitability. Even though several studies show encouraging results, more studies need to be done in 
animal models with spontaneous seizures in order to have a better comparison to the human situation.  
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INTRODUCTION 
Epilepsy is characterized by recurrent unprovoked seizures and affects 0.5-1% of the population (Hauser and 
others, 1991; Brodie and Kwan, 2002). More than 30% of the epilepsy patients have uncontrolled seizures or 
unacceptable medication-related side effects despite adequate pharmacological treatment (Brodie and Kwan, 
2002). These patients have ‘refractory epilepsy’. The underlying pathophysiological process that transforms a 
normal brain into an epileptic brain is termed epileptogenesis.  
Epilepsy surgery is an invasive but often curative treatment option that aims at removing the ictal onset zone 
believed to be responsible for seizure occurrence (Wiebe and others, 2001). For patients in whom the ictal 
onset zone is not well circumscribed or localized in functional brain tissue, few treatment options are left. The 
inability to adequately treat all patients with refractory epilepsy provides a continuous impetus to investigate 
novel forms of treatment.  
A possible alternative way of treating refractory patients involves neuromodulation through neurostimulation. 
In our group, we have demonstrated the efficacy and safety of vagus nerve stimulation (VNS) and deep brain 
stimulation (DBS) in both patients and experimental animal models for epilepsy (Boon and others, 2001; Vonck 
and others, 2002; Vonck and others, 2004; Dedeurwaerdere and others, 2005; Dedeurwaerdere and others, 
2006). Other possible alternative treatments are newly developed AED (Fisher, 1993), the ketogenic diet 
(Freeman and others, 1998; Freeman and others, 2006) and transcranial magnetic stimulation (Handforth and 
others, 1998). In spite of all these developments, a significant number of patients continue to have 
uncontrolled seizures which makes a further search for alternative treatments mandatory (Jacobs and others, 
2001).  
A promising treatment option that also receives considerable attention in other neurodegenerative diseases 
(e.g. Parkinson’s disease) is cell therapy (Lindvall and others, 2004; Raedt and Boon, 2005). In general, there are 
two main strategies that involve the use of cells for the treatment of brain disorders. Firstly, cells can be 
transplanted to replace lost neurons and/or to release disease modifying substances. Secondly, endogenous 
cells can be manipulated to affect and modify the disease process.  
Temporal lobe epilepsy (TLE) is the most prevalent form of refractory symptomatic epilepsy (Engel, Jr., 2001). 
Because of its focal nature and the associated cellular defects, this epilepsy syndrome is highly attractive to be 
treated with cell therapy. This review will highlight the most typical cellular alterations in TLE and then discuss 
various cell therapy strategies including neural grafting to reconstruct damaged epileptic networks, stimulation 
of endogenous repair and cell transplantation for local delivery of seizure suppressing substances.  
 76 Manuscript 2  
 
CELLULAR BASIS AND ANIMAL MODELS OF TEMPORAL LOBE EPILEPSY 
Although the exact cause for the development of seizures in TLE is still under debate, human TLE is very 
frequently associated with specific pathophysiological changes that are believed to play an important role in 
the generation or intensification of the epileptic state. 
The most frequent lesion in human TLE and status epilepticus (SE) models is hippocampal sclerosis, evident in 
up to 90% of surgically resected hippocampi (Thom and others, 2002). Hippocampal sclerosis is characterized 
by extensive gliosis combined with a selective loss of neurons in the dentate gyrus and the hippocampus 
proper. Neuronal loss involves both glutamatergic neurons (granule cells in dentate gyrus, pyramidal neurons 
in hippocampus proper) and inhibitory interneurons in dentate hilus and CA1 region. Neuronal cell loss and 
gliosis can extend to other mesiotemporal regions such as amygdala, entorhinal, perirhinal and temporopolar 
cortex (Yilmazer-Hanke and others, 2000; Jutila and others, 2001; Salmenpera and others, 2001; Hermann and 
others, 2002; Wieser, 2004). Most affected neurons are pyramidal neurons of CA1 and CA3 region, excitatory 
mossy cells in the hilus, and GABAergic inhibitory interneurons also expressing somatostatin, parvalbumin, or 
neuropeptide Y. Especially the loss of inhibitory interneurons is believed to be a key factor underlying the 
increased excitability of the epileptic hippocampus (Thompson and others, 1998; Gorter and others, 2001).  
Mossy fiber sprouting is the growth of aberrant collaterals of granule cell axons (also called mossy fibers) into 
the inner molecular layer of the dentate gyrus where they preferentially make synaptic connections with 
dendrites of other granule neurons, forming excitatory feedback loops (Buckmaster and others, 2002; 
Scharfman and others, 2003). Mossy fiber sprouting is presumably caused by the loss of normal postsynaptic 
targets of the granule neurons. One of the arguments for this hypothesis is that the degree of mossy fiber 
sprouting is correlated to the degree of neuronal loss in hippocampal sclerosis (Cavazos and Cross, 2006). 
Electrophysiological studies on human hippocampal slices and experimental studies in animal models for TLE 
have shown that the extend of mossy fiber sprouting is correlated with excitability of the hippocampus 
(Cavazos and others, 1991; Franck and others, 1995).  
By far the most used animal model for TLE, demonstrating spontaneous seizures and typical brain damage, is 
the status epilepticus (SE) model. In this model SE is evoked by systemic or intracerebral injection of 
excitotoxins (kainic acid or pilocarpine) or by tetanic electrical stimulation of temporal lobe structures. After a 
latent period, during which epileptogenesis occurs, spontaneous seizures are displayed (Leite and others, 
2002).  
Another commonly used model for TLE is the kindling model. In this model temporal lobe structures are 
repeatedly stimulated by short electrical pulse trains. The animals respond to the stimulation by displaying an 
electrical discharge on the EEG (afterdischarge) and abnormal behaviour. With increasing number of 
stimulations rats display more complex afterdischarges or more severe seizures. Rats consistently displaying 
tonic-clonic seizures are termed fully kindled. Spontaneous seizures are only seen after a large amount of 
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stimulations but even then gross morphological damage, seen in the status epilepticus model, are not or only 
moderately evident. Based on the controlled induction of epileptogenesis, the kindling model is a very 
interesting tool to study the role of events associated with epileptogenesis (McIntyre and others, 2002). 
Frequently used parameters to assess efficacy of treatments in this model are the current intensity needed to 
evoke an afterdischarge, termed afterdischarge threshold (ADT), and the number of stimulations needed to 
fully kindle the rats, termed kindling rate.  
STRUCTURAL REPAIR OF DAMAGED EPILEPTIC NETWORKS 
CELL TRANSPLANTATION FOR REPAIR OF HIPPOCAMPAL CIRCUITRY 
In case of TLE, the sclerotic hippocampus is the most obvious target for circuitry reconstruction given its 
presumed role in the TLE (Wieser, 2004). However, mediating structural repair of damaged hippocampal 
networks to restore balance between excitation and inhibition is without doubt an enormous challenge. As 
already described higher, hippocampal sclerosis involves the loss of different types of both excitatory and 
inhibitory neurons in different regions throughout the hippocampal structure. Therefore, cellular repair of 
hippocampal sclerosis will probably require multiple grafts of different cell types throughout the hippocampal 
structure.  
Successful reestablishment of balanced excitatory drive and inhibitory input will demand a great deal of the 
transplanted cells. They will need to: 1) survive; 2) disperse and/or migrate to appropriate cell layers; 3) 
generate appropriate phenotypes in correct relative numbers and at the proper locations in the hippocampus; 
4) attract suitable afferent input and 5) establish appropriate local and long distance efferent connections with 
the proper target host and grafted neurons.  
The need for proper integration is evident from electrophysiological studies in sclerotic hippocampi which 
showed that endogenous neurons which display inappropriate synaptic connectivity (Lynch and Sutula, 2000; 
Buckmaster and others, 2002) and/or integrate at ectopic locations in the hippocampus (Scharfman and others, 
2000) are part of hyperexcitable networks. It is therefore very likely that grafted neurons which do not 
integrate properly could enhance excitability rather than suppressing it.  
Indeed, there have been reports which demonstrated pro-epileptic effects of hippocampal transplantation. In a 
series of experiments, Buzsaki and colleagues transplanted fetal hippocampal tissue chunks or dissociated fetal 
hippocampal tissue into intact (Buzsaki and others, 1991) or fimbria-fornix lesioned, seizure-prone 
hippocampus (Buzsaki and others, 1987a; Buzsaki and others, 1987b; Buzsaki and others, 1988a; Buzsaki and 
others, 1988b; Buzsaki and others, 1989a; Buzsaki and others, 1989c). By performing electrophysiological 
recordings the authors found that reciprocal electrophysiological connectivity was established between the 
graft and the intact or lesioned host brain. However, they found that the most typical EEG pattern in the 
transplant was highly synchronous bursting behaviour with concurrent large amplitude EEG spikes. 
Spontaneous EEG seizures were also frequently recorded from the graft which spread into the host brain 
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(Buzsaki and others, 1987a; Buzsaki and others, 1987b). Moreover, spontaneous behavioural convulsions were 
detected in a high fraction of the transplanted rats (Buzsaki and others, 1988b; Buzsaki and others, 1989a; 
Buzsaki and others, 1991).  
Although the exact mechanism for this transplantation-induced epileptiform activity was not unravelled, the 
authors suggested that the hyperexcitability of the graft was caused by a lack of afferent control, extensive 
formation of recurrent excitatory circuitry and insufficient GABAergic inhibition within the graft (Buzsaki and 
others, 1988b). Buzsaki and colleagues hypothesized that the grafted hippocampal cells served as an epileptic 
focus that kindled the host brain by repeated seizure induction (Buzsaki and others, 1989a; Buzsaki and others, 
1991). 
FETAL HIPPOCAMPAL CELL TRANSPLANTATION  
In spite of the hurdles, described in the previous chapter, fetal hippocampal neurons have been transplanted 
into the hippocampus of the intraventricular kainic acid model (Shetty and Turner, 1996; Shetty and Turner, 
1997a; Shetty and Turner, 1997b; Shetty and others, 2000; Shetty and Turner, 2000; Zaman and others, 2000; 
Zaman and Shetty, 2001; Zaman and Shetty, 2003). In this model there is selective loss of CA3 pyramidal 
neurons (Shetty and Turner, 1996) and subsequent expression of spontaneous limbic seizures (Nadler, 1981; 
Sater and Nadler, 1988).  
A considerable fraction of the transplanted fetal hippocampal cells was able to survive upon transplantation in 
the damaged CA3 region. However, this survival was severely influenced by postlesion delay (PLD), age of the 
rats and the type of transplanted cells. Highest survival rates (77%) were seen when fetal CA3 cells were 
transplanted in young mature rats with a PLD of 4 days (Shetty and Turner, 1996). However if the PLD was 
longer, the fraction of surviving cells was much lower (e.g. 21 to 31% if PLD was 45 days) (Zaman and others, 
2001). Survival in case of transplantation with longer PLD could be dramatically enhanced (up to 99%) by pre-
treating the cells with a cocktail of growth factors and an anti-apoptotic factor (Hattiangady and others, 2006). 
Survival rates of transplanted cells also strongly depended on cell specificity. Survival of CA1 cells, transplanted 
into the damaged CA3 region, was much lower compared to that of CA3 cells after a PLD of 4 days (respectively 
42 % and 77%). When fetal striatal cells were transplanted survival was even worse (only 4 to 12%) (Zaman and 
others, 2000).  
The migration of fetal hippocampal cells upon transplantation in the intraventricular KA model was minimal 
with the cells remaining clumped at the grafting site (Shetty and others, 1994; Shetty and Turner, 1995). By 
using retrograde tracing, Shetty and colleagues, showed that grafted fetal hippocampal CA3 neurons formed 
short-distance efferent projections to ipsilateral CA1 region and entorhinal cortex and long-distance efferent 
projections to septum and contralateral hippocampus (Shetty and Turner, 1996). However, efferent projections 
to contralateral hippocampus were only seen in case of homotopic grafting, which means grafting of CA3 
neurons in proximity of the damaged CA3 region. If CA3 neurons were transplanted in the CA1 regions or CA1 
neurons in the damaged CA3 region no long-distance projections towards contralateral hippocampus were 
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found (Shetty and Turner, 1997a; Shetty and others, 2000). Growth of host afferent projections into the cluster 
of grafted cells was also demonstrated. Using histochemical staining and anterograde labelling, afferent 
cholinergic fibers, mossy fibers and commissural fibers of contralateral CA3 neurons were found in the 
transplantation area (Shetty and Turner, 1996). Highest density of afferent fibers in the transplant was seen in 
case of homotopic grafting. The authors hypothesized that the need for homotopic grafting could be due to the 
fact that axon guidance pathways in the host may be highly specific, requiring accurate placements of the 
grafts to achieve access (Turner and Shetty, 2003). Both the limited migration and the need for homotopic 
grafting are very important disadvantages for potential repair of damaged hippocampal circuitry using fetal 
hippocampal neurons.  
Nevertheless, if fetal CA3 neurons were transplanted homotopically, transplantation could result in partial 
reversal of secondary pathological alterations including aberrant mossy fiber sprouting, possibly by providing 
an appropriate target (Shetty and Turner, 1997b; Hattiangady and others, 2006). Additionally, loss of glutamic 
acid decarboxylase (GAD) positive interneurons could be reversed. As the graft did not seem to donate the 
GAD-positive cells, the authors hypothesized that the loss of CA3 afferents led to a downregulation of GAD 
protein expression, which was reversed by replacing CA3 cells (Shetty and Turner, 2000).  
Unfortunately in their series of experiments the authors did not perform electrophysiological analysis of 
connectivity, so it remains uncertain whether the transplanted cells also functionally integrated. They also did 
not monitor for epileptic activity so it is not clear whether grafting of fetal CA3 neurons and the reversal of 
some pathological secondary changes resulted into a normalization of the imbalance between excitation and 
inhibition or a dampening of the epileptic activity.  
NEURAL STEM/PROGENITOR CELL TRANSPLANTATION  
Transplantation of fetal brain tissue has important limitations which will probably always limit its application on 
a large clinical scale. These limitations include the inability to expand or store fetal cells, resulting in a high 
number of fetuses needed for one single transplantation (e.g. 6-8 fetal donors to tread one PD patient) 
(Lindvall, 2001). Another limitation is that purity and viability of the transplant is difficult to control so that 
outcome of transplantation is highly variable (Bjorklund and others, 2003). Moreover, as already described in 
the previous chapter, transplanted fetal cells have very limited migratory capabilities and homotopic grafting 
seems to be required.  
Because neural stem/progenitor cells are self-renewing cells which can migrate throughout the brain and are 
able to generate different neuronal progeny, they could, at least in theory, overcome the limitations of fetal 
tissue and be a promising alternative cell source. Transplantable neural stem/progenitor cells can be derived in 
several ways from different sources. They can be produced almost completely in vitro starting from embryonic 
stem cells (ESC) using specific differentiation protocols (Strubing and others, 1995; Okabe and others, 1996; Li 
and others, 1998; Mujtaba and others, 1999; Carpenter and others, 2001; O'Shea, 2001; Westmoreland and 
others, 2001; Kim and others, 2002; Wichterle and others, 2002; Conti and others, 2005). Expandable neural 
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progenitor cells can also be generated by immortalizing neuroepithelial precursor cells, derived from defined 
embryonic regions, prior to their terminal mitosis. This can be done by transfecting the cells with a vector 
containing a transcript encoding for a (temperature sensitive) immortalizing oncogene (Martinez-Serrano and 
Bjorklund, 1997; Whittemore and Onifer, 2000). Neural stem/progenitor cells can also be isolated directly from 
different regions of the embryonic central nervous system (CNS) but also from restricted areas in the adult 
brain such as  hippocampus, SVZ, striatum, substantia nigra, cortex, spinal cord, septum and optic nerve (Lois 
and Alvarez-Buylla, 1993; Palmer and others, 1995; Gage and others, 1995; Weiss and others, 1996; 
Shihabuddin and others, 1997; Palmer and others, 1999; Gage, 2000; Lie and others, 2002).  
Following transplantation in the brain, neural stem/progenitor cells seem to be able to functionally integrate 
into neural networks (Auerbach and others, 2000; Wernig and others, 2004). However, there are only few 
reports demonstrating the ability of neural stem/progenitor cells to functionally replace lost neurons and 
reconstruct damaged circuitry (Lindvall and Kokaia, 2006). Transplantation for stroke seems to be most 
successful with reports on migration of neural progenitor cells towards the lesion with formation of new 
neurons (Kelly and others, 2004) and reestablishment of neural connections with functional recovery (Ikeda 
and others, 2005; Hayashi and others, 2006). Systemically injected neural stem cells, in a model for multiple 
sclerosis, migrate to inflammatory demyelinating lesions, where they can remyelinate axons (Pluchino and 
others, 2003).  
To our knowledge, studies showing structural repair of damaged circuitry in sclerotic hippocampus by 
transplantation of neural stem/progenitor cells are unavailable. In one study, neural stem cells, isolated from 
human embryos, have been injected systemically one day after induction of SE with pilocarpine. Transplanted 
cells were found in the hippocampus, amygdala and pyriform cortex six weeks after transplantation. About 30% 
of the cells were immunopositive for GABA and parvalbumin, two proteins also expressed by inhibitory 
interneurons. Surprisingly, the grafted cells did not express the pan-neural markers Neuronal Nuclei (NeuN) or 
β3-tub (β-III-tubulin), indicating that they most probably were not neurons. Transplantation did however result 
in a significant decrease in daily seizure frequency, seizure severity and the number of rats that displayed 
spontaneous seizures. It was demonstrated that field excitatory postsynaptic potentials (EPSP) in the CA1 
region were decreased (Chu and others, 2004). This indicates that transplantation could have anti-
epileptogenic effects without evidence of structural repair by the transplanted cells.  
A conditionally immortalized neural progenitor cell line, called MHP36, has been developed and has shown 
potential to replace, at least in part, CA1 pyramidal neurons in models where the CA1 region was specifically 
damaged, either by excitotoxic lesioning (Virley and others, 1999) or ischemia (Sinden and others, 1997). These 
MHP36 cells were also transplanted into four sites of the rat brain, extending from the anterior to the posterior 
pyriform cortex, three weeks after SE. However, in this study no replacement of lost pyramidal CA1 or CA3 
neurons was reported but a significant augmentation in the number of seizures was found after transplantation 
(Meldrum and others, 2000).  
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In a study, performed at the Ghent University Hospital, adult SVZ-derived neural stem cells were transplanted 
in the lesioned hippocampus of the intrahippocampal kainic acid SE model (Raedt and others, 2007b). Adult 
neural stem cells were transplanted 3 days or 3 weeks following lesioning. This resulted in a low (about 1%) but 
robust survival of the cells for at least six weeks after transplantation. However, only a fraction of the cells 
differentiated towards neurons while the majority of the cells generated astrocyte-like cells probably 
contributing to gliosis in response to the lesion.  
STIMULATING ENDOGENOUS REPAIR AS A STRATEGY? 
In ischemia models neuronal replacement by endogenous neural precursors has been demonstrated in both 
the striatum and the hippocampus. In the permanent middle cerebral artery occlusion model a small number 
of lost medium spiny interneurons in the striatum were replaced by endogenous SVZ-derived progenitor cells 
(Arvidsson and others, 2002; Parent and others, 2002; Yamashita and others, 2006). In the four vessel occlusion 
model, transient induction of global ischemia leads to selective degeneration of CA1 pyramidal neurons. In this 
model a fraction of the lost CA1 neurons were replaced by endogenous neural progenitors migrating from the 
posterior periventricular region (PPV) to the damaged CA1 region (Nakatomi and others, 2002; Bendel and 
others, 2005). Brief intraventricular infusion of growth factors in the first week after stroke markedly increased 
reconstitution of CA1 (Nakatomi and others, 2002).  
Recently, enhanced proliferation and migration of neural precursor cells from the PPV towards damaged 
hippocampal CA1 and CA3 regions has been reported in the pilocarpine SE model for TLE. However, these 
neural precursor cells exclusively generated glial cells in the damaged hippocampal regions without any 
indication of neuronal replacement (Parent and others, 2006). One strategy that could lead to promoting 
endogenous repair of sclerotic hippocampus could be to identify the factors which promote neuronal 
replacement in ischemically damaged hippocampus and/or block neuronal replacement in the sclerotic 
hippocampus.  
In the pilocarpine SE model but also in other models for TLE, seizure-activity stimulates neurogenesis in the 
granule cell layer of the hippocampus (Parent and others, 1997; Bengzon and others, 1997; Jessberger and 
others, 2005; Smith and others, 2005). However, as the granule cell layer is relatively spared in case of TLE, it is 
not yet clear whether this enhanced neurogenesis is an attempt of the brain to repair damage or whether it is a 
part of the epileptogenic process. It seems that a fraction of the newborn granule cells contributes to the 
formation of abnormal circuitry by migrating towards ectopic locations in the hippocampus (Scharfman and 
others, 2000), contributing to mossy fiber sprouting (Parent and others, 1997) or generating a persistent basal 
dendrite which projects into the hilus and receives synaptic input from sprouted mossy fibers (Shapiro and 
Ribak, 2006). However, the great majority of the newborn neurons generated in response to seizures, form 
granule cells which normally integrate into the granule cell layer.  
In order to further elaborate on the role of enhanced neurogenesis in response to seizures we recently 
performed a study, in collaboration with the University of Goteborg, in which we blocked seizure-induced 
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neurogenesis in rats by using low-dose brain radiation one day before hippocampal kindling. We found that 
suppression of seizure-induced neurogenesis did not slow down of prevent kindling, indicating that new 
neurons generated in response to seizures play no major role in kindling epileptogenesis (Raedt and others, 
2007a). We believe that further studies are needed in other models to further unravel the role of granule cell 
neurogenesis in TLE before strategies for suppressing or enhancing endogenous hippocampal neurogenesis 
could be developed.  
CELL GRAFTING FOR LOCAL DELIVERY OF SEIZURE SUPPRESSING SUBSTANCES 
Several neurotransmitters and neuromodulators have anticonvulsant effects. Because they are synthesized and 
secreted by brain-derived cells in normal physiological conditions, they are suitable candidates for cell based 
delivery therapy. According to this strategy noradrenaline (NA, table 1), acetylcholine (AchE; table 2), GABA 
(table 3) and adenosine secreting cells (table 4) have been investigated in transplantation studies.  
NORADRENALINE SECRETING CELLS (TABLE 1) 
The inhibitory effects of NA were reported in temporal lobe epileptogenesis. When extracellular NA levels are 
artificially augmented by blocking its uptake or by electric stimulation of the noradrenaline rich locus coeruleus 
(LC), there is a significant attenuation of the kindling rate (McIntyre and others, 1982). On the other hand 
depletion of the noradrenergic system by injecting 6-hydroxydopamine (6-OHDA) has facilitating effects on 
kindling (Corcoran, 1988). Transplantation of NA rich fetal LC cells in the hippocampus of NA depleted rats 
reversed the facilitating effect of the lesion but only when NA release by the graft is under control of the host 
brain and sufficient in response to kindling stimulation (Barry and others, 1987; Bengzon and others, 1991; 
Kokaia and others, 1994). Grafting of NA neurons only affected kindling epileptogenesis but not fully kindled 
seizures. Also no antiepileptic effects could be demonstrated if the LC tissue was transplanted into intact 
hippocampus (Bengzon and others, 1993). NA-rich neurons have also been transplanted in NA depleted rats 
into extra-hippocampal regions, such as the amygdala-pyriform cortex. In this experiment grafting only affected 
seizure development if the transplanted LC neurons re-innervated the host hippocampi bilaterally (Barry and 
others, 1989). Compared to fetal LC neurons, NA-rich superior cervical ganglion (SCG) neurons demonstrated 
less survival, integration and NA release (Cenci and others, 1993). Therefore transplantation of SCG neurons 
had little or no effects on kindling rate in NA-depleted rats (Kokaia and others, 1994). Transplantation of fetal 
LC neurons in a hippocampus, which is epilepsy prone due to subcortical denervation, gave some protection 
against picrotoxin–induced behavioural seizures and resulted in less interictal spikes (Buzsaki and others, 
1988b).  
Fetal LC tissue was also transplanted in the hippocampus of the pilocarpine-induced SE model. After 
transplantation the number of spontaneous seizures was reduced from approximately 11/week to less than 
1/week, with the effect starting between 5 and 6 weeks after grafting surgery and being maximal at about 9 
weeks. However, no appropriate control groups were used in this study (Bortolotto and others, 1990). Milder 
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effects were seen when LC cells were transplanted in immature rats after kainic acid-induced SE. In this study, 
there was no reduction in the percentage of rats that developed spontaneous seizures, but the transplanted 
rats displayed fewer spontaneous seizures than sham-transplanted controls. No difference in susceptibility to 
kindling induced seizures was seen eight months after grafting (Holmes and others, 1991). 
We can conclude from these studies that NA-releasing cells can have inhibitory effects on epileptogenesis in 
specific animal models where the hippocampus is rendered epilepsy prone. NA releasing grafts do not seem to 
have large effects on established epilepsy. This limits suitability of NA releasing cells for possible clinical 
applications in TLE.  
Table 1 Overview of the transplantation studies with noradrenaline releasing cells 
Cell 
source 
Model Time point of 
transplantation 
Target Effect on seizures References 
Fetal LC 
tissue 
Kindling after 
NA-depletion 
2 weeks after depletion 
6 to 11 months before 
kindling 
Hippocampus Lower kindling 
rate 
Barry et  
al. 106 
Fetal LC 
tissue 
Kindling after 
NA-depletion 
and intact rats 
Fully kindled Hippocampus No effect on 
seizure rate 
Bengzon et 
al. 108  
Fetal LC 
tissue 
Picrotoxin 
after NA-
depletion 
10 days after depletion 
5 months before 
picrotoxin injection 
Hippocampus Protection against 
picrotoxin 
induced seizures, 
less interictal 
spikes 
Buszaki et 
al. 37  
Fetal LC 
tissue 
Subcortically 
denervated 
epilepsy-prone 
hippocampus 
Chronic epilepsy state Hippocampus Reduction in 
spontaneous 
seizures 
Bortolotto 
et al. 111  
Fetal LC 
tissue 
Pilocarpine SE  
+ kindling  
2 weeks after SE 
6 to 11 months before 
kindling 
Amygdala or 
pyriform 
cortex 
Decrease of 
kindling rate 
Barry et  
al. 109  
Fetal LC 
tissue 
KA SE + 
kindling 
10 days after SE 
230 days  before 
kindling 
Intracerebro-
ventricular 
Same fraction of 
epileptic rats; 
lower seizure 
frequency; no 
effect on kindling 
rate 
Holmes et 
al. 112  
Fetal LC 
or SCG 
tissue 
Kindling after 
NA- depletion 
and aspirative 
lesion of the 
fimbria-fornix  
4 weeks after depletion 
2 weeks after lesion 
8 months prekindling 
Fimbria-fornix 
lesion cavity 
Lower (LC tissue) 
or no effect (SCG 
tissue) on kindling 
rate  
Kokaia et  
al. 105  
KA: kainic acid; LC: locus coeruleus; TLE: temporal lobe epilepsy; NA: noradrenaline; SCG: superior cervical 
ganglion; SE: status epilepticus 
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ACETYLCHOLINE SECRETING CELLS (TABLE 2) 
The septohippocampal system is known to play a role in the regulation of hippocampal excitability. It comprises 
the medial septum (MS) and the vertical limb of the diagonal band of Broca which are connected with the 
hippocampus via the fimbria-fornix (FF). These projections are predominantly cholinergic and GABAergic (Rye 
and others, 1984). Lesioning the FF increases susceptibility for seizure development (Cassel and others, 1987) 
and produces chronic epileptiform activity like interictal spiking and decreased afterdischarge thresholds 
(Buzsaki and others, 1989b). These epileptogenic effects are predominantly due to loss of cholinergic afferents, 
since selective immunolesioning of these afferents with 192 IgG-saporin, induces comparable effects (Kokaia 
and others, 1996; Ferencz and others, 1997).  
Where embryonic, acetylcholine (AchE)-rich basal forebrain tissue was transplanted in the hippocampus of 
fimbria-fornix lesioned rats, contradictory results were found. Implantation of embryonic basal forebrain tissue 
into the hippocampus of fimbria-fornix lesioned rats showed that the grafted rats displayed more severe 
convulsions in response to the proconvulsant pentylenetetrazol (PTZ), but were less reactive to audiogenic 
stimulation. In this study there was only a poor re-innervation of the deafferented hippocampus (Cassel and 
others, 1987). In a subsequent study opposite effects were found, with a reduction of the reactivity to PTZ and 
an increase of the reactivity to sound. In this study the authors reported an improved integration of the graft 
(Cassel and others, 1991). Due to these conflicting results, conclusions about grafting AChE neurons and seizure 
susceptibility can not be drawn.  
Table 2 Overview of the transplantation studies with acetylcholine releasing cells 
Cell  
source 
Model Time point of 
transplantation 
Target Effect on 
seizures 
References 
Fetal basal 
forebrain 
tissue  
PTZ and audiogenic 
stimulation after 
lesion of  the 
fimbria-fornix  
10 days after lesion 
1 year before 
epilepsy induction 
(PTZ, sound)  
Hippocampus More 
reactive to 
PTZ; Less 
reactive to 
sound 
Cassel et 
al. 114 
Fetal basal 
forebrain 
tissue  
PTZ and audiogenic 
stimulation after 
lesion of  the 
fimbria-fornix 
8-9 days after lesion 
3, 7 or 12 months 
before epilepsy 
induction (PTZ, 
sound) 
Hippocampus Less reactive 
to PTZ; 
More 
reactive to 
sound  
Cassel et 
al. 118  
Septal-
diagonal 
band tissue 
Picrotoxin after  
192-IgG-saporin 
lesioned basal 
forebrain system 
10 days after lesion 
5 months before 
picrotoxin injection 
Hippocampus Decrease in 
kindling rate 
Ferencz et 
al. 119  
 PTZ: pentylenetetrazol 
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Intrahippocampal transplantation of AChE rich fetal septal tissue after saporin-induced lesioning of the 
forebrain cholinergic system reversed the lesion-induced facilitation of the kindling rate (Ferencz and others, 
1998). The authors propose that the suppression of epileptogenesis in the grafted animals may be due to 
restoration of the cholinergic activation of inhibitory GABAergic interneurons, although there was no direct 
proof for this assumption.  
In all these studies cholinergic grafts were implanted before induction of epileptogenesis. Whether or not 
grafts of cholinergic-rich neurons can have anticonvulsive effects after the epileptic syndrome has been 
established is still unclear.  
GABA RELEASING CELLS (TABLE 3) 
Initial evidence that administration of GABA inhibits seizure activity was reported in studies using 
neurotransmitter application in dogs (Meldrum, 1978). Peripheral administration of GABA or GABA agonists has 
several limitations, such as limited capacity to cross the blood-brain barrier, undesirable side effects and 
proconvulsant activity in primates and humans (Meldrum, 1978), due to the diffuse stimulation of GABAA 
receptors within the brain. An alternative to increase GABA release at the epileptic focus is to implant GABA-
releasing cells.  
In different regions of the brain, contributing to the manifestation of seizures, a consistent loss of glutamic acid 
decarboxylase (GAD)-positive interneurons has been demonstrated. These regions are the substantia nigra pars 
reticulata (SNr) (Loscher and Schwark, 1985; Turski and others, 1989), the basolateral amygdala (BLA) 
(Lehmann and others, 1998), the striatum (Loscher and Schwark, 1987), the pyriform cortex (PC) (Lehmann and 
others, 1998), and the hippocampus (Shetty and Turner, 2000; Gorter and others, 2001). GABA releasing cells 
have been grafted in some of these structures in different models for TLE.  
GABA-rich fetal striatal tissue has been transplanted into the SNr of fully amygdala kindled rats (Loscher and 
others, 1998). SNr was chosen because of its presumed role in the spreading of seizure activity (Loscher and 
Ebert, 1996). After transplantation, a significant increase in ADT was seen. Also a significant decrease in seizure 
severity was evident. These seizure-suppressing effects were transient and disappeared in the weeks following 
transplantation.  
As an alternative for fetal GABAergic cells, Thompson and coworkers have engineered conditionally 
immortalized mouse neurons to deliver GABA by driving GAD65 expression that could be shut down by the 
administration of doxycycline. This cell line has been transplanted into the SNr (Thompson and others, 2000), 
the pyriform cortex (Gernert and others, 2002) and the hippocampal dentate gyrus (Thompson, 2005) of rats 
prior to kindling. The effect of transplantation in the SNr was dependent on the location within the SNr. 
Transplantation in the posterior SNr significantly facilitated kindling development. When cells were 
transplanted in the anterior SNr kindling rate decreased but not significantly (Thompson and others, 2000). 
Transplantation of the cells in the pyriform cortex caused a temporary increase in ADT but did not effect 
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kindling rate (Gernert and others, 2002). The reason why this anticonvulsant effect was partial and transient 
could have several explanations such as a decrease of in vivo GABA-release, progressive cell death of 
transplanted cells or down regulation of GABA receptors in the host tissue. Transplantation of the cells in the 
hippocampus improved the results. After transplantation an elevation of ADT, a slower entorhinal kindling rate 
and a longer latency between entorhinal stimulation and behavioural seizures was found. The transplanted 
cells showed limited survival and were detected only in 30% of the transplanted animals three weeks after 
grafting (Thompson, 2005). These GABA releasing cells have also been transplanted into the anterior substantia 
nigra 45-65 days after pilocarpine induced SE (Thompson and Suchomelova, 2004). Seven to ten days following 
transplantation there was a robust suppression of behavioural seizures and a reduction in interictal spikes. The 
evaluation of the seizure suppressing effect of GABA releasing transplants ended 13 days after transplantation, 
while it would have been interesting to investigate whether this anticonvulsant effect was long lasting.  
The effect of GABA releasing cells on seizures are more convincing than earlier studies with NA and AchE 
releasing cells. Long-term cell survival and video-EEG monitoring is required in animal models with 
spontaneous seizures in order to evaluate the duration of the anticonvulsant effect and the possible presence 
of side effects. 
Table 3 Overview of the transplantation studies with GABA releasing cells 
Cell  
source 
Model Time point of 
transplantation 
Target Effect on seizures References 
Fetal striatal 
tissue 
Amygdala 
kindling  
Fully kindled SN Transient higher 
ADT 
Less severe seizures 
Löscher et  
al. 125 
GABA secreting 
cortical neural 
cell line  
Entorhinal 
cortex 
kindling  
10 days before 
kindling  
SN Posterior SN: 
higher kindling rate 
Anterior SN:  
lower kindling rate 
Thompson
et al. 127  
GABA secreting 
cortical neural 
cell line 
Entorhinal 
cortex 
kindling  
12 days before 
kindling 
Pyriform 
cortex 
Increase in ADT; 
No difference in 
kindling rate 
Gernert et 
al. 128  
GABA secreting 
cortical neural 
cell line 
Entorhinal 
cortex 
kindling  
7- 10 days 
before kindling  
Hippocampus Higher ADT 
Lower ADD 
Lower kindling rate 
Thompson 
et al. 129  
GABA secreting 
cortical neural 
cell line 
Pilocarpine 
SE  
45-65 days 
after SE 
Anterior SN Seizure-suppression 
up to 13 days after 
transplantation 
Thompson  
et al. 130  
ADD: afterdischarge duration;  ADT: afterdischarge threshold; SE: status epilepticus; SN: substantia nigra 
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ADENOSINE RELEASING CELLS (TABLE 4) 
Adenosine and its analogues have powerful antiseizure and neuroprotective activities (Lee and others, 1984; 
Fredholm, 1997). During epileptic seizures or status epilepticus, extracellular adenosine concentrations are 
elevated. This is considered to be an endogenous protective mechanism in order to control the ongoing 
seizure. Unfortunately, during the process of epileptogenesis the tonic inhibition of adenosine decreases due to 
downregulation of its A1-receptors and increased break down of adenosine by adenosine kinase (Boison, 2005; 
Boison, 2006). However, because of its great potential to control seizures, adenosine might be a good 
alternative substance for treating epilepsy. 
When administered systemically, adenosine and adenosine agonists cause adverse effects which have 
prevented its therapeutic use (Gouder and others, 2003). Therefore experiments have been set up in which 
adenosine was released locally in the brain of kindled rats by synthetic polymers (Boison and others, 1999). 
Analysis of adenosine release revealed that a release of 20-50 ng/day by the polymer is sufficient to provide 
protection against seizures. The anticonvulsant effects lasted up to fourteen days after transplantation of the 
polymer. At this moment adenosine release was reduced to less than 10 ng per day. These experiments 
showed that the amounts of adenosine required to locally suppress seizure activity were in the range, 
achievable for adenosine released from cell sources. Transplantation of cells, which have the capacity to 
survive and permanently release adenosine, is a promising tool to achieve a more sustained suppression of 
seizure activity. Baby hamster kidney fibroblasts (Huber and others, 2001), mouse myoblasts (Guttinger and 
others, 2005b) and mouse ESC -derived glia (Fedele and others, 2004; Guttinger and others, 2005a), all 
genetically engineered to release adenosine, have been transplanted in fully kindled rats. Transplantation of 
engineered hamster kidney fibroblasts and mouse myoblasts resulted in an almost complete suppression of 
kindled seizures up to 14 days after transplantation. After 14 days there was a gradual loss of seizure 
protection which could be attributed to a limited survival of the cells (Huber and others, 2001; Guttinger and 
others, 2005b). This survival dependant effect was even more evident from the experiments where mouse 
embryonic stem cell-derived glial cells were transplanted into fully kindled rats. Three days after 
transplantation complete suppression of seizures in 100 % of the animals and 90% cell viability was found. 
Seven days after transplantation, seizure suppression was lost and viable cells were no longer detectable. 
In all studies seizure-suppressant effects could be contributed to the adenosine release since injection of the 
A1 receptor antagonist DPCPX (8-cyclopentyl-1,3-dipropyl-xanthine) abolished the adenosine-induced seizure 
suppressing effects. From these studies it is evident that the search for a cell source, which is able to survive for 
prolonged time in the brain while continuously secreting anti-seizure substances, is of major importance to 
develop cell therapies for the treatment of refractory TLE patients. 
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Table 4 Overview of the transplantation studies with adenosine releasing cells 
 
 
CONCLUSION 
In TLE, structural changes in the hippocampus are believed to play a key role in the generation of epileptic 
seizures. However, given the complexity of hippocampal circuitry and cell damage in case of hippocampal 
sclerosis, structural repair of epileptic hippocampal networks will require complex transplantation strategies in 
which proper integration and rewiring of the implanted neurons will be of crucial importance. Fetal 
hippocampal transplantation has been successful in reversing some pathological changes but important 
disadvantages, such as limited migration and the need for homotopic transplantation, have urged the search 
for alternative cell types. Exogenous and endogenous neural progenitor cells could be used for the repair 
hippocampal damage. However, increased knowledge about injury-induced neurogenesis and differentiation 
pathways will be necessary in order to guide the cells towards the cell type they have to replace and prevent 
them from contributing to pathological processes such as gliosis.  
In another strategy, cells are transplanted for the release of neurotransmitters or neuromodulatory agents. 
Transplantation studies for epilepsy have mainly grafted therapeutic cells before the epileptogenesis induction. 
Although there are already promising results with certain substances, such as GABA and adenosine, further in 
vivo studies in animal models with spontaneous seizures are mandatory to initiate extrapolations to the human 
situation. 
Cell  
source 
Model Time point of 
transplantation 
Target Effect on seizures References 
Encapsulated, 
engineered baby 
hamster kidney 
cells 
Hippocampal 
kindling  
Fully kindled Lateral 
ventricle 
Day 1-14: almost complete 
suppression of seizures 
Day 14-24: gradual loss of 
seizure protection 
Huber et  
al. 137 
Encapsulated, 
engineered adult 
mouse myoblasts 
Hippocampal 
kindling 
Fully kindled Lateral 
ventricle 
Day 1-7: complete 
suppression of seizures in all 
rats 
Day7-week 8: gradual loss of 
seizures protection 
Güttinger 
et al. 138  
Encapsulated, 
engineered 
embryonic stem 
cells derived glia 
Hippocampal 
kindling 
Fully kindled Lateral 
ventricle 
Day 3: complete suppression 
of seizures in all rats 
Day 7: no seizure suppression 
Güttinger 
et al. 140 
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INTRODUCTION ON ADULT NEUROGENESIS 
DISCOVERY OF ADULT NEUROGENESIS 
The dogma that neurogenesis, i.e. the birth of new neurons, is confined to a discrete period during 
development no longer stands. There is now clear evidence for persistent neurogenesis throughout life in two 
regions of the adult mammalian brain: the dentate gyrus of the hippocampus and the olfactory system. The 
first demonstration of adult neurogenesis was in a study done by Joseph Altman and Gopal D. Das. Those 
authors injected thymidine, radioactively labelled with tritium, to label dividing cells in adult rats. Once in the 
bloodstream, tritiated thymidine competes with endogenous thymidine in all cells in the S-phase of cell division 
and is permanently incorporated in the DNA. Using autoradiography Altman & Das identified labelled granule 
cells in the dentate gyrus of the hippocampus (Altman and Das, 1965). It took another 15 years for the next 
evidence on adult neurogenesis. Michael Kaplan used electron microscopy to proof the neuronal nature of cells 
labelled with tritiated thymidine (Kaplan and Hinds, 1977). In this latter study neurogenesis was demonstrated 
both in the hippocampus and in the olfactory bulbs.  
In the early 90’s technical advances, such as the use of 5-bromo-2 deoxyuridine (BrdU) or retroviral techniques 
to label dividing cells together with double-labelling immunohistochemistry and confocal microscopy, 
confirmed new neuron production in the dentate gyrus of the hippocampus (Cameron and others, 1993) and 
the olfactory bulbs with origin of the new neurons in the subventricular zone (SVZ) (Corotto and others, 1993; 
Luskin, 1993). Like tritiated thymidine, BrdU is a thymidine analogue that can be administrated systemically to 
label dividing cells. In contrast to tritiated thymidine, BrdU can be detected with immunohistochemistry, which 
allows the combination with two or more markers. Retroviral techniques depend on the local injection of 
retroviruses which can only infect dividing cells. Gene products from the incorporated viruses or viral genome 
can be detected at a later time in differentiated cells. Transduction of proliferating cells with a retrovirus 
expressing green fluorescent protein (GFP) even allows visualization of living cells which make studies on their 
functional properties possible. All these technical progresses have paved the path for further elaboration on 
the basic mechanisms and regulation of neurogenesis in both normal and pathological brain. In 1998, Peter S. 
Ericksson, a professor working at the Sahlgrenska University Hospital of Göteborg, discovered that 
neurogenesis also occurs in adult humans by analyzing the hippocampus of patients who had deceased from 
tongue or larynx cancer and had been injected with BrdU for diagnostic puporses (Eriksson and others, 1998).  
In the following paragraphs we will give a short introduction on neurogenesis in the olfactory system and 
hippocampus of the normal adult brain. For more detailed information we refer to some excellent reviews 
(Kempermann and Gage, 1999; Gross, 2000; Lie and others, 2004; Ming and Song, 2005). It is very important to 
acknowledge that in both regions, neurogenesis comprises a dynamic process and is not a single event. Next to 
proliferation, it involves fate decision, migration, synaptic integration and survival. 
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NEUROGENESIS IN THE ADULT OLFACTORY SYSTEM  
As already stated above, the origin of the new neurons in the adult olfactory bulbs is found in the SVZ (fig. 1). 
 
Fig 1: Schematic overview of the formation of new interneurons in the olfactory bulbs from NSC in the subventricular zone (SVZ). In this 
illustration four developmental stages are discriminated. Stage 1. Proliferation: astroglial-like stem cells (B-cells; GFAP+) give rise to 
transient amplifying cells (C-cells; GFAP-, Dlx2+). Stage 2. Fate specification: C-cells differentiate into young migrating neuroblasts (A-cells; 
PSA-NCAM+, DCX+). Stage 3: Migration: Neuroblasts migrate in chains through the rostral migratory stream (RMS) towards the olfactory 
bulb. Once reaching the bulb, new neurons migrate radially to the outer cell layers. Stage 4: Synaptic integration: Immature neurons 
differentiate into either granule neurons or periglomerular neurons. The specific properties of each stage are summarized below, mainly on 
the basis of studies in adult rodents. Figure modified from (Ming and Song, 2005) 
In the SVZ, a subset of Glial Fibrillary Acidic Protein (GFAP)-positive astrocytes are believed to be the resident 
neural stem cells (NSC) (Doetsch and others, 1999; Imura and others, 2003). These astroglial-like NSC, termed 
B-cells, give rise to more rapidly dividing transiently amplifying progenitor cells, termed C cells (Doetsch, 2003). 
In the C-cells GFAP is no longer expressed but early neuronal transcription factors, such as distal-less 
homeobox2 (Dlx2) were found to be expressed in the C-cells (Doetsch and others, 2002). The C-cells, in their 
turn, give rise to young migrating neuroblasts, termed A-cells. Most of these A-cells express the polysialylated 
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form of the neural cell adhesion molecule (PSA-NCAM) and doublecortin (DCX), two molecules associated with 
neuronal migration. These neuroblasts migrate along the rostral migratory stream (RMS) towards the olfactory 
bulbs.  
This migration along the RMS is a very unique process, called chain migration, in which dividing neuroblasts 
migrate closely associated with each other within a tube-like structure, formed by astrocytes (Lois and others, 
1996). This astrocytic ribbon consists of slowly dividing cells which are presumed to have the same 
characteristics as the B-cells in the SVZ (Gritti and others, 2002). Based on removal and transplantation of the 
olfactory bulbs it is hypothesized that (unknown) chemoattractants in the olfactory bulbs are important driving 
forces for the directed migration of SVZ-derived neuroblasts (Liu and Rao, 2003). Another factor which seems 
to play an important role is Slit, a repulsant present in the striatum. From slit mutants it is evident that this 
factor prevents lateral migration of the neuroblasts into the striatum (Wu and others, 1999). 
In migrating A-cells, expression of signs of mature neuronal phenotype is delayed until the cells have reached 
the olfactory bulbs. Once there, they become positive for neurotransmitters and their receptors and show 
electrophysiological signs of neuronal maturity (Carleton and others, 2003). The RMS terminates in the core of 
the olfactory bulbs where the neuroblasts switch to radial migration towards their target areas in the granule 
and the periglomerular cell layer. There they generate granule and periglomerular interneurons respectively. 
Although the majority of the newly generated neurons die, there are arguments that adult neurogenesis 
contributes to the growth of olfactory bulbs throughout life and leads to a partial neuronal turnover (Winner 
and others, 2002). Very recently, Eriksson and co-workers, described the presence of a RMS and the generation 
of new neurons in the olfactory bulb has also in humans (Curtis and others, 2007). 
NEUROGENESIS IN THE ADULT HIPPOCAMPUS  
In the adult hippocampus neurogenesis takes place in the dentate gyrus (fig. 2). As in the SVZ the NSC have 
astrocytic electrophysiological properties and resemble radial glia (Seri and others, 2001). The cells express the 
precursor cell marker nestin but also the astrocytic marker GFAP. These astroglial NSC (also called type 1 cells), 
with their cell bodies and vascular endfeet in the SGZ, have radial processes going through the granule cell 
layer (GCL) and short tangential processes extending along the border of the GCL and the hilus.  
The type 1 astroglial stem cells slowly divide and give rise to transiently amplifying progenitor cells or type 2 
cells. These type 2 cells can be divided in two groups: type 2a and type 2b cells. Type 2a cells have retracted 
their processes, still express nestin but are no longer positive for GFAP. Type 2b cells are still positive for nestin 
but also express DCX and PSA-NCAM. The highly proliferative type 2 cells give rise to type 3 cells which are no 
longer positive for nestin but still express PSA-NCAM and DCX (Kempermann and others, 2004). The type 3 cells 
become postmitotic and migrate radially into the GCL while they further develop to mature neurons (Hastings 
and Gould, 1999; van Praag and others, 2002; Kempermann and others, 2004). This stage of neuronal 
development is characterized by transient expression of calretinin, which is later exchanged for calbindin, 
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present in mature granule cells. During the calretinin phase the cells also express NeuN, the second known 
mature marker that persists in new neurons.  
 
Fig 2: Schematic overview of the formation of new granule neurons in the granule cell layer (GCL) of the dentate gyrus from NSC in the 
subgranular zone (SGZ). In this illustration five developmental stages are discriminated. Stage 1. Proliferation: astroglial-like stem cells (type 
1-cells; GFAP+, Nestin+) give rise to transient amplifying cells (type 2a-cells; GFAP-, Nestin+). Stage 2. Fate specification: Type 2a-cells give 
rise to migrating neuroblasts (type 3 cells; Nestin-, PSA-NCAM+, DCX+) over an intermediate phase (type 2b-cells; Nestin+, PSA-NCAM+, 
DCX+). Stage 3. Migration: Neuroblasts migrate a short distance in the GCL. Stage 4. Axon/dendrite targeting: Immature neurons extend 
their axonal projections along mossy fiber pathways to the CA3 pyramidal cell layer. They send their dendrites in the opposite direction 
towards the molecular layer. Stage 5. Synaptic integration: New granule neurons receive input from the entorhinal cortex and send outputs 
to the CA3 and hilus regions. The specific properties of each stage are summarized below, mainly on the basis of studies in adult rodents. 
Figure modified from (Ming and Song, 2005) 
The first signs of neuronal function, in terms of the generation of action potentials and detectability of 
synapses, can be found when the cell still expresses nestin. As during embryogenesis GABAergic input precedes 
glutamatergic input (Ambrogini and others, 2004). The first axonal contact in the target CA3 region has been 
found as early as 3 to 5 days after division (Hastings and Gould, 1999). However, it takes 4 to 7 weeks for the 
new cells to become functionally indistinguishable from older granule cells (van Praag and others, 2002; 
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Jessberger and Kempermann, 2003). As in the olfactory bulbs the majority of the newborn neurons in the 
dentate gyrus of the hippocampus die. To give an idea: about 4800 surviving granule cells are generated per 
day in a C57BLACK6 mouse at the age of 36 days. This number decreases strongly with age. 
ADULT NEUROGENESIS AND NEURAL DAMAGE 
NEUROGENIC AND NON-NEUROGENIC REGIONS 
From both neurogenic regions (SVZ and hippocampus) neural stem cells can be isolated, expanded in culture 
and induced to generate both neurons and glial cells (Reynolds and others, 1992; Palmer and others, 1997). 
However, cells with the same in vitro properties have also been derived from other brain regions such as the 
caudal portions of the SVZ, the striatum, the neocortex, the optic nerve, the septum, the corpus callosum, the 
spinal cord, the substantia nigra, the retina and the hypothalamus (Palmer and others, 1995; Weiss and others, 
1996; Shihabuddin and others, 1997; Palmer and others, 1999; Tropepe and others, 2000; Lie and others, 
2002). This indicates that quiescent NSC also reside in other regions of the brain. Consequently it was 
investigated whether neurogenesis also occurs in those brain regions. There have been some reports which 
claim that neurogenesis occurs at low levels in the amygdala (Bernier and others, 2002), CA1 area of the 
hippocampus (Rietze and others, 2000), the dorsal vagal complex of the adult brainstem (Bauer and others, 
2005), the spinal cord (Yamamoto and others, 2001a) and the substantia nigra (Zhao and others, 2003). 
However some of these results are still disputed (Kempermann and others, 1997; Horner and others, 2000; Lie 
and others, 2002; Frielingsdorf and others, 2004). Also in the neocortex extremely low levels of neurogenesis 
were reported and the newborn neurons only survived transiently (Gould and others, 2001). But again 
conflicting results exist (Kornack and Rakic, 2001; Koketsu and others, 2003). Overall, whether neurogenesis in 
intact adult brain takes place beyond hippocampus and olfactory bulbs remains highly controversial. Even if 
new neurons are generated in those “non-neurogenic” regions it is estimated to be in extremely low numbers.  
A very likely, though not proven, explanation for the fact that neurogenesis only takes place in the olfactory 
bulbs and the granule cell layer and not in other regions containing neural progenitor cells is that the 
microenvironment needs to be permissive to sustain the formation and integration of newborn neurons. A lot 
of efforts have been made to unravel the factors which either promote or block neurogenesis in respectively 
the neurogenic and non-neurogenic region. Knowledge of these factors may contribute to strategies of brain 
repair through stimulation of endogenous neurogenesis.  
One important factor for the modulation of precursor cell activity is thought to be cell-cell contact 
(Kempermann, 2006a). In both the SVZ and the hippocampus the astroglial-like NSC are in close contact with 
other astrocytes through gap junctions and with endothelial cells through vascular endfeet resting on basal 
membrane of the endothelial cells (Filippov and others, 2003).  
Also diffusible molecules seem to regulate neurogenesis. Agasse and colleagues showed that factors secreted 
by SVZ cells promote neurogenesis in vitro, whereas protein factors from cortex actively inhibit neurogenesis 
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(Agasse and others, 2004). But when apoptosis was induced in the cortical explants, neurogenesis was 
promoted instead of blocked. Factors, which could play a role in this permissive and inhibitory signalling, are 
those which also play an important role in the regulation of neurogenesis and brain patterning during 
development. For example, it is known that bone morphogenic proteins (BMP) play an important role in 
patterning the embryo along the dorso-ventral axis. Reagents that block the BMP signalling pathway convert 
ectoderm effectively into neural tissue during embryogenesis. Lim and colleagues showed that blocking BMP 
signalling by ectopic expression of noggin allowed neurogenesis in the non-neurogenic striatum (Lim and 
others, 2000). 
ADULT NEUROGENESIS IN PHOTOTOXIC LESION MODELS 
In analogy to the in vitro study, performed by Agasse and colleagues, other studies have shown that the lack of 
neurogenic permissiveness in non-neurogenic regions may sometimes be overcome by a pathological stimulus 
in these brain regions. Pathology-induced neurogenesis can occur in two modalities: local dormant precursor 
cells may be activated to generate new neurons or precursor cells from normally neurogenic regions, e.g. the 
SVZ, may be attracted to migrate to the damaged sites.  
In an elegant study, Magavi and coworkers, stereotactically injected a phototoxic drug into layer IV of the 
anterior cortex. Corticothalamic neurons in proximity to the lesion incorporated the drug and subsequent 
exposure to laser light induced death of these cells through apoptosis. The authors observed that doublecortin 
(DCX) positive precursor cells migrated towards the lesion. By labelling dividing cells with BrdU at the time of 
the lesion and staining for a neuronal markers up to 28 weeks after labelling they found that new neurons were 
generated at the lesion site. By retrograde labelling, using fluorogold, they confirmed that the cells adequately 
projected to the thalamus (Magavi and others, 2000). Using an analogue targeted apoptosis approach the same 
group showed that endogenous neuroblasts replace ablated corticospinal projection neurons in juvenile mice 
with a portion of these new neurons extending axons to the spinal cord (Chen and others, 2004). These studies 
are very promising as they show that cell death in non-neurogenic regions is sufficient to render the 
environment permissive for neurogenesis and that endogenous neural progenitors mediate cellular repair. 
However one needs to keep in mind that the damage in these models is very “sterile” and not a realistic model 
for brain injury.  
ADULT NEUROGENESIS IN ISCHEMIC LESION MODELS 
In models with more extensive damage, such as ischemia, neural replacement by endogenous neural 
precursors has also been demonstrated (fig. 3). Two independent studies showed that after inducing a focal 
ischemic lesion in the striatum by permanent occlusion of the middle cerebral artery, a small fraction (about 
0.2%) of the lost medium spiny interneurons in the striatum was replaced (Arvidsson and others, 2002; Parent 
and others, 2002b). In a study done by Yamashita and colleagues, a cell-type-specific viral infection method 
was used to show that these new striatal neurons were derived from the GFAP-expressing NSC present in the 
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SVZ (fig. 3). The newborn cells migrated from the SVZ to the peri-infarct region in close association with the 
blood vessels (Yamashita and others, 2006).  
In the four vessel occlusion (4-VO) model short and transient induction of global ischemia selectively affects 
hippocampal CA1 pyramidal neurons. In this model, Nakatomi and coworkers found that after the ischemic 
stimulus damaged CA1 neurons were replaced by endogenous neural progenitors (fig. 3). At least a portion of 
these progenitors arose from the posterior periventricular region (PPV). Brief intraventricular infusion of 
growth factors in the first week after stroke markedly increased reconstitution of CA1 (Nakatomi and others, 
2002). In this model neuronal replacement was associated with partial behavioural recovery although the role 
of replaced neurons in functional improvement still needs to be proven.  
In both the focal and global ischemia models, about a 10-fold increase in proliferation of dentate granule cell 
precursors has been observed. This resulted in a net increase of the number of newly generated granule 
neurons (fig. 3). As in normal animals, the granule neurons generated in response to the ischemic lesion 
integrated into the GCL. The relevance of increased granule cell neurogenesis in response to ischemia is 
currently not yet clear (Liu and others, 1998; Scharfman and others, 2000; Kee and others, 2001; Tanaka and 
others, 2004; Matsumori and others, 2006; Lichtenwalner and Parent, 2006).  
 
Fig 3: Endogenous neurogenesis is stimulated in focal and global ischemia models. A) After focal ischemic damage to the striatum (STM) 
SVZ-derived neuroblasts migrate towards the STM where they replace at least in part lost striatal neurons; B) In both focal and global 
ischemia models dentate granule cell neurogenesis is stimulated in the dentate gyrus; C) after transient global ischemia neuroblasts from 
the posterior periventricular region (PPV) migrate towards damaged CA1 region where they replace lost pyramidal neurons (arrows). 
Abbreviations: DG, dentate gyrus; OB, olfactory bulb; PPV, posterior periventricular region; RMS, rostral migratory stream; STM, striatum; 
SVZ, subventricular zone. Figure adopted from (Lichtenwalner and Parent, 2006) 
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ADULT NEUROGENESIS IN OTHER LESION MODELS  
In 6-OHDA nigrostriatal lesion models for PD induced cell proliferation was evident in the substantia nigra but 
only glial cells were generated (Lie and others, 2002). In this lesion model also direct migration of SVZ precursor 
cells into the striatum was seen. However in contrast to an ischemic lesion where a low level of regenerative 
neurogenesis was constitutively found (Arvidsson and others, 2002),a low level of neuronal differentiation of 
the SVZ precursors cells was only evident after infusion with transforming growth factor-α (Fallon and others, 
2000). In the neurogenic regions a reduced neurogenesis was found and no signs of induced regeneration 
(Hoglinger and others, 2004).  
In a quinolinic-acid model of Huntington disease medium spiny neurons of the striatum are degenerated. In 
response to the lesion, progenitor cell migration through the RMS is enhanced for up to 30 days. Additionally, a 
fraction of the SVZ-derived precursor cells migrate into the lesioned striatum. However, the cells adopted 
exclusively a glial fate and no regeneration of medium spiny striatal neurons could be demonstrated (Gordon 
and others, 2007).  
Traumatic injury comprises several types of cellular damage (axonopathies, ischemia, hypoxia, excitotoxicity) 
and therefore the neurogenic response to trauma is complex and highly variable. So far, trauma-induced 
functional neurogenesis beyond the neurogenic regions has not been described yet. Migration of SVZ-derived 
precursor cells towards the lesion is evident but the cells uniquely adopt a glial fate and thereby seem to 
contribute to the glial scar (Kernie and others, 2001; Salman and others, 2004). In a fluid percussion model of 
traumatic brain injury there is a net increase (4 to 5 fold) in neurogenesis in both the ipsilateral and 
controlateral hippocampus (Dash and others, 2001; Kernie and others, 2001). The trauma-induced neurogenic 
response in the dentate gyrus is reduced in FGF-2-deficient mice and can be stimulated by gene transfer with 
FGF-2 (Yoshimura and others, 2003). Although percussion trauma also induces an increase in proliferation of 
SVZ precursors it is not yet clear whether this also lead to enhanced neurogenesis in the olfactory bulb.  
Adult spinal cord has been demonstrated to contain multipotent precursor cells which can generate neurons 
after implantation into neurogenic regions. In case of injury to the spinal cord there is increased proliferation of 
the precursor cells. Most studies described that these neural precursors primarily generate astrocytes response 
to the lesion (e.g. (Yamamoto and others, 2001b; Takahashi and others, 2003)). A recent study, though, 
demonstrated that transduction of endogenous neural precursor cells with a neurogenic transcription factor 
(Neurgenin2) and treatment with a growth factor (BDNF) could induce in situ neuronal differentiation of the 
spinal cord NSC (Ohori and others, 2006).  
Taken together, besides in stroke models, evidence for neuronal cell replacement from endogenous precursor 
cells at the lesion site is extremely limited. However, an increasing amount of studies show that modulation of 
the damaged environment in a variety of lesions by growth factor infusion, cell transplantation, gene transfer 
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can stimulate neuronal replacement from endogenous sources  (Fallon and others, 2000; Nakatomi and others, 
2002; Yoshimura and others, 2003; Ohori and others, 2006).  
NEUROGENESIS IN EPILESY  
Many intrinsic (e.g. aging, hormones, neurotransmitters, growth factors) and extrinsic (e.g. environmental 
enrichment, exercise, stress) factors influence the individual stages of adult neurogenesis. However also 
pathological situations, such as mechanical lesions, excitotoxicity, ischemia, traumatic brain injury and seizures, 
affect different stages of neurogenesis (Gould and Tanapat, 1997; Parent and others, 1997; Dash and others, 
2001; Kee and others, 2001; Parent, 2002).  
Seizure-activity, in both the kindling and SE models, has a profound influence on the process of neurogenesis in 
both the olfactory system and the dentate gyrus. In the SVZ, precursor cell proliferation is stimulated both after 
amygdala kindling (Sato and others, 2002) and pilocarpine (PILO)-induced SE (Parent and others, 2002a). In 
case of PILO-induced SE, migration of SVZ-derived progenitor cells along the rostral migratory stream (RMS) to 
the olfactory bulbs is enhanced (Parent and others, 2002a). Whether this higher number of migrating 
neuroblasts also results in more surviving olfactory bulb neurons is not yet elucidated.  
Several studies in kindling and SE models have shown that seizure-activity significantly affects different stages 
of adult hippocampal neurogenesis (fig. 5) (Parent and others, 1997; Bengzon and others, 1997; Gray and 
Sundstrom, 1998; Parent and others, 1998; Scott and others, 1998; Scharfman and others, 2000; Nakagawa and 
others, 2000; Ferland and others, 2002; Romcy-Pereira and Garcia-Cairasco, 2003; Huttmann and others, 2003; 
Mohapel and others, 2004; Jessberger and others, 2005; Smith and others, 2005; Pierce and others, 2005; 
Shapiro and others, 2005; Shapiro and Ribak, 2005; Parent and others, 2006; Overstreet-Wadiche and others, 
2006; Shapiro and Ribak, 2006; Bonde and others, 2006). Seizure-activity in both models has clear stimulating 
effects on the proliferation of hippocampal radial glia-like stem and type 2 and type 3 progenitor cells (Parent 
and others, 1997; Bengzon and others, 1997; Gray and Sundstrom, 1998; Parent and others, 1998; Scott and 
others, 1998; Huttmann and others, 2003; Jessberger and others, 2005; Smith and others, 2005).This results in 
a net increase of neurogenesis. In the chemoconvulsant and electrical SE models, precursor cell proliferation is 
increased five- to tenfold after a latent period of a few days (Parent and others, 1997; Gray and Sundstrom, 
1998; Parent, 2002; Jessberger and others, 2005). In the amygdala kindling model and the rapid hippocampal 
kindling model, neurogenesis is increased respectively three to six times. In case of amygdala kindling increases 
are only seen after nine stage IV/V seizures while in the hippocampal kindling model neurogenesis is already 
increased three-fold five days after experiencing one single seizure (Bengzon and others, 1997). In models 
where kindling seizures are evoked by flurothyl or high intensity sound, no neural cell damage is evident but 
there is an upregulation of neurogenesis to the same extent as in electrical kindling models. This indicates that 
increased neurogenesis is caused by the seizure itself and not by seizure-induced damage (Ferland and others, 
2002; Romcy-Pereira and Garcia-Cairasco, 2003). This increase in neurogenesis after seizures is only temporary 
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and returns back to baseline or even below within the first month after the seizures (Parent and others, 1997; 
Nakagawa and others, 2000).  
Next to this increased rate of precursor cell proliferation and neurogenesis, seizure activity can also modulate 
the migration of neuroblasts (fig. 4). After kindling, but more prominently after SE, a part of the newborn 
neurons migrate aberrantly from the SGZ to ectopic locations in the molecular layer and the hilus of the 
dentate gyrus where they differentiate towards mature granule neurons (Parent and others, 1997; Scharfman 
and others, 2000; Parent, 2002; Smith and others, 2005; Pierce and others, 2005; Shapiro and others, 2005; 
Shapiro and Ribak, 2005; Parent and others, 2006; Shapiro and Ribak, 2006). Although these ectopic neurons 
demonstrate classic granule cell membrane properties and firing behaviour, they might contribute to the 
formation of hyperexcitable networks since they have an increased proportion of somatic and dendritic 
asymmetric (presumably excitatory) synapses (Dashtipour and others, 2003; Pierce and others, 2005), 
increased mossy fiber innervation (Pierce and others, 2005) and a distinct pattern of activation during 
spontaneous seizures. Furthermore, spontaneous epileptiform bursts have been recorded from these ectopic 
hilar granule cells, but not from conventional granule cells (Scharfman and others, 2000).  
Synaptic integration of the newborn granule neurons can also be altered (fig. 4). Morphological analysis shows 
that part of the newborn granule cells have a persistent basal dendrite, which is normally only temporarily 
present in migrating immature neurons (Pierce and others, 2005; Shapiro and others, 2005; Shapiro and Ribak, 
2005; Shapiro and Ribak, 2006). 
Fig 4: Schematic illustration of the influence of seizure-activity on the different stages of adult hippocampal neurogenesis. These influences 
range from increased proliferation of neural stem and progenitor cells to migration defects leading to ectopically positioned new granule 
cells. Also synaptic integration of the new cells is altered. The new neurons might show abnormal growth of basal dendrites and contribute 
to mossy fiber sprouting. Also their functional integration is sped up. However it seems that mature seizure-generated granule neurons 
receive reduced excitatory drive and enhanced inhibitory input. Figure adopted from (Kempermann, 2006b). 
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This basal dendrite projects into the hilus and is innervated by mossy fibers (Pierce and others, 2005; Shapiro 
and Ribak, 2006). Parent and coworkers have demonstrated that part of the newly born neurons form axonal 
collaterals which innervate neighbouring granule cells instead of CA3 or hilar neurons (Parent and others, 
1997). This process is called mossy fiber sprouting and is described more extensively higher in this dissertation. 
The morphological development of immature granule cells is accelerated after seizures. The extension and 
arborisation of dendrites is sped up and the newborn neurons receive more rapidly excitatory input from 
appropriate (perforant path) but also from pathological afferents (sprouted mossy fibers) (Overstreet-Wadiche 
and others, 2006).  
Although most changes in hippocampal neurogenesis in case of seizures suggest a pro-epileptic role, a recent 
study has shown that epilepsy-generated mature granule neurons in the GCL are suppressed, as they receive 
less excitatory drive and more inhibitory input compared to new granule neurons generated in physiological 
conditions (Jakubs and others, 2006). This observation suggests that the new neurons adjust their functional 
status to their local network environment and therefore might help to compensate for pathological excitation 
in epileptic seizures.  
Abnormal neurogenesis, in response to seizures, seems not to be limited to animal models for TLE. In human 
TLE patients a higher number of neural precursors (Crespel and others, 2005; Thom and others, 2005) and the 
presence of putative ectopic granule cells (Parent and others, 2006) have been reported. Up till now, it is still 
not clear whether this seizure-induced alteration of neurogenesis is an attempt of the brain to repair neural 
damage or whether it is a part of the pathogenesis of TLE. 
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RATIONALE  
A recent study evaluated the effectiveness of AED treatment in a large patient group (2200 patients) and 
demonstrated that patients with TLE showed the worst prognosis. Only 20% of patients with TLE remained 
seizure free for longer than one year. In case of HS and dual pathology (HS and another lesion) seizures were 
controlled only in 11% and 3% respectively {Semah, 1998 377 /id}. This is in line with the current assessment 
that TLE is the most medically refractory form of human epilepsy. As newer AED do not differ markedly in 
efficacy from the more traditional ones, most medically refractory TLE patients are considered for epilepsy 
surgery {Spencer, 2002 27 /id}. A recent randomized controlled study has demonstrated the superior outcome 
of resective surgery compared to medical therapy. 58% of the TLE patients were seizure free for at least one 
year compared to 8% in the medical group {Wiebe, 2001 14 /id}. But there are a considerable number of 
patients in whom resective surgery cannot be performed because presurgical evaluation has revealed that 
seizures originate in both temporal
 
lobes, or that there is a risk for substantial decline in memory after
 
temporal lobectomy. Only 30% to 50% of the surgical candidates who are enrolled in a presurgical evaluation 
protocol eventually undergo surgery {Boon, 1999 17 /id}. One of the major side effects of resective surgery in 
the temporal lobe is reported to be an acceleration of cognitive decline, especially in those patients in which 
presurgical memory and MRI was normal and surgery did not lead to a control of seizures {Helmstaedter, 2003 
378 /id}. Hoping to minimize the risk of memory loss, less invasive surgical
 
procedures and smaller resections 
e.g. amygdalohippocampectomy
 
have been adopted. Unfortunately, there is evidence of memory
 
decline even 
with these more limited resections {Gleissner, 2002 379 /id}. The inability to adequately treat all refractory 
MTLE patients with resective surgery and the reported risk of cognitive decline after resection of temporal lobe 
structures provides a continuous impetus to search for non-resective treatments which are able to control or 
even cure MTLE with the preservation or even restoration of cognitive functions.  
Neurostimulation is one of the recent developments in the treatment of epilepsy. Two forms of 
neurostimulation are particularly interesting for the treatment of epilepsy, namely vagus nerve stimulation 
(VNS) and deep brain stimulation (DBS).  
To date, only VNS is an approved neurostimulation therapy for epilepsy. Two prospective multicentre double-
blind studies have demonstrated the efficacy of VNS by reporting a reduction in seizure frequency of 
respectively 24 % {1995 380 /id} and 28% {Handforth, 1998 319 /id}. In an open label study performed at Ghent 
University Hospital and Dartmouth Hitchcock Medical Centre a reduction in seizure frequency of 55% was 
demonstrated {Vonck, 2004 24 /id}. Unfortunately, the number of patients rendered seizure-free (without 
medication) with VNS is low.  
DBS of CNS structures such as the anterior and centromedian nuclei of the thalamus, the caudate nucleus, the 
subthalamic nucleus and the hippocampus is a more invasive treatment option. Multicentre studies are in 
progress to assess the value of DBS of the anterior thalamus and subthalamic nucleus {Loddenkemper, 2001 
381 /id}. An open label trial performed at Ghent University Hospital has demonstrated the efficacy and safety 
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of DBS of medial temporal lobe structures with a significant reduction of epileptic seizures and epileptic spikes 
{Vonck, 2002 26 /id}. Up till now only one randomized controlled study has been performed, with DBS focussed 
to the anterior thalamic nucleus, but this study did not confirm efficacy {Fisher, 1992 382 /id}. Since the precise 
mechanism of action of for both neurostimulation techniques (VNS, DBS) is not yet elucidated, it is difficult to 
adjust stimulation parameters or to identify ideal treatment candidates in order to optimize outcome.  
Because even after VNS or DBS a lot of patients remain refractory, preclinical studies are ongoing to develop 
new treatments for refractory TLE patients. A possible alternative treatment option for TLE is cell therapy in 
which cells are used to mediate structural and/or neurochemical repair of hyperexcitable networks. There are 
two main approaches in which cell therapy could be applied to treat TLE. In a first approach, exogenous cells 
are transplanted into the epileptic brain, with or without previous manipulation in vitro. In a second approach, 
endogenous cell replacement is manipulated to reduce hyperexcitability.  
The first type of cells that were transplanted into different brain regions of various TLE models were fetal brain 
cells. A review of these experiments is given in the introduction. In general, transplantation of fetal 
hippocampal cells in damaged areas of the hippocampus resulted in the partial replacement of lost neurons, 
the restoration of some appropriate synaptic connections and the partial reversal of some biochemical 
abnormalities {Turner, 2003 383 /id}. Alternatively, fetal cells were derived from regions containing high 
amounts of neurotransmitters involved in endogenous inhibitory mechanisms (NA, AchE, and GABA) and 
transplanted into the epileptogenic zone or areas that regulate seizure threshold and/or propagation prior to 
kindling or before the induction of acute seizures. In many cases this resulted into an increased threshold to 
evoke seizures, a reduction in seizure severity and/or a decrease in kindling rate {Nilsen, 2004 384 /id;Raedt, 
2007 385 /id}. The effect of fetal cell transplantation on spontaneous seizures was rarely studied.  
Although the results were very promising, clinical applications on a large scale will always be hampered by 
ethical and practical problems associated with the use of fetal tissue. One of the major problems is the inability 
to expand or store fetal tissue which implies that a high amount of fetuses are needed to obtain sufficient 
tissue for transplantation.  
In analogy to cell therapy for other neurodegenerative diseases, it is mandatory that we search for alternative 
donor cells to replace fetal tissue {Lindvall, 2004 267 /id}. Great promise holds for stem and/or progenitor cells 
to replace fetal cells for the repair of damaged neural networks. As described in the introduction, stem and 
progenitor cells with neuropotency can be isolated from the blastocyst (embryonic stem cells), embryonic and 
fetal brain tissue, adult neural tissue and adult non-neural tissues. Especially the potential for self-renewal and 
differentiation towards neural cell types make neuropotent stem/progenitor cells potentially useful for 
transplantation in a variety of different neurological diseases such as Parkinson’s disease, stroke, Huntington’s 
disease, epilepsy, etc. Particularly interesting for future use in a clinical setting are neuropotent adult-derived 
(somatic) stem cells since these do not involve ethical issues and would make autologous transplantation 
possible, free of immunorejection problems.  
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Neural stem cells (NSC) isolated from adult CNS regions (hippocampus, SVZ, spinal cord, etc.) but also stem 
cells-derived from adult non-neural tissue such as skin, adipose tissue, liver and bone marrow were reported to 
express neural markers after in vitro differentiation. However, conflicting reports in literature {Bertani, 2005 
386 /id;Lu, 2005 387 /id;Neuhuber, 2004 388 /id} motivated us to compare the in vitro neurogenic potential of 
bone marrow-derived multipotent stem cells, called multipotent adult progenitor cells (MAPC), to that of brain-
derived neural stem cells {Raedt, 2006 634 /id}.  
Alternative cell sources have been transplanted into the brain of TLE models with promising antiepileptic and 
anti-epileptogenic effects. Fibroblasts {Huber, 2001 312 /id}, myoblasts {Guttinger, 2005 368 /id}, embryonic 
stem cells and embryonic stem cell-derived glia {Guttinger, 2005 369 /id}, engineered to release high amounts 
of adenosine were encapsulated in semi-permeable polymers and transplanted in the lateral ventricle of fully 
kindled rats. This resulted in a robust suppression of kindling evoked seizures {Guttinger, 2005 368 
/id;Guttinger, 2005 369 /id;Huber, 2001 312 /id}. Grafting of conditionally immortalized neuroprogenitor cells, 
isolated from mouse embryonic cortex and engineered to release high amounts of GABA, increased kindling 
threshold and suppressed kindling rate after transplantation in the substantia nigra, the hippocampus and the 
pyriform cortex {Gernert, 2002 306 /id;Thompson, 2000 309 /id;Thompson, 2005 363 /id}. These GABA 
releasing cells were also grafted in rats with spontaneous epileptic seizures and had a significant suppression of 
epileptic spikes and seizures as a result {Thompson, 2004 310 /id}. However, up till now, no long term 
antiepileptic effects after transplantation of adenosine- or GABA-releasing cells could be demonstrated due to 
progressive cell death of the transplanted cells, including those that did not secrete the therapeutic agent 
{Fedele, 2004 311 /id;Guttinger, 2005 369 /id;Huber, 2001 312 /id;Thompson, 2005 363 /id}. So in order to 
obtain more robust antiepileptic effects, other cell types and/or transplantation paradigms need to be tested in 
order to maximize cell survival and suppression of evoked or spontaneous seizures.  
In this dissertation, we transplanted adult-derived NSC in the damaged hippocampus of the intrahippocampal 
KA model for TLE. Since habitual seizure parameters were not yet determined for this model, we first 
monitored this model for an extended time using video-EEG monitoring to assure its future usefulness for 
testing of seizure-suppressive effects of antiepileptic therapies, such as cell transplantation. Consequently, we 
set up a transplantation experiment to assess the influence of several variables (such as the presence of a KA 
lesion, delay between lesion and transplantation and delay between transplantation and tissue examination) 
on different outcome parameters (such as survival, dispersion and differentiation).  
A second cell therapy approach involves modulation of endogenous neurogenesis. Endogenous neurogenesis is 
reported to be stimulated after different types of brain insults such as seizures, stroke and trauma. In stroke, 
endogenous neuroprogenitor cells of the SVZ migrate towards the damaged striatum and hippocampus where 
they replace respectively lost striatal and hippocampal neurons {Bendel, 2005 389 /id;Parent, 2003 390 
/id;Yagita, 2001 391 /id;Parent, 2002 38 /id}. This endogenous repair can be stimulated by perfusion of growth 
factors in the ventricles following stroke {Nakatomi, 2002 263 /id}. Neurogenesis is also increased after seizures 
but whether this is a reflection of endogenous repair, a contribution to the formation of epileptic networks or a 
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bystander effect of increased neural activity is not yet elucidated. Especially in the hippocampus, there are 
reasons to believe that aberrant neurogenesis in response to seizures could contribute to epileptogenesis. 
Firstly, increased neurogenesis and epileptogenesis seem to occur during the same time window {Parent, 1997 
125 /id;Smith, 2005 132 /id}. Secondly, synaptic integration of newborn neurons is accelerated and enhanced 
in response to seizures {Overstreet-Wadiche, 2006 129 /id}. Thirdly, in contrast to normal situations part of the 
newborn neurons form a persistent basal dendrite on which they receive excitatory inputs and they form axons 
which innervate neighboring excitatory neurons {Shapiro, 2005 136 /id}. Fourthly, some newborn granule 
neurons seem to contribute to the formation of recurrent excitatory networks by their involvement in mossy 
fiber sprouting {Parent, 1997 125 /id}. Finally, part of the newborn neurons migrates towards ectopic location 
in the hilus in proximity to the CA3 layer. This abnormal location could predispose the cells to contribute to 
hyperexcitable networks. For example, they exhibit abnormal spontaneous network bursts after pilocarpine-
induced status epilepticus {Scharfman, 2000 134 /id}. They receive dense mossy fiber innervation {Pierce, 2005 
133 /id} and they are likely to be innervated by CA3 pyramidal cells because they exhibit closely synchronized 
burst discharges in slices from pilocarpine-treated rats {Scharfman, 2000 134 /id}.  
Based on these indications for a contributing role of aberrant neurogenesis in the formation of hyperexcitable 
networks, we have explored the possibility to block seizure induced increases in neurogenesis using low-dose, 
whole brain radiation in order to interfere with epileptogenesis in a kindling model for TLE.  
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AIMS 
The aims of this dissertation were to test the feasibility of two different cell therapy approaches for TLE: cell 
transplantation and modulation of endogenous neurogenesis. The following questions were raised:  
CELL TRANSPLANTATION FOR TEMPORAL LOBE EPILEPSY: 
A. Neuropotency of multipotent adult progenitor-like cells and adult neural stem cells  
1. Can we isolate cell clones from the bone marrow which display the high proliferative potential, 
morphology and phenotypic profile as described for multipotent adult progenitor cells (MAPC)? 
2. Are the MAPC-like cells pluripotent? In other words can we differentiate them towards endodermal 
(endothelium), mesodermal (hepatocytes) and ectodermal (neuroepithelium) cells?  
3. Can we isolate neurosphere-forming neural stem cell (NSC) clones from the SVZ of adult rats?  
4. Can these NSC be differentiated towards the three neural lineages: neurons, oligodendrocytes and 
astrocytes? 
5. Which in vitro differentiation protocols can be used to compare neuropotency of both MAPC-like cells 
and NSC? 
6. Which techniques can be used to evaluate neuropotency?  
7. Is there a difference in the neuropotency of MAPC-like cells and NSC? 
B. Intrahippocampal kainic acid model for temporal lobe epilepsy 
1. What is the mortality rate after SE induced by intrahippocampal KA injection? 
2. What is the fraction of rats displaying spontaneous seizures after intrahippocampal KA injection?  
3. At what time following KA-induced SE can spontaneous seizures be detected? 
4. What is the behavioural component of the spontaneous seizures?  
5. What is the mean duration of the spontaneous seizures? 
6. Is there a large variation in seizure frequency among rats?  
7. Is there a progression in seizure frequency? 
8. Do the spontaneous seizures occur in a circadian rhythm?  
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9. Could the intrahippocampal KA model be used for the evaluation of anti-epileptic effects of cell 
transplantation?  
C. Transplantation of adult neural stem cells in the intrahippocampal kainic acid  model 
1. Do adult-derived NSC survive after transplantation in the intact or KA-lesioned hippocampus? 
2. Is the survival rate affected due to the presence of the lesion? 
3. Are the dispersion and/or integration of the transplanted cells different in intact compared to lesioned 
hippocampus? 
4. To which type of cells do NSC differentiate after transplantation? 
5. Is the cell fate of the NSC influenced by the presence of a KA lesion?  
6. Are outcome parameters of the transplantation (survival, dispersion, integration and differentiation) 
affected by a longer delay between the lesion and the transplantation? 
7. Is survival of the NSC stable over time? 
8. Could NSC be used for the structural repair of damaged epileptic networks in the intrahippocampal 
kainic acid model? 
9. Could NSC be used for the local delivery of seizure-modifying substances? 
MODULATION OF ENDOGENOUS NEUROGENESIS  
1. Can low-dose, whole brain radiation suppress neurogenesis in the rapid kindling model for TLE? 
2. Is there a permanent suppression of neurogenesis? 
3. Is there a difference in afterdischarge thresholds and afterdischarge duration between radiated and non-
radiated rats? 
4. Does radiation affect kindling rate? 
5. Is brain inflammation different between radiated and non-radiated rats? 
6. Can radiated rats be fully kindled? 
7. Does radiation affect permanence of the fully kindled state? 
8. Could suppression of seizure-induced neurogenesis be a potential cell therapy for TLE? 
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OUTLINE OF THE THESIS 
Chapter 1 provides a general introduction on epilepsy, the treatment of epilepsy and animal models for 
epilepsy, all with a special focus on temporal lobe epilepsy (TLE).  
Chapter 2 present two reviews. The first review more generally deals with cell therapy in different neurological 
diseases (Parkinson’s disease, stroke and epilepsy). In an addendum the reader is updated with the most recent 
information concerning the items discussed in this first review. The second manuscript focuses specifically on 
cell therapy for TLE.  
Chapter 3 provides a general introduction on neurogenesis and its modulation in reponse to different lesions 
and epileptic seizures.  
Chapter 4 describes the rationale for testing the feasibility of cell transplantation and modulation of 
endogenous neurogenesis as potential cell therapies for TLE. Specific questions regarding both approaches that 
have been addressed in this dissertation are clearly formulated. Methods and results of our original research 
are reported in Chapter 3 and Chapter 4. 
Chapter 5 focuses on the feasibility of cell transplantation as potential treatment of TLE. It is a compilation of 
three manuscripts. The first manuscript describes an in vitro experiment in which we compared the 
neuropotency of two adult-derived stem cell types: brain-derived neural stem cells and bone marrow–derived 
multipotent stem cells. The second manuscript describes a long term video-EEG monitoring study to 
characterize spontaneous seizures in the intrahippocampal kainic acid (KA) rat model for TLE. The third 
manuscript describes a study in which adult neural stem cells were transplanted in the sclerotic hippocampus 
of the intrahippocampal KA model for TLE.  
Chapter 6 focuses on the feasibility of modulating endogenous neurogenesis as potential treatment for TLE. It 
comprises one study in which rats were exposed to low-dose, whole brain radiation in order to suppress 
neurogenesis during kindling epileptogenesis.  
Chapter 7 discusses the results obtained from this dissertation. The different observations are put in the 
context of the current literature and the main questions and objectives, formulated in this thesis.  
Chapter 8 provides a general conclusion by answering the research questions, formulated in chapter 2.  
Chapter 9 provides future perspectives for further research within the field of cell transplantation and 
modulation of endogenous neurogenesis.  
Finally a summary of this dissertation is presented in English, Dutch and French.  
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In this manuscript we compared the neuropotency of bone marrow-derived multipotent stem cells with that of 
brain-derived NSC. Because we isolated and expanded the bone marrow-derived cells as described for MAPC 
but the cells did not display the same multilineage potential we termed those cells MAPC-like cells. Both the 
morphology and the expression of five neural antigens were compared between NSC and MAPC-like cells 
before and after neural differentiation by three different protocols. To compare neural antigen expression both 
real-time polymerase chain reaction (RT-PCR) and immunocytochemistry were used.  
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SUMMARY  
There is accumulating evidence for a neurogenic potential of bone marrow -derived cells both in vitro as well as 
in vivo. Most claims of neural “transdifferentiation” have based their conclusions on morphology and neural 
gene expression. Recently, doubts have been raised about the validity of both outcome parameters since non-
neural cells can extend neurites and show aberrant neural gene expression as a response to stress inducing 
factors. In this study we compared bone marrow-derived Multipotent Adult Progenitor Cell (MAPC)-like cells 
and neural stem cells (NSC) in their morphology and neural gene expression profile after neural differentiation 
using three differentiation protocols. We evaluated the expression of five neuro-glial antigens [neurofilament 
200 (NF-200); beta III tubulin (β3 tub); tau; glial fibrillary acidic protein (GFAP); myelin basic protein (MBP) and 
RIP antigen] using real time PCR (RT-PCR) and immunocytochemistry (ICC). MAPC-like cells adopted a neural-
like morphology in one protocol but a fibroblast-like morphology in the two other protocols. RT-PCR and ICC 
show that MAPC-like cells already express the neural antigens beta III tubulin and NF200 at baseline, but 
without upregulation of these genes after exposure to three distinct differentiation protocols. In contrast, NSC 
adopt neural and glial morphologies with a clear increase in expression of all neuro-glial genes in all 
differentiation protocols used. In conclusion, our data demonstrate that neural-like morphology and expression 
of a limited set of neural marker genes by MAPC-like cells after differentiation is no absolute proof of neural 
transdifferentiation because MAPC-like cells only partially meet the criteria which are fulfilled by NSC after 
neural differentiation.  
 Chapter 5 | Cell transplantation for TLE 133 
 
INTRODUCTION 
An adult stem cell source that is easy accessible and can be differentiated towards different neural cell types 
could be the ultimate cell source for cell therapy of neurodegenerative diseases. It is therefore not surprising 
that initial reports of a possible neurogenic potential of bone marrow-derived cells led to an explosion of 
reports which claimed that bone marrow-derived cells can adopt a neural identity (Eglitis and Mezey, 1997; 
Brazelton and others, 2000; Mezey and others, 2000; Priller and others, 2001; Nakano and others, 2001; Zhao 
and others, 2002; Mezey and others, 2003; Weimann and others, 2003; Munoz-Elias and others, 2004). 
However, more recent studies have clearly shown that such in vivo differentiation may be partial, extremely 
rare (Wagers and others, 2002) or may be artifactual (Alvarez-Dolado and others, 2003). In some studies, 
donor-derived cells are found in the brain after transplantation but these do not express neural antigens 
(Castro and others, 2002; Massengale and others, 2005). In other studies a fraction of the transplanted bone 
marrow cells do express neural antigens but these cells have a morphology distinct from adult neurons 
(Brazelton and others, 2000; Mezey and others, 2000; Zhao and others, 2002). Studies in which differentiation 
from blood stem cells to neurons was quantified, measured an extremely low efficiency of differentiation 
towards neural cells (Wagers and others, 2002). Original reports that bone marrow cells could differentiate 
towards Purkinje neurons were challenged by others, reporting that these cells were the result of fusion of 
donor cells with endogenous Purkinje neurons (Alvarez-Dolado and others, 2003; Weimann and others, 2003) 
Next to these in vivo studies, several in vitro studies have shown that stem cells could be isolated out of bone 
marrow and that these stem cells were capable of transdifferentiation towards neural-like cells (Sanchez-
Ramos and others, 2000; Woodbury and others, 2000; Deng and others, 2001; Kohyama and others, 2001; Kim 
and others, 2002; Jiang and others, 2002; Kabos and others, 2002; Rismanchi and others, 2003; Jiang and 
others, 2003; Levy and others, 2003; Locatelli and others, 2003; Padovan and others, 2003; Dezawa and others, 
2004; Munoz-Elias and others, 2004; Tondreau and others, 2004; Magaki and others, 2005; Bossolasco and 
others, 2005). In some of these studies, bone marrow-derived cells were even capable of differentiation 
towards cells of the three different germinal layers (endoderm, mesoderm and ectoderm). These cells were 
called Multipotent Adult Progenitor Cells (MAPC) (Reyes and others, 2001; Jiang and others, 2002; Schwartz 
and others, 2002)or Marrow-Isolated Adult Multilineage Inducible (MIAMI) cells (D'Ippolito and others, 2004).  
Most differentiation studies base their conclusions on morphological data, namely the formation of neurite like 
extensions, and immunohistochemical data, namely the expression of neural antigens, data. However recent 
evidence suggests that a neural-like morphology or neural antigen expression may not be as specific as 
previously thought. For example, Woodbury et al. recently developed a differentiation protocol where bone 
marrow stromal cells rapidly (within several hours) display neural morphology and show an enhanced 
expression of neural antigens by exposure to relatively simple chemicals such as dimethylsulfoxide (DMSO) and 
butylated hydroxyanisol (BHA) (Woodbury and others, 2000). However, further investigation with time-lapse 
video recording shows that the formation of neurites in this differentiation protocol is not the result of an 
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outgrowth of dendrite- and axon-like structures but rather a consequence of cell shrinkage and retraction of 
the cell edge (Neuhuber and others, 2004; Lu and others, 2004; Bertani and others, 2005). These “shrink-
effects” are probably the consequence of stress on the cells caused by the chemicals used in the differentiation 
protocols. This assumption is based on the fact that exposure of the stromal cells, but also of other cell types 
(HEK 293 cells, fibroblasts), to different stressors (actin filament-depolymerising agents, detergents, high 
molarity sodium chloride, extremes of pH …) results in the same type of morphology change. These results are 
strongly in favour of the hypothesis that the “neural morphology” of bone marrow-derived cells using the 
Woodbury protocol is in fact a “stress”- artefact.  
Similarly, the relevance of an enhanced expression of neural antigens as an indication for neural differentiation 
should also be questioned for several reasons. First, some neural antigens are already expressed at baseline in 
native, non-neural bone marrow-derived cells (Woodbury and others, 2002; Goolsby and others, 2003; 
Neuhuber and others, 2004; Tondreau and others, 2004; Ratajczak and others, 2004; Bertani and others, 2005). 
Second, the exposure of mesenchymal stem cells to stressors also cause an enhancement of the expression of 
neural markers Neuronal Nuclei (NeuN) and Neuron Specific Enolase (NSE) (Lu and others, 2004), but also 
Neurofilament 200 (NF200) and Tau (Bertani and others, 2005). Finally, when different studies using the same 
type of stem cells and the same differentiation protocol are compared for antigen expression before and after 
differentiation, several inconsistencies can be found for different markers (Woodbury and others, 2000; 
Neuhuber and others, 2004; Lu and others, 2004; Bertani and others, 2005).  
To better evaluate neural differentiation of bone marrow-derived cells, we compared neural differentiation of 
bone marrow-derived MAPC-like cells and brain-derived neural stem cells (NSC) using various differentiation 
protocols. We evaluated the expression of five different neuro-glial antigens (NF-200, beta III tubulin, Tau, Glial 
fibrillary acidic protein, myelin basic protein) at baseline and after differentiation. The expression profile of the 
neuroectodermal genes was measured using immunocytochemistry (ICC) and real-time PCR (RT-PCR). It was 
found that although bone marrow-derived cells can obtain some characteristics of neural cells, only neural 
stem cells gave rise to cells which met all criteria screened for.  
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MATERIALS AND METHODS 
CULTURE OF MAPC-LIKE STEM CELLS 
All animal procedures and experiments were approved by the local Ethical Committee of the University of 
Ghent. Isolation of bone marrow-derived stem cells was performed using the same procedure as described for 
MAPC (Jiang and others, 2002). In brief, the femurs of adult Sprague-Dawley rats (n=2, body weight 250 g, 
Harlan) were flushed and bone marrow mononucleated cells (BMMNC) were collected by Ficoll-Hypaque 
separation. BMMNC’s were initially plated in expansion medium on fibronectin coated plates at a density of 
6x10
5 
cells/cm
2
.  
MAPC expansion medium consisted of the following: 57.5 % low glucose DMEM (Cambrex, Verviers, Belgium), 
39 % MCDB-201 (Sigma, Bornem, Belgium), 1 % insulin-transferrin selenium (ITS, Sigma), 0.5 % linoleic acid-
bovine serum albumin (LA-BSA, Sigma), 100 µM ascorbic acid 2-phosphate (Sigma), 100U/ml penicillin 
(Cambrex), 100U/ml streptomycin (Cambrex), 10 ng/ml PDGF-BB (R&D), 10ng/ml EGF (Sigma), 2 % Fetal Calf 
Serum (FCS, Serum Supreme, Cambrex) and 1000 units/mL mLIF (Chemicon, Temecula, CA, USA). Half of the 
medium was changed every three days. After three weeks, the hematopoietic fraction (CD45
+
 and red blood 
cells) were depleted using paramagnetic beads. Cells were separated with 2 sequential MACS LD columns 
(Miltenyi Biotech, Utrecht, The Netherlands). After depletion, cells were plated in fibronectin coated flat-
bottomed 96 well plates at a density of 1 cell per well to generate single cell clones. Clones were expanded at 
densities between 0.5 and 1.5 × 10
3
/cm
2
.  
Five single cell MAPC-like clones were withdrawn on the basis of their spindle-like morphology, their expansion 
capacity ( > 40 population doublings), and their phenotypic expression profile (MHC I
-
 , MHC II
-
, CD44
-/dim
) using 
flow cytometry analysis. Using Real-Time Polymerase Chain Reaction (RT-PCR) relative expression of Oct4 was 
compared between the five MAPC-like cell clones and the clone with the highest expression was chosen to be 
used for further analysis in this study.  
CULTURE OF NEURAL STEM CELLS 
Neural stem cells were isolated according to a recently published protocol (Gobbel and others, 2003). In brief, 
the brain of female Sprague-Dawley rats (n=2, body weight 250 g, Harlan) was removed and placed in artificial 
cerebrospinal fluid (124 mM NaCl, 5 mM KCl, 3.2 mM MgCl2, 105 mM NaHCO3, 10 mM glucose, and 2 mM 
CaCl2). The subventricular zone was removed bilaterally by microscopic dissection. To dissociate the tissue, it 
was placed into a digestion medium containing 0,5 mM Na2EDTA (Sigma), 1,0 mM cysteine (Sigma), 0,9 mg/ml 
papain (Worthington, Lakewood, NJ) and 1 mg/ml DNase (Sigma), dissolved in Earle’s balanced salt solution 
and this for 45 minutes. Digestion was stopped by adding ovomucoid (Sigma). After a mechanical dissociation, 
the cells were plated in a 96 well flat-bottomed plate at a density of 2000 cells per well in a chemically defined 
medium. The NSC growth medium consisted of NS-A medium (Euroclone, Milan, Italy) with an additional 2 mM 
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L-glutamine (Cambrex), 3 mM D-glucose (Sigma), 1.2 mM sodium bicarbonate (Sigma), 0.46 mM HEPES (Sigma), 
2 % B27 (Gibco BRL, Rockville, MD), 1 % N2-supplement (Gibco BRL), 100 U/ml penicillin (Cambrex), 100 U/ml 
streptomycin (Cambrex), 20 ng/ml of human recombinant epidermal growth factor (EGF; Sigma), and 20 ng/ml 
of human recombinant basic fibroblast growth factor (bFGF; R&D, Minneapolis, MN, USA). Cells were grown at 
37 °C in 5 % CO2 and 95 % air with saturated humidity. They were passaged once cell clusters were formed, 
approximately 2 weeks after initial isolation and every 1–2 weeks thereafter. At the fourth passage, the cells 
were plated in a flat-bottomed 96 well plate at a density of 1 cell per well. A single cell clone was chosen to be 
used in this study on the basis of its capacity to form neurospheres and the survival and morphology after in 
vitro differentiation.  
KARYOTYPING 
MAPC-like cells and NSC, subcultured at a 1:4 dilution 24 hours before harvesting, were collected and subjected 
to a 1.5-hour colcemid incubation, followed by lysis with hypotonic KCL and fixation in acid/alcohol. 
Metaphases were analyzed after G banding (Dewald and others, 1985).   
DIFFERENTIATION OF MAPC-LIKE CELLS INTO MESENCHYMAL LINEAGES 
ADIPOGENESIS  
To induce MAPC-like cells to differentiate into adipocytes, cells were plated into six-well plates at a density of 
20 × 10
3
/cm
2
 and incubated in adipogenic induction medium consisting of DMEM supplemented with 10 % FCS, 
100 U/ml penicillin, 100 U/ml streptomycin, 1 µM dexamethasone, 0,2 mM indomethacin, 10 µg/ml insulin, 0,5 
mM methylisobutylxanthine (all from Sigma). Medium was replaced every 3-4 days during 3 weeks. 
Differentiation was appreciated by morphological examination and Oil Red O staining was performed to detect 
lipid accumulation (Pittenger and others, 1999). 
OSTEOGENESIS 
To induce MAPC-like cells to differentiate into osteoblasts, cells were plated into six-well plates at a density of 
3 × 10
3
/cm
2
 and incubated in osteogenic induction medium consisting of DMEM supplemented with 10 % FCS, 
100 U/ml penicillin, 100 U/ml streptomycin, 0,1 µM dexamethasone, 50 µM ascorbic acid 2-phosphate, 10 mM 
beta-glycerophosphate (Sigma). Medium was replaced every 3-4 days during 3 weeks. Von Kossa’s staining was 
performed in order to demonstrate calcium deposition in differentiated cultures (Pittenger and others, 1999).  
NEURAL DIFFERENTIATION OF MAPC-LIKE CELLS AND NSC 
All differentiations were done with the cells plated on matrigel in DMEM/B27 medium (Gibco BRL) with an 
additional 2 mM L-glutamine (Cambrex), 3 penicillin mM D-glucose (Sigma), 1,2 mM sodium bicarbonate 
(Sigma), 0,46 mM HEPES (Sigma), 2 % B27 (Gibco BRL), 1 % N2-supplement (Gibco BRL), 100U/ml (Cambrex), 
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100U/ml streptomycin (Cambrex). In order to enhance survival of NSC during differentiation 3 % FCS was added 
to the differentiation medium. MAPC-like cells were differentiated in medium devoid of FCS in order to induce 
differentiation. Cells were differentiated parallel by three methods based on previously published protocols: 
the Jiang method (Jiang and others, 2003), the Kohyama method (Kohyama and others, 2001) and the Kabos 
method (Kabos and others, 2002). In brief, for MAPC-like cells, the Jiang method consisted of a 
predifferentiation phase in which the cells are exposed to bFGF (100 ng/m, R&D) for seven days. After this 
neural induction phase MAPC-like cells were exposed to Sonic Hedgehog (100 ng/ml, R&D) and FGF-8 (10 
ng/ml, R&D) for another seven days. In the case of NSC differentiation the cells were directly plated for seven 
days in the presence of SHH (100 ng/ml) and FGF-8 (10 ng/ml) without a predifferentiation phase. In the 
Kohyama protocol MSC cells were incubated for three days with 10 µmol/ml 5-azacytidine, 10 % FCS, Nerve 
Growth Factor (NGF, R&D, 50 ng/ml), Brain Derived Factor (BDNF, R&D, 50 ng/ml) and Neurotrophin-3 (NT-3, 
R&D, 50 ng/ml) for the induction of neural differentiation. After the induction phase, cells were incubated with 
serum-free medium containing NGF, NT-3, BDNF (all 50 ng/ml) for seven days. NSC cells were not subjected to 
the induction phase and were directly plated for seven days in the presence of the cytokines NGF, NT-3 and 
BDNF (all 50 ng/ml). In the Kabos method cells were incubated for seven days with 20 ng/ml bFGF and 20 ng/ml 
EGF in order to induce differentiation. In the following phase, cells were exposed to 1 µM retinoic acid (RA, 
sigma) and 1mM dibutyril cyclic AMP (db-cAMP, sigma) for an additional seven days. NSC were directly plated 
in medium containing 1 µM RA and 1 mM db-cAMP and this also for seven days.  
After seven days of differentiation, morphology of the cells was evaluated, a fraction of the cells were fixated 
for immunocytochemistry and RNA was extracted from the remaining cell fraction. 
REAL-TIME POLYMERASE CHAIN REACTION FOR OCT4 AND NEURO-GLIAL MRNA’S 
RNA was extracted from the cells using a kit (Aurum
TM
 total RNA kit, Bio-Rad, Hercules, CA, USA). cDNA was 
prepared using a first strand synthesis kit (iScript
TM
 cDNA Synthesis Kit, Bio-Rad). Using the standard curve 
method the relative amount of expression of Oct4 and neuroectodermal genes was determined by 
normalization using hypoxanthine phosphoribosyl transferase (HPRT) as a housekeeping gene (Peinnequin and 
others, 2004). For HPRT, the oligonucleotides used were GCG TCC CTT TTG ATT TGC A (sense primer) and TCA 
CAA GGG AAG TGA CAA TCT ACC T (antisense primer), for Oct4 CTG TAA CCG GCG CCA GAA (sense primer) and 
TGC ATG GGA GAG CCC AGA (antisense primer), for beta3-tubulin (β3-tub) GGA GCT GTT CAA GCG CAT CT 
(sense primer) and CCC GTG TAC CAG TGG AGG AA (antisense primer), for NF200 GCTG TCC TTC TTG AGC TTC 
TTT G (sense primer) and TTG TTG TCG GGC TAT GAA GAA A (anti-sense primer), for Tau AAG CCA GTG GAC 
CTG AGC AA (sense primer) and TTC GAC TGG ACT CTA TCC TTG AAG T (antisense primer), for Glial Fibrillary 
Acidic Protein (GFAP) GAG AGA TTC GCA CTC AGT ACG A (sense primer) and TGG ACC GAT ACC ACT CTT CTG TT 
(antisense primer), for Myelin Basic Protein (MBP) ATT CCG AGG AGA GTG TGG GTT T (sense primer) and GAA 
GTT TCG TCC CTG CGT TTC (antisense primer). All primers were designed with Primer Express 2.0 software 
(Applied Biosystems, Foster City, CA, USA) and tested for specificity using NCBI’s BLAST software. All primers 
were manufactured and HPLC purified by Operon Biotechnologies (Cologne, Germany). PCR reagents were 
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obtained from Eurogentec (Seraing, Belgium) as SYBR Green I mastermixes and used according to the 
manufacturer's instructions. Reactions were run on ABI Prism 7000 Sequence Detection System (Applied 
Biosystems). The cycling conditions were as follows: 10 min at 95ºC, 40 cycles at 95ºC for 15 s and 60ºC for 60 
s. After PCR amplification, a melting curve was generated for every PCR product to check the specificity of the 
PCR reaction (absence of primer-dimers or other non-specific amplification products). To quantify gene 
expression, normalized mRNA expression levels of Oct4 in the five MAPC-like cells clones were compared with 
levels in rat testis. Normalized mRNA expression levels of neuro-glial genes in MAPC-like cells and NSC before 
(respectively M0 and N0) and after differentiation according to the Jiang (M1, N1); the Kohyama (M2, N2) and 
the Kabos (M3, N3) protocol were compared with levels of expression in a NSC clone that was differentiated 
following a standard protocol (Nstandard). According to this protocol, cells are plated on poly-D-lysine in medium 
devoid of growth factors but with the addition of 3 % Fetal Bovine Serum (Reynolds and Weiss, 1996; Gobbel 
and others, 2003). Therefore, the formula to quantify expression of the genes of interest (Genes int) is: [Relative 
expression (Gene int) in Nx or Mx/Relative expression (HPRT) in Nx or Mx]/ [Relative expression (Gene int) in 
Nstandard/Relative expression (HPRT) in Nstandard]. 
IMMUNOCYTOCHEMISTRY FOR CNS ANTIGENS 
Undifferentiated and differentiated NSC and MAPC-like cells were stained for the same markers from which the 
gene expression was analysed using RT-PCR, except for oligodendrocytes, which were stained with RIP 
antibody because this resulted in stainings compared to immunocytochemistry for MBP. Cells were fixated with 
4 % paraformaldehyde for 10 minutes and subjected to immunocytochemistry. MAPC-like cells and 
differentiated NSC are adherent and can be processed easily. In order to prevent differentiation induced by 
plating undifferentiated NSC on coated surface, cytocentrifuged preparations (Cytospin
 
2; Cytospin, Shandon, 
UK) were made and fixated. The
 
PFA-fixed preparations were quenched with 50 mM NH4Cl for 10 min,
 
permeabilized with 0.2–0.5 % Triton X-100 (TX100) in phosphate-buffered
 
saline (PBS) for 5 min, and blocked 
using 0.4 % fish
 
skin gelatin/PBS for 30 min, followed by incubation first with primary antibodies
 
(ms, mouse 
monoclonal; rb, rabbit polyclonal): ms anti-nestin 1:50 (chemicon, MAB 353), ms anti-β3 tub 1:100 (Sigma SDL-
SD10), ms anti-NF200 1:100 (chemicon, MAB5262), rb anti-tau 1:5000 (Dako, A 0024), rb anti-GFAP, 1:100 
(Dako, Z0334), ms anti-oligodendrocytes 1:5000 (Chemicon, RIP, MAB1580) and then with secondary 
antibodies Alexa Fluor 488 goat anti-mouse IgG
 
(H+L) (Molecular Probes) 1:1000 and goat anti-rabbit Texas Red 
IgG (H+L) (Vector Laboratories, Burlingame,
 
CA) 1:1000 diluted in 0.4 % fish skin gelatin/phosphate-buffered
 
saline for 2 h each. To test the specificity of the secondary antibodies the primary antibody step was omitted. 
Cross reactivity of the primary antibodies with human antigens allowed testing the antigen specificity by 
staining HUVEC cells as a negative control and rat brain as a positive control. The coverslips were mounted in
 
Mowiol supplemented with 4,6-diamidino-2-phenylindole (DAPI).
 
Immunoreactive (IR) cells were visualized 
using a Bio-Rad Radiance 2100 confocal laser scanning microscope.  
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RESULTS 
ISOLATION OF MAPC-LIKE CELLS 
We successfully isolated cells from the bone marrow of adult rats using the protocol described by Jiang et al. 
(Jiang and others, 2002). After three weeks, bulk cultures were depleted of CD45
+
 and red blood cells and were 
subsequently plated in MAPC expansion medium at a density of one cell per well. Five clones were selected on 
the basis of a similar morphology (fig 1), flowcytometric data (MHC I and MHCII neg, CD44
-/dim
) and growth 
characteristics (data not shown) as true MAPC cells. All these five clones were subjected to the neural 
differentiation protocol described in the study by Jiang et al (Jiang and others, 2002). Since none of the clones 
differentiated towards cells positive for tau, GFAP or RIP using this protocol, we will designate these cells as 
MAPC-like cells. After these initial differentiation attempts, we used RT-PCR analysis to determine the levels of 
Oct4 expression in these five cell clones (table 1). The clone with the highest expression, clone 3.5b1, was 
chosen to be used for further analysis.  
Cytogenetic analysis after 40 population doublings showed that all clones had a normal karyotype (fig 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1: Morphology of bone marrow derived MAPC-like cells. 
Selection of MAPC-like cell clones was done on the basis of a high 
expansion capacity (> 40 population doublings) and a spindle like 
morphology. Figure 1 is a picture taken by a digital camera 
through the ocular of a stereomicroscope. The magnification of 
the stereomicroscope is set at 200x. On the picture the spindle 
like morphology of the MAPC-like cells clone is clear.  
Table 1: Levels of Oct4 mRNA expression in five MAPC-
like cell clones relative to expression in rat testis. 
RNA was extracted from five MAPC-like cell clones. cDNA was prepared 
using a first strand synthesis kit (iScriptTM cDNA Synthesis Kit, Bio-Rad). 
RT-PCR reactions were run on ABI Prism 7000 Sequence Detection 
System. The cycling conditions were as follows: 10 min at 95ºC, 40 cycles 
at 95ºC for 15 s and 60ºC for 60 s. After PCR amplification, a melting 
curve was generated for every PCR product to check the specificity of the 
PCR reaction. Using the standard curve method the relative amount of 
expression of Oct4 was determined by normalization using HPRT as a 
housekeeping gene. To quantify gene expression, normalized mRNA 
expression levels of Oct4 in MAPC-like cell clones were compared with 
levels of expression in rat testes. 
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ISOLATION AND PHENOTYPIC CHARACTERISATION OF NSC CELLS 
Neural stem cells were isolated from the subventricular zone of the brain by plating dissociated, subventricular 
cells in a special defined neural stem cell expansion medium (Gobbel and others, 2003). Two weeks after initial 
isolation, large spherical clusters of cells, or neurospheres, which grew loosely attached to the substrate, were 
present in the culture. These neurospheres were passaged mechanically when the diameter of the 
neurospheres ranged from 100 to 150 µm. The dissociated cells were plated again and secondary neurospheres 
appeared in culture. Neurospheres were passaged every 7 to 10 days after plating. At the fourth passage, the 
cells were plated at a density of 1 cell per well in a 96 well plate. Approximately 4 % of the cells formed 
neurospheres which could be passaged continuously (>10 passages). Using the culture and isolation technique 
specially designed for adult rat neural stem cells, we were able to keep single cell clones of NSC in culture for 
over one year (Gobbel and others, 2003). Formation of neurospheres and expansion capacity were used as 
criteria for the selection of a clone which was used in this study. Cytogenetic analysis of the cells after 40 
population doublings showed that cells also had a normal karyotype (data not shown).  
 
Fig 2: Representative example of a metaphase spread (left) and an ideogram (right) of G banded karyotype of MAPC-like cells. MAPC-like 
cells were passaged for 40 cell doublings. Cells were harvested 24 hours after replating, subjected to a 1.5-hour colcemid incubation 
followed by lysis with hypotonic KCL and fixation in acid/alcohol and cytogenetically analyzed. Metaphase spread and ideogram show no 
large chromosomal abnormalities. Karyotype analysis of NSC gave analogue results (data not shown). 
MESENCHYMAL DIFFERENTIATION OF MAPC-LIKE CELLS 
When inducing the adipogenic differentiation, the cells adopted a round morphology and accumulated large, 
cytoplasmic vacuoles in which accumulation of lipid was detected with Oil Red O staining (fig 3a), while in non-
induced cells no staining was detected (fig 3b). The osteogenic differentiation was demonstrated by calcium 
deposition in cell culture by positive Von Kossa’s stain in large portion of cells (fig 3c) while non-induced cells 
were all negative (fig 3d).  
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Fig 3: Mesenchymal differentiation of MAPC-like cells. a and b: Adipogenic differentiation was induced by plating MAPC-like cells at a 
density of 20 × 103/cm2 in the presence of 10 % FCS, 1 µM dexamethasone, 0,2 mM indomethacin, 10 µg/ml insulin, 0,5 mM 
methylisobutylxanthine. The cells adopted a round morphology and accumulated large, cytoplasmic vacuoles in which accumulation of lipid 
was detected with Oil Red O staining (a), while in non-induced cells no staining was detected (b). c and d: Osteogenic differentiation was 
induced by plating MAPC-like cells at a density of 3 × 103/cm2 in the presence of 10 % FCS, 0,1 µM dexamethasone, 50 µM ascorbic acid 2-
phosphate, 10 mM beta-glycerophosphate. In these osteoblasts calcium deposition could be demonstrated by Von Kossa’s staining (c) 
while non-induced cells were all negative (d). 
NEURAL DIFFERENTIATION OF MAPC-LIKE CELLS AND NSC 
MAPC-like cells and NSC were differentiated according to three previously described protocols: the Jiang 
method (Jiang and others, 2003), the Kohyama method (Kohyama and others, 2001) or the Kabos method 
(Kabos and others, 2002). In contrast to NSC, MAPC-like cells were first predifferentiated by incubation with 
neural induction factors: bFGF (Jiang method); 5-azacytidine/NGF/NT-3/BDNF (Kohyama method) and 
bFGF/EGF (Kabos method). In all three methods, MAPC-like cells formed neurite like extensions and in case of 
the Jiang and Kabos method the cells rounded up and appeared as very bright cells by phase contrast 
microscopy (fig 4a). Quantification however showed that the proportion of cells that immunostain positive for 
nestin, a marker for neuroprogenitor cells, was lower after predifferentiation (about 15%) than at baseline 
conditions (about 30%, fig 4b).  
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Fig 4: Comparative analysis of morphology and expression of nestin on predifferentiated MAPC-like cells towards neural cells using 3 
different protocols. A: Neural predifferentiation of MAPC-like cells by plating them on matrigel in the presence of (a, Jiang method) 100 
ng/ml bFGF; (b, Kohyama method) 5-azacytidine (10 µmol/ml), NGF (50 ng/ml), NT-3 (50 ng/ml), BDNF (50 ng/ml), 10 % FBS; (c, Kabos 
method) EGF (20 ng/ml) and bFGF (20 ng/ml). In all three cases cells extend processes and in the presence of bFGF (a and c) the cells keep 
dividing, round up were very bright under phase contrast microscope view. B: Immunocytochemistry analysis showed that there is a clear 
increase in the number of cells expressing nestin in the Jiang (b) and the Kabos (d) differentiation method at the end of the 
predifferentiation phase compared to baseline condition where the MAPC-like cells are undifferentiated (a). The increase in nestin 
expression was not seen in the Kohyama differentiation (c).  
Predifferentiated MAPC-like cells and NSC were then differentiated by culturing them for seven days in the 
presence of other differentiation factors (Jiang method: SHH, FG-8; Kohyama method: NGF, BDNF, NT-3; Kabos 
method: RA, cAMP). MAPC-like cells differentiated with the Jiang method displayed a bipolar morphology and 
rounded cell bodies, which is typical for young neurons. MAPC-like cells, differentiated with the Kohyama or 
Kabos method, also developed long extensions but adopted a more fibroblast-like morphology (fig 5). NSC cells 
displayed a large number of neurite-like processes in all three conditions. Cells with a bipolar morphology and 
cells with a polarized morphology were present. In addition, a significant fraction of cells with glial-like 
morphology could be detected between the differentiated cells.  
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Fig 5: Comparative analysis of morphology of MAPC-like cells and NSC at the end of differentiation using 3 different protocols. At the end of 
differentiation morphology of the cells was evaluated. MAPC –like cells differentiated according to the Jiang protocol (M1) displayed 
bipolar morphology and round cell bodies, both typical for young neurons. Kohyama (M2) and Kabos (M3) differentiation led to cells 
displaying a more fibroblast-like morphology. NSC cells differentiated according to the N1, N2, N3 protocol all extended much neurite-like 
processes and cells with bipolar, polarized and glial morphology were present between the differentiated cells. 
QUANTITATIVE REAL-TIME PCR FOR NEURO-GLIAL MRNA’S  
Normalized mRNA expression levels of neuro-glial genes in MAPC-like cells and NSC before (respectively M0 
and N0) and after differentiation according to the Jiang (M1, N1); the Kohyama (M2, N2) and the Kabos (M3, 
N3) protocol were calculated. The results demonstrate that neural markers β3-tub and NF-200 are expressed in 
NSC before (N0) and after N1, N2 and N3 differentiation. Expression is however less than in the NSC clone, 
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differentiated using the standard protocol. In addition, the increase of β3-tub and NF-200 expression after 
differentiation is limited: β3-tub expression is 1.5 to 2 times higher after differentiation, NF200 expression is 7 
to 8 times higher after differentiation. RT-PCR analysis showed that β3-tub and NF-200 were also expressed in 
MAPC-like cells. β3-tub expression was even higher in MAPC-like cells before (M0) than after differentiation 
(M1, M2, M3). In the case of NF200, expression in M0 was lower than M1 and M2 but higher than M3 
expression. We subsequently analyzed expression of differentiation markers for neurons (Tau), astrocytes 
(GFAP) and oligodendrocytes (MBP). Expression of Tau, GFAP and MBP could not be demonstrated in MAPC-
like cells before or after differentiation. In contrast, all three markers showed a baseline expression in NSC 
before differentiation. After differentiation, increase in expression was noted: 1 tenfold increase for tau, a 100-
fold increase for MBP and a 1000-fold increase for GFAP. For all three markers there is a clear augmentation in 
expression due to differentiation (table 2).  
Table 2: Comparative analysis of mRNA expression for different proteins of MAPC-like cells and NSC before 
and after differentiation using 3 different protocols 
 beta III tubulin NF200 Tau GFAP MBP 
M0 0,121 ± 0,002 0,033 ± 0,002 0 0 0 
M1 0,053 ± 0,008 0,074 ± 0,008 0 0 0 
M2 0,051 ± 0,001 0,057 ± 0,001 0 0 0 
M3 0,012 ± 0,001 0,009 ± 0,001 0 0 0 
N0 0,427 ± 0,056 0,127 ± 0,056 0,561 ± 0,042 0,005 ± 0,001 0,005 ± 0,000 
N1 0,655 ± 0,028 0,842 ± 0,028 6,829 ± 0,804 13,868 ± 0,760 0,656 ± 0,041 
N2 0,743 ± 0,085 0,970 ± 0,085 7,744 ± 0,524 18,549 ± 1,340 0,782 ± 0,042 
N3 0,861 ± 0,158 0,844 ± 0,158 4,874 ± 1,352 12,891 ± 3,231 0,311 ± 0,040 
 
RNA was extracted from MAPC-like cells and NSC before (respectively M0 and N0) and after differentiation with the Jiang (M1, N1); the 
Kohyama (M2, N2) and the Kabos method (M3, N3). cDNA was prepared using a first strand synthesis kit (iScriptTM cDNA Synthesis Kit, 
Bio-Rad). RT-PCR reactions were run on ABI Prism 7000 Sequence Detection System. The cycling conditions were as follows: 10 min at 
95ºC, 40 cycles at 95ºC for 15 s and 60ºC for 60 s. After PCR amplification, a melting curve was generated for every PCR product to check 
the specificity of the PCR reaction. Using the standard curve method the relative amount of expression of neuroectodermal genes was 
determined by normalization using HPRT as a housekeeping gene. To quantify gene expression, normalized mRNA expression levels of 
neuro-glial genes in MAPC-like cells NSC before (respectively M0 and N0) and after differentiation according to the Jiang (M1, N1); the 
Kohyama (M2, N2) and the Kabos (M3, N3) protocol were compared with levels of expression in a NSC clone that was differentiated 
following a standard protocol (Nstandard). According to this protocol cells are plated on poly- -lysine in medium devoid of growth factors 
but with the addition of 3% Fetal Bovine Serum (FBS). The formula to quantify expression of the genes of interest (Genes int) is: [Relative 
expression (Gene int) in Nx or Mx/Relative expression (HPRT) in Nx or Mx]/ [Relative expression (Gene int) in Nstandard/Relative expression 
(HPRT) in Nstandard]. 
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IMMUNOCYTOCHEMICAL STAINING OF NEUROGLIAL ANTIGENS 
Immunocytochemistry of NSC and MAPC-like cells yielded the following results. The presence of β3-tub and 
NF200 could not be demonstrated in non-differentiated NSC; but differentiated NSC stained positive for these 
markers. β3-tub and NF200 could also be demonstrated in MAPC-like cells and this before and after 
differentiation (figure 6A).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 6: Comparative analysis of antigen reactivity of MAPC-like cells and NSC at the end of differentiation using 3 different protocols. 
Immunocytochemistry analysis of MAPC-like cells and NSC cells before (resp. M0 and N0) and after differentiation according to the Jiang 
protocol (M1, N1); the Kohyma method (M2, N2) and the Kabos method (M3, N3). A: M0 cells stained slightly positive for B3tub and 
NF200. N0 cells did not stain for NF200 and B3tub. Between the differentiated NSC and MAPC–like cells there were cells that stained 
positive for NF200 and B3tub. B: No TAU-, RIP- or GFAP-positive cells could be demonstrated either before or after differentiation. 
Undifferentiated NSC were negative for TAU and GFAP but some stained positive for the RIP marker. After all three differentiations TAU, 
GFAP and RIP positive cells were present among the differentiated cells. 
A 
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Immunocytochemistry for Tau, RIP and GFAP showed that MAPC-like cells did not stain positive for these 
markers before of after differentiation in contrast to differentiated NSC. Undifferentiated NSC did only stain 
positive for RIP but not for TAU or GFAP (figure 6B). One can conclude from both techniques that β3-tub and 
NF200 are expressed in MAPC-like cells both in undifferentiated as in differentiated state; whereas TAU, GFAP 
and MBP are not expressed in MAPC-like cells neither in undifferentiated nor in differentiated state. Both RT-
PCR and ICC demonstrated that differentiated NSC were positive for all markers investigated and this in all 
three differentiation paradigms. RT-PCR could detect expression of β3-tub, NF200, TAU and GFAP genes in 
undifferentiated neural stem cells while ICC could not detect the presence of these antigens. 
 (Fig 6 continued) 
B 
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DISCUSSION 
Most studies that demonstrated neural differentiation of bone marrow-derived cells based their conclusion on 
the adoption of a neural-like morphology and the expression of neural genes. Recent evidence, however, 
shows that a non-neural cell can adopt a neural morphology and show aberrant expression of neural antigens 
as a response to different stressors rather than being the result of neural transdifferentiation (Neuhuber and 
others, 2004; Lu and others, 2004; Bertani and others, 2005). To further investigate the significance of neural 
morphology and neuroglial antigen expression as proof of neural differentiation, bone marrow-derived MAPC-
like cells were compared in their morphology and neuro-glial gene expression profile with positive control NSC 
cells before and after neural differentiation by three different protocols.  
In this study, we were able to isolate stem cells out of the mesenchymal cell fraction of rat bone marrow with 
an expansion capacity and a spindle-like morphology characteristic for MAPC cells, a rare subpopulation of 
MSC, described by Verfaillie et al. (Jiang and others, 2002). MAPC’s have been shown to differentiate to cells of 
the three germinal layers (endoderm, ectoderm and mesoderm). We were able to differentiate the MAPC-like 
cells towards mesodermal cell fates, such as osteoblasts and adipocytes, using protocols described for 
mesenchymal stem cells. To date, no other group has published that pluripotent cells could be generated using 
the method described by Jiang in 2002 suggesting that the critical parameters necessary for terminal 
transdifferentiation are unknown. Pluripotency is a required property of MAPC but since we were also unable 
to reproducibly obtain differentiation to neuronal cells, we designate the cells MAPC-like. Because we were 
especially interested in the neural transdifferentiation capacity of bone marrow-derived MAPC-like cells, we 
compared the neural transdifferentiation capacity of a MAPC-like cell clone with that of tissue-specific NSC 
isolated from the subventricular zone of adult rats. Several studies have shown that NSC can differentiate 
towards electrically active neurons, astrocytes and oligodendrocytes (Whittemore and others, 1999; Toda and 
others, 2000; Liu and others, 2000; Song and others, 2002).  
We selected a MAPC-like cell clone on the basis of its Oct4 expression which was highest compared to four 
other clones analyzed. Oct4 is also expressed in precursors of gametes or primordial germ cells (PGC), in 
undifferentiated embryonic stem cells (ESC), embryonic germ cells (EGC) and embryonic carcinoma cells (ECC). 
Its exact role is not yet elucidated, but expression of Oct4 in ESC  is important in maintaining self-renewal and a 
pluripotent state (Niwa and others, 2000; Cavaleri and Schöler, 2006). This seems also to be the case in MAPC 
since clones with high Oct4 expression have a higher pluripotency than clones with low Oct4 expression 
(Verfaillie, Personal Communication).  
NSC could be successfully isolated, cultured and differentiated using a standard protocol (Gobbel and others, 
2003). The NSC were subjected to three differentiation protocols which were specifically designed for neuronal 
differentiation of bone marrow-derived stem cells. The protocols, however, were slightly modified taking into 
account the different nature of the cells. The most important modification was the omission of the neural pre-
induction phase in which bone marrow stem cells are forced to differentiate towards the neural stem or 
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progenitor cell phase. In the Jiang and Kabos methods the factors used in this pre-induction phase are growth 
factors used to culture neural stem cells. Therefore, in the case of NSC differentiation, this step could be 
omitted without any influence on the outcome of differentiation. In the neural induction phase of the Kohyama 
method, 5-azacytidine is used. This demethylating agent is believed to have enhancing effects on 
transdifferentiation of cells and has been used for transdifferentiation of bone marrow-derived cells to 
cardiomyocytes (Makino and others, 1999) and hepatocytes (Yamazaki and others, 2003). In our study, this 
factor was omitted since no transdifferentiation is needed in case of NSC differentiation. MAPC-like cells were 
differentiated using the protocols as originally described by the authors. The Jiang method has been optimized 
for neural differentiation of MAPC-like cells. The Kohyama method is designed for differentiating mesenchymal 
stem cells and the Kabos method uses unfractionated bone marrow as starting material.  
Another neural differentiation method is a protocol described by Woodbury et al (Woodbury and others, 
2000). Initially MAPC-like cells and NSC were compared in their potential for neural differentiation using this 
method but this protocol caused massive cell death of NSC (data not shown). This is in line with recent 
evidence showing that the adoption of neural morphology and the enhancement of neural gene expression in 
cells that are differentiated using the Woodbury protocol are likely to be stress artefacts (Neuhuber and others, 
2004; Lu and others, 2004; Bertani and others, 2005). Therefore this differentiation protocol was omitted from 
this study.  
In all three protocols, NSC differentiated towards cells with appropriate neural and glial morphology and 
positive for all neural or glial markers investigated with ICC and RT-PCR analysis. Semi-quantitative analysis 
showed that there was a clear augmentation in expression of three markers, tau, GFAP and MBP after 
differentiation. For the other two markers investigated, β3-tub and NF200, expression levels did not change 
dramatically due to differentiation. These data demonstrate that each of the three protocols, as we performed 
them in the laboratory, can indeed induce neural differentiation. 
Our MAPC-like cells express nestin at baseline, an intermediate filament protein predominantly expressed by 
neural stem cells. This baseline expression has also been demonstrated in standard rat bone marrow-derived 
stromal cells (Wislet-Gendebien and others, 2003). Although we would expect an augmentation of nestin 
expressing cells after the neural induction phase, we could not demonstrate this with our 
immunocytochemistry data. The proportion of cells, positive for nestin, was even less after predifferentiation 
than at baseline conditions. Further differentiating these “predifferentiated” cells resulted only in the Jiang 
method in cells with a bipolar neural-like morphology. In the other differentiation protocols, the cells formed 
extensions but adopted a more fibroblast-like morphology. MAPC-like cells were positive for two neural 
markers (β3-tub and NF200) already at baseline but there was no clear upregulation of these genes after 
exposure to all differentiation protocols. In the case of tau, GFAP and MBP, cells did not express these markers 
before or after differentiation at levels detectable with RT-PCR or ICC. 
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In contrast to our study, the Minneapolis group did report the differentiation of bone marrow-derived MAPC 
cells towards cells positive for different neural, astrocyte and oligodendrocyte markers using the protocol we 
used in our study. This group succeeded in differentiating murine MAPC-like cells towards functional neurons 
using a complex co-culture differentiation protocol (Jiang and others, 2003). Our MAPC-like cells also had 
multipotent capacity since we were able to differentiate them towards different mesodermal cell fates. 
However, we did not succeed in differentiating rat MAPC-like cells towards neuroectodermal phenotypes on a 
persuasive basis, although several attempts were made to reproduce the neural differentiation results of the 
Minneapolis group. By comparing the outcome of the neural differentiation of the MAPC-like cells with that of 
a positive control, adult NSC, we demonstrate that the protocols used in this study can induce neural 
differentiation but only in cells that have this potential.  
In summary, our results show that bone marrow-derived MAPC-like cells express “neural markers” nestin, β3-
tub and NF200 and can be induced to extend neurite-like extensions. However these factors cannot be seen as 
proof for a neuropotency since the differentiation protocols tested have no clear inducing or enhancing effects 
on the expression of neuro-glial genes in MAPC-like cells while, for β3-tub and NF200, they do in the positive 
control NSC. Recent studies have demonstrated that the formation of neurite-like structures is not always the 
result of the development of axons or dendrites but can also be induced by exposing cells to several stressors 
(Neuhuber and others, 2004; Lu and others, 2004; Bertani and others, 2005). In all protocols used in this study 
to differentiate MAPC-like cells, the FCS used to culture MAPC-like cells is withdrawn from the medium. Several 
studies have demonstrated that removal of serum induces oxidative stress and DNA fragmentation. So as an 
alternative explanation, the formation of neurite-like extensions by MAPC-like cells in our study could be the 
result of stress induced by serum-withdrawal. There are also several indications why the expression of β3-tub 
and NF200 is no proof for a true neural phenotype. First, the present study demonstrates that differentiated 
MAPC-like cells do not express other pan-neural or glial markers such as tau and GFAP or MBP; while these are 
expressed in differentiated NSC. Second, β3-tub and NF200 but also other presumed neural-specific markers 
are not exclusively expressed in neural cells but also in hematopoietic progenitor cells (Goolsby and others, 
2003) and undifferentiated bone marrow stromal cells (Tondreau and others, 2004; Bertani and others, 2005). 
Third, a recent study showed that it is possible to induce expression of neural specific antigens and 
neurotransmitters by exposing bone marrow cells to different mixes of growth factors. A closer evaluation, 
however, showed that the intracellular distribution of the antigens was different from that seen in adult 
neurons, implicating that these cells probably cannot function as true neurons (Jin and others, 2003).  
The main conclusion of our study is that the expression of neural antigens by MAPC-like cells in this study 
probably is a phenomenon of aberrant expression rather than true transdifferentiation. We conclude this 
based on the fact that subjection of multipotent MAPC-like cells, to neural differentiation protocols, which 
were adopted from other transdifferentiation studies and proven to work for NSC, did not induce or upregulate 
expression of the analyzed neural and glial antigens. Our study does not rule out that MAPC or mesenchymal 
stem cells may have the potential to differentiate towards neural cells. The data, however, show very clearly 
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that validation of transdifferentiation of cells towards neural cell types, using only morphology and a limited 
set of neural antigen expression as outcome parameters, is not sufficient and that one has to be very rigorous 
in the interpretation of these neural transdifferentiation experiments. Furthermore, we show that the critical 
steps in neural differentiation of MAPC cells are not yet fully understood and undefined parameters may 
profoundly influence the results obtained in different laboratories. 
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In this manuscript we describe the results of a long term video-EEG monitoring study of rats which had 
experienced a status epilepticus (SE) evoked by injection of kainic acid through a cannula in the hippocampus. 
The rats were monitored with video-EEG during two separate periods: the first 21 weeks after SE and week 40 
to week 42 after SE. Characteristics of spontaneous seizures such as seizure duration, severity and frequency 
were determined. We investigated whether spontaneous seizures came in a circadian pattern and whether 
there was a progression of seizure severity.  
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SUMMARY 
Intrahippocampal injection of kainic acid (KA) in rats evokes a status epilepticus and leads to spontaneous 
seizures. However to date, precise electroencephalographic and clinical characterization of spontaneous 
seizures in this epilepsy model using long-term video-EEG monitoring has not been performed.  
Rats were implanted with bipolar hippocampal depth electrodes and a cannula for the injection of KA (0.4 
µg/0.2 µl) in the right hippocampus. Video-EEG monitoring was used to determine habitual parameters of 
spontaneous seizures such as seizure frequency, severity, progression and day-night rhythms.   
Spontaneous seizures were detected in all rats, with 13 out of 15 animals displaying seizures during the first 
eight weeks after status epilepticus. A considerable fraction (35%) of the spontaneous seizures did not 
secondary generalize. Seizure frequency was quite variable and the majority of the KA treated animals had less 
than one seizure per day. A circadian rhythm was observed in all rats that showed sufficient seizures per day. 
This study shows that the characteristics of spontaneous seizures in the intrahippocampal KA model display 
many similarities to other SE models and to human TLE.  
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INTRODUCTION 
Mesial temporal lobe epilepsy (TLE) is the most common form of symptomatic epilepsy and is characterized by 
complex partial seizures (with or without secondary generalization) originating from temporal lobe regions 
(Engel, 1996). TLE development covers three phases; 1) an initial precipitating insult of the brain such as febrile 
seizures, head trauma, SE, or stroke initiating a cascade of events; 2) a period of epileptogenesis during which 
several processes (either molecular or structural) occur; 3) chronic epilepsy characterized by the occurrence of 
spontaneous seizures.  
Chronic TLE models need to resemble the epileptic state in which spontaneous and recurrent seizures occur 
(Mascott and others, 1994; Loscher, 1997). In rodents, spontaneous seizures that originate from the temporal 
lobe, can be provoked by brain infarction (Kelly and others, 2001; Kelly and others, 2006), traumatic brain 
damage (Kharatishvili and others, 2006), febrile seizures (Dube and others, 2006), kindling (Michael and others, 
1998) and status epilepticus (SE). The SE model of chronic TLE has been extensively studied (Ben-Ari and 
others, 1980; French and others, 1982; Cavalheiro and others, 1983; Sater and Nadler, 1988; Lothman and 
others, 1989; Leite and others, 1990; Cavalheiro and others, 1991; Stafstrom and others, 1992; Tanaka and 
others, 1992; Mascott and others, 1994; Bertram and Cornett, 1994; Lemos and Cavalheiro, 1995; Leite and 
others, 1996; Hellier and others, 1998; Miettinen and others, 1998; Arida and others, 1999; Bragin and others, 
1999; Nissinen and others, 2000; Gorter and others, 2001; Glien and others, 2001; Mazarati and others, 2002; 
Klitgaard and others, 2002; Furtado Mde and others, 2002; Brandt and others, 2003). In this model SE can be 
induced either by electrical or by chemical (kainic acid, pilocarpine) stimulation of various brain regions. 
Electrical stimulation has been applied to the perforant path (Gorter and others, 2001; Mazarati and others, 
2002), the ventral hippocampus (Lothman and others, 1989; Bertram and Cornett, 1994), or the amygdala 
(Nissinen and others, 2000; Brandt and others, 2003). Pilocarpine (PILO), ac chemoconvulsant, can be 
administered systemically or intracerebrally, both leading to spontaneous seizures in a high fraction of rats 
(Leite and others, 1990; Cavalheiro and others, 1991; Lemos and Cavalheiro, 1995; Arida and others, 1999; 
Glien and others, 2001; Klitgaard and others, 2002; Furtado Mde and others, 2002). Another frequently used 
chemoconvulsant, kainic acid (KA), is a structural analogue of glutamic acid and is isolated from the seaweed 
Digenea simplex. KA can be injected as a single bolus systemically or intracerebrally (Ben-Ari and others, 1980; 
French and others, 1982; Cavalheiro and others, 1983; Sater and Nadler, 1988; Stafstrom and others, 1992; 
Tanaka and others, 1992; Mascott and others, 1994; Leite and others, 1996; Hellier and others, 1998; Miettinen 
and others, 1998; Bragin and others, 1999). Direct injection of KA into specific brain regions, evokes SE at much 
lower doses and limits direct toxic effects to small brain areas. KA has been injected directly in the amygdala 
(Ben-Ari and others, 1980; Tanaka and others, 1992; Mascott and others, 1994), in the ventricle (Sater and 
Nadler, 1988), in the entorhinal cortex (Miettinen and others, 1998) and in the hippocampus (French and 
others, 1982; Cavalheiro and others, 1983; Leite and others, 1996; Bragin and others, 1999; Bragin and others, 
2004; Bragin and others, 2005). These studies show that intracerebral injection of KA efficiently induces SE 
which on its turn induces epileptogenesis, that leads to spontaneous seizures.  
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For the intrahippocampal KA model electrophysiological features of epileptogenesis and spontaneous seizures 
resemble those of patients with refractory TLE (Bragin and others, 1999; Bragin and others, 2004). Long term 
video-EEG monitoring of the intrahippocampal KA model to determine habitual seizures parameters has not 
yet been performed. In this study, we injected KA in the hippocampus of unanaesthesized rats which were 
subsequently monitored for several months with video-EEG. We determined the duration of the SE, the 
fraction of rats displaying spontaneous seizures and seizure parameters such as seizure type, duration and 
frequency. We also assessed the progression in seizure occurrence and determined whether spontaneous 
seizures came in a circadian pattern.  
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MATERIALS AND METHODS 
ANIMALS 
Female Sprague-Dawley rats, weighting 200-220g (Harlan, Horst, The Netherlands), were kept under 
environmentally controlled conditions (12h normal light/dark cycles, 20-23°C and 50% relative humidity) with 
food and water ad libitum. The animals were treated according to guidelines approved by the European Ethics 
Committee (decree 86/609/EEC). The study protocol was approved by the Animal Experimental Ethical 
Committee of Ghent University Hospital (ECP 05/38).  
SURGERY 
All rats (n=17) were anesthetized with an intraperitoneal injection of a ketamine (57 mg/kg) and xylazine (9 
mg/kg) mixture. The rats were fixated in a stereotactic frame (Bilaney Consultants, Düsseldorf, Germany), the 
skull was exposed and nine holes were drilled to place the epidural and depth electrodes. Two custom-made 
epidural electrodes and one reference electrode (stainless steel screws, 1.57mm diameter, Bilaney, Germany) 
were placed on both sides of the skull over  the frontal cortex and on the left side of the sutura lambdoidea 
respectively. Two polyimide coated stainless steel wires (70µm diameter, CFW, USA, distance between the two 
contact points: 0.5mm) were glued together to form bipolar electrodes. These depth electrodes were placed in 
both hippocampi (AP= - 5.6 mm, ML= ± 4.5 mm, DV=-5.5 mm relative to bregma). The electrode in the right 
hippocampus (fig 1a) was fixed to a stainless steel guide cannula (fig 1c; 0.81 mm o.d.; Plastics One, Sevenoaks, 
UK) using a shrinking tube (fig 1d), which was heated to fix the electrode to the cannula. The guide cannula was 
closed off using a dummy cannula (fig 1b; Plastics One). The distance between the tips of the electrode and the 
cannula was 3.5 mm. In this way the cannula ended just above the hippocampus preventing additional damage 
to the hippocampus (fig 1). In the remaining four burr holes, anchor screws were placed to fix the electrodes on 
the skull by acrylic cement. All electrodes were lead to a connector which was attached via a commutator to 
the EEG cables.  
INTRAHIPPOCAMPAL KA INJECTION 
One week after surgery the rats were manually restrained. The dummy cannula was removed and a 30 G 
needle was lowered in the guide cannula. A mechanical stop placed on the needle allowed positioning of the 
injection needle at the same depth of the lowest tip of the recording electrode in the hippocampus. In 15 rats, 
0.4 µg/0.2 μl of KA (Ocean Produce International, Shelburne, Canada) was slowly injected (0.1 µl/min) into the 
right hippocampus using a 1µl Hamilton syringe attached to the needle (Sigma, Bornem, Belgium). In two rats 
saline (0.2 µl) was injected using the same protocol. After injection the needle was left in place for an 
additional minute after which it was slowly retracted and the cannula was closed off with a dummy cannula.  
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Fig 1: Schematic drawing of the stereotactic implantation of bipolar depth electrodes in the left hippocampus and a electrode-cannula 
complex in the right hippocampus: This image is a schematic overview of a coronal brain section 5.6 mm posterior to bregma (Paxinos and 
Watson, 1998), to illustrate the position of left and right hippocampal depth electrodes (ML: ± 4.5 mm, DV: -5.5 mm compared to bregma). 
The right bipolar hippocampal electrode (a) is combined to a guide cannula (c) using a shrinking tube (d) which is heated. The guide cannula 
is closed off using a dummy cannula (b). KA is injected through the guide cannula at the same depth of the most ventral electrode tip.  
VIDEO-EEG-MONITORING  
The video-EEG monitoring was performed under environmentally controlled conditions (12h normal light/dark 
cycles, 20-23°C and 50% relative humidity) in an isolated room. Lights were on from 8 AM until 8 PM. The unit 
existed of 8 custom-made cages. A 4-channel MOSFET input operational amplifier functioned as an impedance 
buffer and connected the electrodes on the head to the cable. The EEG signals were sampled at 200 Hz with 16 
bit resolution (PCI-6033E, National Instruments, Texas, USA) and stored on a PC. Video was recorded using an 
infrared sensitive camera (CAMCOLBUL5, Velleman, Ghent, Belgium) coupled to a PCTV card (Miro Video 
Studio PCTV, Pinnacle Systems, California, USA) and was stored in a compressed format (MPEG-4) on a PC using 
a freeware program (VirtualDub version 1.6.14). This program marked date and time on the captured video so 
synchronizing video-images with EEG.  
MONITORING OF STATUS EPILEPTICUS 
In three consecutive sessions (8 KA, 7 KA and 2 controls) rats were monitored for seizure activity for 48 hours 
after injection of KA or saline. Epileptiform activity could not be detected in the EEG of the two rats injected 
with saline and these rats did not display clinical seizure activity. In the KA treated rats, we separately 
evaluated epileptic activity in the EEG and seizure semiology. We calculated the time between KA injection and 
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the appearance of epileptiform discharges on the hippocampal electrodes and on the epidural electrodes. The 
EEG duration of the SE was defined as the time between the occurrence of the first epileptiform discharges in 
the EEG and the time point after which no high frequency, high amplitude discharges were detected. Duration 
of the clinical, behavioural SE was defined on the basis of clear motor symptoms observable on the video 
images. In case of wild running and jumping of the animals we interrupted the SE with pentobarbital 
(Nembutal, 60 mg/kg, i.p.), as this behaviour often culminates in the death of the animal. Rats were left in the 
monitoring cages for 48 hours after KA injection for the continuous recording of video-EEG and were then 
transferred to their regular cages until the next monitoring session, one week after SE.  
MONITORING OF SPONTANEOUS SEIZURES 
The occurrence of spontaneous seizures was monitored for 21 weeks, during 72 hours per week, in all rats 
starting one week after SE. Forty weeks after SE, a second video-EEG monitoring period of 14 days was started 
in four surviving KA treated rats. The EEG of both monitoring periods was screened for spontaneous EEG 
seizures. An EEG seizure was defined as a period of consistent, repetitive changes in amplitude and frequency 
of electrical activity that persisted for more than 10 s (fig. 2). Video-images were evaluated for clinical 
behaviour in the periods where EEG seizures were detected and seizure semiology was scored using a modified 
scale of Racine (Racine, 1972). Seizures accompanied by immobility, facial clonus, wet dog shakes, head 
nodding, chewing (severity stage 1 and 2) were grouped as partial seizures. More severe seizures of stages 3, 4 
or 5 were grouped as partial seizures with secondary generalization (SG) and defined as: stage 3: unilateral 
clonus of one forepaw, stage 4: bilateral clonus of forepaws and rearing, stage 5: bilateral clonus of forepaws, 
rearing and falling, tonic-clonic seizures. During this long term video-EEG monitoring we determined several 
seizure parameters: seizure type, seizure duration, seizure frequency, progression of seizure and variation in 
seizure occurrence related to circadian rhythm. Duration of the seizures was determined on the EEG (see fig 2 
for a typical example). Seizure frequency was defined as the total number of detected seizures during the 
relevant period divided by the recording period in days, which started after the detection of the fist seizure. 
The time course of seizure progression was assessed and we tested whether the occurrence of spontaneous 
seizures was related to a circadian rhythm.  
DATA ANALYSIS AND STATISTICS  
The recorded EEG was evaluated using custom made software programmed in LabView 7.0 (National 
Instruments). Statistical analysis was performed in SPSS version 12. Unless otherwise stated, all data are 
expressed as means and standard error of the mean. In several cases, assumptions for parametric statistics 
were not fulfilled and non-parametric Wilcoxon and Spearman rank tests were used. P<0.05 was assumed to 
indicate a significant difference.  
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RESULTS 
STATUS EPILEPTICUS 
Fifteen unanaesthesized rats were restrained and injected with KA (0.4 µg/0.2 µl) through a cannula placed in 
the right hippocampus. All 15 injected rats displayed SE with repeated EEG epileptic discharges and recurrent 
motor seizures. The mean latency between KA injection and the appearance of the first epileptiform discharge 
on the hippocampal EEG was 2 ± 1 min. The first epileptic discharge was seen on the scalp electrodes after a 
mean latency of 21 ± 6 min. Clinically, behavioural arrest (sometimes with jumping behaviour) was seen after 
KA injection. Behavioural arrest gradually evolved towards discrete motor seizures. After a mean latency of 66 
± 15 minutes the first discrete motor seizure was observed. This behaviour further progressed towards rapidly 
recurring generalized tonic clonic convulsions. Later in time after KA injection, convulsions were spaced by 
longer intervals and disappeared. Two rats had to be injected with pentobarbital (Nembutal, 60 mg/kg, i.p.) 
during SE because they displayed extremely wild running and jumping. One animal was injected 130 min and 
the other one 210 min after the start of the SE. The duration of SE in these two rats was not included for 
further analysis. The mean duration of behavioural SE was 457 ± 38 minutes which was significantly shorter 
than the EEG duration of 603 ± 19 minutes (p < 0.01, Wilcoxon signed rank test). After the last EEG discharge 
epileptiform spikes were still evident for at least 24 hours.  
SPONTANEOUS SEIZURES 
SEIZURE TYPE 
In 13 of the 15 KA treated rats spontaneous seizures were detected during the first 8 weeks that were 
monitored after SE. In the other two rats spontaneous seizures were found during the second monitoring 
period at 40 to 42 weeks after SE. The mean latency to the first detected seizure in these 13 rats was 28 ± 4 
days. The first detected spontaneous seizure was a partial seizure with SG in 9 of the 15 rats. We detected a 
total of 1329 EEG seizures during both monitoring periods (fig 2). Clinically, 876 (66%) of the seizures were 
partial seizures with SG and 453 (34%) were partial seizures without SG. All rats, but one, displayed partial 
seizures without SG. By evaluating both seizure types in individual rats, we found that the number of detected 
partial seizures with SG per rat (median: 25, range: 1-280) was significantly higher (p < 0.05, Wilcoxon signed 
rank test) than the number of detected partial seizures without SG (median: 5, range: 0-213). We also found 
that the occurrence frequency of both seizure types in an individual rat was positively correlated (Spearman 
correlation coefficient, rho=0.76, p<0.01). This implies that rats with a high number of partial seizures also have 
a lot of partial seizures with SG.  
 Chapter 5 | Cell transplantation for TLE 165 
 
 
Fig 2: Example of EEG pattern of a spontaneous seizure in the intrahippocampal KA model: This EEG pattern is recorded using depth 
electrodes placed in the right (KA injected) hippocampus. The duration of the seizure was determined on the EEG by the time between the 
start and the end of the discharge ( ). 
SEIZURE DURATION 
The mean duration of spontaneous seizures in the KA treated rats was 64 ± 4s. The duration of partial seizures 
was 46 ± 5s which is significantly shorter than the duration of partial seizure with SG, which was 72s ± 7s 
(Wilcoxon signed rank test, p < 0.05). Duration of spontaneous seizures during the first monitoring period did 
not change significantly over time and was not different from the duration of seizures in the second monitoring 
period. 
SEIZURE FREQUENCY 
As seizures are rare events, a large variation in the frequency of spontaneous seizures (expressed as 
seizures/day) was found among rats during the first monitoring period (range: 0-7.40 seizures per day, median: 
0.56, Table 1). Four rats out of the 15 tested had more than one seizure per day and three out of 15 displayed 
more than three seizures per day (Table 1). No correlation was detected between SE duration (electrographic 
as well as clinical) and seizure frequency, but a negative correlation was detected between the latency to the 
first seizure detection and the seizure frequency (Spearman correlation coefficient, rho= - 0.59, p<0.05).  
During the second monitoring period, 40 weeks after KA injection, four of the fifteen rats were monitored again 
and this continuously for 14 days. Among these four rats there was again considerable variation in seizure 
frequency (range: 0.38-9.92 seizures per day, median: 0.95, Table 1).  
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PROGRESSION OF EPILEPSY 
Once seizures appear we generally observed a progression in seizure severity, frequency of occurrence and 
duration. As seizure frequency covered quite a large range of values we analysed the development over time of 
this variable only for the four rats that had sufficiently high seizure rates (a total of 715 seizures were used). 
There was a significant correlation between time and seizure frequency (Spearman correlation coefficient 
rho=0.47, p<0.05, fig 3).  
We also found a higher seizure frequency in the second monitoring period compared to the first in the four rats 
tested (table 1). Two rats, in which no spontaneous seizures were detected during the first monitoring session, 
Table 1: Mean daily seizure frequency for each individual rat during the first and second  montoring period. 
  First 
monitoring 
period 
Second 
monitoring 
period 
Rat 1 7.40 n.m. 
Rat 2 6.61 n.m. 
Rat 3 3.22 n.m. 
Rat 4 1.15 9.92 
Rat 5 0.78 n.m. 
Rat 6 0.75 n.m. 
Rat 7 0.60 n.m. 
Rat 8 0.56 n.m. 
Rat 9 0.34 n.m. 
Rat 10 0.20 n.m. 
Rat 11 0.15 0.76 
Rat 12 0.13 n.m. 
Rat 13 0.08 n.m. 
Rat 14 0.00 0.38 
Rat 15 0.00 1.14 
This table shows the mean daily frequency of spontaneous seizures measured during the first (left) and the second (right) monitoring 
period. In this table rats are vertically sorted depending on the daily frequency of total spontaneous seizures (upper rows: high frequency; 
lower rows: low frequency). Mean daily seizures frequency was calculated by dividing the total number of detected seizures by the number 
of days monitored starting from day of the first seizure detection. During the first monitoring period the median seizure frequency is 0.56 
(range: 0.00-7.40 seizures/day). Three rats (1-3) displayed more than three seizures per day. One rat (4) had more than one but less than 
three seizures per day. Four rats (5-8) had at least one seizure every two days. Five rats (9-13) had less than one seizure in two days and in 
two rats (14-15) no seizures were detected during the first monitoring period. During the second monitoring period four of the fifteen rats 
were monitored again, but now continuously, for spontaneous seizures. For all four rats the daily seizure frequency was higher than in the 
first monitoring period. The median daily seizure frequency in this period was 0.95 seizures/day (range 0.38-9.92).   
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displayed 0.38 and 1.13 spontaneous seizures/day during the second monitoring period. In the two other KA 
treated rats an increase in spontaneous seizure frequency is seen compared to the last two weeks of the first 
monitoring session (9.92 compared to 1.15 seizures/day and 0.76 compared to 0.15 seizures/day). 
 
Fig 3: Seizure frequency in function of time: This graph shows seizure frequency (number of seizures per day) in function of time using four 
rats displaying in average more than one seizure per day. There is a significant positive correlation between seizure frequency and time 
(rho=0.47, p<0.05). Individual data points on this graph represent daily seizure frequency determined for periods during which seizures 
frequencies remained relatively stable.  
SEIZURE OCCURRENCE AND CIRCADIAN RHYTHM 
The four rats, which displayed a relative high seizure rate, were also used to analyse a possible circadian 
component in seizure occurrence. The distribution of seizure occurrence as a function of time of day is 
illustrated in fig 4. A clear time lock with the day-light period could be found. The mean diurnal seizure 
frequency was 0.25 ± 0.02 seizures/hr, the mean nocturnal seizure frequency was 0.15 ± 0.01 seizures/hr. Both 
were significantly different from overall mean seizure frequency, being 0.20 ± 0.03 seizures/hr. Overall 62 ± 1% 
of the seizures occurred during the lights on period. In summary we found a clear circadian rhythm in the 
occurrence of spontaneous seizures with a significantly higher (p<0.01, Mann-Whitney U test) seizure 
frequency during the day (08:00-20:00) compared to seizure frequency during the night (20:00-08:00) with the 
highest seizure frequency between 14:00 and 16:00. 
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Fig 4: Circadian rhythm of spontaneous seizures: Based on the four rats, displaying in average more than one seizure per day, the mean 
seizure frequency (seizures/hour) was determined for each two hour segment of the day ( ). From this graph it is evident that there is a 
circadian rhythm in the occurrence of seizures with significantly higher seizure frequencies during the day (08:00-20:00) compared to 
frequencies during the night (20:00-08:00; ). Both mean seizure frequency during the day (0.25 ± 0.02 seizures/hr) and during the 
night (0.15 ± 0.01 seizures/hr) were significantly different from the mean overall seizure frequency per two hours (0.20 ± 0.04 seizures/hr; 
). Seizure frequencies of the four individual rats were also displayed in this graph ( ).  
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DISCUSSION 
This study confirms that injection of KA directly in the hippocampus of unanaesthesized rats induces a SE in all 
rats (Bragin and others, 2004). This is not the case in other SE models, using excitotoxins or continuous 
electrical stimulation to evoke SE. In the intraperitoneal KA model, 93% (Stafstrom and others, 1992), in the 
intraperitoneal PILO model, 83% (Mello and others, 1993), in the intrahippocampal PILO model, 71%, (Furtado 
Mde and others, 2002), in the continuous hippocampal and perforant path stimulation model, 70% (Bertram 
and Cornett, 1994; Gorter and others, 2001) and in the amygdala stimulation model 87% (Nissinen and others, 
2000) of the animals developed SE.  
We found that the EEG duration of the SE after intrahippocampal KA injection was about 10 hours. The clinical 
duration of the SE, assessed by the occurrence of motor seizures, was significantly shorter being only about 7 
to 8 hours. After continuous hippocampal stimulation the length of SE is between 6 and 12 hours as assessed 
by behavioural and electrographic monitoring (Mathern and others, 1997), in the continuous perforant path 
stimulation SE model total time spent in EEG seizures was 9 h (Mazarati and others, 2002) and in the 
continuous amygdala stimulation model about 12 hours (Nissinen and others, 2000). In a lot of studies on the 
SE model status is interrupted after a certain amount of time with diazepam or phenobarbital (Lemos and 
Cavalheiro, 1995; Gorter and others, 2001; Glien and others, 2001; Klitgaard and others, 2002; Furtado Mde 
and others, 2002). Overall, the duration of SE, when not interrupted, seems to be independent of the induction 
method.  
We showed that SE, induced by intrahippocampal KA injection, leads to spontaneous seizures in all rats. In the 
majority of the animals (87%), seizures were detected during the first eight monitoring weeks. Analogue high 
fractions of animals with spontaneous seizures were reported after SE evoked by intraperitoneal injection of 
multiple low doses KA (97%) and PILO (100%) (Hellier and others, 1998; Glien and others, 2001) and after SE 
evoked by continuous electrical stimulation in the amygdala (87%), the hippocampus (100%) or the perforant 
path (100%) (Bertram and Cornett, 1994; Nissinen and others, 2000; Gorter and others, 2001). In humans the 
risk for spontaneous seizures after SE is lower being 37% within one year and 56 % within 3 years (Hauser and 
others, 1990). This lower risk is most likely a reflection of the immediate attempts to interrupt SE in patients 
and the chronic treatment of post-SE patients with AED. 
We demonstrated that about 30% of the spontaneous seizures were partial without SG. After intrahippocampal 
PILO administration 16% of the partial seizures did not secondary generalize (Furtado Mde and others, 2002). 
In the continuous amygdala stimulation model, the fraction of partial seizures without SG increased with time: 
from 21% during the first 10 weeks after SE to 77% in the following weeks (Nissinen and others, 2000). In the 
continuous perforant path stimulation model a similar increase in the fraction of partial seizures, that did not 
generalize, was reported about 2 months after SE (Gorter and others, 2001). In our study we could not detect 
an increase of the proportion of partial seizures without SG with time. In human refractory TLE, seizures are 
mainly partial without SG since many AED control SG much better than partial seizures (Wieser, 2004). 
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Therefore TLE models that allow screening of partial seizures without SG are very useful for the development 
of new treatments of refractory TLE.  
We found that mean seizure duration was about 64 s with secondary generalized seizures taking longer than 
non secondary generalized seizures. In the intraperitoneal KA model seizures last for about 30 s (Leite and 
others, 1990). In the intraperitoneal PILO model seizure duration varied between 30s and 60 s (Leite and 
others, 1990; Glien and others, 2001). In the continuous hippocampal stimulation model seizures are recorded 
with a duration between 64 and 106 s (Bertram and Cornett, 1994). In the perforant path stimulation model 
seizures last up to 120 s (Mazarati and others, 1998; Gorter and others, 2001). In the amygdala stimulation 
model seizures last in average for 49 s (Nissinen and others, 2000). In TLE patients, it has been reported that 
partial seizures with SG typically last for about 1 minute (Theodore and others, 1994). Overall, duration of 
seizures is rather similar among the different experimental models and humans with TLE. 
The daily frequency of spontaneous seizures varied considerably among the KA treated animals and varied 
from very few to 7 seizures per day. We showed that 20% of the animals displayed frequent seizures with more 
than three seizures per day, while 73% of the animals had a low seizure frequency with less than one seizure 
per day. Other studies have also reported that post-SE rats can be divided into frequently and rare seizing rats. 
In the continuous amygdala stimulation model, 31% of the animals display frequent seizures (Nissinen and 
others, 2000). In the perforant path stimulation model, frequent seizures (four or more per day) are detected 
in 67% to 76% of the rats (Mazarati and others, 1998; Gorter and others, 2001).  
As reported by Mazarati and coworkers we could not detect a correlation between the duration of the SE and 
the daily frequency of spontaneous seizures (Mazarati and others, 2002). We did find that a short latency to 
detection of the first spontaneous seizure was an indicator for a high frequency of spontaneous seizures. This 
was also reported in the continuous amygdala stimulation model (Nissinen and others, 2000).  
The daily frequency of convulsive seizures increases systematically during the first twenty weeks after SE, be it 
with a large variation within and among animals. In the intraperitoneal KA model a progression in the number 
of convulsive seizures is seen from 2 to 6 months after kainite treatment (Hellier and others, 1998). In the 
intraperitoneal PILO model a significant increase in the number of seizures was seen during the first two 
months after SE (Arida and others, 1999). In the continuous hippocampal stimulation model an increase in 
seizure frequency was reported during the three months after the first seizure (Bertram and Cornett, 1994). In 
the continuous perforant path stimulation model progression of seizure frequency was seen in the first two 
months after SE but only in a subgroup of rats. The authors demonstrate that this progression is associated 
with loss of hilar interneurons combined with mossy fiber sprouting (Gorter and others, 2001). The progression 
of seizure frequency in our and other models parallels the situation in most human patients suffering from TLE 
in whom a worsening of the epileptic state over time has also been described (Engel, 1996; Wieser, 2004).  
In our study, we found that seizure frequency has a link to the circadian rhythm with the seizures occurring 
more frequently during the day (lights on) compared to the night (lights off). The highest seizure rate, although 
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not significant, was found in the period between 14:00 and 16:00. Overall 62 ± 1% of the seizures occurred 
during the day. The same tendency was found in the continuous hippocampal stimulation model were about 
65% of the seizures occurred during the day with a peak occurrence at 15:00 (Quigg and others, 1998). Also in 
the amygdala stimulation model and the intraperitoneal KA model it was found that a higher fraction 
(respectively 57% and 64%) of the seizures occurred during the day (Hellier and Dudek, 1999; Nissinen and 
others, 2000). Hellier and coworkers normalized seizure occurrence for the activity-state of the animal and they 
found that more seizures come in periods of inactivity (82%) compared to periods of activity (18%) (Hellier and 
Dudek, 1999). Remarkably, spontaneous seizures in TLE patients preferentially occur during the day with a peak 
between 13:30 and 16:30, a period of the day during which humans are most active (Quigg and others, 1998).  
CONCLUSION 
To our knowledge this is the first report in which long term video-EEG monitoring is performed for the 
characterization of spontaneous seizures in the intrahippocampal KA model. We found that intrahippocampal 
KA induces SE and spontaneous seizures in each animal. By using video and EEG monitoring we showed that a 
high fraction of the seizures were partial without SG. We found that seizure frequency was quite variable with 
a limited fraction of rats displaying a high seizure frequency. In these frequently seizing rats a progression of 
the epileptic state and a circadian rhythm in seizure occurrence was found. All seizure characteristics 
investigated in this study corresponded with commonly found properties of seizures in experimental models 
and human patients with TLE. Therefore we suggest that the intrahippocampal kainic acid model is a valuable 
alternative model for spontaneous temporal lobe seizures.  
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In this study we explore the potential of adult neural stem cells (NSC) after transplantation in an experimental 
model for temporal lobe epilepsy. We describe the isolation of NSC from the subventricular zone of adult GFP-
reporter mice, their expansion as neurospheres in culture and their transplantation into the sclerotic 
hippocampus of the intraventricular kainic acid rat model. Three and six weeks after transplantation we 
evaluated the survival, dispersion and differentiation of the transplanted NSC. To assess the effect of the kainic 
acid lesion on the outcome of NSC transplantation we also transplanted NSC into the intact hippocampus of 
control rats. We evaluated the effect of a longer delay between lesion and grafting by transplanting the NSC 
with a postlesion delay of 3 days and 3 weeks.   
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SUMMARY 
Transplantation of cell lines secreting seizure modifying substances has lead to the suppression of seizures in 
models for temporal lobe epilepsy (TLE). However, the inability of these cell lines to survive long-term after 
transplantation makes the search for alternative cell sources mandatory. In this study transplantation of adult-
derived neural stem cells (NSC) was evaluated in the intrahippocampal kainic acid (KA) model for TLE.  
NSC, derived from the subventricular zone (SVZ) of transgenic green fluorescent protein (GFP) reporter mice 
and expanded as neurospheres, were transplanted in the intact and sclerotic hippocampus of respectively 
control (Norm group) and intrahippocampal KA injected rats and thisthree days (KA3d group) and three weeks 
(KA3w group) after KA injection. Survival, dispersion and differentiation of NSC were compared between the 
different groups, three and six weeks after transplantation.  
In the Norm and both KA groups a small but comparable fraction of GFP expressing NSC survived for at least six 
weeks after transplantation with a higher and more robust survival rate in the KA3d compared to the KA3w 
group. In both KA groups cell dispersion was significantly lower than in the Norm group. In all three groups cells 
mainly differentiated towards astrocytes but the astrocytic differentiation was significantly stimulated in both 
KA groups.  
Our study indicates that adult-derived NSC are able to survive long-term upon transplantation in the 
hippocampus where they seem to contribute to the astrogliotic response on the KA lesion. These results 
indicate that NSC could be further investigated for local delivery of seizure modifying substances in the 
sclerotic hippocampus.  
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INTRODUCTION 
Epilepsy is a chronic disorder of the central nervous system, affecting 1% of the human population. It is 
characterized by the abnormal and synchronized firing of a large number of neurons, resulting in various 
clinical symptoms. Although treatment with antiepileptic drugs (AED) is effective in the majority of patients, 
~30% remains medically refractory (Kwan and Brodie, 2000). Temporal lobe epilepsy (TLE) is the most common 
form of epilepsy in adults, with many patients being refractory (60%-75%) (Spencer, 2002). Epilepsy surgery is 
an invasive but often curative treatment option that aims at removing the ictal onset zone believed to be 
responsible for seizure occurrence (Wiebe and others, 2001). However, in a substantial number of patients 
surgery is not an option due to a potential risk of compromising normal brain function (Clusmann and others, 
2002). For these patients the ongoing search for alternative treatments such as newly developed AED, dietary 
treatments, transcranial magnetic stimulation and neurostimulation may prove successful (Freeman and 
others, 1998; Handforth and others, 1998; Vonck and others, 2002; Velasco and others, 2005). Next to these 
recently developed therapies, cell transplantation has also been suggested as a potentially valuable alternative 
to temporal lobe resection (Bjorklund and Lindvall, 2000; Nilsen and Cock, 2004).  
In different animal models for TLE neuronal excitability was decreased by transplanting fetal cells releasing 
antiepileptic substances such as GABA (Loscher and others, 1998; Ross and others, 2002), noradrenaline 
(Bortolotto and others, 1990; Bengzon and others, 1990; Lindvall and others, 1990; Kokaia and others, 1994) 
and acetylcholine (Ferencz and others, 1998; Ferencz and others, 2001). Since this approach involves the need 
of a high number of fetuses it is associated with a lot of ethical and practical issues which may always restrict 
the clinical application of such treatments.  
Based on the promising results of fetal tissue transplantation for the local delivery of epilepsy modifying 
substances, other cell types have been engineered to secrete inhibitory substances. In a series of experiments, 
Boison and colleagues induced inactivation of adenosine metabolizing enzymes in different self-renewing cell 
types to generate adenosine overexpressing cell lines. Adenosine overexpressing fibroblasts, myoblasts and 
embryonic stem cell-derived glia, encapsulated in semi-permeable polymers were grafted in the lateral 
ventricles of fully kindled rats resulting in a complete suppression of seizures (Huber and others, 2001; Fedele 
and others, 2004; Guttinger and others, 2005a; Guttinger and others, 2005b). Thompson and coworkers 
engineered a conditionally immortalized mouse neuronal cell line to deliver GABA by driving GAD65 expression 
using a doxycycline controlled promoter. Grafting of these cells into the anterior substantia nigra (SNr) 
(Thompson and others, 2000; Thompson and Suchomelova, 2004), the pyriform cortex (Gernert and others, 
2002) and the dentate gyrus of the hippocampus (Thompson, 2005) of rats had clear antiepileptic effects in 
both the kindling and status epilepticus (SE) model.  
An important limitation of the studies described above was that the cell lines were unable to survive long-term 
after transplantation even when they were not engineered to overexpress the antiepileptic substance. As a 
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consequence the antiepileptic effect was only temporary (Huber and others, 2001; Thompson, 2005; Guttinger 
and others, 2005a; Guttinger and others, 2005b).  
Neural stem cells (NSC) are a heterogeneous population of self-renewing and multipotent cells found in 
embryonic brain but also in different regions of the adult brain including the hippocampus, the subventricular 
zone (SVZ), the striatum, the substantia nigra, the cortex, the spinal cord, the septum and the optic nerve (Lois 
and Alvarez-Buylla, 1993; Palmer and others, 1995; Gage and others, 1995; Weiss and others, 1996; 
Shihabuddin and others, 1997; Palmer and others, 1999; Gage, 2000; Lie and others, 2002). NSC have been 
successfully isolated from the rodent and the human brain (Palmer and others, 1995; Weiss and others, 1996; 
Gritti and others, 1999; Nunes and others, 2003; Westerlund and others, 2005). A widely used method for the 
expansion of NSC is to grow them as free floating aggregates, termed neurospheres (Reynolds and Weiss, 1996; 
Weiss and others, 1996). In vitro these neurosphere cultures are able to generate both neurons, astrocytes and 
oligodendrocytes (Reynolds and Weiss, 1996; Weiss and others, 1996; Svendsen and others, 1999; Vescovi and 
others, 1999; Gobbel and others, 2003). Neurosphere-derived cells are able to survive for prolonged time 
periods after transplantation in the brain where they are able to generate both neurons and glia especially in 
neurogenic regions such as the SVZ and the hippocampus (Soares and Sotelo, 2004; Muraoka and others, 
2006). There are also indications that transplanted NSC are able to survive in brains affected by a lesion 
(Herrera and others, 1999; Dziewczapolski and others, 2003; Kelly and others, 2004; Richardson and others, 
2005a).  
Intrahippocampal injection of kainic acid (KA) in rats causes SE and spontaneous seizures after a latent period 
(Raedt and others, 2007). Histopathological changes caused by KA injection and the subsequent status 
epilepticus resembles hippocampal sclerosis, which is characterized by selective neuronal cell death and 
extensive gliosis (Engel, Jr., 2001).  
In this study, we investigated whether SVZ-derived NSC were able to survive long-term after transplantation in 
the sclerotic hippocampus of the intrahippocampal KA rat model for TLE. To determine the effect of the 
sclerotic lesion on the survival, dispersion and differentiation of the NSC, we compared the results with 
outcome of transplantation in a non-sclerotic hippocampus of control rats. To assess whether outcome 
parameters changed over time rats were killed three weeks and six weeks after transplantation. We also 
evaluated the effect of a longer delay between the lesion and the transplantation by grafting the cells both 3 
days and 3 weeks after KA injection.  
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MATERIALS AND METHODS  
All animal procedures and experiments were approved by the local Ethical Committee of the University of 
Ghent (ECP05-38). The animals were kept under environmentally controlled conditions (12h normal light/dark 
cycles, 20-23°C and 50% relative humidity) with food and water ad libitum.  
ISOLATION OF NEURAL STEM CELLS 
NSC were isolated from transgenic green fluorescent protein (GFP) mice according to a previously reported 
protocol (Raedt et al., 2006). In these mice ubiquitous expression of GFP is seen in all tissues because the GFP 
coding region is placed under the transcriptional control of the chicken β-actin promoter and human 
cytomegalovirus enhancer (Manfra and others, 2001). In brief, two male mice (20g) were sacrificed with 
pentobarbital overdose (Nembutal, Sanofi Santé B.V., France; 180 mg/kg). Their brains were removed and 
placed in artificial cerebrospinal fluid (124 mM NaCl, 5 mM KCl, 3.2 mM MgCl2, 105 mM NaHCO3, 10 mM 
glucose and 2 mM CaCl2). The SVZ was microdissected bilaterally and dissociated by placing it for 45 minutes 
into a digestion medium containing 0.5mM Na2EDTA (Sigma, Bornem, Belgium), 1.0 mM cysteine (Sigma), 0.9 
mg/ml papain (Worthington, Lakewood, NJ) and 1 mg/ml DNase (Sigma), dissolved in Earle's balanced salt 
solution. Digestion was stopped by adding ovomucoid (0.5 mg/ml, Sigma). After mechanically dissociating the 
tissue, cells were plated in a 96-well flat-bottomed plate at a density of 10,000 cells per well in a chemically 
defined medium. The NSC growth medium consisted of NS-A medium (Euroclone, Milan, Italy) with an 
additional 2 mM L-glutamine (Cambrex, Verviers, Belgium), 3 mM D-glucose (Sigma), 1% N2 supplement 
(Invitrogen, Merelbeke, Belgium), 100 U/ml penicillin (Cambrex), 100 U/ml streptomycin (Cambrex), 20 ng/ml 
of human recombinant epidermal growth factor (EGF, Sigma) and 20 ng/ml of recombinant human basic 
fibroblast growth factor (bFGF, R&D, Minneapolis, MN, USA). Cells were grown at 37°C in 5% CO2 and 95% air 
with saturated humidity. They were passaged once cell clusters, with a diameter of about 100 µm, were 
formed, approximately 2 weeks after initial isolation. Subsequent passages were done every 1–2 weeks. When 
sufficiently large cell numbers were obtained, cells were further cultured in T75 flasks at a density of 750.000 
per flask. After ten passages, cells were used for in vitro differentiation and in vivo transplantation 
experiments. At each passage NSC were evaluated for their GFP expression using flow cytometry analysis. 
IN VITRO DIFFERENTIATION OF THE NEURAL STEM CELLS 
Cells were differentiated by plating them at a density of 50000 cells/cm
2
 on matrigel coated (BD biosciences, 
Erembodegem, Belgium) chamber slide systems (VWR International, Leuven, Belgium). During the first 24 
hours of differentiation, cells were cultured in the presence of NSC growth medium with addition of 3% Fetal 
Calf Serum (FCS, Serum Supreme, Cambrex) which was devoid of EGF. This medium was then replaced by 
medium without EGF and bFGF, but with 3% FCS. Medium was changed every 48 hours for 5 days. Cells were 
fixed with 4% paraformaldehyde (PFA) for 15 min and subjected to immunocytochemistry. The fixed cells were 
rinsed with 50 mM NH4Cl for 10 min, permeabilized and blocked in phosphate-buffered saline (PBS) containing 
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0.4% fish skin gelatine (FSG) and 0,3% Triton X-100 (PBS/FSG/TX100). This was followed by incubation first with 
primary antibodies (ms, mouse monoclonal; rb, rabbit polyclonal): rb anti-tau 1:2000 (Dako, Heverlee, Belgium; 
A 0024), rb anti-GFAP 1:400 (Dako, Z0334), ms anti-RIP 1:5000 (Chemicon, MAB1580) and then with secondary 
antibodies Alexa Fluor 594 goat anti-rabbit IgG 1:1000 (Invitrogen, Merelbeke, Belgium; A11072) or Alexa Fluor 
594 goat anti-mouse IgG 1:1000 (Invitrogen, A11020) diluted in PBS/FSG /TX100 for 2 hours each. Chamber 
slides were then rinsed and mounted with Vectashield mounting medium (Labconsult, Brussels, Belgium). Each 
chamber slide was stained for only one of the three markers. To assess the fraction of cells expressing a specific 
marker, immunopositive cells were counted in eight randomly selected high-power fields. The relative amount 
of cells positive for a specific marker was obtained by dividing the total number of immunopositive cells by the 
total number of counted nuclei. In control studies the primary antibody was omitted and no immunostaining 
was detected in these controls.  
INTRAHIPPOCAMPAL KA INJECTIONS 
Rats (Sprague Dawley, n=24, 175-200g, Harlan, the Netherlands) were anesthesized using isoflurane (Abbot, 
Louvain-La-Neuve, Belgium) and fixated in a stereotactic frame (Bilaney Consultants, Düsseldorf, Germany). 
Their skull was exposed and a hole was burred for injection of 0.2 µl KA solution (2 mg/ml) using a 30G 
injection needle attached to a Hamilton syringe (1µl). KA was injected in the right hippocampus (AP:-5.6, 
ML:+4.5 and DV:-5.5 mm relative to bregma) (Paxinos and Watson, 1998) over a time period of 1 minute. After 
injection the needle was left in place for an additional three minutes and then slowly retracted. The burr hole 
was closed with bonewax (Ethicon, Johnson and Johnson Medical, Dilbeek, Belgium) and the skin was closed. 
Gas anaesthetics were stopped and during the first minutes of awakening, the rat developed a status 
epilepticus (SE) which spontaneously stopped several hours after its induction. 
TRANSPLANTATION OF NEURAL STEM CELLS 
NSC were labelled by adding 5-bromo-2-deoxyuridine (BrdU, 5µM, Roche, Vilvoorde, Belgium) to the medium. 
After two days cells were harvested, mechanically dissociated and resuspended in medium consisting of 
Dulbecco’s Phosphate Buffered Saline (DPBS; Invitrogen), 3 mM D-glucose (Sigma) and 20 ng/ml bFGF (R&D) in 
a concentration of 100,000 cells/µl. Transplantation of NSC was done in 3 experimental groups: in normal, non-
lesioned rats (Norm group, n=12), in rats 3 days after KA injection (KA3d group, n=12) and in rats 3 weeks after 
KA injection (KA3w group, n=12). In both KA treated groups cells were transplanted at the same site where 
previously the lesion was made. Rats were anesthesized with a combination of ketamine and xylazine (80 
mg/kg and 7.5 mg/kg respectively, IP). The animals were positioned into a stereotactic frame, their skull was 
exposed and a burr hole was made through which a transplantation needle (26S gauge) was lowered in the 
hippocampus (AP:-5.6, ML: +4.5 and DV:-5.5 mm relative to bregma). Cells were injected at a rate of 1 µl/min 
using a 10 µl Hamilton syringe as two deposits. After injecting 1µl of the cell suspension the needle was left in 
place for 2 minutes. The needle was then moved 0.5 mm up and an additional 0.4 µl was injected. The needle 
was not moved for an additional five minutes and was then slowly retracted. The burr hole was closed with 
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bonewax and the skin was closed. At the end of the transplantation procedure the viability of the remaining 
NSC was checked using the trypan blue exclusion method. Starting one day before transplantation, rats 
received daily injections (10 mg/kg, i.p.) of cyclosporin (Sandimmune, Novartis Pharma, Vilvoorde, Belgium) 
until they were killed (Pakzaban and others, 1995). 
TISSUE PROCESSING 
In all groups half of the rats (n=6) were killed three weeks after transplantation, the other half (n=6) six weeks 
after transplantation. Rats were terminally anesthesized using a pentobarbital overdose (180 mg/kg). The 
animals were then transcardially perfused with PBS at 37°C and postfixed overnight with 4% PFA. Brains were 
isolated and left overnight in 4% PFA at 4°C. Brain tissue was then cryoprotected in a 30% sucrose solution 
(30g/100ml) for three days. The cerebellum and frontal lobes were removed and the remaining brain tissue 
was frozen in ice-cold isopentane and stored in liquid nitrogen, until further processing. 
IMMUNOHISTOCHEMICAL STAINING OF THE SECTIONS 
Horizontal brain sections (30 µm) were made using a cryostat. Only sections containing hippocampus were 
preserved. Free-floating sections were washed 3 times in PBS. Then they were blocked for 45 minutes in 
PBS/FSG/TX100 followed by an overnight incubation with primary antibodies, also diluted in PBS/FSG/TX100: 
ms anti-NeuN 1:500 (Chemicon, MAB377), rb anti-GFAP 1:1000 (Dako, Z0334), ms anti-RIP 1:2000 (Chemicon, 
MAB1580), rb anti-NG2 1:200 (Biognost, Heule, Belgium; AB5320), rabbit serum anti-GFP (Invitrogen A6455), 
ms anti-BrdU 1:200 (Roche, 11170376001). This was followed by staining with secondary antibodies during 2 
hours, also diluted in PBS/FSG /TX100: Alexa Fluor 594 goat anti-mouse IgG (H+L) 1:1000 (Invitrogen, A11020), 
Alexa Fluor 594 goat anti-rabbit IgG 1:1000 (Invitrogen, A11072) and FITC goat anti-rabbit IgG 1:1000 (Jackson, 
Suffolk, England; 111-096-047). 
Before incubation with anti-BrdU antibody, a pre-treatment with formamide/SSC at 65°C for 2 hours, followed 
by incubation with respectively SSC (5 min, room temperature), 2N HCl (30 min, 37°C) and 0.1M boric acid (10 
min, pH 8.5, room temperature) was necessary to denature the DNA. After incubation with the secondary 
antibody, sections were rinsed four times with PBS and nuclei were stained with 4’-6-diaminido-2-phenylindole 
(DAPI) during 1 minute. Afterwards sections were rinsed in PBS and mounted with Vectashield mounting 
medium. On the sections with BrdU-staining nuclei were not stained with DAPI. The sections were further 
analyzed with an epi-fluorescence microscope and a Bio-Rad Radiance 2100 confocal laser scanning 
microscope. Confocal images were processed with ImageJ (Rasband, W.S., U. S. National Institutes of Health, 
Bethesda, MD, http://rsb.info.nih.gov/ij/) 
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SURVIVAL, DISPERSION AND DIFFERENTIATION OF NSC 
Epi-fluorescence microscopy was performed to assess the number of surviving, transplanted cells. To do this, 
only cells that double labelled for BrdU and GFP were counted. Because GFP fluorescence was lost due to pre-
treatment of the tissue for BrdU immunostaining, we also used immunohistochemistry to identify GFP-
containing cells. In preliminary experiments we found that there was no difference between the numbers of 
GFP containing cells before pre-treatment, identified by native GFP fluorescence, and after pre-treatment, 
identified by immunohistochemistry for GFP.  
All GFP/BrdU double labelled cells on every third hippocampal section were counted. The Abercrombie formula 
for correction of cell counts was used to obtain estimates of total cell numbers from the raw cell counts 
(Abercrombie, 1946; Dobrossy and Dunnett, 2004):  
P = (1/f) x A x [M / (D + M)]  
where P is the corrected cell number, A is the raw cell count from the entire graft, f is the frequency of sections 
counted, M is the section thickness and D is the average diameter of the BrdU labelled nuclei. To compare cell 
survival between groups, numbers of cells were presented as fraction of the total number of transplanted cells.  
Cell dispersion was measured on the same sections, used for assessment of survival, by determination of the 
maximal distance between two BrdU/GFP double-labelled cells for each section. Sections, containing only 
transplanted cells aligned along the needle tract, were excluded. The mean maximal distance was calculated 
and used as a measure for dispersion.  
Every third slide containing transplanted cells was used for assessing colocalisation of GFP with neuronal 
(NeuN), astrocyte (GFAP) or oligodendrocyte (RIP, NG2) markers using confocal laser scanning microscopy. For 
each marker expression was checked in 20 GFP positive cells which were randomly selected from all sections 
stained for this specific marker.  
DATA ANALYSIS 
All values are expressed as means ± standard error of the mean (SEM). Statistical analysis was performed using 
a two-factor (treatment and survival time) analysis of variance (ANOVA). If two-way ANOVA demonstrated a 
significant effect of treatment (P<0.05) a Bonferroni post-hoc test was performed to determine which of the 
three treatment groups significantly differed.  
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RESULTS 
IN VITRO CULTURE AND DIFFERENTIATION OF NSC 
Neurosphere-forming NSC were successfully isolated from the SVZ of β-actin-GFP reporter mice. Two weeks 
after initial isolation, neurospheres, growing loosely attached to the substrate, were present in the culture. 
These neurospheres were passaged mechanically when their diameter ranged from 100 to 150 µm. The 
dissociated cells were replated and gave rise to new neurospheres. These neurospheres were further passaged 
every 7 to 10 days after plating. Flow cytometry analysis, performed at each passage, showed that NSC stably 
expressed GFP for at least 10 passages (fig 1A). 
 
 
Fig 1: GFP expression and differentiation of NSC after ten passages in vitro. A: Flow cytometry analysis shows that NSC derived from β-
actin-EGFP reporter mice still express GFP after 10 passages in vitro. (B-C): Plating these expanded NSC on matrigel coated plates in the 
absence of growth factors and the presence of 3% serum resulted in the differentiation towards neurons, astrocytes and oligodendrocytes. 
Five days after initiation of differentiation cells were stained for the presence of tau (neuronal marker), GFAP (astrocyte marker) and RIP 
(oligodendrocyte marker) using immunocytochemistry. B: The majority of the cells (37 %) expressed the glial marker GFAP. C: A large 
fraction of cells (14 %) differentiated towards neuronal cells expressing tau (middle). D: A very low fraction of cells (0.4%) expressed the 
oligodendrocyte marker RIP (right, arrow). About half of the cells were still immature and did not yet express differentiation markers. 
(Scale bar= 50µm)  
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After 10 passages a fraction of the cells was used for transplantation while the other fraction was subjected to 
in vitro differentiation. Quantitative analysis, five days after initiation of the differentiation, showed that the 
majority of the cells (36.9%) expressed the glial marker GFAP (fig 1B). A large fraction of cells (13.8 %) 
differentiated towards cells expressing the neuronal marker tau (fig 1C) and a very low fraction of cells (0.4 %) 
expressed the oligodendrocyte marker RIP (fig. 1D). About half of the cells did not express differentiation 
markers. All differentiated cells still expressed GFP after differentiation. 
IN VIVO SURVIVAL AND DISPERSION OF NSC IN INTACT AND SCLEROTIC HIPPOCAMPUS  
Three and six weeks after transplantation of 140,000 BrdU-labelled NSC in non-sclerotic (Norm group) and 
sclerotic hippocampus (KA3d and KA3w group), we checked for the presence of transplanted cells. We found 
that a high amount of cells stained positive for BrdU but not for GFP (fig. 2A). We counted only the number of 
cells that double-labelled for BrdU and GFP to assess survival to avoid overestimation of cell survival.  
In non-sclerotic hippocampus the total number of BrdU/GFP expressing cells, three weeks after 
transplantation, was estimated to be ~1% of the total number of transplanted cells (Table 1). Comparing 
survival of transplanted cells using two–way ANOVA showed a significant effect (p<0.05) of treatment. Post-hoc 
analysis could not reveal differences in survival between the Norm group and both KA groups indicating that 
the presence of the sclerosis did not significantly affect survival. We did find that survival of the NSC was 
significantly higher (p<0.05) when grafted three days compared to three weeks after the lesion. Six weeks after 
transplantation survival in the KA3d group was even more than twice as much compared to survival in the 
KA3w group.  
  Total number of surviving cells  % of number of transplanted cells 
  Norm KA3d KA3w *
 
 Norm KA3d KA3w * 
three weeks 1460 ± 339 2484 ± 559  1394 ± 547  1.0 ± 0.2 1.4 ± 0.4  0.8 ± 0.3 
six weeks 853 ± 282 2132 ± 286 632 ± 303   0.6 ± 0.2  1.2 ± 0.2  0.5 ± 0.2 
NSC, isolated from the SVZ of β-actin-GFP reporter mice, were labelled with BrdU prior to transplantation. GFP/BrdU labelled cells were 
transplanted in non-sclerotic hippocampus (Norm group, n=12) and in sclerotic hippocampus three days (KA3d group, n=12) or three 
weeks (KA3w, n=12) after the KA lesion. Both three and six weeks after transplantation half of the transplanted animals were killed and the 
brain was sectioned. Each third hippocampal brain section was immunostained for BrdU and GFP and the number of double positive cells 
was counted on these sections. Using the formula of Abercrombie the total number of surviving GFP expressing cells in hippocampus was 
estimated. Results are expressed as mean ± SEM. * Indicates a significant (p<0.05) lower survival of GFP expressing NSC in KA3w group 
compared to the KA3w group.  
Table 1: Survival of GFP expressing NSC in non-sclerotic (Norm) and sclerotic (KA3d and KA 3w) hippocampus 
three and six weeks after transplantation.  
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Two-way ANOVA did not demonstrate an effect of time although in all three groups the number of GFP 
expressing cells found six weeks after transplantation was lower compared to three weeks after 
transplantation. 
Although we transplanted cells in two deposits (DV:-5.5 and – 5.0 mm relative to bregma), only one continuous 
cluster of transplanted cells could be identified. Since we made horizontal sections we only assessed dispersion 
in the horizontal plane. In the Norm group mean maximal distance between transplanted cells was about 1.3 
mm three weeks after transplantation (Table 2, Norm). The presence of a sclerotic lesion clearly affected 
dispersion of the transplanted cells since the mean maximal distance between two cells in both KA groups was 
about 650 µm, which was only half of the distance measured in non-sclerotic hippocampus. Two-way ANOVA 
confirmed that there was an effect of treatment (p<0.05) and post-hoc analysis showed that in both KA groups 
dispersion was significantly different from dispersion in the Norm group. ANOVA did not show an effect of time 
indicating that cells did not migrate three weeks after transplantation. Especially in non-sclerotic hippocampus, 
there was a tendency of the cells to align along fracture planes (the alvear layer, the hippocampal fissure and 
the subgranular layer of the dentate gyrus) of the hippocampus. In the sclerotic hippocampus BrdU/GFP 
positive cells tended to remain close to each other in dense clusters (fig. 2C). In all three groups, single or 
isolated groups of BrdU/GFP positive cells were found at the border of the lateral ventricles (fig 2D). In the 
Norm group, but not in both KA groups, isolated transplanted cells were found in the granule cell layer of the 
hippocampus (fig 2E).  
 
  
Cell dispersion  
(Mean maximal distance measured on individual horizontal hippocampal sections) 
  Norm KA3d * KA3w *
 
three weeks 1250 ± 264 646 ± 58 639 ± 148 
six weeks 1392 ± 384 751 ± 113 514 ± 237 
 
 
NSC, isolated from the SVZ of β-actin-GFP reporter mice, were labelled with BrdU prior to transplantation. GFP/BrdU labelled cells were 
transplanted in non-sclerotic hippocampus (Norm group, n=12) and in sclerotic hippocampus three days (KA3d group, n=12) or three 
weeks (KA3w, n=12) after the KA lesion. Both three and six weeks after transplantation half of the transplanted animals were killed and 
the brain was sectioned. Each third hippocampal brain section was immunostained for BrdU and GFP and the maximal distance between 
two double positive cells was measured on these sections. The mean maximal distance was calculated and used as a measure for 
dispersion. Results are expressed as mean ± SEM. * Indicates a significant (p<0.05) lower dispersion of GFP expressing NSC in both the 
KA3d and KA3w groups compared to the Norm group.  
Table 2: Dispersion of GFP expressing NSC in intact (Norm) and sclerotic (KA3d and KA 3w) hippocampus 
three and six weeks after transplantation.  
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Fig 2: Survival and dispersion of transplanted BrdU/GFP positive NSC. Adult NSC, isolated from the SVZ of β-actin-GFP reporter mice, were 
labelled with BrdU prior to transplantation. GFP-BrdU labelled cells were transplanted in non-sclerotic hippocampus (Norm group, n=12) 
and in sclerotic hippocampus three days (KA3d group, n=12) or three weeks (KA3w, n=12) after the KA lesion. Three and six weeks after 
transplantation half of the transplanted animals were killed and the brain was sectioned. Each third hippocampal brain section was 
immunostained for BrdU and GFP. A: Immunostaining revealed a lot BrdU positive cells (red) that did not contain GFP (green). To assess 
survival only cells double-labelled for GFP and BrdU were counted. B: GFP-positive cells are spread over long distance and preferentially 
align along fracture planes in non-sclerotic hippocampus which is probably the result of passive diffusion due to cell injection. C: In sclerotic 
hippocampus transplanted cells stay in a rather dense cluster. D: Adult NSC are able to migrate towards the border of the lateral ventricle 
(circle) and E: to integrate into the granule cell layer (Scale bar is 100µm in A,B,C,D and 10µm in E)  
IN VIVO DIFFERENTIATION OF NSC IN INTACT AND SCLEROTIC HIPPOCAMPUS 
In all groups we found that a large percentage of the GFP positive cells double-labelled for the astrocyte 
marker, GFAP. Two-way ANOVA indicated an effect of treatment on the fraction of transplanted cells 
expressing GFAP and post-hoc analysis showed that there was a significant difference (p<0.05) between the 
Norm group and both KA groups. In the sclerotic hippocampus the fraction of transplanted cells expressing 
GFAP was significantly higher (about 50% to 70%) and almost double of the fraction in the non-sclerotic 
hippocampus (about 30% to 40%). Transplanted cells expressing GFAP in the Norm group had multiple fine 
processes, resembling normal astrocytes. In the KA groups GFAP expressing transplanted cells displayed dense 
staining of the enlarged cell bodies and enlarged cell processes, resembling reactive astrocytes (fig 3). Using 
ANOVA we could not demonstrate an effect of time on the number of GFAP expressing transplanted cells 
which indicates that all differentiation occurs in the first three weeks after transplantation. 
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Fig 3: In vivo differentiation towards GFAP positive astrocytes. A and B: images, made using epi-fluorescence microscopy, show 
representative examples of sections containing GFP positive transplanted cells which also doublestain for GFAP (scale bar= 200 µm). A: In 
non-sclerotic hippocampus NSC align along the hippocampal fissure where they predominantly differentiate towards GFAP positive 
astrocytes. B: In sclerotic hippocampus grafted cells remain in dense clusters and the majority of the cells express GFAP. C and D: confocal 
images showing the difference in morphology and staining pattern of GFAP expressing GFP positive, transplanted cells (scale bar=10µm). C: 
GFP positive cells, which express GFAP, form multiple thin filaments in a non-sclerotic hippocampus, resembling normal astrocytes. D: GFP 
positive cells, which express GFAP, show excessive staining for GFAP, an enlarged cell body and thick processes in a sclerotic hippocampus 
resembling reactive astrocytes.  
We also evaluated the fraction of GFP positive cells expressing NeuN three and six weeks after transplantation 
in both non-sclerotic and sclerotic hippocampus. In all experimental groups a low percentage of cells 
differentiated towards neuronal cells (table 3). The largest fraction of neural differentiation, about 6%, was 
found in non-sclerotic hippocampus six weeks after transplantation. In non-sclerotic hippocampus, cells 
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expressing NeuN had migrated away from the transplanted cell cluster and were found integrated in the 
granule cell layer (GCL).  
In sclerotic hippocampus NeuN expressing GFP positive cells did not integrate into the GCL but remained in 
close proximity of the cell cluster (fig 4). Using ANOVA we could not demonstrate effects of treatment nor time 
on the fraction of GFP positive cells expressing Even after an extensive search we could not identify GFP-
positive cells that stained positive for one of both oligodendrocyte markers (RIP/NG2). A large proportion of 
grafted cells inside the cluster were not immunoreactive for any of the antigens tested. 
Table 3: Proportion of GFP expressing NSC that demonstrated double immunolabelling for NeuN or GFAP in 
intact (Norm) and sclerotic (KA3d and KA 3w) hippocampus three and six weeks after transplantation. 
  % of GFP+ cells expressing GFAP  % of GFP+ cells expressing NeuN 
  Norm KA3d * KA3w *
 
 Norm KA3d KA3w 
three weeks 30.0 ± 6.9 64.0 ± 7.6 50.1 ± 11.5  3.0 ± 2.0 2.0 ± 1.2 2.0 ± 1.2 
six weeks 38.6 ± 6.1 69.0 ± 8.3 56.5 ± 7.3  5.8 ± 2.0 1.0± 1.0 3.8 ± 2.4 
GFP labelled NSC, isolated from SVZ of β-actin-GFP reporter mice, were transplanted in non-sclerotic (Norm group, n=12) and in sclerotic 
hippocampus, lesioned with KA three days (KA3d group, n=12) or three weeks (KA3w, n=12) before grafting. Both three and six weeks after 
transplantation half of the transplanted animals were killed and the brain was sectioned. Every 15th hippocampal brain section was stained 
for GFAP or NeuN. In each animal, 20 GFP expressing cells were randomly selected from two sections stained for NeuN or GFAP. The 
fraction of GFP positive cells that immunostained for respectively the neuronal or the astrocyte marker was calculated. Results are 
expressed as mean ± SEM. * Indicates a significant (p<0.05) higher fraction of NSC expressing GFAP in both the KA3d and KA3w groups 
compared to the Norm group.  
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Fig 4: In vivo differentiation towards NeuN positive neuronal cells: A and B: images, made using epifluorescence microscopy, showing 
representative examples of sections containing GFP positive transplanted cells which also doublestain for NeuN (scale bar= 200 µm). A: In 
non-sclerotic hippocampus some GFP positive cells were found in dentate granule cell layer and stained positive for NeuN,  (yellow circle). 
B: In sclerotic hippocampus grafted cells did not integrate in granule cell layer but remained in dense clusters. Some of the cells within the 
cluster immunostained for NeuN. C and D: confocal images showing in closer detail NeuN expressing cells in non-sclerotic and sclerotic 
hippocampus (scale bar=10µm). C: In non-sclerotic hippocampus NeuN expressing cells are found integrated in the dentate granule layer. 
D: Sparse NeuN expressing GFP positive cells in a sclerotic hippocampus are found distributed throughout the cluster of transplanted cells.  
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DISCUSSION 
The main findings of this study were the following: firstly, we found that a fraction of BrdU labelled NSC, 
isolated from the SVZ of adult β-actin-GFP reporter mice and expanded as neurospheres in vitro, was able to 
survive for at least six weeks after transplantation in non-sclerotic (Norm group) and sclerotic hippocampus 
(KA3d and KA3w group). Secondly, we found that a delay of three days between induction of the lesion and 
transplanting of the NSC results in a higher, more robust cell survival compared to a delay of three weeks. 
Thirdly, we showed that dispersion of transplanted cells was reduced in sclerotic hippocampus. Fourthly, we 
found that a large fraction of the transplanted NSC differentiated towards astrocytes and that this was 
enhanced by transplantation in a sclerotic hippocampus. Fifthly, we detected both in non-sclerotic and sclerotic 
hippocampus a small fraction of GFP expressing NSC that had differentiated towards cells expressing the 
neuronal marker, NeuN.  
The number of GFP expressing cells that survived after transplantation for at least three weeks was about 1% 
of the total number of transplanted cells. This is rather low compared to other studies where a survival rate of 
41% and 66% was found after transplantation of hippocampus-derived NSC in respectively the hippocampus of 
normal rats and the striatum of hemiparkinsonian rats (Gage and others, 1995; Dziewczapolski and others, 
2003). In our study, we could have underestimated cell survival by excluding BrdU labelled cells that did not 
doublestain for GFP. Although presence of BrdU in GFP-negative cells could be explained by downregulation of 
GFP expression after transplantation, we had several reasons to be cautious about using only BrdU to assess 
cell survival. Firstly, we isolated the cells from transgenic mice in which stable expression of GFP is seen in all 
tissues, including brain, throughout life (Okabe and others, 1997; Manfra and others, 2001). Secondly, in this 
study the cells kept expressing GFP during in vitro culture and differentiation. Thirdly, in a recent study it was 
clearly shown that BrdU from dying cells can be recycled in endogenous proliferating cells, or cells undergoing 
simple DNA repair (Burns and others, 2006).  
The survival of GFP expressing transplanted cells in our study more closely resembles the results of another 
recent transplantation study. In that study, SVZ-derived rat NSC, transfected with an adenoviral vector 
containing the gene encoding for GFP, were transplanted into an intact hippocampus of rats from the same or 
a different strain. These authors showed that after allogenic transplantation of 100,000 cells only 3000 GFP-
expressing cells were retrieved three weeks after transplantation (Muraoka and others, 2006). This survival 
rate was higher if cell transplantation was done in an autologous manner. We have transplanted mouse cells 
into rat hosts. Although we used cyclosporine as immunosuppressant, interspecies barrier could be one of the 
contributing factors for the low survival.  
In our study, we demonstrated that a longer delay between making the lesion and performing the 
transplantation resulted into lower survival rates. This time dependant decrease in survival was also observed 
after transplantation of fetal CA3 neurons in a KA induced lesion. In these experiments survival of cells, 
transplanted 45 days after making the lesion, was up to four times lower compared to transplantation four 
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days after the lesion (Zaman and others, 2001; Turner and Shetty, 2003). This time dependant effect on survival 
of transplanted cells was explained by the presence of an enhanced neurotrophic factor environment for up to 
10 to 14 days after lesion development (Lowenstein and others, 1993). A combined neurotrophic 
supplementation and caspase inhibition has been shown to dramatically enhance survival of grafts placed into 
the injured adult hippocampus at an extended time-point (i.e. 4-months) after injury (Hattiangady and others, 
2006). This may represent an alternative strategy to enhance survival of SVZ-derived NSC in our setup.  
The majority of the GFP positive cells in non-sclerotic hippocampus were found to align fracture planes of the 
hippocampus. In sclerotic hippocampus, dispersion of transplanted cells was lower and cells remained in dense 
clusters. This could be due to the presence of the glial scar which formed a barrier which transplanted cells 
could not cross. An alternative explanation could be that cells remained close to the lesion because they were 
attracted to it. Endogenous SVZ-derived NSC possess a high pathotropism and have been shown to be strongly 
attracted to excitotoxic lesions in hippocampal CA1 and CA3 regions, induced by SE. The NSC migrated towards 
the lesions where they differentiated towards glial cells (Parent and others, 2006). Although our study did not 
allow discriminating whether dispersion of transplanted cells was the result of passive diffusion or active 
migration, we found isolated cells at a distance of the injection site at places that could only be reached by 
active migration through the parenchyma, for example in the GCL or at the border of the lateral ventricles.  
Doublestaining for neuronal, astrocyte and oligodendrocyte markers showed that the majority of the NSC 
differentiated towards astrocytes. Several other studies have shown that a high percentage of expanded NSC 
adopt a glial fate upon transplantation into the adult brain (Gage and others, 1995; Carpenter and others, 
1997; Hammang and others, 1997; Dziewczapolski and others, 2003; Shear and others, 2004; Soares and 
Sotelo, 2004; Muraoka and others, 2006). The type of glial fate seems to depend on the site of transplantation. 
When hippocampus-derived NSC were transplanted in an intact hippocampus, a large cell fraction 
differentiated towards astrocytes (Gage and others, 1995). When these cells were transplanted into the 
striatum, the majority generated NG2-positive oligodendrocyte precursors while only 0.1% of the cells 
differentiated towards astrocytes (Dziewczapolski and others, 2003). Based on two findings in our study we 
hypothesize that the transplanted NSC were recruited in hippocampal sclerosis in response to the KA lesion. 
Firstly, we showed that transplantation in sclerotic hippocampus resulted in a higher fraction of transplanted 
cells expressing GFAP. Secondly, in lesioned hippocampus, GFAP positive cells showed intense staining for 
GFAP, enlarged cell bodies and thickened processes and therefore resembled reactive astrocytes.  
Next to this glial differentiation a portion of NSC differentiated towards cells expressing NeuN, a marker for 
mature neurons. Other transplantation studies have indicated that NSC, derived from adult brain, only 
generate neurons in the adult brain when they are transplanted into neurogenic regions such as the 
hippocampus or the olfactory bulb (Gage and others, 1995; Suhonen and others, 1996; Shihabuddin and 
others, 2000; Lie and others, 2002; Richardson and others, 2005b; Muraoka and others, 2006). Adult NSC even 
respond to local differentiation cues and are able to adopt region specific neural phenotypes (Shihabuddin and 
others, 2000; Richardson and others, 2005b). The maximal fraction of 6% NeuN expressing cells, six weeks after 
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transplantation in non-sclerotic hippocampus, resembled the fraction seen in a similar study performed by 
Muraoka and coworkers (Muraoka and others, 2006). These authors showed that the number of NeuN 
expressing could be doubled by performing autologous transplantation. In another study the fraction of SVZ-
derived NSC differentiated towards neurons was even higher (about 27%). In this study NSC were cultured as 
monolayer instead of neurospheres, which could promote the selection of neuroprogenitor cells (Richardson 
and others, 2005b). Also these authors used BrdU as the only marker to identify transplanted cells. Because the 
hippocampus is a region containing a lot of dividing neuronal precursors, a transfer of BrdU from dying 
transplanted cells to dividing endogenous neuroblasts is possible, resulting in an overestimation of neuronal 
differentiation (Burns and others, 2006). Comparing neuronal differentiation between groups in our study 
revealed that the presence of a KA lesion did not affect the fraction of NSC differentiating towards neurons but 
did affect the site of neural differentiation. In non-lesioned hippocampus transplanted cells expressing NeuN 
were found exclusively in the granule cell layer while in the lesioned hippocampus NeuN expressing cells were 
found on different locations in the hippocampus. This could be explained by the lack of signals driving 
migration and integration into the GCL.  
In conclusion, our study is the first in which NSC were transplanted into a KA lesioned hippocampus. By 
comparing this to transplantation of NSC in non-lesioned hippocampus we showed that a comparable but 
limited fraction of NSC is able to survive for at least six weeks after transplantation and that transplanted NSC 
seem to contribute to hippocampal sclerosis in response to the KA lesion. Further studies are needed to look 
for manipulations that could enhance the fraction of cells that survive after transplantation (e.g. autologous 
transplantation, pre-treatment with anti-apoptotic substances, local infusion of survival factors). However 
based on their stable survival, NSC may be investigated to deliver seizure modifying substances in the sclerotic 
hippocampus.  
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In this manuscript we describe an experiment to further elucidate the role of neurogenesis in epileptogenesis. 
We subjected rats to low-dose radiation, in order to suppress hippocampal neurogenesis, and evaluated the 
effect of radiation on the development of rapid hippocampal kindling. We radiated the whole brain of half of 
rats using a small dose of 8 Gy. Both non-radiated and radiated rats were subjected to a rapid hippocampal 
kindling protocol one day after radiation. Suppression of seizure-induced neurogenesis was evaluated during 
the kindling acquisition (first week after radiation) and the kindling retest phase (two and three weeks after 
radiation). We assessed the effect of radiation on afterdischarge threshold, afterdischarge duration and 
kindling rate both during kindling acquisition and the kindling retest phase.  
 
 204 Manuscript 6 
 
SUMMARY  
Adult hippocampal neurogenesis is enhanced in several models for temporal lobe epilepsy (TLE). In this study 
we used low-dose, whole brain radiation to suppress hippocampal neurogenesis and then studied the effect of 
this treatment on epileptogenesis in a kindling model for TLE. 
Half of the rats were exposed to a radiation dose of 8 Gy one day before the initiation of a rapid kindling 
protocol. Afterdischarge threshold (ADT), afterdischarge duration (ADD), clinical seizure severity and 
inflammation were compared between groups. On the first and third day after radiation, rats were injected 
with 5′-bromo-2′-deoxyuridine (BrdU) to evaluate neurogenesis. Seven and twenty-one days after radiation, 
numbers of doublecortin (DCX) positive neuroblasts in subgranular zone and granule cell layer were compared 
between groups.  
In this study, we showed that radiation significantly suppressed neurogenesis and neuroblast production during 
kindling acquisition. Radiation also prevented an increase in ADT which became significantly lower in radiated 
rats. On the third and fourth kindling acquisition day radiated rats developed more severe seizures more 
rapidly, which resulted in a significantly higher mean severity score on these days. Differences in ADD could not 
be demonstrated.  
Our results demonstrate that brain radiation with a relatively low dose effectively suppressed the generation of 
new granule cells and transiently enhanced excitability during kindling acquisition. Although seizure-induced 
neurogenesis was lower in the radiated rats we could not detect a strong effect on the final establishment of 
the permanent fully kindled state, which argues against a prominent role of seizure-induced neurogenesis in 
epileptogenesis. 
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INTRODUCTION 
Recent studies have demonstrated that active neurogenesis takes place in discrete regions of the adult brain in 
mammals, including humans (Kempermann and Gage, 1999; Gross, 2000; Lie and others, 2004; Ming and Song, 
2005). Brain regions where neurogenesis is most prominent are the subventricular zone (SVZ) of the lateral 
ventricle and both the subgranular zone (SGZ) and granule cell layer (GCL) of the hippocampus (Eriksson and 
others, 1998; Alvarez-Buylla and others, 2000; van Praag and others, 2002). Outside these regions, 
neurogenesis is either very sparse or non existent in the intact adult brain. Neurogenesis is a dynamic process 
consisting of different subsequent stages, including proliferation, fate specification, migration, synaptic 
integration and survival.  
In the dentate gyrus a subset of astrocytes, residing in the SGZ, has been proposed to be the neural stem cells. 
These cells divide and give rise to neuroblasts, which exit the cell cycle and migrate into the GCL where they 
further develop to mature granule cells, establish synaptic connectivity and become functionally integrated 
(Kempermann and others, 2004). 
Experimentally induced seizures can modulate all stages of neurogenesis in dentate gyrus. Status epilepticus 
(SE) as well as kindling have stimulating effects on the proliferation of neural stem and/or precursor cells in the 
SGZ resulting in a net increase in granule cell neurogenesis (Parent and others, 1997; Bengzon and others, 
1997; Gray and Sundstrom, 1998; Parent and others, 1998; Scott and others, 1998; Nakagawa and others, 
2000; Ferland and others, 2002; Romcy-Pereira and Garcia-Cairasco, 2003; Huttmann and others, 2003; 
Mohapel and others, 2004; Jessberger and others, 2005; Smith and others, 2005; Parent and others, 2006). In 
the chemoconvulsant and electrogenic status epilepticus models, neurogenesis is increased five- to tenfold 
after a latent period of a few days (Parent and others, 1997; Gray and Sundstrom, 1998; Jessberger and others, 
2005). In the kindling model, neurogenesis is increased respectively three to six times (Bengzon and others, 
1997; Smith and others, 2005). This increase in neurogenesis is only temporary and returns back to baseline 
levels or even below in the first month after seizures (Parent and others, 1997; Nakagawa and others, 2000).  
In addition to an enhanced neurogenesis, seizures can also affect migration of the neuroblasts. In both the 
amygdala kindling model and SE models newly generated neurons were found in ectopic locations in the hilus 
(Parent and others, 1997; Scharfman and others, 2000; Smith and others, 2005; Pierce and others, 2005; 
Shapiro and others, 2005; Shapiro and Ribak, 2005; Parent and others, 2006; Shapiro and Ribak, 2006; Bonde 
and others, 2006). Studies in the PILO SE model show that these ectopic neurons have morphological and 
electrophysiological properties comparable with granule cells in the GCL (Scharfman and others, 2000). 
However when these cells are examined a few months after status, they display spontaneous, regular 
epileptiform bursts synchronously or a few milliseconds later than epileptiform bursts in CA3 cells (Scharfman 
and others, 2000). Synaptic integration of newborn neurons can be altered in an epileptic situation. Seizures 
can accelerate the development of excitatory input to immature dentate granule cells during the first two 
weeks after their formation (Overstreet-Wadiche and others, 2006). Seizure-activity also seems to induce part 
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of the newborn neurons to form aberrant mossy fiber recurrent connections and persistent basal dendrites 
which project into the hilus and are innervated by mossy fibers (Parent and others, 1997; Pierce and others, 
2005; Shapiro and Ribak, 2005; Shapiro and Ribak, 2006).  
The kindling model is a widely accepted experimental model for TLE (Goddard, 1983; McNamara, 1984). 
Regular electrical kindling consists of daily stimulating a discrete area of the limbic system for one second, 
every day. Every stimulus triggers an electrographic event, the afterdischarge (AD), which threshold (the 
intensity of the current needed to evoke an AD) and duration reflect the level of excitability within the limbic 
circuit (McNamara, 1984). As the electrographic response to the kindling stimulation intensifies, behavioural 
responses to the stimulation increase in severity. An animal is considered to be fully kindled if kindling 
stimulation reproducibly evokes a generalized tonic-clonic seizure. Once an animal is fully kindled it remains 
displaying stage 5 seizures, in response to stimulation, for months or years (Goddard and others, 1969). Using 
the regular kindling protocol, it takes 10 to 15 days for the rodent to become fully kindled, strongly dependent 
on the region which is stimulated. There are also alternative kindling protocols where rodents can be fully 
kindled over a shorter period. The alternate day rapid hippocampal kindling protocol allows to fully kindle a 
rodent with 48 stimulations, spread over the course of four stimulation days (Lothman and others, 1985; 
Lothman and Williamson, 1994). In case of hippocampal kindling, neurogenesis is already increased three-fold 
five days after experiencing one single seizure and six-fold after 40 kindling stimulations (Bengzon and others, 
1997). Whether this seizure-induced neurogenesis contributes to kindling epileptogenesis and the generation 
of a permanent fully kindled state is not yet elucidated.  
Therefore, in this study, we exposed rats one day before rapid hippocampal kindling to low-dose whole brain 
radiation, a commonly used technique to suppress neurogenesis (Wojtowicz, 2006). Studies on the mechanism 
of radiation-induced suppression of neurogenesis show that radiation causes an increase in apoptosis of neural 
precursor cells and early postmitotic neurons together with a decrease in neural stem/precursor cells 
proliferation (Peissner and others, 1999; Monje and others, 2002; Monje and Palmer, 2003). Low dose (1-15 
Gy) radiation does not cause gross tissue changes and spares adult neurons (Calvo and others, 1988; Tada and 
others, 2000). However, the use of this radiation also has limitations since other effects of radiation, besides 
suppression of neurogenesis, such as inflammation, alterations in microvasculature and changes in metabolic 
and signalling pathways could contribute to the effects seen after radiation (Monje and Palmer, 2003; Silasi and 
others, 2004). Our paradigm only suppressed the generation of new neurons in response to seizures. Immature 
neurons, which had arisen from progenitor division during ongoing neurogenesis in the weeks prior to the 
radiation, were still available for integration in aberrant circuitry.  
Here, we specifically elaborated on the effect of early radiation on kindling epileptogenesis. AD threshold, AD 
duration and behavioural response were compared between radiated and non-radiated rats during kindling 
acquisition and retest stimulation, one and two weeks after the end of kindling acquisition in the fully kindled 
state. Neurogenesis or neuroblast formation was quantified over the same period.  
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METHODS 
ANIMALS 
Female Sprague-Dawley rats (200-225 g body weight; Harlan, the Netherlands) were treated according to 
guidelines approved by the European Ethics Committee (decree 86/609/EEC). The study protocol was approved 
by the Animal Experimental Ethical Committee of Ghent University Hospital (ECP 06/13). The animals were kept 
under environmentally controlled conditions (12h normal light/dark cycles, 20-23°C and 50% relative humidity) 
with food and water ad libitum.  
SURGERY 
All rats were anesthetized with a ketamine (80 mg/kg) and xylazine (7.5mg/kg) mixture (pH 4.0) 
intraperitoneally and positioned in a stereotactic frame (Bilaney Consultants, Düsseldorf, Germany). After 
exposure of the skull, 8 small burr holes were drilled for the placement of anchor screws and electrodes. 
Epidural electrodes were custom made by soldering an insulated copper wire to a screw. Two epidural 
electrodes were used for the recording of surface EEG. One was placed on the left side of the skull at the height 
of the frontal cortex and one on the left side at the height of the parietal cortex. One epidural electrode was 
placed at the height of the sutura lambdoidea and was used as reference/ground electrode. A quadripolar 
electrode was custom-made by gluing together two recording electrodes (polyimide coated stainless steel 
wires, 70µm diameter, California Fine Wire, USA) and two stimulation electrodes (polyimide-coated stainless 
steel wire, 125µm diameter, Plastics One, USA). Each of the wires was cut at a different length so that the 
electrode tips were separated by 400 µm from each other. This quadripolar registration/stimulation electrode 
was inserted in the right hippocampus (AP -3.9, ML -1.7, DV -4.0 mm relative to bregma). All four electrode tips 
were in the hippocampus (fig. 1A). In the remaining four burr holes, anchor screws were placed to fix the 
electrodes on the skull by dental cement. All electrodes were lead to a connector which could be attached to 
the EEG cables.  
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EXPERIMENTAL SETUP  
The setup of the experiment is given in fig. 1B and explained below. We repeated the same experiment twice, 
using 16 rats per session. We pooled the kindling data of both experimental sessions for analysis.  
 
Fig 1: Implantation of registration/stimulation electrode and experimental setup. A: A quadripolar registration/stimulation electrode is 
stereotactically positioned in the right hippocampus (AP-3.9, ML-1.7, DV-4 mm relative to bregma). All four tips are located in the 
hippocampus. Hippocampal EEG is recorded on the first and third most dorsal tips. Kindling stimulations are delivered through the second 
most dorsal and the most ventral electrode tips. Electrode tips are spaced by 0.5 mm . B:  Seven days after electrode implantation half of 
the rats (n=16) were exposed to low-dose (8 Gy), whole brain irradiation. On the first and the third day after radiation, rats were injected 
intraperitoneally with BrdU (50 mg/kg) twice a day to label all dividing cells. Staining hippocampal sections for BrdU at the end of the 
experiment allowed us to assess the level of neurogenesis in these first days after radiation. One day after radiation all rats (non-radiated 
and radiated) were subjected to a rapid kindling protocol. This protocol consists of an acquisition phase during which rats are stimulated 
twelve times a day, every 30 minutes, for four alternating days. One and two weeks after termination of the acquisition phase, rats were 
retested for their kindling response in the kindling retest phase. The number of doublecortin (DCX) positive cells at the end of the 
experiment indicates the level of neurogenesis at that time point.  
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AFTERDISCHARGE THRESHOLD DETERMINATION  
Following surgery, rats were allowed to recover for at least one week. At the day of radiation, rats were placed 
in the kindling setup and connected through a commutator to the digital EEG-recording system and to the 
constant current stimulator. In all rats the minimal stimulation intensity to evoke an afterdischarge in the 
hippocampus (afterdischarge threshold, ADT) was determined to assure that all rats that would be subjected to 
the radiation were responsive to kindling stimulation. Therefore a 10 second pulse train (20 Hz, 1 ms square 
wave pulses) was delivered to the two stimulation contacts of the quadripolar registration/stimulation 
electrode, placed in the hippocampus. The first stimulation train had a minimal current intensity of 25 µA. 
Stimulation intensity was increased with 25 µA steps until the AD threshold (ADT) was reached and a 
hippocampal seizure could be detected on the EEG in response to the stimulation.  
RADIATION  
After determining ADT, 16 rats were randomly divided into two groups: a radiated group (n= 8) in which rats 
were subjected to low-dose, whole brain radiation and a non-radiated group (n=8) in which rats underwent the 
same experimental procedures but were not radiated. Before radiation the rats were anesthetized by 
intraperitoneal injection of a ketamine/xylazine mixture (80mg/kg and 7.5mg/kg respectively, pH 4.0) and fixed 
in a stereotactic frame (Bilaney Consultants). The radiation was performed with 5 MV photons on a SL75-5 
Elekta linear accelerator, at a dose rate of 3.5 Gy per minute. By exposing the rats for 2 minutes and 17 
seconds, a total dose of 8 Gy was delivered. A single field of 2 x 2 cm at a distance of 100 cm to the dental 
cement, fixing the electrodes to the head, was used. The thickness of the dental cement was about 1 cm, 
compensating for the build-up effect under the skin. The field was centred on the animal's head and its cranial 
border was put just behind the eyes. The dose at skin level under the dental cement was verified with 
thermoluminescent dosimetry.  
ALTERNATE DAY RAPID KINDLING 
In this experiment we used the alternate day rapid kindling protocol described by Lothman and others 
(Lothman and others, 1985; Lothman and Williamson, 1994). This consists of a kindling acquisition period 
during which 48 kindling stimulations are given spread over four alternating days, interleaved by days without 
stimulation. So, rats receive twelve stimuli per day which are separated by 30 minute intervals. The first 
stimulus for each animal on each day is used to determine the ADT as described above. The remaining 11 
kindling stimulations are given at 400µA in amplitude, which was always above threshold. The typical 
behaviour associated with the hippocampal AD’s is classified according to the adjusted version of the scale of 
Racine: stage 1, immobility, eye closure, twitching of vibrissae, facial clonus, wet dog shakes; stage 2: head 
nodding, chewing, severe facial clonus, wet dog shakes; stage 3: clonus of one forelimb; stage 4: rearing, 
bilateral forelimb clonus; stage 5: rearing, bilateral forelimb clonus, loss of balance and falling (Racine, 1972). 
The duration of all afterdischarges was also measured on the EEG. To check for a retained kindling response, 
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rats were retested one and two weeks after the end of the acquisition phase. On these retest days ADT, seizure 
stage and ADD were evaluated.  
5′-BROMO-2′-DEOXYURIDINE (BRDU) INJECTION 
To evaluate neurogenesis in the early phase of kindling all rats received four intraperitoneal 5′-bromo-2′-
deoxyuridine (BrdU, Roche diagnostics, Vilvoorde, Belgium) injections (50 mg/kg). Two injections were given on 
the first day after radiation and two were given at the third day after radiation. The first of two daily BrdU 
injections was given immediately before the determination of the ADT; the second injection was given 
immediately after the last (twelfth) kindling stimulation. So, BrdU injections were separated by 6 hours.  
TISSUE PREPARATION 
Rats were terminally anesthetized using pentobarbital (Nembutal, Sanofi Santé B.V., France; 180 mg/kg) and 
perfusion-fixed through the ascending aorta with 4% paraformaldehyde in 0.1 M phosphate buffer (PB) and 
0.2% glutaraldehyde (pH 7.4). After in situ postfixation overnight (at +4°C), the brains were dissected and 
transferred to 30% sucrose in PB. After three days at +4°C, the brains were frozen at −20°C to −30°C in 2-
methylbutane and stored at −80°C. Coronal and horizontal sections (40µm) were obtained by
 
the use of a 
freezing microtome and stored in a cryoprotectant
 
(25% ethylene glycol and 25% glycerin in a 0.05 M PB)
 
at -
20°C before immunohistochemistry.  
IMMUNOHISTOCHEMISTRY 
Free floating sections were treated with 0.6% H2O2 in Tris-buffered saline (TBS; 0.15 M NaCl and 0.1 M Tris-HCl,
 
pH 7.5) for 30 min to block endogenous peroxidase activity. For immunohistochemical detection of 
incorporated BrdU, DNA denaturation was performed in the following manner:
 
tissue was incubated in 50% 
formamide and 2× SSC (0.3 M NaCl and 0.03 M sodium citrate) for 2 hr at 65°C, rinsed for
 
15 min in 2× SSC, 
incubated again for 30 min in 2 M HCl at 37°C,
 
and rinsed for 10 min in 0.1 M boric acid at pH 8.5. To stain for 
doublecortin (DCX) and vimentin, sections were pre-treated for 30 min with preheated (80°C) NaCitrate 
(10mM, pH9) before blocking of endogenous peroxidase activity.  
Following extensive washes in TBS, sections were blocked with a solution containing TBS, 0.25% Triton X-100 
and 3% donkey serum for 30 min. The same solution was used during the incubation with primary antibodies. 
Primary antibodies were applied overnight
 
at 4°C. For chromogenic immunodetection, tissue sections were 
rinsed three times and incubated for 2 hr with
 
biotinylated donkey secondary antibodies. After extensive 
washes in TBS an avidin-biotin-peroxidase
 
complex solution (Vectastain Elite ABC-kit Standard, Vector 
Laboratories, Burlingame, CA) was applied for 1 hr before 5 min of peroxidase detection
 
(using 0.25 mg/ml 3,3’-
diaminobenzidine, 0.01% H2O2, and 0.04%
 
NiCl). Sections were placed on Superfrost Plus slides (Menzel-Gläser, 
Braunschweig, Germany), alcohol dehydrated and mounted in Neo-mount (Merck, Darmstadt, Germany). 
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For epifluorescence detection sections were washed extensively and incubated with fluorochrome-conjugated 
species-specific secondary antibodies. Sections were placed on Superfrost Plus slides and mounted in 
vectashield mounting medium (H-1000, Vector Laboratories).  
The following antibodies and final dilutions were used. Primary antibodies: mouse anti-BrdU (1:400; Roche 
Diagnostics, Vilvoorde, Belgium), rat anti-BrdU (1:250, Nordic Biosite AB, Täby, Sweden), goat anti-DCX (1: 125, 
Santa Cruz Biotechnology, Heidelberg, Germany), mouse anti-vimentin (1:25, DAKO, Heverlee, Belgium), mouse 
anti CD11b/c (OX42, 1:100, BD Biosciences, Erembodegem, Belgium), mouse anti-NeuN (1:100, Chemicon, 
Temecula, CA, USA). Secondary antibodies: biotinylated donkey anti-mouse IgG (1:1000, 
JacksonImmunoResearch, Suffolk, England), biotinylated donkey anti-goat IgG (1:1000, 
JacksonImmunoResearch), donkey anti-rat-Alexa488 (1:1000, Molecular Probes, Eugene, Oregon, USA) and 
donkey anti-mouse-Alexa555 (1:1000, Molecular Probes).  
 
QUANTIFICATION 
The number of BrdU and DCX-positive cells was determined in the granule cell layer (GCL) [including the 
subgranular zone (SGZ)] in six (BrdU) or twelve (DCX) immunoperoxidase-stained, 40-µm-thick coronal
 
sections 
taken 480 µm (BrdU) or 240 µm (DCX) apart. The numbers of positive
 
cells were counted within the GCL and 
two cell diameters below
 
the GCL (representing SGZ), ignoring the cells in the uppermost focal plane and
 
focusing through the thickness of the section to avoid errors
 
caused by oversampling (Gundersen and others, 
1988; Coggeshall and Lekan, 1996). Sample and GCL area estimations were obtained by
 
planimetry, using a 
Lucivid device (MicroBrightField, Colchester,
 
VT) attached to a Leica microscope. The section thickness of 40
 
µm 
was used in the estimation of dissector sample volume. Section thickness and intersection distance were used 
for the estimation of
 
absolute GCL volume. Cell numbers were expressed as cells per GCL.   
Using a laser-scanning confocal microscope (Leica, TCS-NT, Leica Microsystems, Bensheim, Germany) we 
determined the percentage of newly generated cells differentiating into neurons. Therefore BrdU positive cells 
within the GCL and SGZ were randomly selected and analysed for BrdU / NeuN double labelling. In total we 
evaluated 612 BrdU labelled cells in the non-radiated group and 207 BrdU labelled cells in the radiated group.  
To assess for inflammation, numbers of vimentin and CD11b/c positive cells were counted in four high power 
fields (200x), selected from four defined hippocampal regions (CA1, CA3, hilus and granule cell layer) per 
section. This was done on four mid-dorsal sections, spaced by 480 µm, of the kindled hippocampus.  
DATA ANALYSIS 
All data (kindling parameters and cell counts) were measured and scored in a blind manner. Before analysis, 
normality of the data was assessed using the Kolmogorov-Smirnov test. A parametric T-test was used to 
compare normally distributed data; a non-parametric Mann-Whitney U test was used to compare data which 
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was not normally distributed. All data were expressed as means and standard error of the mean. P<0.05 was 
assumed to indicate a significant difference.  
ADT’s were compared using the Mann-Whitney U test. For every kindling day, the mean seizure stage and 
mean ADD was calculated for each rat. Seizure stages were compared between groups using the Mann-
Whitney U-test, ADD’s were compared using the Student’s t test.  
To assess progression of seizure severity within one kindling day, seizure stages of each individual rat were 
plotted as a function of stimulation number. Since the time between two stimulations in all rats was exactly 30 
minutes, stimulation number could be multiplied by 30 minutes and time values could used as abscissa of the 
seizure progression curves. Using a curve-fitting program Kaleidograph (Synergy Software) an exponential 
function with stage 5 as a maximal attainable value could be fitted to the seizure progression curve of each rat. 
Time constants of these functions were determined and compared between groups using a T-test to check for 
differences in seizure stage progression rate.  
Numbers of BrdU labelled cells, CD11b/c positive microglia and vimentin positive astrocytes were compared 
between groups using the Mann Whitney U-test. Number of DCX labelled neuroblasts were compared using 
the T-test. 
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RESULTS 
EFFECT OF RADIATION ON NEUROGENESIS AND NEUROBLAST FORMATION 
To assess for radiation-induced differences in the rate of neurogenesis during the early kindling acquisition 
phase, BrdU was injected twice a day on the first and second kindling acquisition session, respectively one and 
three days after radiation (fig. 1B). Three weeks after radiation the rats were killed. In four, randomly chosen, 
radiated and non-radiated rats the number of BrdU-labelled cells in the GCL (including SGZ) were counted and 
the fraction of BrdU positive cells which double-labelled for NeuN was determined. In radiated rats we found 
545 ± 157 BrdU-positive cells per GCL which was significantly lower (p<0.01, Mann-Whitney U test) and only 
17% of the level in control, non-radiated rats (3134± 998 cells/GCL, fig 2A). By analyzing the fraction of BrdU 
positive cells that double-labelled for NeuN, we found no difference between radiated and non-radiated rats. 
In radiated rats 81 ± 6 % and in non-radiated rats 79 ± 2 % of the BrdU positive cells were labelled for NeuN. 
This indicates that the fraction of newborn cells that differentiate towards neurons during the first three days 
of kindling acquisition and that survive for at least three weeks was not affected by the radiation. Taken 
together, based on the BrdU positive cells counts, we found that neurogenesis in radiated rats during the first 
three days after radiation was reduced to about 17 % of the level in non-radiated rats. Representative 
examples of BrdU staining in radiated and non-radiated rats and double-labelling for BrdU and NeuN are given 
in fig 2B.  
In the same rats, used for quantification of BrdU positive cells, the amount of DCX positive neuroblasts in the 
SGZ and GCL was determined three weeks after radiation and after 70 kindling stimulations (fig 3). The number 
of DCX labelled cells 21 days after radiation was 11378 ± 1399 cells/GCL in radiated rats which was 44 % of the 
number in non-radiated rats (25741 ± 2134 cells/GCL, p<0.01, T-test, fig 3A). In order to investigate whether 
neuroblast formation was more efficiently suppressed in the first week after radiation, during kindling 
acquisition, we repeated the experiment. In this session half of the rats (four radiated and four non-radiated) 
were killed one week after radiation, at the end of the kindling acquisition, to quantify the number of DCX-
positive neuroblasts at that time point. In radiated rats 863 ± 203 DCX
 
expressing neuroblasts / GCL were 
found. This was only 5% of the 17782 ± 2134 neuroblasts/GCL that were counted in non-radiated rats (p<0.01, 
T-test, fig 3A). These results show an almost complete suppression of neuroblast production at the end of the 
acquisition phase. Fig 3A illustrates the partial rebound of neuroblast production in radiated rats from 5% (7 
days post radiation) to 44% (21 days post radiation) of non-radiated, control levels. 
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Fig 2: Level of neurogenesis during the first days of radiation: BrdU was injected in rats twice daily on day 1 and day 3 after radiation. 
Twenty-one days after radiation, after 70 kindling stimulations, rats are sacrificed and the number of BrdU positive cells in the SGZ and the 
GCL, in four radiated and four non-radiated rats, were counted in six coronal sections taken 480 µm apart. The volumes of the GCL were 
determined and the results were expressed as number of cells per GCL. A: In radiated rats 545 ± 157 BrdU labelled cells/GCL were found 
while in non-radiated rats 3134± 998 cells/GCL were counted. As the fraction of BrdU labelled cells co-expressing NeuN was highly 
comparable (81% in radiated rats compared to 79% in non-radiated rats), the difference in BrdU positive cell counts reflects a reduction in 
neurogenesis in radiated rats to levels which are 17% of the neurogenesis in non-radiated rats.  = p < 0.01. B: Representative examples 
of chromogenic staining for BrdU in radiated (left) and non-radiated rats (middle) (scale bar = 200µm). The right picture is an example of 
fluorescent doublestaining for BrdU (green) and NeuN (red) (scale bar= 20µm) 
 
For both the radiated and non-radiated groups, the number of DCX positive cell numbers was significantly 
lower at the end of the acquisition phase (after 48 kindling stimulations) than at the end of the retest phase 
(after 70 kindling stimulations), which could be explained based on the stimulatory effect of seizures on 
proliferation. However, one needs to be aware that numbers of DCX positive neuroblasts counted on day 7 and 
day 21 after radiation involves two separate experiments which makes it difficult to compare numbers. 
Representative examples of DCX staining in radiated and non-radiated rats at the end of kindling acquisition 
are illustrated in respectively fig 3B and 3C. DCX stainings in rats three weeks after radiation are shown in fig 3D 
(radiated) and 3E (non-radiated).  
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Fig 3: Level of neurogenesis at the end of the kindling acquisition and retest phase: To assess for differences in neuroblast production at 
the end of the kindling acquisition phase (one week after radiation) and at the end of the kindling retest phase (three weeks after 
radiation) the number of DCX positive cells in the SGZ and the GCL was counted in four radiated and non-radiated rats. Cells were counted 
in twelve immunoperoxidase-stained, 40-µm-thick coronal sections taken 240 µm apart. The volumes of the GCL were determined and the 
results were expressed as number of cells per GCL. A: Seven days after radiation and after 48 kindling stimulations 863 ± 203 DCX+ 
neuroblasts / GCL were found in radiated rats and 17782 ± 2134 neuroblasts / GCL in non-radiated rats. This shows that the level of 
neurogenesis in radiated rats is only 5 % of the level in non-radiated controls.  Three weeks after radiation and after 70 kindling 
stimulations 11378 ± 1399 cells/GCL were found in radiated and 25741 ± 2134 cells/GCL in non-radiated rats. This shows that the level of 
neurogenesis in radiated rats is 44 % of the level in non-radiated controls.  = p < 0.01. B; DCX staining in the hippocampus of radiated 
rats at the end of the kindling acquisition, seven days after radiation. C: DCX staining in the hippocampus of non-radiated rats at the end of 
the kindling acquisition, seven days after radiation. D: DCX staining in the hippocampus of radiated rats 21 days after radiation. E: DCX 
staining in the hippocampus of non-radiated rats 21 days after radiation. Scale bar =100 µm.  
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EFFECT OF RADIATION ON KINDLING 
EFFECT OF RADIATION ON AD THRESHOLD 
In all rats, used in this study, the stimulation threshold to evoke an afterdischarge (fig. 4A) was measured at the 
beginning of each kindling day. The ADT remained below 200 µA in all rats throughout the experiment. During 
the first two kindling days ADT did not significantly differ between radiated and non-radiated rats (fig. 4B). At 
kindling day 1 ADT was respectively 50 ± 3 µA and 56 ± 3 µA. At kindling day 2 levels were respectively 57 ± 3 
µA and 72 ± 6 µA. However, as kindling acquisition progressed, ADT increased further in non-radiated rats 
while it remained around 60 µA in radiated rats. This resulted in significantly lower ADT levels in radiated rats 
compared to non-radiated rats. The difference reached significance (p<0.05, Mann-Whitney U test) on kindling 
day 3: 64 ± 4 µA in radiated rats versus 83 ± 7 µA in non-radiated rats. This difference remained significant 
(p<0.01, Mann-Whitney U test) on kindling day 4 (66 ± 3 µA versus 92 ± 7 µA) and was still observed at retest 
day 1 (59 ± 4 µA versus 91 ± 14 µA, p<0.01, Mann-Whitney U test) and retest day 2 (60 ± 4 µA versus 89 ± 8 µA, 
p< 0.01, Mann-Whitney U test).  
EFFECT OF RADIATION ON AD DURATION 
The AD duration was longer on acquisition day 2 than on acquisition day 1 in all rats irrespective of treatment. 
For the remaining kindling days of the acquisition and retest phase the AD duration remained stable in all rats. 
No difference in AD duration could be demonstrated between radiated and non-radiated rats neither during 
kindling acquisition phase nor during retest phase (fig. 4C).  
EFFECT OF RADIATION ON BEHAVIOURAL STAGE  
At acquisition day 1 and 2 no difference in mean seizure severity could be detected between radiated and non-
radiated rats (fig. 4D). However, at acquisition day 3 and 4 mean seizure severity was significantly higher in 
radiated compared to non-radiated rats. At kindling day 3 mean seizure stage in radiated and non-radiated rats 
was respectively 4.0 ± 0.1 and 3.4 ± 0.1 (p<0.05; Mann-Whitney U test). At kindling day 4, radiated rats still 
displayed more severe seizures than non-radiated rats with the mean seizure stage being 3.8 ± 0.1 and 3.2 ± 
0.1 respectively (p<0.01; Mann-Whitney U test). 
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Fig 4: Rapid kindling parameters: The effect of radiation on kindling was evaluated by three outcome parameters: the afterdischarge 
threshold, the afterdischarge duration and seizure severity stage. A: Representative example of a hippocampal afterdischarge in non-
radiated (top) and radiated (bottom) rats. The bar above each EEG trace represents 10 seconds which is also the duration of the kindling 
stimulation. B: Evolution of the afterdischarge threshold (ADT), measured at the start of each kindling day. From the graph it is evident that 
during the first two kindling days ADT did not significantly differ between radiated and non-radiated rats. During the remaining of the 
kindling, ADT remained significantly lower in radiated compared to non-radiated rats with stimulation intensity being respectively 64.3 ± 
4.3 µA and 83.3 ± 7.2 µA at kindling day 3; 66.1 ± 3.3 µA and 92.2 ± 7.1 µA at kindling day 4; 59.1 ± 3.8 and 90.9 ± 14 µA at retest day 1 and 
60.0 ± 4.1 µA compared to 88.6 ± 7.8 µA at retest day 2. C: The mean duration of all twelve afterdischarges, determined for each kindling 
day, did not differ between radiated and non-radiated rats, throughout kindling acquisition and retest phase. D: Mean seizure severity 
stage on kindling day 3 and 4 is significantly higher in radiated compared to non-radiated. At kindling day 3 mean seizure stage of radiated 
rats is 4.0 ± 0.1 compared to 3.4 ± 0.1 in non-radiated rats. At kindling day 4 mean seizure stages are respectively 3.8 ± 0.1 compared to 3.2 
± 0.1. This difference is no longer evident on both kindling retest days. Scale bar =200 µm; = p< 0.05;  = p < 0.01 
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Retesting the rats one and two weeks after the fourth kindling day showed that this difference in mean seizure 
severity was not longer evident. Apparently the difference in treatment did not prevent the rats from reaching 
the fully kindled state.  
At retest day 1 mean seizure stage in radiated was 4.5 ± 0.1 and 4.2 ± 0.1 in non-radiated rats. At retest day 2 
mean seizure stage was respectively 4.5 ± 0.1 and 4.4 ± 0.2 (n.s., Mann Whitney U test). 
For each rat, seizure stage acquisition within one kindling day could also be illustrated by plotting seizure stage 
as a function of time. The time points as abscises of the plots were obtained by multiplying stimulation number 
by 30 minutes which is the fixed time period between two stimulations. For each rat this resulted in a “severity 
progression curve” to which an exponential function could be fitted with stage 5 as the maximal attainable 
value. The time constant of this exponential curve reflected the rate by which seizure severity increased during 
the day. Time constants were significantly lower in radiated compared to non-radiated rats on kindling day 3 
(p<0.01, T-test) and kindling day 4 (p<0.05, T-test). On kindling day 3 mean time constants were 90 ± 14 min for 
radiated and 151 ± 16 min for non-radiated rats. On kindling day 4 mean time constants were respectively 108 
± 12 min and 168 ± 18 min. On both retest days, time constants were no longer different between radiated and 
non-radiated rats. The mean time constants were respectively 39 ± 8 minutes versus 61 ± 11 min on retest day 
1 and 38 ± 9 min versus 50 ± 14 min on retest day 2. So, on kindling day 3 and 4 radiated rats progressed more 
rapidly to the most severe seizure than non-radiated rats but this was no longer evident on both retest days. 
This is also illustrated in fig. 5 which shows the mean seizure severity curves of both groups and the mean 
exponential functions which fit best to the progression curves, on acquisition day 3 (fig. 5A) and 4 (fig. 5B) and 
on both retest days (fig. 5C and 5D).  
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Fig 5: Seizure stage progression on individual kindling days: To evaluate seizure stage progression during one day, seizure stages could be 
plotted as a function of time. Time points in the X-axis were calculated by multiplying stimulation number with 30 minutes, the exact time 
between two stimulations. To this “severity progression curve” an exponential function can be fitted which is characterized by a maximum 
amplitude of stage 5 and a time constant, τ. Time constants were significantly lower in radiated compared to non-radiated rats on kindling 
day 3 (p<0.01, T-test) and 4 (p<0.05, T-test). This difference was no longer evident on both retest days. This figure shows mean seizure 
progression curves ( ) and the mean exponential function which fits best to the progression curves (----) on kindling day 3 (A) and 
kindling day 4 (B) and both retest day (C, D). 
 
EFFECT OF RADIATION ON INFLAMMATION 
We found CD11b/c positive reactive microglia and vimentin positive reactive astrocytes both in kindled, non-
radiated (fig 6A-D) and kindled, radiated rats (fig 6E-6H) at the end of the acquisition phase, seven days after 
radiation. Quantitative analysis could not reveal differences in the number of activated microglia between non-
radiated (100 ± 15 cells/high power field; fig 6 A, 6B) and radiated rats (78 ± 17 cells/high power field; fig 6E, 
6F). We also could not detect differences in the number of reactive astrocytes in non-radiated (106 ± 12 
cells/high power field; fig 6C,6D) compared to radiated rats (101 ± 4 cells/high power field; fig 6G,6H). This 
indicates that radiation has no or only little effects on kindling induced inflammation at day seven after 
radiation through activated microglia or astrocytes.  
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Fig 6: Inflammation at the end of kindling acquisition: Both in non-radiated (A-D) and radiated (E-H) kindled rats CD11b/c positive activated 
microglia (A, B, E, F) and vimentin positive reactive astrocytes (C, D, G, H) were present in different brain regions. To compare between 
groups CD11b/c (A) and vimentin (C) positive cells were counted in four high power fields selected from distinct regions of the stimulated 
hippocampus (1: CA1 region, 2:CA3 region, 3: hilus and 4: granule cell and molecular layer of dentate gyrus). B and F show a representative 
example of a high power image selected from the hilar region containing CD11b/c positive microglia. D and H show a representative 
example of a high power image selected from the hilar region containing vimentin positive reactive astrocytes. From the images and the 
quantitative analysis no significant difference in number of reactive microglia and astrocytes were evident. Scale bar = 200µm 
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DISCUSSION 
This study shows that the exposure of rats to whole brain low dose (8Gy) γ-radiation one day before the 
initiation of rapid hippocampal kindling significantly reduces seizure-induced neurogenesis and neuroblast 
formation during kindling acquisition. Radiating rats just prior to kindling does not prevent epileptogenesis but 
significantly affects several parameters of the kindling acquisition. These kindling parameters are modified in a 
way which reflects higher excitability in response to stimulation. Firstly, rats that have been radiated show less 
increase in the threshold to evoke an afterdischarge compared to non-radiated controls. This leads to a 
significantly lower ADT in radiated rats which becomes evident five days after radiation and remains 
significantly lower for at least three weeks after radiation. This represents a higher excitability of hippocampal 
networks. Secondly, although radiation has no effect on the duration of afterdischarges radiated rats acquire 
more rapidly more severe seizures at the end of the kindling acquisition phase (five to seven days after 
radiation) compared to non-radiated rats.  
Other studies have investigated the effect of radiation on the course of amygdala kindling epileptogenesis 
(Jenrow and others, 2001; Jenrow and others, 2006). A high radiation dose of 25 Gy, applied focally to the 
amygdala prior to kindling, does not affect stimulation threshold to evoke a generalized seizure but causes an 
increased tendency for seizure activity to propagate into brain stem circuits. However if radiation is applied 
later, when the kindled state is already established, the tendency of seizures to spread into brains stem circuits 
is decreased (Jenrow and others, 2001; Jenrow and others, 2006). Next to the fact that the radiation is applied 
much more focal in these studies, the authors also use a radiation dose which is much higher than in our study. 
Both aspects make it difficult to compare the results of these studies with ours.  
By keeping the radiation dose as low as possible, we wanted to minimize other side effects of radiation such as 
changes in dendritic branching, vasculature, demyelination or radionecrosis, which have been reported to 
appear after radiation at doses of 20 Gy or higher (Calvo and others, 1988; Hodges and others, 1998; Raber and 
others, 2004; Wojtowicz, 2006). Conflicting reports are found in literature about inflammation induced by low 
doses of radiation. Some reports describe chronic inflammation as the major side effect of radiation (Monje 
and others, 2003; Monje and Palmer, 2003). However other studies cannot demonstrate any inflammation 
after low dose radiation (Snyder and others, 2005; Wojtowicz, 2006). In our study we find inflammatory 
astrogliosis and microglial response in both kindling groups but we can not demonstrate differences in extent 
of this response due to radiation. Although our study can not rule out that radiation induces inflammation, it 
argues against the possibility that a difference in inflammation, though reactive microglia and astrocytes, is 
responsible for the differences seen in hippocampal excitability and kindling rate one week after radiation.  
Our study demonstrates that there is a recovery in neuroblast formation of up to 50% at the end of the 
experiment. This is in contrast to other radiation studies, which use a single low dose (10 Gy) radiation and see 
a stable and prolonged suppression of precursor proliferation and neurogenesis after radiation (Tada and 
others, 2000; Monje and others, 2002; Mizumatsu and others, 2003; Snyder and others, 2005). Whether, next 
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to a rebound of neuroblasts formation, there is also partial recovery of functional neurogenesis cannot be 
concluded from this study. A way to do so would be to repeat the experiment but inject BrdU with a delay of 
some weeks after the radiation and then look for BrdU/NeuN positive cells some weeks after labelling. The 
partial restoration of neuroblasts production, three weeks after radiation, could be the result of stimulatory 
effects of seizures on neuroblast proliferation (Jessberger and others, 2005). A similar recovery in the 
proliferation of hippocampal neuroblasts is reported in rats eight days after 5Gy radiation, which was applied 
24 hours before induction of status epilepticus. This recovery is prevented by delivering a second 5Gy radiation 
dose four days after SE (Parent and others, 1999). In our experiments a suppression of neurogenesis during the 
week of kindling acquisition is sufficient so we chose to keep the radiation dose as low as possible and not to 
radiate a second time during the process of kindling to minimize side effects. However, if longer suppression of 
neurogenesis would be required it seems that delivery of two fractionated radiation doses of 10 Gy spaced by 
24 hours is very effective even after pathological stimulation (Snyder and others, 2005; Wang and others, 
2005).  
It is evident from studies on neurogenesis in different animal models for TLE that status epilepticus as well as 
single seizures can promote neurogenesis in the dentate gyrus of the hippocampus (Bengzon and others, 1997; 
Gray and Sundstrom, 1998; Scott and others, 1998; Scharfman and others, 2000; Nakagawa and others, 2000; 
Scott and others, 2000; Madsen and others, 2000; Mohapel and others, 2004; Smith and others, 2005; Parent 
and others, 2006). In addition to an increased generation of neuroblasts, seizures also promote the synaptic 
integration of newborn neurons (Overstreet-Wadiche and others, 2006). Part of the newborn neurons appears 
to be important in the reorganization of hippocampal networks, typical for TLE. They migrate towards ectopic 
locations in the hippocampus, contribute to mossy fiber sprouting and receive inputs of sprouted mossy fibers, 
including on their basal dendrites (Scharfman and others, 2000; Scharfman and others, 2003; Pierce and others, 
2005; Shapiro and Ribak, 2005; Parent and others, 2006; Shapiro and Ribak, 2006).  
Our results indicate that seizure-induced neurogenesis has no major contributing role in kindling 
epileptogenesis since blocking the birth of new neurons during kindling acquisition does not slow down 
kindling epileptogenesis nor prevents the rats from becoming fully kindled. However, as we radiated the 
animals only one day before kindling, we cannot exclude that immature granule neurons, generated during 
ongoing neurogenesis in the weeks before kindling, survived the radiation and contributed to the formation of 
aberrant circuitry by abnormal migration or the formation of aberrant synaptic connections. A recent study 
demonstrated that next to neurons generated after SE, neurons born two days before SE showed accelerated 
maturation and received excitatory perforant-path input
 
earlier than newborn granule cells in normal brains. 
Part of these neurons were also targets for polysynaptic innervation, likely from
 
mossy fiber recurrent 
collaterals (Overstreet-Wadiche and others, 2006). So it could be that late phases of ongoing neurogenesis, 
which are not affected by radiation, contribute to kindling epileptogenesis.  
In our study, we find that 8Gy radiation induces alterations of kindling parameters which reflect less inhibition 
in the hippocampus and a higher tendency of rats to display generalized tonic-clonic seizures during kindling 
 Chapter 6 | Modulation of endogenous neurogenesis in TLE 223 
 
acquisition. During the course of rapid hippocampal kindling we report an increase in ADT in non-radiated rats, 
but not in radiated rats. This increase in threshold is typically seen when kindling stimulations are delivered in 
the dentate gyrus of the dorsal hippocampus and was first described by Racine and coworkers (Racine and 
others, 1977). Since then, other studies have also reported an increase in inhibition in the dentate gyrus during 
or after hippocampal kindling (Tuff and others, 1983; Maru and Goddard, 1987; Milgram and others, 1995; 
Nusser and others, 1998; Gutierrez and Heinemann, 2001). A potential mechanism for this increased inhibition 
is suggested to be the release of GABA by granule cells neurons (Schwarzer and Sperk, 1995; Gutierrez and 
Heinemann, 2001; Gutierrez, 2002; Gomez-Lira and others, 2002).  
Radiation suppresses seizure-induced neurogenesis and leads to an enhanced excitability; however, many 
factors besides neurogenesis could be involved in this process. We cannot exclude that other side effects of 
low dose radiation such as formation of free radicals, effects on metabolic and signalling pathways or changes 
in microvasculature contribute to the differences observed between radiated and non-radiated kindled rats 
(Monje and others, 2002; Silasi and others, 2004; Wojtowicz, 2006). To make assumptions on possible 
causative relationships, we need to work out new model systems in which we are able to very selectively block 
hippocampal neurogenesis in response to seizures without directly affecting other brain regions or functions. 
One alternative model in which seizure-induced neurogenesis is blocked and the effect on epileptogenesis has 
been investigated is the continuous infusion of cytosine-b-D-arabinofuranoside (AraC) into the ventricles of rats 
that have experienced a pilocarpine induced status epilepticus. In this model a significant reduction of the 
frequency and duration of spontaneous seizures was demonstrated, while no difference in severity score could 
be demonstrated (Jung and others, 2004). These results are in contrast to the relationship we found in our 
study but they also do not allow drawing conclusions about a possible causative relationship between 
decreased neurogenesis and less epilepsy since AraC also blocks gliogenesis, which is enhanced in the 
pilocarpine model.  
Taken together, our study shows that low-dose brain radiation suppressed seizure-induced neurogenesis 
during kindling acquisition and caused an enhanced excitability of hippocampal networks. It slightly accelerated 
kindling, but had little effect on the finally reached epileptic state. This suggests that seizure-induced 
neurogenesis could play a role in epileptogenesis, but on the other hand also that (short duration) block of 
neurogenesis does not critically affect the final outcome of kindling epileptogenesis.  
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CELL THERAPY FOR TLE THROUGH CELL TRANSPLANTATION 
NEUROPOTENCY OF ADULT-DERIVED STEM CELLS 
There are several ways to define a stem cell, but most definitions include as a requisite the capacity for self-
renewal coupled to the potential to generate various types of differentiated progeny (Watt and Hogan, 2000; 
Clarke and Frisen, 2001). Totipotent stem cells have the potential to differentiate to all mammalian cell types 
and therefore to generate a new organism. The zygote and single blastomeres from a 2-4 cell morula stage are 
thought to be the only existing totipotent cell types. Pluripotent stem cells can generate cells from all three 
germ layers (endoderm, mesoderm and endoderm) but no longer the extra-embryonic tissues and therefore 
cannot generate a new organism. Human and mouse embryonic stem cells (ESC) have pluripotent capacities 
(Evans and Kaufman, 1981; Martin, 1981). A second source of pluripotent stem cells are derived from mouse 
(Matsui and others, 1992; Resnick and others, 1992) and human (Shamblott and others, 1998) primordial germ 
cells (PGCs) and are termed embryonic germ (EG) cells. EG cells are the only cells beyond the gastrulation 
stage, for which pluripotency has been demonstrated in such as a rigorous way, both in vitro and in vivo. During 
gastrulation pluripotent cells are destined to become mesoderm, endoderm and ectoderm and subsequently to 
produce tissue specific cells. Stem cells which generate different tissue-specific cell types are called multipotent 
stem cells, while stem cells that produce only one differentiated cell type are termed unipotent stem cells.  
A considerable number of reports over the past few years have tackled the general belief that the 
differentiation potential of adult stem cells is limited by tissue-specific boundaries. These reports describe the 
ability of stem cells to produce cells of other tissues or even other germ layers. This phenomenon is called 
plasticity. Bone marrow (BM)-derived cells were reported to generate skeletal muscle cells (Ferrari and others, 
1998; Bittner and others, 1999; Gussoni and others, 1999), cardiac muscle cells (Orlic and others, 2001), 
hepatocytes (Lagasse and others, 2000), astrocytes (Eglitis and Mezey, 1997) and neurons (Azizi and others, 
1998; Kopen and others, 1999; Brazelton and others, 2000; Mezey and others, 2000; Sanchez-Ramos and 
others, 2000; Woodbury and others, 2000; Black and Woodbury, 2001; Deng and others, 2001; Kohyama and 
others, 2001; Priller and others, 2001; Kim and others, 2002; Jiang and others, 2002; Kabos and others, 2002; 
Mezey and others, 2003; Jiang and others, 2003; Jin and others, 2003; Qian and Saltzman, 2004; Munoz-Elias 
and others, 2004; Abouelfetouh and others, 2004; D'Ippolito and others, 2004). Hepatic oval cells (Toma and 
others, 2001) and stem cells derived from adipose tissue (Toma and others, 2001) and skin (Toma and others, 
2001) have been differentiated towards neural cell types. Muscle-derived cells have been reported to 
reconstitute all hematopoietic lineages when transplanted into irradiated mice (Jackson and others, 1999). For 
neural stem cells (NSC) it was demonstrated that they could generate HSC (Bjornson and others, 1999), muscle 
cells (Galli and others, 2000; Tsai and McKay, 2000) and endothelial cells (Wurmser and others, 2004). Two 
adult-derived stem cell types, namely NSC (Clarke and others, 2000) and multipotent adult progenitor cells 
(MAPC) (Jiang and others, 2002), even contribute to most tissues of the mouse embryo when injected into 
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mouse blastocysts. In the brain, MAPC-derived cells differentiated towards appropriate region specific 
neuronal phenotypes but also towards astrocytes and oligodendrocytes (Keene and others, 2003).  
Although these reports indicate that some adult-derived cells could be capable for reprogramming and 
transdifferentiation, cautious interpretation of these apparent in vitro and in vivo lineage switches is 
mandatory. Several alternative explanations can be given for the apparent lineage switch.  
Firstly, populations of tissue-specific stem or progenitor cells may be more heterogeneous than previously 
thought and may contain cells with a similar antigenic profile, but with more differentiation potential. In the 
tissue-specific environment these cells only generate the appropriate cell phenotype, but in other niches they 
are capable of producing other phenotypes.  
Secondly, a mixed cell population derived from specific tissues may contain precursor cells which normally 
reside in distant organs. For example, muscle-derived cells may contain HSC with the latter being responsible 
for the repopulation of the hematopoietic system after transplantation of muscle-derived cells in lethally 
irradiated mice (Jackson and others, 1999).  
Thirdly, cell fusion between two cell types originating from different tissues can result into cells with 
characteristics of one cell type while still expressing markers, specific for the other cell type. BM-derived cells 
and NSC were shown to spontaneously fuse with ESC, resulting in the adoption of ESC characteristics while still 
expressing donor specific markers (Terada and others, 2002; Ying and others, 2002). Fused NSC/ESC 
contributed to multiple lineages of mouse chimeras (Ying and others, 2002).  
Fourthly, some studies demonstrating in vivo plasticity rely on cell markers which can be transferred upon 
death of the transplanted cells. 5′-bromo-2′-deoxyuridine (BrdU) or tritiated thymidine labelling of the DNA of 
proliferating cells and subsequent identification with immunohistochemistry or autoradiography is frequently 
used. Recently, it has been demonstrated that oligonucleotides from transplanted death cells can be recycled 
in endogenous proliferating cells or cells undergoing DNA repair (Burns and others, 2006). Similar marker 
recycling occurs when membrane intercalating dyes are used (Yoon and others, 2005). Preferentially, 
transgenetically labelled cells are used which for example express GFP or β-galactosidase genes under the 
control of a tissue specific promoter.  
Fifthly, a lot of studies which claim transdifferentiation have based their conclusion solely on morphology and 
expression of some tissue specific marker genes or proteins. However, care should be taken in the 
interpretation of this evidence. For example, it has recently been shown that fibroblasts can be induced to 
adopt neural morphology and express neural antigens when exposed to stressors (Lu and others, 2004; Bertani 
and others, 2005).  
In this study we isolated cells from the BM of adult rats and cultured them according to the protocol described 
for MAPC (Jiang and others, 2002). Consequently single cell-derived clones with extensive proliferative 
capacity, similar morphology and a comparable phenotypic expression profile for the investigated markers 
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(MHC I
-
 , MHC II
-
, CD44
-/dim
) were derived. Since MAPC were reported to be capable of generating cells from the 
three germ layers (endoderm, ectoderm and mesoderm), several attempts were made to differentiate multiple 
cell clones towards cells expressing endothelial, hepatocyte or neuroglial markers using the differentiation 
protocols originally described. RT-PCR and immunocytochemistry were used for the detection of differentiation 
markers. However, no reproducible results were obtained for any of the lineages. Therefore we termed our 
cells MAPC-like. Among these MAPC-like cell clones we identified clones which expressed Oct4, a presumed 
marker for pluripotency.  
In order to investigate whether neural transdifferentiation could be optimized we exposed an Oct4 expressing 
MAPC-like cell clone to four different neural “transdifferentiation” protocols. In order to objectively assess 
neural transdifferentiation of the MAPC-like cells, we compared morphology and neural antigen expression to 
that of NSC, subjected to the same differentiation protocols. NSC were obtained by isolating cells from the 
subventricular zone (SVZ) of adult rats and culturing them as spherical clusters (neurospheres) as described by 
Gobbel and coworkers (Gobbel and others, 2003). A single cell-derived NSC clone was selected based on its 
ability to generate cells expressing neuronal, astrocyte and oligodendrocyte markers using a standard NSC 
differentiation protocol (Reynolds and Weiss, 1996).  
The first neuronal transdifferentiation protocol was optimized for neural differentiation of MAPC (Jiang and 
others, 2002; Jiang and others, 2003). The second protocol was described by Kohyama and colleagues for the 
differentiation of MSC (Kohyama and others, 2001). The third protocol was described by Kabos and coworkers 
and reported neural differentiation of unfractionated bone marrow as starting material (Kabos and others, 
2002). The fourth protocol used was described by Woodbury and coworkers and was applied for neural 
differentiation of MSC (Woodbury and others, 2000; Black and Woodbury, 2001; Woodbury and others, 2002). 
An overview of the used protocols is given in table 1.  
Using RT-PCR and immunocytochemistry gene and antigen expression of three neuronal markers (β3tub, 
NF200 and tau), an astrocyte marker (GFAP) and two oligodendrocyte markers [MBP (RT-PCR) or RIP 
(immunocytochemistry)] were evaluated. Marker expression was screened in NSC and MAPC-like cells before 
and after differentiation.  
We found that undifferentiated NSC expressed all five neuroglial genes at baseline. Immunocytochemistry 
analysis showed that NSC expressed the RIP antigen at baseline but no clear expression of the other markers 
was found. In three of the four differentiation protocols NSC adopted complex neuronal and glial 
morphologies, upregulated expression of all five neuroglial genes and stained positive for both the neuronal 
and glial antigens.  
In the Woodbury protocol NSC did not survive differentiation. This finding is in line with recent evidence 
suggesting that the rapid induction of neural morphology and expression of neural markers in the Woodbury 
differentiation protocol represents a stress artefact rather than true transdifferentiation (Neuhuber and others, 
2004; Lu and others, 2004; Bertani and others, 2005). In these studies time-lapse video recording showed that 
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the adoption of “neural” morphology was due to a retraction of the cytoplasm while leaving behind long 
processes. Although these processes strikingly resembled neurites they showed no motility or further 
elaboration. These studies also demonstrated that similar “neuronal morphology” and expression of neuronal 
antigens (NeuN, NSE, NF-200, Tau, …) could be obtained by exposure of MSC but also of other cell types (HEK 
293 cells, fibroblasts) to DMSO alone or to other stressors such as actin filament-depolymerising agents, 
detergents, high molarity sodium chloride and pH extremes.  
Table 1: Four protocols for neural differentiation of MAPC-like cells and NSC 
 
Jiang  
method 
Kohyama method Kabos  
method 
Woodbury 
method 
Pre-differentiation 
phase 
 
(MAPC-like cells) 
7 days: 
100 ng/ml bFGF 
 
3 days: 
10 µmol/ml 5-aza 
50 ng/ml NGF 
50 ng/ml BDNF 
50 ng/ml NT-3 
7 days: 
20 ng/ml bFGF 
20 ng/ml EGF 
1 day: 
5 ng/ml bFGF 
 
Differentiation 
phase 
 
(MAPC-like cells  
and NSC) 
7 days: 
10 ng/ml FGF-8 
100 ng/ml SHH 
 
9 days: 
50 ng/ml NGF 
50 ng/ml BDNF 
50 ng/ml NT-3 
 
7 days: 
1 µM RA 
1mM db-cAMP 
7 days: 
100 µM BHA 
2% DMSO 
10 µM forskolin 
2 mM valproic acid 
10 mM KCl 
Abbreviations: 5-aza, 5-azacytidine; BDNF, brain-derived neurotrophic factor; bFGF, basic fibroblast growth factor; BHA, butylated 
hydroxyanisol; db-cAMP, dibutyril cyclic adenosine monophosphate; DMSO, dimethylsulfoxide; EGF, epidermal growth factor; FGF, 
fibroblast growth factor; NGF, nerve growth factor; NT-3, neurotrophin-3; RA, retinoic acid; SHH, sonic hedgehog  
In our study, RT-PCR and immunocytochemistry indicated that undifferentiated MAPC-like cells expressed 
nestin, β3-tub and NF200 at baseline. After differentiation using the three remaining protocols (Jiang, Kohyama 
and Kabos method), we found that MAPC-like cells extended neurite-like structures and adopted a neural-like 
morphology only in the Jiang protocol. β3-tub and NF200 were still expressed in differentiated MAPC-like cells 
but β3-tub expression was downregulated and NF-200 expression was only very sparsely upregulated in two of 
the three differentiation protocols. Differentiated MAPC-like cells did not express the other neuroglial markers: 
tau, GFAP, MBP, RIP.  
This failure of MAPC-like cells to upregulate or de novo express neuroglial markers is in contrast with the 
successful neural transdifferentiation of MAPC reported by Jiang and colleagues (Jiang and others, 2002; Jiang 
and others, 2003). The most likely explanation for this incongruence is that the MAPC-like cell clones derived in 
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our study were substantially different from the MAPC clones originally described by Jiang and colleagues. This 
hypothesis was further supported by the inability of our MAPC-like cells to generate cells from the three 
germinal layers and the fact that they expressed neuronal markers at baseline, which was not the case for the 
MAPC, described by Jiang and coworkers. Most probably the cell lines used in our study were a subtype of MSC 
with low expression of CD44 and a high expansion capacity. As MSC, our cells could be differentiated 
reproducibly towards mesenchymal cell types (osteoblasts and adipocytes (Pittenger and others, 1999)).  
As already described earlier there have been numerous reports claiming neural transdifferentiation of BM-
derived cells, most of them based on the adoption of neural morphology and expression of neuro-glial markers 
by the differentiated cells. Our study indicates that both parameters should be interpreted with caution. 
Although we found that MAPC-like cells can adopt neural morphology and express neural markers, a 
comparison with NSC showed that this did not equal neuropotency. The fact that neural transdifferentiation 
protocols, proven to work for differentiation of NSC, did not lead to upregulation or de novo expression of 
neural makers in the MAPC-like cells, supported this conclusion.  
Apart from the results of our study, there are several lines of evidence from the literature indicating the lack of 
specificity of morphology change and marker expression. Firstly, reports have shown that cells adopt neural-
like morphologies due to the retraction of cytoplasm in response to different stressors (Neuhuber and others, 
2004; Lu and others, 2004; Bertani and others, 2005). Secondly, stressors can also induce or enhance the 
expression of neural markers even in cells with no multilineage potential such as fibroblasts (Lu and others, 
2004; Bertani and others, 2005). Thirdly, mature neural genes and antigens such as β3-tub, NeuN, MAP2, NF-
200 are also expressed in hematopoietic progenitor cells (Goolsby and others, 2003) and undifferentiated bone 
marrow stromal cells (Woodbury and others, 2002; Neuhuber and others, 2004; Tondreau and others, 2004; 
Ratajczak and others, 2004; Bertani and others, 2005), indicating that these makers are not uniquely expressed 
in neurons. Fourthly, when different studies, using the same type of stem cells and the same differentiation 
protocol, are compared for antigen expression before and after differentiation, several inconsistencies are 
found for different markers (Woodbury and others, 2000; Neuhuber and others, 2004; Lu and others, 2004; 
Bertani and others, 2005). Fifthly, a recent study showed that it is possible to induce expression of neural 
specific antigens and neurotransmitters by exposing bone marrow cells to different growth factors mixes. But a 
closer evaluation showed that the intracellular distribution of the antigens was different from the one seen in 
adult neurons, implicating that these cells probably cannot function as true neurons (Jin and others, 2003). 
Only a limited number of studies have performed electrophysiological analysis on the BM-derived putative 
neurons (Kohyama and others, 2001; Hofstetter and others, 2002; Hung and others, 2002; Dezawa and others, 
2004; Wislet-Gendebien and others, 2005). In two reports neuron-like cells derived from MSC lacked not only 
voltage-gated Na+ and K+ currents and action potentials, but also functional neurotransmitter receptors 
(Hofstetter and others, 2002; Padovan and others, 2003). Other reports showed that MSC do acquire some 
electrical properties of functionally active neurons (Kohyama and others, 2001; Hung and others, 2002; Dezawa 
and others, 2004; Wislet-Gendebien and others, 2005).  
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Kohyama and coworkers recorded outward rectifying potassium currents and increased Ca
2+
 uptake in 
response to neurotransmitters and high extracellular potassium from the differentiated MSC. However, no 
voltage-gated fast sodium currents were measured and the resting membrane potentials in the cells were 
higher compared to normal functional neurons (Kohyama and others, 2001).  
Hung and coworkers differentiated MSC using retinoic acid (RA) and β-mercaptoethanol and could record 
voltage dependent currents from these differentiated MSC five days after differentiation. They also showed 
Ca
2+
 uptake in response to glutamate or high K
+
 buffer but the observed elevation in intracellular Ca
2+
 was 
either slow or delayed (Hung and others, 2002). 
Wislet-Gendebien and colleagues reported that nestin-positive MSC, co-cultured with cerebellar granule 
neurons, had a resting membrane potential of -57 mV and inward sodium currents after 15 days of co-culture. 
Ionic currents in response to neurotransmitters (GABA, glutamate and glycine) were measured and single 
action potentials evoked. However trains of action potentials were not evoked nor was spontaneous synaptic 
activity detected indicating that the cells were still in an intermediate phase of neuronal development. The 
authors excluded the possibility that these results were due to cell fusion of MSC with cerebellar granule 
neurons by showing that similar results were obtained when MSC were co-cultured with formalin-fixed granule 
neurons in the presence of granule cell conditioned medium (Wislet-Gendebien and others, 2005).  
Dezawa and colleagues overexpressed the intracellular domain of Notch in MSC and subjected them to a neural 
differentiation protocol using forskolin, bFGF, ciliary neurotrophic factor (CNTF), BDNF and NGF. 
Electrophysiological analysis showed the presence of both outward rectified potassium current and inward fast 
sodium currents. Also action potentials could be evoked in these differentiated MSC. Exposure of the 
differentiated MSC to GDNF resulted in more than 40% of the cells expressing tyrosine hydrolase (TH) 
suggestive of dopaminergic commitment. Further evidence for dopaminergic-like neuronal differentiation 
resulted from studies in which K
+
 depolarization resulted in the release of 1.1 pmol dopamine/10
6
 cells and 
improvement of the rotational behaviour of a rat model for Parkinson’s disease to a similar extent as described 
for fetal midbrain transplantation (Dezawa and others, 2004).  
Taken together, there is a large body of evidence that BM-derived cells can acquire neural-like morphologies 
and express neural antigens in vitro. But our own study, together with others, has shown that both parameters 
are too unspecific to validate neural transdifferentiation of adult non-neural cells. There have been 
electrophysiological studies showing that MAPC but also MSC can generate cells with functional properties of 
immature neurons but this requires complex differentiation protocols involving the use of genetic engineering 
or coculture with astrocytes or mature neurons. Based on our own results and the conflicting reports in 
literature on neuropotency of BM-derived stem cells, we chose to transplant adult-derived NSC in a model for 
TLE.  
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CHRONIC MODEL FOR TEMPORAL LOBE EPILEPSY: THE INTRAHIPPOCAMPAL KAINIC ACID 
MODEL 
The intrahippocampal kainic acid (KA) model is a chronic model for temporal lobe epilepsy (TLE) that consists of 
the injection of a small amount of KA, a glutamatergic analogue. Injection of KA has excitotoxic effects, causing 
a local lesion and the induction of status epilepticus (SE). As in other SE models, the intrahippocampal KA 
model develops highly comparable neuropathological alterations as to human TLE patients. These alterations 
include hippocampal sclerosis, extensive mossy fiber sprouting and dispersion of the GCL (Schwarcz and others, 
1978; French and others, 1982; Cavalheiro and others, 1982; Leite and others, 1996; Riban and others, 2002).  
Intracranial injection of KA in anaesthesized rats results in spontaneous recurrent seizures occurring at a low 
frequency only in a small proportion of animals. This is most likely due to the anti-epileptogenic effects of the 
anaesthesia used during local KA injection. For example, Bragin and coworkers injected 20 anaesthesized rats in 
the right posterior hippocampus with 0.4µg/0.2µl KA. Rats underwent 4 weeks of video-EEG monitoring from 3 
to 8 months after KA treatment but seizures were only detected in 8 out of 20 rats (40%) (Bragin and others, 
1999b). In a follow-up study, the same group injected KA in unanaesthesized rats and seizures were detected in 
73% of the rats during the first three months after KA injection (Bragin and others, 2004).  
In analogy to human patients, Bragin and coworkers detected aberrant high frequency oscillations (HFO’s) in 
the EEG recorded from the dentate gyrus ipsilateral to the intrahippocampal KA injection (Bragin and others, 
1999a). These HFO’s consisted of ripples (100-200 Hz) and fast ripples (200-500 Hz) and only occurred in rats 
that developed spontaneous seizures later on. The latency to the first HFO was positively correlated with the 
latency to the first seizure detection and the frequency of spontaneous seizures (Bragin and others, 2004). 
Therefore, HFO’s are considered as pathological and probably epileptogenic. Bragin and colleagues also found 
two seizure onset types in this model which are also described in human patients. A large fraction (74%) of the 
seizures started locally in the dentate gyrus ipsilateral to the KA injection, with an increase in frequency of 
interictal EEG spikes (hypersynchronous type) and 26% of seizures started bilaterally with a decrease of EEG 
amplitude and parallel increase in frequency (low-voltage fast type) (Bragin and others, 2005).  
Despite detailed anatomopathological characterization and electrophysiological description of interictal and 
ictal phenomena, habitual seizure parameters such as seizure frequency, duration and severity were not yet 
characterised for the intrahippocampal KA model. Therefore, we monitored SE and subsequent spontaneous 
seizures in this model using video-EEG monitoring. We found that SE and spontaneous seizure characteristics in 
this model were very similar to those in other SE models for TLE (table 2).  
As reported by Bragin and others, we found that intrahippocampal KA injection through a cannula in 
unanaesthesized rats induced a SE in every rat (Bragin and others, 2004). Therefore, intrahippocampal KA 
injection represents the most efficient among all methods to evoke a SE (table 2). The fraction of rats 
developing SE after intraperitoneal injection of KA is 93% (Stafstrom and others, 1992), after intraperitoneal 
PILO injection 61-73% (Glien and others, 2001), after intrahippocampal injection of PILO 71% (Furtado Mde and 
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others, 2002). Continuous stimulation of the hippocampus evokes SE in 70% (Bertram and Cornett, 1994), of 
the perforant path in 71%-100% (Mazarati and others, 1998; Gorter and others, 2001) and of the amygdala in 
87% of the rats (Nissinen and others, 2000).  
In our study all rats survived SE although we needed to terminate SE in two rats to prevent possible death of 
the animals. The highest mortality was seen after systemic injection of a single bolus of KA or PILO with can 
reach up to 50% (Hellier and others, 1998) and 40 % (Glien and others, 2001) respectively (table 2). However, 
injection of repeated low doses with individual adjustments of the dose highly reduces mortality to respectively 
15% and 7 % (Hellier and others, 1998; Glien and others, 2001). In the models in which SE is evoked by 
continuous electrical stimulation mortality was highest after stimulation of the amygdala (20%) (Nissinen and 
others, 2000). Continuous stimulation of the hippocampus or the perforant path induces SE without causing 
mortality (Bertram and Cornett, 1994; Mazarati and others, 2002).  
The duration of SE, measured on the EEG, after intrahippocampal KA injection was about 10 hours. In many 
studies, using other SE models, electrographic duration of SE could not be determined because SE was 
terminated by pentobarbital or diazepam injection to limit variability and/or mortality (Gorter and others, 
2001; Glien and others, 2001; Furtado Mde and others, 2002) or due to the absence of EEG recording 
(Stafstrom and others, 1992; Hellier and others, 1998). Studies that did determine the electrographic duration 
of SE showed that this was comparable to our findings despite the use of other methods for its induction (table 
2). The duration of SE induced by continuous hippocampal stimulation varied between 6 and 12 hours (Bertram 
and Cornett, 1994), SE after continuous perforant path stimulation lasted for 9 h (Mazarati and others, 2002) 
and in the continuous amygdala stimulation model for about 12 hours (Nissinen and others, 2000).  
  
 
 Table 2: Comparison of the intrahippocampal KA model with other SE models for human TLE  
Abbreviations: AM, amygdala; d, day; HC, hippocampus; ip, intraperitoneal; KA; kainic acid; min, minute; n.d., not determined; PILO, pilocarpine; PP, perforant path; Ref, references; SE: status epilepticus; SPRD, 
Sprague Dawley; SRS, spontaneous recurrent seizures; stim, stimulation; wk, week 
 
Ref.  
Rat strain 
(age) 
 Induction (dose)  
Rats 
with SE 
 
SE duration 
(EEG) 
 
Rats with SRS 
(monitoring period) 
 SRS onset (d)   
Partial 
SRS 
 
SRS 
duration 
 
Rats with 
frequent SRS 
(≥3/d) 
Raedt 
(2007) 
 SPRD   
(200-220g) 
 single KA       
(0.4µg/0.2µl, HC) 
 100%  10 h  87%  
(21 wks; 72h/wk) 
 28 (7-63) 
 
 34%  64 ± 4 s  3 of 15 rats 
(20%) 
Hellier  
(1998) 
 SPRD  
(150-250 g) 
 multi KA             
(5 mg/kg,ip) 
 n.d.  n.d.  97%  
(28 wks; 6-8h/wk) 
 77 ± 38 
 
 n.d.  n.d.  n.d. 
Stafstrom 
(1990) 
 SPRD 
(60d) 
 single KA        
(10-12 mg/kg, ip) 
 93%  n.d.  44%  
(3 months; n.d.) 
 34 (4-121) 
 
 n.d.  40 s (video)  n.d. 
Glien  
(2001) 
 Wistar  
(200-225 g) 
 single PILO           
(30 mg/kg, ip) 
 73%  interrupted  78%  
(19 wks;    12-56h/wk) 
 12-72 
 
 n.d.  27 s (video)  n.d. 
Glien  
(2001) 
 Wistar  
(200-250g) 
 multi PILO        
(10 mg/kg, ip) 
 61%  interrupted  100%  
(19 wks; 12-56h/wk) 
 10-75 
 
 n.d.  27 s (video)  n.d. 
Furtado 
(2002) 
 Wistar 
(200-250 g) 
 single PILO      
(2.4 µg/µl, HC) 
 71%  interrupted  71% 
(30 days; 8h/d) 
 2-30 
 
 16%  n.d.  n.d. 
Bertram 
(1994) 
 SPRD   
(200-225g) 
 90 min stim  
(400µA) in HC 
 70%  6-12 h  100%  
(18 wks; continuously) 
 n.d.  n.d.  64-106 s  n.d. 
Gorter  
(2001) 
 Wistar  
(350-550 g) 
 90 min stim  
(500µA) in PP 
 71%  interrupted  100%  
(6 m,continuously) 
 7.2-8.6  n.d.  60 s  10 of 15 rats 
(67%) 
Mazarati 
(2002) 
 Wistar    
(12-14wk) 
 30 min stim  
(20V) in PP 
 100%  9 h  n.d.  20-32 
 
 n.d.  120 s  13 of 17 rats 
(76%) 
Nissinen 
(2000) 
 SPRD   
(320-390 g) 
 20-30 min stim  
(400 µA) in AM 
 87%  12h  87% (26 wks; 
24h/d;3.5d/wk) 
 28 (6-85) 
 
 21%-77%  49 s  4 of 13 rats 
(31%) 
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We detected spontaneous seizures in 13 out of 15 animals (87%) during the first 21 weeks after SE, with all 
these rats having their first seizure in the first eight weeks after SE. In the remaining two rats seizures were 
detected during the second monitoring period 40 to 42 weeks after induction of SE. Similar high numbers of 
animals developing spontaneous seizures were reported in other SE models. Intraperitoneal injection of a 
single dose or multiple doses of PILO induced spontaneous seizures in respectively 78% and 100 % of the 
injected animals (Glien and others, 2001). After intraperitoneal injection of multiple small doses of KA, 97% of 
the animals developed spontaneous seizures (Hellier and others, 1998). SE evoked by continuous stimulation in 
the hippocampus or in the perforant path resulted into spontaneous seizures in all treated rats (Gorter and 
others, 2001; Mazarati and others, 2002), while after continuous amygdala stimulation spontaneous seizures 
were detected in 87% of the animals (Nissinen and others, 2000). When comparing these studies, it is noted 
that most studies, including ours, did not continuously monitor the rats and that the number of weeks or 
months of monitoring varied among the different studies (table 2). Hence, rare seizures could have been 
missed leading to an underestimation of the fraction of epileptic rats.  
An important characteristic of acquired epilepsy is the delay between the initial brain insult and the onset of 
spontaneous seizures, the so called “latent period”. Determination of the latent period can only be performed 
when rats are monitored continuously (24h/day, 7 days/week). A study by Gorter and colleagues reported the 
first spontaneous seizure after a mean latent period of only one week in a model where SE was induced by 
continuous perforant path stimulation (Gorter and others, 2001). In the other models, the duration between SE 
and the first seizure detection was higher, most likely due to the fact that animals were monitored only during 
a fraction of time. In our study, rats were monitored for 72 hours per week and the time between SE and the 
first seizure detection varied between 7 and 63 days. In studies which monitored post-SE rats for similar 
fractions of time, the duration between SE and the first seizure detection was comparable (table 2): after 
intraperitoneal injection of PILO the first seizure was detected 10 to 75 days after SE (Glien and others, 2001), 
after continuous amygdala stimulation the first seizure was detected 6 to 85 days after SE (Nissinen and others, 
2000). In the study done by Hellier and colleagues rats were monitored for only 6 to 8 hours per week. In this 
study the mean duration for the first seizure detection was longer: 77 days (Hellier and others, 1998).  
We found that 34% of the spontaneous seizures were partial without secondary generalization (SG). Only a few 
other studies recorded simultaneously video and EEG which is mandatory to determine the number of seizures 
that evolve to SG (table 2). In the intrahippocampal PILO model, 16% of the partial seizures did not secondary 
generalize (Furtado Mde and others, 2002). In the continuous amygdala stimulation model 21% of the partial 
seizures do not show SG during the first 10 weeks of monitoring but this increased up to 77% in the following 
weeks (Nissinen and others, 2000).  
The mean seizure duration varied between 27 and 120 seconds among models (table 2). In studies which 
determined duration of seizures based on video-images, the average seizure duration ranged between 27 and 
40 seconds (Stafstrom and others, 1992; Glien and others, 2001). In studies using EEG to determine seizure 
 Chapter 7 | General Discussion 241 
 
length, seizure duration varied from 49s to 106s (Bertram and Cornett, 1994; Nissinen and others, 2000; Gorter 
and others, 2001). We determined seizure duration based on the EEG and found that this was on average 64s.  
As described in other SE models, seizure frequency was highly variable among rats (table 2). We found that 
three of the 15 rats (20%) had frequent seizures, while 73% of the animals had a low seizure frequency with 
less than one seizure per day. This dichotomy in frequently and rare seizing rats has also been described for the 
continuous amygdala and perforant path stimulation models. In the continuous amygdala stimulation model, 
31% of the animals displayed frequent seizures (Nissinen and others, 2000). In the perforant path stimulation 
model, the proportion of rats with frequent seizures was higher, being 67% to 76% (Gorter and others, 2001; 
Mazarati and others, 2002). 
We found that the frequency of convulsive seizures increased over time during the first 20 weeks after SE. Also 
rats that were monitored a second time 40 weeks after SE all showed a higher seizure frequency compared to 
the first monitoring session. This shows that the epileptic state in the intrahippocampal KA model is 
progressive. An increase in seizure frequency over time has also been reported in all other SE models (Bertram 
and Cornett, 1994; Hellier and others, 1998; Arida and others, 1999; Nissinen and others, 2000; Gorter and 
others, 2001). Gorter and coworkers identified a subgroup of rats in which progression of seizure frequency 
was most evident and showed that this progression was associated with loss of hilar interneurons combined 
with mossy fiber sprouting (Gorter and others, 2001). The progression of seizure frequency in our and other 
models parallels the situation in most human patients suffering from TLE in whom a worsening of the epileptic 
state over time has been described (Engel, 1996; Wieser, 2004).  
Monitoring for 24 hours/day showed that seizures followed a circadian pattern and occurred more frequently 
during the day (lights on). Overall 62 ± 1% of the seizures occurred during the day. The same tendency was 
found in the intraperitoneal KA models and in the continuous amygdala and hippocampus stimulation models 
where also about 60 % of the seizures occurred during the day (Hellier and others, 1998; Quigg and others, 
1998; Nissinen and others, 2000). Hellier and coworkers normalized seizure occurrence for the activity-state of 
the animal and they found that more seizures occur during periods of inactivity (82%) compared to periods of 
activity (18%) (Hellier and others, 1998).  
Taken together, by performing an extensive characterization of the intrahippocampal KA model, using video-
EEG monitoring, we found that a high proportion of treated rats became epileptic and that seizure parameters 
resembled those of other post-SE TLE models. Intrahippocampal KA injection has the disadvantage of being 
more difficult and time consuming than single systemic injection of proconvulsants. However, for the screening 
of efficacy of focal treatments (such as cell transplantation) this model has the advantage that initial injury and 
subsequent epilepsy is also focal with a large number of partial seizures without SG and the presence of the 
seizure focus in the hippocampus ipsilateral to the KA injection (Nadler, 1981; Bragin and others, 1999b; Bragin 
and others, 2005; Dudek and others, 2006). The high fraction of epileptic rats combined with focal injury and 
seizure origin motivated us to use this TLE model for the evaluation of cell transplantation. 
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CELL TRANSPLANTATION IN THE INTRAHIPPOCAMPAL KAINIC ACID MODEL 
As described extensively in the introduction, cell transplantation in TLE can be done for two purposes. Firstly, 
cells can be transplanted in order to replace lost cells and repair damaged circuitry. Secondly, cells can be 
grafted for the local delivery of seizure-suppressing substances.  
CELL TRANSPLANTATION FOR THE REPAIR OF DAMAGED CIRCUITRY 
As hippocampal sclerosis is believed to play a major role in the pathogenesis and/or aggravation of TLE and as it 
is characterised by the loss of hippocampal neurons, replacement of lost hippocampal neurons and repair of 
hippocampal circuitry may represent a cure for TLE. In the review on cell therapy in models for TLE, presented 
higher in this dissertation, we listed a number of studies which transplanted fetal hippocampal neurons in the 
sclerotic hippocampus of an intracerebral KA model for TLE. Part of the transplanted cells formed appropriate 
synaptic connections and in some cases a partial reversal of anatomopathological changes such as mossy fiber 
sprouting and loss of GAD immunoreactivity was demonstrated (Shetty and Turner, 1997; Shetty and others, 
2000). However two major issues arose from these studies. Firstly, successful results were only obtained when 
homotopic transplantation was performed, which means that the appropriate cell type needs to be 
transplanted directly at the correct location (Shetty and Turner, 1997; Shetty and others, 2000; Zaman and 
others, 2000). Secondly, the transplanted fetal cells did not migrate but remained clumped at the grafted site 
(Turner and Shetty, 2003). Both issues are important disadvantages for the repair of hippocampal sclerosis 
which is characterized by widespread loss of different hippocampal cell types. Structural repair of hippocampal 
sclerosis would require a high amount of injections on different locations throughout the hippocampus, 
probably resulting in extended damage rather than repair.  
The need of high number of fetuses and the inability to obtain a purified population of transplantable cells 
imply important ethical and practical limitations for the use of fetal tissue for cell based repair. These 
limitations have urged the search for alternative cell sources to replace fetal tissue. As discussed more 
extensively in both reviews in the introduction immortalized neural progenitor cells and neuropotent stem cells 
are promising alternative cell sources.  
At least two immortalized progenitor cell lines have been reported to generate different neuronal phenotypes 
in the adult hippocampus: the RN33b and MHP36 cell line. Both cell lines are able to differentiate towards 
functionally active hippocampal neurons upon transplantation in the adult hippocampus (Shihabuddin and 
others, 1995; Englund and others, 2002) After transplantation in the damaged hippocampus, RN33b cells only 
differentiated towards neurons in regions where they could intermingle with spared host neurons, indicating 
that differentiation of RN33b cells into specific neuronal phenotypes is not autonomous but depends strongly 
on the presence of local cues (particularly the direct cell to cell interaction) (Shihabuddin and others, 1996). In 
contrast to RN33b cells, MHP36 cells migrate towards lesioned brain areas and seem to replace, at least in part, 
lost neurons. In the 4-VO model intrahippocampally transplanted MHP36 cells  migrate to and repopulate the 
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CA1 region, which is selectively lesioned after  5-15 minutes of global ischemia. A fraction of the MHP36 cells 
display pyramidal morphology and express neuronal markers. Electrophysiological studies to demonstrate the 
functionality of these new neurons have not been performed.  
Neuropotent stem/progenitor cells can be derived from ESC or isolated directly from CNS tissue. Neural 
progenitors derived from tau-eGFP ESC were grafted into the mature hippocampus of both normal and 
chronically epileptic rats. In both cases GFP positive ESC-derived neurons remained clustered close to the 
injection site without evidence of functional cell replacement (Ruschenschmidt and others, 2005). A commonly 
reported problem with ESC transplantation is the frequent formation of teratocarcinomas by undifferentiated 
ESC which were co-transplanted in the brain (Bjorklund and others, 2002; Wernig and others, 2004).  
Isolating neural stem/precursor cells directly from CNS tissue avoids this issue. A high number of papers have 
been published on various protocols for the isolation and expansion of NSC from a variety of regions of both 
the developing and adult brain of different mammals, including humans (Gage, 2000). Especially the adult-
derived NSC are very interesting potential cell sources for the replacement of lost neurons as there are no 
ethical issues related to their use and it would make autologous transplantation strategies possible.  
Based on the successful in vitro differentiation results of adult SVZ-derived NSC we chose to use these cells for 
transplantation in the sclerotic hippocampus. We isolated NSC from the SVZ of adult GFP reporter mice and 
expanded them as neurospheres for at least 10 passages. After labelling with BrdU, GFP positive NSC (140.000 
cells) were transplanted in intact and sclerotic hippocampi of control and KA treated rats respectively. In this 
latter, NSC were transplanted three days or three weeks after induction of the KA lesion. We found that a 
limited fraction (1%) of the transplanted cells survived three and six weeks after transplantation both in the 
intact and sclerotic hippocampus. In both cases a small fraction of the GFP
+
 transplanted cells expressed the 
neuronal marker NeuN. In the intact hippocampus a maximum of 6% of the GFP
+
 transplanted cells expressed 
NeuN, while in the sclerotic hippocampus a maximum of 4% of the transplanted cells expressed the neuronal 
marker. A much larger fraction of the transplanted, GFP
+
 cells expressed GFAP both in the intact hippocampus 
(30-40%) and the sclerotic hippocampus (50-60%).  
It is most likely that the GFP-labeled cells expressing NeuN or GFAP are the result of direct differentiation of the 
transplanted NSC. However, recent studies have indicated that transplanted stem cells are able to fuse with 
recipient cells, resulting in cells which express the donor-specific label and display phenotypic properties 
(morphology, marker expression) of the endogenous cells they fused with (Alvarez-Dolado and others, 2003; 
Wang and others, 2003). In vitro, NSC have been shown to spontaneously fuse with other NSC (Chen and 
others, 2006; Jessberger and others, 2007) and with ESC (Ying and others, 2002).  
We hypothesize that if fusion would have occurred in these transplantation experiments it would probably be 
at a very low rate based on two arguments. Firstly, cell fusion only rarely occurs both in vitro (Terada and 
others, 2002; Ying and others, 2002; Chen and others, 2006; Jessberger and others, 2007) and in vivo (Alvarez-
Dolado and others, 2003; Harris and others, 2004). Secondly, Corti and coworkers investigated the possibility of 
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cell fusion between transplanted NSC and endogenous brain cells by transplanting NSC, derived from female β-
actin GFP transgenic mice into male recipients (Corti and others, 2005). Fluorescence in situ hybridization 
(FISH) for the Y-chromosome did not reveal the presence of a Y-chromosome in any of the investigated 
(n=2340 cells) GFP labeled cells, indicating that stable cell fusion of NSC with endogenous brain cells was either 
extremely rare or did not occur (Corti and others, 2005). 
Our study setup does not allow to investigate the possibily of cell fusion. In order to do so we need to 
transplant NSC derived from female β-actin GFP transgenic mice into normal and sclerotic hippocampus of 
male rats and perform FISH for the rat Y chromosome. Alternatively, we could transplant cells from Z/EG donor 
mice into mice ubiquitously expressing Cre recombinase. Cells from Z/EG reporter mice express β-galactosidase 
but when they fuse with Cre expressing cells expression of β-galactosidase switches to GFP expression (Harris 
and others, 2004). 
In the intact hippocampus, donor-derived expressing NeuN were found in the GCL, the zone of active 
hippocampal neurogenesis, but not in other hippocampal regions (CA1, CA3 or hilus). Other studies which 
transplanted rodent NSC derived from the SVZ (Richardson and others, 2005; Muraoka and others, 2006), the 
hippocampus (Gage and others, 1995; Suhonen and others, 1996) or the spinal cord (Shihabuddin and others, 
2000) in the hippocampus also found NeuN expressing cells only in the GCL. This indicates that the presence of 
a neurogenic environment is very important in order for stem cells toi acquire a neuronal phenotype. This 
hypothesis is further strengthened by studies which transplanted the same type of NSC in both neurogenic 
(dentate gyrus, olfactory bulbs, SVZ) and non-neurogenic CNS regions (striatum, spinal cord, cerebellum). In 
these studies donor-derived neurons were only found in the neurogenic regions (Suhonen and others, 1996; 
Shihabuddin and others, 2000; Richardson and others, 2004; Richardson and others, 2005).  
Only 6% of the transplanted cells expressing NeuN was low but comparable to another study which 
transplanted SVZ-derived NSC in the adult hippocampus (Muraoka and others, 2006). This latter study showed 
that the fraction of cells expressing neuronal markers could be enhanced by performing autologous 
transplantation. Besides the interspecies barrier, another factor which could have contributed to the low rate 
of neuronal differentiation may be the culture of the NSC as neurospheres. It has been demonstrated that 
rodent-derived neurospheres lose their neurogenic potential over time (Winkler and others, 1998; Sun and 
others, 2003). A recent study cultured SVZ-derived NSC as monolayers instead of as neurospheres and obtained 
a higher fraction (about 27%) of NSC differentiating towards neuronal cells after grafting in the hippocampus 
(Richardson and others, 2005). However, this study used BrdU as a single marker and did not exclude the 
possibility that BrdU was transferred from dying transplanted cells to endogenous dividing granule cell 
precursors.  
In the sclerotic hippocampus, a maximum of about 4% of the surviving transplanted cells had differentiated 
towards neurons. These donor-derived neurons did not integrate in the GCL but remained within the cluster of 
transplanted cells. This might indicate that neurogenic signals were still present but that the mechanism 
 Chapter 7 | General Discussion 245 
 
responsible for proper integration of new neurons was no longer functional. This would also explain why some 
of the endogenous newborn granule neurons are found at abnormal locations in the hilus or molecular layer in 
the sclerotic hippocampus (Scharfman and others, 2000).  
Based on this limited fraction of neuronal differentiation and the location within the transplanted cell cluster 
there is little or no indication that transplanted NSC replaced lost hippocampal neurons or repaired 
hippocampal circuitry.  
Sofar, reports demonstrating that NSC can generate neurons in damaged brain region are very scarce (Conti 
and others, 2006; Martino and Pluchino, 2006). Most successful results were obtained by using human fetus-
derived NSC. In one study, human fetal NSC were transplanted in the rat brain near the ischemically damaged 
striatum. Following transplantation, the NSC migrated towards the lesion where the majority of the NSC 
differentiated towards neuronal cells (Kelly and others, 2004). Similarly, human fetal NSC generated a small 
fraction of dopaminergic neurons upon transplantation in the striatum of Parkinsonian rats (Svendsen and 
others, 1997). 
To our knowledge, no studies have yet reported replacement of lost pyramidal neurons or hilar interneurons by 
NSC, grafted in a sclerotic hippocampus. One study injected β-galactosidase labelled human fetal NSC in the tail 
vein of rats one day after PILO-induced SE. Six weeks later cells were found in the hippocampus, amygdala and 
pyriform cortex. About 20 % of the cells expressed GFAP and 30% expressed GABA and parvalbumin, two 
markers for inhibitory hilar interneurons (Chu and others, 2004). Surprisingly, those presumed interneurons did 
not express the pan-neural markers, NeuN or β3tubulin, indicating that they were not neurons. Despite the 
lack of neuronal repair, the authors did find that the fraction of animals which developed spontaneous seizures 
in the six weeks after PILO induced SE was lower after transplantation. Furthermore, the transplanted animals 
that did develop spontaneous seizures had a significantly lower seizure frequency, less severe seizures and 
demonstrated less aggressive behaviour compared to non-transplanted rats.  
This latter report is one out of many studies which show that transplantation of NSC induces behavioural 
improvement without evidence that the transplanted NSC give rise to functionally integrated neurons with 
significant replacement of lost cells. It seems that transplantation of NSC can also induce “bystander” effects 
which in their turn can affect disease progression (Martino and Pluchino, 2006). One of these bystander effects 
is the release by NSC of neurotrophins such as NGF, BDNF, CNTF and GDNF which could result in increased 
survival and function of endogenous brain cells which survived the initial brain insult (Lu and others, 2003; Yan 
and others, 2004; Ryu and others, 2004). Another bystander effect is immunomodulation and alteration of the 
inflammatory environment after transplantation of NSC. For example, it has been shown that transplanted NSC 
induce apoptosis of T-lymphocytes by the upregulation of membrane expression of certain death receptor 
ligands (such as FASL, TRAIL and APO3L) (Pluchino and others, 2005) and hamper infiltration of blood-born 
monocytes at the lesion border of ischemic areas where the NSC accumulate (Kelly and others, 2004).  
 246 Chapter 7 | General Discussion 
 
Taken together, neural stem or precursor cells derived from ESC or primary CNS tissue do not seem to replace 
neurons and/or mediate circuitry repair in a sclerotic hippocampus. To achieve this, probably other cell sources 
and/or approaches will be required. If we would succeed to generate cells which replace one or more 
hippocampal phenotypes in a sclerotic hippocampus a crucial next step would be to make sure that the grafted 
neurons make appropriate synaptic contacts in order to restore the deregulated balance between excitation 
and inhibition. It is likely that the introduction of new excitatory neurons in a sclerotic and hyperexcitable 
hippocampus could have aggravating effects if they are not “connected” in an appropriate way. This need for 
appropriate integration was already obvious from early transplantation reports which show that 
intrahippocampal grafting of fetal hippocampal neurons can have pro-epileptic effects with induction of 
epileptic spikes and occasional behavioural seizures (Buzsaki and others, 1988; Buzsaki and others, 1991).  
Another factor complicating neural repair in case of hippocampal sclerosis could be the extensive gliosis. As the 
hippocampus is highly structurally organized in different cell layers, migration of the transplanted cells towards 
appropriate location will be required. However, the astrocytic scar forms a barrier for migrating cells. In our 
study, we found that the dispersion of the transplanted NSC was two times higher in intact hippocampus 
compared to sclerotic hippocampus. This is most probably a reflection of the presence of gliotic scar tissue.  
CELL TRANSPLANTATION FOR LOCAL DELIVERY OF ANTI-EPILEPTIC SUBSTANCES 
In a less complex, but until now more successful, alternative approach cells are transplanted for the local 
delivery of inhibitory substances in epileptic brain structures, responsible for the generation and/or spreading 
of the seizures. Originally, fetal brain tissue was isolated from regions containing high amounts of seizure 
suppressing neurotransmitters, such as GABA (striatum), noradrenaline (locus coeruleus) and acetylcholine 
(basal forebrain) and transplanted. For a detailed overview of these different transplantation studies we refer 
to the introduction of this dissertation. Because of the practical and ethical limitations of fetal cell 
transplantation also non-fetal cells were engineered to secrete antiepileptic substances, such adenosine and 
GABA.  
Adenosine kinase, an adenosine-metabolizing enzyme, was disrupted in fibroblasts (Huber and others, 2001), 
myoblasts (Guttinger and others, 2005b) and embryonic stem cells (Fedele and others, 2004; Guttinger and 
others, 2005a). Consequenlty these cells release high amounts of adenosine. These adenosine-secreting cells 
were encapsulated in semi-permeable polymers and transplanted in the lateral ventricles of fully kindled rats. 
After transplantation of the encapsulated cells a temporary but complete suppression of kindling seizures was 
found.  
Thompson and colleagues engineered a conditionally immortalized mouse neuronal cell line (CN1.4) to deliver 
GABA by driving GAD65 expression using a doxycycline controlled promoter. Grafting of these cells into the 
anterior SNr (Thompson and others, 2000; Thompson and Suchomelova, 2004), the pyriform cortex (Gernert 
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and others, 2002) and the dentate gyrus of the hippocampus (Thompson, 2005) of rats showed clear 
antiepileptic effects.  
A common reported problem for the adenosine- and GABA-releasing cells was the inherent inability to survive 
in the brain upon transplantation which made that the antiepileptic effects were only short-lasting. Even 
control cells, which were not engineered to overexpress GABA or adenosine, did not survive for a long time 
after transplantation.  
We found that a fraction of the adult-derived NSC survived for at least six weeks after transplantation in both 
the intact and damaged hippocampus. Therefore adult-derived NSC may represent an alternative cell source 
for the long-term delivery of antiepileptic substances. However more studies are necessary to increase the 
fraction of surviving cells. In our study only about 1% of the transplanted NSC seemed to survive. This was 
rather low compared to a study done by Gage and coworkers, in which it was reported that 41% of the 
hippocampus-derived NSC survived after homotopic transplantation in the adult hippocampus (Gage and 
others, 1995). Several explanations are possible for the lower survival rates found in our study.  
Firstly, we heterotopically transplanted SVZ-derived NSC in the hippocampus. In case of fetal cell grafting, 
heterotopic transplantation also led to lower survival rates (Zaman and others, 2000). 
Secondly, we xenotransplanted mouse cells into a rat brain. A recent study demonstrated that allogenic 
transplantation of SVZ-derived NSC resulted in significantly less survival compared to autologous 
transplantation (Muraoka and others, 2006). The interspecies barrier could be an important factor for the 
lower survival even with suppression of the immune rejection by cyclosporine.  
Thirdly, we cultured the NSC as neurospheres. Neurospheres are heterogeneous clusters which contain NSC 
but also more differentiated cells. In contrast, monolayer culture seems to allow a more selective expansion of 
NSC (Conti and others, 2005). In the study done by Gage and colleagues the hippocampal stem cells were 
expanded as monolayers (Gage and others, 1995). So, the higher number of surviving neurons may represent a 
higher fraction of NSC in culture.  
Fourthly, in our study we might have underestimated cell survival by only counting the cells that double-
labelled for BrdU and GFP. However, we found that a considerable fraction of cells were positive for BrdU but 
not for GFP. Gage and coworkers transplanted NSC which were double-labelled with BrdU and a transgenic 
marker, in this case β-galactosidase (Gage and others, 1995). As in our study, the authors found that the 
fraction of transgenetically-labelled cells was lower than the fraction of BrdU labelled cells. However in this 
study the number of BrdU labelled cells was counted and it was stated that the expression of the transgene 
was downregulated. However, as already stated above, BrdU can be transferred from dying cells to 
endogenously dividing cells resulting in false positive results (Burns and others, 2006).  
In our study, we could not demonstrate differences in the survival of transplanted cells in a normal or sclerotic 
hippocampus. We did find that cell survival in a sclerotic hippocampus was significantly higher when cells were 
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transplanted early (three days) after making the KA lesion compared to transplantation after a longer 
postlesion delay (three weeks). The same was found in case of homotopic fetal hippocampal cell 
transplantation. Fetal CA3 cells transplanted early (4 days) after the lesion survived two to four times more 
compared to fetal cells transplanted 45 days after induction of the KA lesion (Zaman and others, 2001; Turner 
and Shetty, 2003). The authors speculate that this is due to the enhanced neurotrophic factor environment 
that is present up to 14 days after lesion development (Lowenstein and others, 1993). In line with their 
hypothesis, the authors pre-treated the cells before transplantation for three hours with growth factors (bFGF, 
BDNF, NT-3) and an anti-apoptotic substance (the caspase inhibitor Ac-YVAD-cmk). Because of this pre-
treatment, survival rates were increased up to 99%, even when cell were transplanted with a postlesion delay 
of 4 months (Zaman and Shetty, 2002; Zaman and Shetty, 2003; Hattiangady and others, 2006).  
Our study showed that a high fraction of the transplanted cells expressed GFAP and displayed an astrocytic 
morphology indicating that they had differentiated towards astrocytes. Compared to the intact hippocampus, 
the fraction of cells acquiring an astrocytic phenotype was enhanced in the sclerotic hippocampus. Moreover, it 
was evident that the transplanted cells adopted a morphology resembling reactive astrocytes with thick 
processes, an enlarged cell body and intense staining for GFAP. Both findings indicate that transplanted NSC 
were recruited in the host astogliotic response to the lesion. 
Recent experiments have indicated that astrocytes could play a prominent role in the generation and/or 
spreading of seizures by the release of glutamate (Tian and others, 2005; Kang and others, 2005). Therefore, in 
future experiments, it will be necessary to investigate whether astrogliosis is enhanced by transplanting NSC 
and to determine the effect of introducing exogenous astrocyte-like cells on the excitability of the brain. 
Indeed, one could imagine that an increase of the number of reactive astrocytes could lead to an aggravation 
of the epilepsy. If the latter would be the case it could be more advantageous to transplant alternative cell 
types which secrete seizure-suppressing substances but, in contrast to NSC, do not contribute to the neural cell 
compartment. For example, ex vivo modified fibroblasts could be used as these cells are able to stably survive 
for prolonged periods (up to one year) while continuously secreting a transgene protein (Blesch and others, 
2001; Liu and others, 2002; Tobias and others, 2003; Pizzo and others, 2004).  
On the other hand, introducing cells which directly integrate into the epileptic network may also be 
advantageous, especially if the donor-derived astrocytes are recruited instead of endogenous astrocytes. This 
would allow a more direct manipulation of the disease process and the epileptic network. For example, it has 
been demonstrated that the level of glutamine synthetase is decreased in an epileptic hippocampus (Eid and 
others, 2004). Glutamine synthetase is an enzyme which is expressed in astrocytes and is responsible for the 
metabolisation of glutamate to glutamine. The defective breakdown of glutamate, which is an excitatory 
neurotransmitter, could be an important causative factor for the generation of seizures. Indeed, a microdialysis 
study in TLE patients has demonstrated that an epileptic seizure is preceded by increased levels of glutamate 
(During and Spencer, 1993). Therefore, genetic engineering of NSC prior to their transplantation to induce 
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overexpression of glutamine synthetase could be a strategy to reduce the extracellular levels of glutamate in 
the epileptic network and thereby reducing local excitability.  
Together, NSC could be an interesting cell source for cell-based delivery purposes. However, further research is 
mandatory to indentify conditions which can enhance the fraction of cells which survive after transplantation. 
It is also mandatory to find out whether the transplantation of NSC enhances the gliotic response and, if so, 
whether this aggravates the epileptic state.  
CELL THERAPY FOR TLE THROUGH MODULATION OF ENDOGENOUS NEUROGENESIS  
As already indicated in the introduction short and transient induction of global ischemia in the 4-VO model 
selectively affects hippocampal CA1 pyramidal neurons. In this model it was demonstrated that neural 
precursors residing in the posterior periventricular region (PPV) migrate towards the lesioned CA1 regions were 
they can replace CA1-like pyramidal cells (Nakatomi and others, 2002). Recently Parent and co-workers found 
that also in the PILO model for TLE precursor cells from the PPV migrate to the damaged hippocampal regions. 
However, in these hippocampal regions the precursor cells did not generate neurons, but exclusively 
differentiated towards glia. In contrast to the ischemically lesioned hippocampus there was no neural repair in 
this model for TLE (Parent and others, 2006b). Identification of the factors which promote neural replacement 
in case of an ischemic lesion and/or prevent regeneration in case of excitotoxic lesions could perhaps 
contribute to new strategies for stimulating endogenous repair in case of hippocampal sclerosis.  
In the PILO model for TLE, but also in other TLE models, it was found that seizures enhance neurogenesis in the 
neurogenic regions: the olfactory system and the dentate gyrus (Parent and Lowenstein, 2002). In the SVZ of 
the PILO model for TLE, precursor cell proliferation was clearly upregulated after 2 hours of SE. BrdU labelling 
and focal injection of retroviral reporters into the rostral SVZ showed that most of the new neurons, generated 
in response to SE, migrate via the normal RMS pathway to their appropriate targets in the olfactory bulb. A 
small fraction of the SVZ-derived neuroblasts generated after SE left the RMS prematurely and migrated into 
injured forebrain regions. However, only a very small part of these new neurons persisted in these cortical 
regions for more than 5 weeks after SE. This indicates that even if neural replacement in cortical areas is 
present, it is only moderate (Parent and others, 2002). Studies investigating the possible role of this seizure-
induced increase in SVZ neurogenesis have not been performed.  
Most studies have focussed on seizure induced alterations in hippocampal neurogenesis, which is not 
surprising given the prominent role of the hippocampus in TLE. Those studies found that single seizures as well 
as prolonged SE severely influence granule cell neurogenesis in the dentate gyrus of the hippocampus. In 
contrast to most other disease models, seizure-induced neurogenesis is thought to contribute to the disease 
progression rather than being an endogenous repair mechanism.  
Seizure activity has been demonstrated to stimulate proliferation of both radial glia-like NSC (Huttmann and 
others, 2003) and DCX positive migrating neuroblasts (Jessberger and others, 2005). This results in an increase 
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in net neurogenesis in the hippocampus of both kindling and SE models for TLE (Parent and others, 1997; 
Bengzon and others, 1997; Gray and Sundstrom, 1998; Parent and others, 1998; Scott and others, 1998; 
Parent, 2002; Jessberger and others, 2005; Smith and others, 2005; Overstreet-Wadiche and others, 2006). The 
majority of the newborn granule cells, generated in response to seizures, integrate appropriately into the GCL 
and develop the same morphological and functional properties as newborn granule neurons in non-epileptic 
rats. However, these developmental processes seem to be accelerated in response to seizures (Overstreet-
Wadiche and others, 2006). The accelerated integration of higher number excitatory neurons could enhance 
excitability of hippocampal networks. In addition a portion of the newborn granule neurons show 
inappropriate migration, differentiation, and integration in response to seizures, further suggesting a pro-
epileptic role of enhanced neurogenesis in response to seizures (Scharfman and others, 2000; Parent, 2002; 
Jessberger and others, 2005; Shapiro and Ribak, 2006; Parent and others, 2006a).  
To further elaborate on the possible role of seizure-induced aberrant neurogenesis in epileptogenesis, we 
suppressed neurogenesis during hippocampal kindling acquisition, which is a validated model for temporal lobe 
epileptogenesis (Lothman and Williamson, 1994). To do this, the rat brain was exposed to low-dose (8Gy) 
radiation one day before the initiation of rapid kindling. This radiation dose was reported to selectively induce 
apoptosis in neuronal precursors and immature neurons, while leaving mature neurons and gliogenesis 
unaffected. By injecting rats with BrdU at the first and second kindling day and staining for the neuronal marker 
NeuN, three weeks after labelling, we found that neurogenesis was suppressed by more than 80% in the first 
days after radiation. Staining for DCX-positive neuroblasts at the end of the kindling acquisition, one week after 
radiation, showed that the number of neuroblasts at that time point was reduced by 95%. However, this 
suppression of neurogenesis did not prevent the rats from becoming fully kindled. Therefore, our results 
suggest that increased neurogenesis in response to seizures play no or only a limited role in kindling 
epileptogenesis and the establishment of hyperexcitable hippocampal networks.  
In fact, we found that radiation-induced suppression of neurogenesis was associated with a more rapid kindling 
rate and more excitable hippocampal networks. Since it was reported that radiation could induce inflammation 
(Monje and others, 2003), we stained the rat brains at the end of the kindling acquisition for CD11 (activated 
microglia) and vimentin (activated astrocytes). We found significant inflammation in both radiated and non-
radiated rats without differences in the extent between both groups. This indicates that radiation-induced 
inflammation is probably not responsible for the higher excitability observed in the radiated rats.  
Based on these results it is tempting to speculate that seizure-induced neurogenesis enhances local inhibition. 
However, low-dose radiation is a rather unspecific tool which causes subtle side-effects such as changes in 
microvasculature and altered metabolic or signalling pathways (Silasi and others, 2004). Those side-effects, and 
not the suppression of neurogenesis, may be responsible for the higher excitability in response to radiation.  
Taken together, our results indicate that enhanced neurogenesis does not contribute to the acquisition or the 
permanence of a fully kindled state and therefore does not play a major role in epileptogenesis. However, our 
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study does not allow discriminating between enhanced neurogenesis being an unspecific side-effect of seizure 
activity or endogenous protection mechanism against increased excitability. In a very recent study, Jakubs and 
colleagues compared seizure-generated granule neurons with granule neurons, generated in response to 
running. They found that new granule cells formed in context of seizures showed reduced excitability and 
demonstrated that this reduced excitability was the result of an increased inhibitory and decreased excitatory 
synaptic input on the developing new neurons (Jakubs and others, 2006). This shows that the addition of more 
excitatory neurons not necessarily results in an increase in net excitability. The authors hypothesized that the 
continuous addition of granule neurons with reduced excitatory and increased inhibitory synaptic input may 
have significant beneficial effects on the epileptic syndrome by increasing the threshold for seizure propagation 
through limbic circuitry.  
In conclusion, although our study argues against a major role of seizure-induced neurogenesis in kindling 
epileptogenesis further studies in different TLE models and human patients are needed to further elaborate on 
the precise role of the seizure-generated neurons.  
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This chapter provides a general conclusion with regard to the research questions formulated in the 
introduction and clarifies how our results contribute to a further understanding of the feasibility of cell therapy 
approaches as potential treatment for TLE. In some answers specific considerations about the used 
methodology are presented.  
CELL TRANSPLANTATION FOR TEMPORAL LOBE EPILEPSY: 
A. Neuropotency of multipotent adult progenitor-like cells and adult neural stem cells  
1. Can we isolate cell clones from the bone marrow which display the high proliferative potential, 
morphology and phenotypic profile as described for multipotent adult progenitor cells (MAPC)? 
Using the protocol which was originally described for the isolation and culture of MAPC and subsequent 
single cell cloning, we were able to generate cell clones with a high proliferative potential (more than 40 
passages) and a spindle- to triangle-shaped morphology. Among those, we could identify clones which 
were negative for MHC I and MHC II and did not or only very moderately express CD44.  
2. Are the MAPC-like cells pluripotent? In other words can we differentiate them towards endodermal 
(endothelium), mesodermal (hepatocytes) and ectodermal (neuronal) cells?  
Despite a high number of attempts we were not able to reproducibly and inarguably differentiate the 
MAPC-like cells towards endothelial cells, hepatocytes or neuronal cells by using the protocols described 
for MAPC differentiation. RT-PCR, flow cytometry and immunohistochemistry analysis showed that 
expression of differentiation markers was incongruent and incomplete.  
3. Can we isolate neurosphere-forming neural stem cell (NSC) clones from the SVZ of adult rodent brain?  
By plating SVZ-derived cells in a chemically-defined expansion medium after mechanical and enzymatic 
dissociation of the microdissected SVZ tissue we obtained neurosphere cultures. These neurospheres 
could be mechanically dissociated and further expanded for an extended number of passages.  
4. Can these NSC be differentiated towards the three neural lineages: neurons, oligodendrocytes and 
astrocytes? 
From these neurosphere cultures singe cell-derived clones could be produced which were able to 
generate the three neural lineages: neurons, astrocytes and oligodendrocytes. 
5. Which in vitro differentiation protocols can be used to compare neuropotency of both MAPC-like cells 
and NSC? 
Four protocols were selected which had been reported to induce neural transdifferentiation of bone 
marrow-derived cells: the Jiang method, the Kohyama method, the Kabos method, the Woodbury 
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method. The Woodbury method was discarded because it caused massive cell death of the NSC. Using 
the other three methods the NSC acquired complex neuronal and glial morphologies. The MAPC-like 
cells only morphologically resembled (immature) neurons using the Jiang method.  
6. Which techniques can be used to evaluate neuropotency?  
Next to analysing morphology of the differentiated cells, we used real-time PCR and 
immunocytochemistry to screen the expression of neuroglial genes and antigens respectively. Both 
techniques showed upregulation or de novo expression of all investigated neuroglial markers in NSC, 
thereby confirming the ability of the three remaining protocols to induce neural differentiation of 
neuropotent cell types. Our results do however indicate that analysis of morphology and screening of 
marker expression to proof neural transdifferentiation should be evaluated very carefully.  
7. Is there a difference in the neuropotency of MAPC-like cells and NSC? 
MAPC-like cells adopted only in one protocol neural morphologies and expressed only two of the six 
evaluated neural markers, without upregulation of their expression after differentiation. We therefore 
assessed that neural morphology and expression of both antigens were aspecific rather than a proof of 
neuropotency. Neural differentiation of NSC was much more robust and reproducible which indicates 
that neuropotency of NSC was higher than that of MAPC-like cells. Based on these results NSC were 
chosen as cell source for future transplantation.  
Consideration about the methodology: Adoption of complex neuronal and glial morphologies and 
upregulation of all investigated neuronal and glial marker genes by the NSC in three different 
differentiation protocol is still no absolute proof for the ability to generate functional neuronal or glial 
cells. To proof functionality electrophysiological studies (patch clamp, calcium imaging) need to be done.  
B. Intrahippocampal kainic acid model for temporal lobe epilepsy 
1. What is the mortality rate after SE induced by intrahippocampal KA injection? 
Intrahippocampal KA injection resulted in SE in all 15 treated rats. All rats survived although in two rats 
SE was interrupted by injecting pentobarbital because they displayed extremely wild running and 
jumping behaviour.  
2. What is the fraction of rats displaying spontaneous seizures after intrahippocampal KA injection?  
Spontaneous seizures were detected in all 15 rats. In the 2 of the 15 rats seizures were only detected in 
the second monitoring period, 40 to 42 weeks after SE.  
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Consideration about the methodology: Since the capacity of our video-EEG setup only allowed the 
recording of video-EEG for 72 consecutive hours/week during the first monitoring period rare seizures 
could be missed leading to an underestimation of the fraction of rats displaying spontaneous seizures.  
3. At what time following KA-induced SE can spontaneous seizures be detected? 
In 13 of the 15 rats at least one seizure was detected in the first eight weeks after SE. The mean latency 
between the SE and the first detected seizures in these 13 rats was about 28 days. 
Consideration about the methodology: As we only record for 72 consecutive hours per week during the 
first monitoring period (see point 2) the latent period (time between SE and first seizure) could not be 
determined.  
4. What is the behavioural component of the spontaneous seizures?  
Two types of clinical seizures could be discriminated. The majority of the seizures (66%) were partial 
seizures with secondary generalization (SG). The remaining seizures did not secondarily generalize and 
no convulsive behaviour could be detected.  
5. What is the mean duration of the spontaneous seizures? 
The spontaneous seizures lasted in average ±64s. Partial seizures with SG had a significantly longer 
duration (±72s) than partial seizures that did not secondarily generalize (±46s).  
6. Is there a large variation in seizure frequency among rats?  
Mean seizure frequency varied considerably among rats (0 to 7.4 seizures per day). In general, seizure 
frequency was relatively low (± 0.56 seizures per day) with 11 of the 15 rats displaying less than one 
spontaneous seizure per day. 
7. Is there a progression in seizure frequency? 
In general, we observed a progression in seizure frequency. In the four rats with the highest number of 
seizures a significant correlation between time and seizure frequency could be demonstrated.  
8. Do the spontaneous seizures occur in a circadian rhythm?  
In the rats which had more than one seizure per day, more seizures occurred during daytime (lights on).  
9. Could the intrahippocampal KA model be used for the evaluation of anti-epileptic effects of cell 
transplantation?  
Because the frequency of spontaneous seizures in the intrahippocampal KA model is rather low and 
highly variable, a lot of animals will be needed to screen anti-epileptic effects of cell transplantation or 
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other treatments. However, this model is very interesting to evaluate the effect of cell transplantation in 
the sclerotic hippocampus since the extent of the initial KA-induced damage is limited and most seizures 
originate from the lesioned hippocampus.  
C. Transplantation of adult neural stem cells in the intrahippocampal kainic acid  model 
1. Do NSC survive after transplantation in the intact or KA-lesioned hippocampus? 
Both in the intact and the sclerotic hippocampus a small fraction of approximately 1% of the 140,000 
GFP/BrdU double-labelled cells were detected three and six weeks after transplantation.  
Consideration about the methodology: Many cells were detected which were only labelled with BrdU 
and not with GFP. Since it cannot be excluded that BrdU was transferred from dying transplanted cells to 
endogenous dividing precursors we only counted GFP/BrdU double-labelled cells. This could be an 
underestimation of the survival if it turns out that the effect is due to a downregulation of GFP.  
2. Is the survival rate affected due to the presence of the lesion? 
The number of donor-derived cells in intact and sclerotic hippocampus was not significantly different 
which indicates that the survival rate of the transplanted cells was not affected by the presence of the 
KA lesion.  
3. Are the dispersion and/or migration of the transplanted cells different in intact compared to lesioned 
hippocampus? 
In the intact hippocampus most of the transplanted cells aligned the fracture planes of the 
hippocampus. A small fraction of the transplanted cells had migrated towards the granule cell layer 
(GCL). In the sclerotic hippocampus the transplanted cells remained in dense clusters. No donor-derived 
cells were detected in the GCL.  
4. To which type of cells do NSC differentiate after transplantation? 
Both in the intact and sclerotic hippocampus transplanted NSC differentiated mainly towards astrocytes 
and only a small fraction differentiated towards neurons. In the intact hippocampus NSC-derived 
neurons were exclusively detected in the GCL. In the sclerotic hippocampus donor-derived neurons were 
found within the cluster of transplanted cells.  
5. Is the cell fate of the NSC influenced by the presence of the lesion?  
The presence of the KA lesion had no major effect on neuronal differentiation but clearly stimulated 
differentiation towards astrocytes. This indicates that the transplanted NSC contributed to the gliotic 
response on the KA lesion.  
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6. Are outcome parameters of the transplantation (survival, dispersion, integration and differentiation) 
affected by a longer delay between the lesion and the transplantation? 
Survival of the transplanted cells was significantly lower if the delay between the lesion and the 
transplantation was longer (three weeks compared to three days). A longer postlesion delay had no 
major influence on the dispersion or the differentiation of the cells. 
7. Is the survival of NSC stable over time? 
The number of transplanted cells detected three and six weeks after transplantation did not significantly 
differ. So even though the fraction of surviving cells was low, survival of the transplanted cells was 
relatively stable over time.  
8. Could NSC be used for the structural repair of damaged epileptic networks in the intrahippocampal 
kainic acid model? 
As stated higher, only a small fraction of the transplanted NSC differentiated towards neurons upon 
transplantation in the sclerotic hippocampus. Those donor-derived neurons remained within the 
transplanted cell cluster. Taken together, there was little proof for neuronal replacement or circuitry 
repair in the sclerotic hippocampus of the intrahippocampal KA model.  
9. Could NSC be used for the local delivery of seizure-modifying substances? 
Based on their relative stable survival, NSC could be used for local delivery approaches. NSC could be 
engineered prior to their transplantation in order to induce them to secrete seizure suppressing 
substances. However, further research is necessary to increase the fraction of NSC that survives after 
transplantation.  
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MODULATION OF ENDOGENOUS NEUROGENESIS  
1. Can low-dose, whole brain radiation suppress neurogenesis in the rapid kindling model for TLE? 
Exposure of the whole rat brain to 8 Gy radiation, one day before the initiation of rapid hippocampal 
kindling, suppressed seizure-induced granule cell neurogenesis during kindling acquisition. In the first 
three days after radiation the number of newborn neurons was 83% less in radiated compared to non-
radiated rats. At the end of the kindling acquisition, one week after radiation and after 48 kindling 
stimulations, the number of neuroblasts in the hippocampus was 95% less in radiated compared to non-
radiated rats.  
2. Is there a permanent suppression of neurogenesis? 
Three weeks after radiation and after 70 kindling stimulations there was a partial recovery of neuroblast 
production. At that time point, the number of neuroblasts in the hippocampus of radiated rats was 56 % 
less than in non-radiated rats.  
3. Is there a difference in afterdischarge threshold (ADT) and afterdischarge duration (ADD) between 
radiated and non-radiated rats? 
In non-radiated rats the ADT increased during hippocampal kindling while it did not in radiated rats. As a 
result the threshold to evoke a seizure became significantly lower in radiated rats.  
No difference in ADD between radiated and non-radiated rats was found throughout kindling.  
4. Does radiation affect kindling rate? 
At the end of the kindling acquisition, five to seven days after radiation, kindling rate was enhanced in 
radiated rats. Both the lower ADT and the higher kindling rate reflected a higher excitability in radiated 
rats.  
5. Is brain inflammation different between radiated and non-radiated rats? 
Both in radiated and non-radiated rats there was evidence of brain inflammation. However, quantitative 
analysis could not demonstrate differences in the extent of inflammation. This indicates that 
inflammation was probably not the main mechanism behind radiation-induced increase in excitability.  
Consideration about the methodology: Besides inflammation radiation can cause other, more subtle, 
side-effects such as changes in microvasculature or alterations in metabolic or signalling pathways. 
Those side-effects could also be responsible for the enhanced excitability during kindling. So, a causative 
link between reduced neurogenesis and enhanced excitability cannot be made based on our experiment.  
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6. Can radiated rats become permanently fully kindled? 
Despite the significant suppression of seizure-induced neurogenesis radiated rats became fully kindled 
and displayed a tonic-clonic seizure in response to each kindling stimulation. As stated higher, radiation 
even enhanced the kindling rate at the end of kindling acquisition.  
7. Does radiation affect permanence of the fully kindled state? 
Radiated rats still displayed tonic-clonic seizures in response to kindling during the retest phase. 
Therefore, seizure-induced neurogenesis does not seem to play a major role in the establishment of a 
permanent hyperexcitable fully kindled state.  
8. Could suppression of seizure-induced neurogenesis be a potential cell therapy for TLE?  
Our results indicate that suppression of seizure-induced neurogenesis did not slow down or prevent 
epileptogenesis. So, blocking neurogenesis has little chance to become a possible treatment for TLE. In 
fact, epileptogenesis was enhanced after radiation. This could be the result of an aspecific side effect of 
radiation or it could indicate that enhanced neurogenesis in response to seizures is an attempt to lower 
hyperexcitability. If the latter would be the case, it may be interesting to investigate the effect of 
stimulating seizure-induced neurogenesis.  
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CELL TRANSPLANTATION FOR TEMPORAL LOBE EPILEPSY 
Reconstruction of damaged neuronal circuitry and subsequent restoration of normal brain function is the 
ultimate goal of cell transplantation for neurodegenerative diseases. Although neuropotent stem cells are 
believed to be ideal candidate donor cells, studies showing functional replacement of lost neurons by 
transplanting neuropotent stem cells have been extremely limited. Stem cells which can be differentiated 
towards neurons in vitro only rarely generate significant numbers of neurons upon transplantation in the 
damaged brain. This indicates that substantial efforts are required to identify factors which mediate the 
permissiveness of the environment to support neuronal differentiation and repair. The most promising study 
sofar was done by Kim and coworkers. In this study ESC were predifferentiated in vitro towards highly enriched 
midbrain NSC using a complex and multi-step protocol. Upon transplantation into a rat model for PD, these 
midbrain NSC generated high amounts of dopaminergic neurons which extended axons to the striatum, formed 
functional synaptic connections and induced subsequent behavioural recovery (Kim and others, 2002). This 
report points out that unravelling neuronal differentiation pathways and generation specific neuronal 
precursor phenotypes is of crucial importance.  
In case of TLE with HS, neuronal damage and circuitry that needs to be restored is much more complex than in 
PD. Functional cell replacement in TLE will require the in vitro production of different precursor cell populations 
of CA1 and CA3 pyramidal neurons but also of different types of interneurons and hilar mossy cells. The 
sclerotic environment will need to be modulated in such a way that the grafted cells can migrate to appropriate 
cell layers and reconnect in a proper way in order to restore the balance between excitation and inhibition and 
the functionality of hippocampal networks. To fulfil these requirements, a lot of additional research is needed 
to further unravel the signalling pathways and pattern determination involved in hippocampal development 
and hippocampal sclerosis.  
Several studies have shown that behavioural recovery after NSC transplantation in a variety of 
neurodegenerative disease models is the result of trophic or neuroprotective effects of NSC rather than 
contribution of the transplanted NSC to functional reconstruction of the damaged circuitry (Lu and others, 
2003; Yan and others, 2004; Ryu and others, 2004; Pluchino and others, 2005). In the PILO model for chronic 
TLE, systemic injection of NSC one day after SE resulted in the incorporation of NSC-derived cells in different 
damaged limbic brain areas. Although there was no functional repair of the damaged circuitry, clear anti-
epileptogenic effects of the transplantation were reported (Chu and others, 2004). This could be the result of 
growth factor secretion by the transplanted NSC and subsequent survival of limbic neurons which normally die 
after SE. If so, strategies in which NSC are used for the secretion of trophic factors or neuroprotective 
molecules could further enhance the anti-epileptogenic effect. In this context NSC have been engineered in 
order to secrete high numbers of neuroprotective molecules such as GDNF (Behrstock and others, 2005; Klein 
and others, 2005), NGF (Andsberg and others, 1998) and NT-3 (Liu and others, 1999) and transplanted in 
disease models such as PD, ALS and stroke. As a result of transplantation, protection of endogenous neurons 
was demonstrated.  
 274 Chapter 9 | Future Perspectives 
 
Sofar, transplantation of cells for the local delivery of anti-seizure substances has proved to be the easiest and 
most promising cell therapy strategy for TLE. In this dissertation, we already discussed the different cell-based 
delivery approaches, using different fetal and non-fetal cell types, with sometimes very potent seizure 
suppressing effects. In most cases the anti-seizure effects were only transient due to the progressive death of 
the transplanted cells. Another major limitation of most transplantation studies was that cells were 
transplanted prior to epileptogenesis in models which do not display hippocampal sclerosis or spontaneous 
seizures. Therefore it is difficult to extrapolate the results to human TLE. In our study, we showed that 
exogenous adult-derived NSC are able to stably survive in a sclerotic hippocampus of a TLE model with 
spontaneous seizures. Therefore, NSC are a promising donor cell type to be investigated for future use in cell-
based delivery strategies for TLE.  
Most successful results in the context of cell-based delivery of seizure-suppressing substances have been 
obtained with encapsulated adenosine-releasing cells transplanted into the lateral ventricle of fully kindled 
rats. For as long as the cells survived, a complete suppression of seizures was seen. The adenosine releasing 
cells were obtained by disruption of the gene encoding for the adenosine metabolizing enzyme, adenosine 
kinase, through chemical mutagenesis (fibroblasts or myoblasts) or genetic engineering (ESC) (Huber and 
others, 2001; Fedele and others, 2004; Guttinger and others, 2005a; Guttinger and others, 2005b). Genetic 
engineering of ESC has led to the production of a transgenic Adk
+/-
 mouse line. By crossing these Adk
+/-
 mice 
homozygous Adk
-/-
 mice can be generated, which only survive for about 14 days after their birth (Boison and 
others, 2002). In collaboration with Dr. Detlev Boison, from the RS Dow Neurobiology Laboratories (Portland, 
Oregon, USA), we will try to isolate NSC from the brain of early postnatal Adk
-/-
 mice. Based on the 
anticonvulsive effects in the kindling model, transplantation of adenosine-releasing NSC, derived from Adk
-/-
 
mice, may result in anti-epileptogenic and/or antiepileptic effects after transplantation in the sclerotic 
hippocampus of the intrahippocampal KA model.  
Next to adenosine, other neuromodulators such as different neuropeptides (galanin, somatostatin, 
neuropeptide Y and dynorphin) exert seizure-suppressing effects and are believed to be physiologically active 
as endogenous anticonvulsants (Zini and others, 1993; Greber and others, 1994; Qian and others, 1997; 
Terman and others, 2000). These neuropeptides could be very interesting candidate molecules for cell based 
delivery strategies. In fact endogenous neurons have been transfected using a viral vector, carrying the gene 
for galanin and neuropeptide Y, to induce secretion of the neuropeptides by the neurons (in vivo gene 
therapy).  
Virus-mediated induction of galanin secretion in endogenous neurons of the hippocampus (Haberman and 
others, 2003; Lin and others, 2003), the inferior collicular cortex (Haberman and others, 2003) and the pyriform 
cortex (McCown, 2006) resulted in an increased threshold to evoke seizures by electrical stimulation 
(Haberman and others, 2003; McCown, 2006) and a decrease or even complete suppression of seizures 
induced by respectively intrahippocampal (Lin and others, 2003) or intraperitoneal injection of kainic acid 
(McCown, 2006).  
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Using a similar approach hippocampal cells have been induced to secrete neuropeptide Y (NP-Y). This 
manipulation prevented the development of SE in response to intrahippocampal KA injection, retarded the 
kindling acquisition and increased the threshold to electrically evoke a seizure (Richichi and others, 2004).  
In these studies, in vivo gene therapy always preceded the induction of the epileptic state and the effect on 
spontaneous seizures was not investigated. Spontaneous seizure models are characterized by extensive and 
progressive neuronal cell death, so the use of endogenous neurons for secreting of the neuropeptide may be a 
limiting factor. Therefore, strategies in which NSC are genetically engineered to release those seizure-
suppressing neuropeptides, prior to transplantation, may be more optimal. Another advantage of this ex-vivo 
gene therapy strategy is that cells can be enriched and characterized before transplantation which may 
augment reproducibility. 
In our transplantation study, the fraction of adult NSC that survived transplantation was rather low, compared 
to other studies, even in the intact hippocampus. Consequently, high numbers of cells will need to be injected 
to yield sufficient release of antiepileptic factors. Therefore, modifications that could contribute to enhanced 
survival will be tested in the future. This includes deriving NSC from other sources (embryonic brain, adult 
hippocampus), the use of other culture methods (monolayer cultures), pre-treating the cells with growth 
factors and anti-apoptotic substances, performing autologous transplantation and/or more effective 
immunosuppression strategies (combination of different immunosuppressants). 
Although we have demonstrated that a fraction of the transplanted NSC is able to survive for at least six weeks 
after transplantation, it could be that prolonged survival of transplanted NSC is compromised by genetic 
engineering and/or the continuous secretion of seizure suppressants. Therefore, it is mandatory to evaluate 
long-term survival of ex vivo manipulated NSC upon transplantation. If manipulated cells are unable to survive 
for extended periods, continuous infusion with growth factors and/or anti-apoptotic substances could be 
evaluated as a strategy to promote long-term survival.  
Even if cells survive for prolonged periods, seizure suppression could be only temporary due to suppression of 
the secretion of the transgene by the donor cells or downregulation of receptor expression by the host cells. 
Therefore it will need to be confirmed whether possible seizure-suppressing effects of transplantation are 
stable and long lasting.  
In the light of possible clinical applications of NSC transplantation, it will be necessary to obtain NSC from 
human sources. One possible source could be human ESC. However further work needs to be done to safely 
and adequately derive phenotypically restricted neuronal and oligodendrocytic progenitors to eliminate the 
possibility that implantation of undifferentiated ESC generate teratocarcinomas. Another possibility is to derive 
NSC from human embryonic (Vescovi and others, 1999; Svendsen and Caldwell, 2000) or adult primary brain 
tissue (Akiyama and others, 2001; Westerlund and others, 2005). Human-derived NSC can be genetically 
engineered to secrete specific proteins. For example human forebrain-derived NSC have been genetically 
engineered to release GDNF and transplanted into the brain of animal models for ALS and PD. In both cases the 
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transplanted cells survived and continued to secrete GDNF (Behrstock and others, 2005; Klein and others, 
2005). In analogy, human NSC could be engineered to deliver seizure-suppressing substances prior to their 
transplantation into animal models with spontaneous seizures. 
Eventually, ex vivo manipulated human NSC, secreting seizure-suppressing substances, could be used for 
transplantation in human refractory epilepsy patients in whom the seizure focus or foci are located in eloquent 
cortex. However, before going to a clinical context it will be necessary to assess the safety of transplanting 
genetically engineered cells. For example, genetic engineering may induce additional mutations which could 
render a cell line tumorigenic. Moreover, uncontrolled release of the transgene could have detrimental effects. 
Therefore transgene expression will need to be controlled. To date, regulatable promoter systems are already 
available, e.g. doxycycline inducible or repressible promoters. However, a more subtle regulation of transgene 
expression than a simple “on”-“off” situation might be required.  
MODULATION OF ENDOGENOUS NEUROGENESIS IN CASE OF TLE 
The role of enhanced dentate granule cell neurogenesis in response to seizures remains unclear. As stated 
earlier, a part of the newborn neurons contribute to the formation of abnormal circuitry by their migration to 
ectopic locations and/or the formation of recurrent synaptic connections (Scharfman and others, 2000; Parent 
and Lowenstein, 2002; Shapiro and others, 2005). The great majority of the newborn neurons integrates 
normally in the GCL but their maturation and synaptic integration is accelerated upon seizure-activity 
(Overstreet-Wadiche and others, 2006). Taken together, in response to seizures more excitatory neurons are 
generated which are more rapidly integrated in the circuitry with some of them generating recurrent and 
excitatory feedback connections.  
In our study we did however not find evidence of reduced epileptogenesis after suppressing seizure-induced 
neurogenesis by using radiation. In fact, radiated rats kindled more rapidly and displayed more excitable 
hippocampal networks. Therefore, the results of our study imply that if seizure-generated neurons contribute 
to epileptogenesis their role is probably only minimal and could even be protective. However, some important 
questions remain unanswered and require further research.  
Firstly, by radiating rats one day before the initiation of kindling we showed that seizure-induced neurogenesis 
did not play a major role in kindling epileptogenesis. However as radiation spares postmitotic neurons it could 
still be that immature neurons, generated during ongoing neurogenesis in the weeks before kindling, 
contribute to kindling epileptogenesis. As it takes approximately four to seven weeks until newborn neurons 
become indistinguishable from mature granule neurons (Kempermann and others, 2004), a delay of two 
months between radiation and kindling would exclude that immature neurons are still present at the start of 
kindling. 
Secondly, we found that a single radiation dose of 8Gy was sufficient to suppress neurogenesis during kindling 
acquisition. However, neurogenesis was not permanently blocked as three weeks after radiation new 
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neuroblasts were generated. This recovery is most probably due to stimulatory effects of seizures. Radiation 
with two fractionated doses of 10 Gy, spaced by 24 hours, was shown to be sufficient for permanent 
suppression of  neurogenesis even after pathological stimulation (Wojtowicz, 2006). Therefore in future studies 
it may be more advantageous to choose for fractionated doses, especially in case of a longer delay between the 
radiation and the initiation of kindling.  
Thirdly, aberrant neurogenesis seems to be more pronounced in post-SE models and could therefore play a 
more prominent role in epileptogenic processes which lead to spontaneous seizures. In a study, done by Parent 
and colleagues, rats were radiated one day before PILO induced SE to suppress neurogenesis and to determine 
the contribution of seizure-generated neurons to mossy fiber sprouting (Parent and others, 1999). Although 
the same authors had previously shown that part of the newborn neurons generate aberrantly sprouted mossy 
fibers (Parent and others, 1997), radiation did not result in a reduction of mossy fiber sprouting. The authors 
hypothesized that mature granule neurons were responsible for most of the mossy fiber sprouting. However, 
the authors could not exclude the possibility that immature neurons, generated in the weeks before radiation, 
were responsible for aberrant mossy fiber sprouting. Also the effect of radiation on the development of 
spontaneous seizures was not investigated. Therefore, a future experiment in which neurogenesis is blocked by 
fractionated radiation several weeks before the induction of SE in rats may be very interesting. Histological 
studies should be done to confirm the suppression of seizure induced aberrant neurogenesis and video-EEG 
monitoring should be performed to assess the effect on the development on spontaneous seizures.  
Fourthly, low-dose radiation is a rather unspecific tool to suppress neurogenesis and can evoke inflammation, 
cause microvascular changes and induce alterations in metabolic and signalling pathways (Monje and Palmer, 
2003; Silasi and others, 2004). So, enhanced excitability and kindling rate after radiation-induced suppression 
of neurogenesis could be the result of aspecific side effects of radiation rather than a proof that seizure-
induced neurogenesis is a protection mechanism against hyperexcitability. In order to make more definite 
conclusions about the role of neurogenesis in epileptogenesis other models for suppression of neurogenesis 
are mandatory. One alternative model in which neurogenesis can be selectively suppressed is currently under 
development at the “Laboratory for Neurodevelopment and Regeneration” (University of Michigan, USA) under 
the supervision of Dr. Jack Parent. In this laboratory a transgenic mouse has been created in which thymidine 
kinase is expressed under the control of the nestin promoter, which is selectively activated in NSC. Thymidine 
kinase metabolizes gangcyclovir into toxic nucleotides, so injection of gangcyclovir in adult nestin-thymidine 
kinase transgenic mice leads to selective apoptosis of adult NSC and subsequent suppression of neurogenesis. 
In this model there may be fewer aspecific side effects compared to radiation. So, it may be interesting to test 
whether in this transgenic model enhanced excitability during kindling epileptogenesis after suppression of 
neurogenesis is also evident. If so, this would further support the idea that seizure-induced neurogenesis is a 
protection mechanism against hyperexcitability. Consequently, strategies could be developed to stimulate 
seizure-induced neurogenesis, e.g. by local infusion of growth factors which stimulate neurogenesis such as 
IGF-1.  
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In stroke models it was found that lost CA1 pyramidal neurons can be regenerated by precursors that migrate 
from the posterior periventricular region (PPV) to the ischemically damaged CA1 region. In case of hippocampal 
sclerosis after PILO induced SE, the same migration of precursor cells from PPV to damaged CA1 and CA3 
regions has been described but the precursor cells exclusively generated glial cells in the damaged regions. 
Unravelling the mechanisms behind pyramidal cell replacement in case of ischemia may lead to strategies to 
stimulate endogenous replacement of pyramidal neurons in case of hippocampal sclerosis and TLE. For 
example it was found that replacement of CA1 pyramidal neurons after ischemia can be dramatically enhanced 
by intraventricular infusion of bFGF and EGF (Nakatomi and others, 2002). So, local infusion of growth factor 
could be one possible strategy to stimulate endogenous repair of hippocampal networks in TLE. As already 
stated above, next to pyramidal neurons also other neuronal phenotypes such as hilar interneurons will need 
to be replaced. One study has demonstrated the generation of new inhibitory interneurons in adult 
hippocampus, indicating that endogenous replacement of lost interneurons may be possible (Liu and others, 
2003). But again it needs to be stressed that even if lost neurons can be replaced by stimulating endogenous 
sources, coordinated integration of these new neurons will be a crucial and highly complex step.  
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SUMMARY 
The treatment of choice for epilepsy is the chronic administration of antiepileptic drugs (AED). However, a high 
fraction of patients with temporal lobe epilepsy (TLE) continues to have uncontrolled seizures and these 
patients are called refractory. Hippocampal sclerosis is believed to be the most important pathological 
substrate for TLE. Resection of the sclerotic tissue is the most successful alternative treatment option for 
refractory TLE. However, a fraction of the refractory TLE patients cannot undergo resective surgery because the 
seizure focus cannot be identified or because of a possible risk for functional loss (language and memory). 
Moreover, a proportion of the TLE patients continues or restarts to have seizures after surgery. For those 
patients it is important to develop alternative treatments. One possible alternative treatment is cell therapy. In 
this study we evaluated the feasibility of two different cell therapy strategies: cell transplantation and 
modulation of endogenous neurogenesis.  
Cell transplantation has already been performed in different models for TLE and this for two different 
purposes: restoration of epileptic neuronal networks and/or local delivery of seizure-suppressing substances. In 
both transplantation approaches fetal cells have been most frequently used as cell source. Ethical and practical 
issues coupled to the use of fetal cells have urged the search for alternative donor cell types. Based on their 
expansion capacity and their ability to generate different neural phenotypes, neuropotent stem cells may be 
ideal candidates to replace fetal brain cells as cell source for transplantation in neurodegenerative diseases. 
Most interesting are adult-derived neuropotent stem cells which may lead to autologous transplantation 
strategies, free of ethical and immunorejection problems.  
In the Laboratory for Clinical and Experimental Neurophysiology (LCEN) at Ghent University Hospital two 
different adult-derived stem cell types were isolated and expanded in culture. Neural stem cells (NSC) were 
derived from the subventricular zone (SVZ) of the brain and multipotent adult progenitor cell (MAPC)-like cells 
from the bone marrow of adult rats. Both cell types were compared as to their efficiency to generate mature 
neural phenotypes after exposure to three neural differentiation protocols. Cell morphology was evaluated and 
the expression of neuronal markers (β3-tubulin, NF-200, tau), an astrocyte marker (GFAP) and oligodendrocyte 
markers (RIP, MBP) was screened using real-time PCR and immunocytochemistry before and after 
differentiation. In contrast to the NSC, the MAPC-like cells did not reproducibly adopt neural morphology nor 
expressed all differentiation markers. This led us to conclude that MAPC-like cells were inferior to NSC in their 
neuropotency. In fact, in line with other recent evidence, our results suggest that the adoption of neural 
morphology and the expression of neural markers by non-neural cells can be a non-specific phenomenon 
rather than proof of neuropotency. Based on the results of these in vitro experiments, we chose to use adult-
derived NSC for future neural transplantation experiments.  
Cell grafting in animal models for TLE has been successful in reversing some pathological alterations and 
suppressing excitability. However, before extrapolations to the human situation can be made, the long-term 
effect of transplantation on spontaneous seizures needs to be investigated more thoroughly in chronic TLE 
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models. The intrahippocampal kainic acid (KA) rat model is a chronic post-status epilepticus (SE) model for TLE. 
This model displays typical hippocampal sclerosis and spontaneous epileptic seizures, mostly originating from 
the hippocampus ipsilateral to the KA lesion. Due to the focal nature of the initial damage and seizure origin, 
the intrahippocampal KA model is very interesting for evaluating local cell transplantation. Sofar, 
characterization of spontaneous seizures in this model had not been performed. In this study, we monitored 
the intrahippocampal KA model for up to 42 weeks with video-EEG recording to determine characteristics of 
spontaneous seizure such as seizure duration, severity and frequency. Overall, we found that the 
characteristics of spontaneous seizures were comparable to other post-SE models. Intrahippocampal KA 
injection was very efficient as all treated rats developed SE and subsequent spontaneous seizures. In 87 % of 
the rats the first spontaneous seizure was detected during the first eight weeks after KA injection. Seizures 
lasted on average about 1 minute and 34 % of all seizures were partial without a clear behavioural component. 
Seizures occurred in a circadian pattern with peak occurrence during the daytime. Seizure frequency was rather 
low and highly variable among rats, but increased with time. This model could be useful to screen the effect of 
cell transplantation on spontaneous seizures given that extensive monitoring on a high number of rats could be 
performed.  
We derived NSC from the subventricular zone (SVZ) of adult green fluorescent protein (GFP)-reporter mice and 
transplanted them into the sclerotic hippocampus of the intrahippocampal KA model, three days and three 
weeks after KA injection. Survival, dispersion and differentiation of the transplanted NSC were evaluated three 
and six weeks after transplantation. To determine the effect of the KA lesion on the outcome parameters, cells 
were also transplanted in normal hippocampus of non-epileptic rats. Three weeks after transplantation, a small 
fraction (about 1%) of the transplanted cells was found in the host brain. This percentage of detected cells 
remained relatively stable for at least six weeks after transplantation. The presence of the lesion had no major 
influence on the survival of the transplanted cells but we found that survival rate was significantly higher if cells 
were transplanted three days compared to three weeks after the KA lesion. In the sclerotic hippocampus cells 
remained in rather dense clusters in contrast to the intact hippocampus, in which cells aligned along 
hippocampal fracture planes. The transplanted NSC differentiated mainly towards astrocytes both in the intact 
and the sclerotic hippocampus. This astrocytic differentiation was clearly stimulated upon transplantation in 
the sclerotic hippocampus, indicating that NSC contribute to the gliotic response to the KA lesion. Although a 
small fraction of the transplanted NSC differentiated towards neuronal cells, there was no indication for 
neuronal replacement or repair of damaged circuitry. Based on their stable survival, NSC could be used for local 
delivery of seizure suppressing substances in sclerotic hippocampus. 
A second potential cell therapy approach for TLE entails the modulation of endogenous neurogenesis. In the 
dentate gyrus of the hippocampus, excitatory granule neurons are continuously generated throughout life. In 
different models for TLE, granule cell neurogenesis is highly affected during epileptogenesis. The number of 
newborn granule neurons is enhanced 3- to 10-fold in response to seizures. A proportion of the immature 
neurons displays inappropriate synaptic connectivity and integrates at ectopic locations. Some of these ectopic 
 Summary 285 
 
granule neurons seem to be incorporated in epileptic networks and display epileptic bursting behaviour. Based 
on these observations several authors have suggested that neurogenesis contributes to epileptogenesis. To 
further explore the role of aberrant neurogenesis in response to seizures we used low-dose, whole brain 
radiation to suppress the generation of new neurons during epileptogenesis in the kindling model for TLE. 
Although new neuron formation in the hippocampus was dramatically suppressed during kindling of the 
radiated rats, this did not prevent the rats from becoming fully epileptic. In fact, the threshold to evoke a 
seizure was decreased and the kindling rate increased in radiated rats. Further research is mandatory to 
determine whether this increased excitability is the result of suppressing seizure-induced neurogenesis or a 
non-specific side effect of the radiation. This study indicated that seizure-induced neurogenesis plays no major 
role in the epileptogenesis. So, blocking the generation of seizure-induced neurons has little potential to 
become a cell therapy option for TLE. 
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SAMENVATTING 
Chronische toediening van anti-epileptica is de standaardbehandeling voor epilepsie. Maar in het geval van 
temporale kwab epilepsie (Temporal Lobe Epilepsy, TLE) blijft een groot percentage van de patiënten aanvallen 
vertonen. Deze patiënten hebben refractaire temporale kwab epilepsie. Hippocampale sclerose is het 
belangrijkste pathologische substraat voor TLE. De chirurgische verwijdering van het sclerotisch weefsel is de 
meest succesvolle alternatieve behandeling voor refractaire TLE. Er is echter een deel van de patiënten bij wie 
chirurgische wegname niet mogelijk is omdat de aanvalsfocus niet kan geïdentificeerd worden of omdat er een 
risico bestaat voor functie-uitval. Bovendien blijft een deel van de geopereerde TLE patiënten aanvallen 
vertonen of beginnen de aanvallen opnieuw na een aanvalsvrije periode. Voor al deze patiënten is het 
belangrijk dat gezocht wordt naar alternatieve behandelingen. Eén van de mogelijke alternatieve 
behandelingen is celtherapie. In deze studie evalueerden wij de toepasbaarheid van twee verschillende 
celtherapie behandelingen: celtransplantatie en modulatie van endogene neurogenese.  
Celtransplantatie is reeds eerder uitgevoerd bij verschillende diermodellen voor TLE en dit voor twee 
doeleinden: herstel van epileptische neuronale netwerken en/of locale secretie van aanvalsonderdrukkende 
stoffen. De meest frequent gebruikte celbron voor beide benaderingen zijn foetale cellen. Ethische en 
praktische problemen, gekoppeld aan het gebruik van foetale cellen, hebben echter aanleiding gegeven tot een 
zoektocht naar alternatieve donor celtypes. Op basis van hun expansievermogen en hun capaciteit om 
verschillende neuronale fenotypes te genereren, zouden neuropotente stamcellen ideale alternatieve celtypes 
kunnen zijn. Meest interessant zijn de neuropotente stamcellen afkomstig van volwassen weefsels, omdat deze 
kunnen leiden tot autologe transplantatie strategieën, vrij van ethische kwesties of afstotingsproblemen.  
In het Laboratorium voor Klinische en Experimentele Neurofysiologie (LKEN) van het Universitair Ziekenhuis 
van Gent werden twee stamceltypes, afkomstig van volwassen weefsels van de rat, geïsoleerd en 
geëxpandeerd in cultuur. Neurale stamcellen (NSC) werden geïsoleerd uit de subventriculaire zone (SVZ) van de 
hersenen en multipotente adulte progenitor cel (MAPC)-achtige cellen uit het beenmerg van volwassen ratten. 
Beide celtypes werden onderworpen aan drie neuronale differentiatie protocollen en vergeleken in hun 
efficiëntie om volwassen neurale fenotypes te produceren. Celmorfologie werd vergeleken en de expressie van 
neuronale merkers (β3-tubulin, NF-200, tau), een astrocytaire merker (GFAP) en oligodendrocytaire merkers 
(RIP, MBP) werd geëvalueerd met behulp van real-time PCR en immunocytochemie voor en na differentiatie. In 
tegenstelling tot de NSC waren de MAPC-achtige cellen niet in staat om op een reproduceerbare manier 
neuronale en gliale morfologieën aan te nemen of om alle differentiatiemerkers tot expressie te brengen. Op 
basis van deze resultaten concludeerden we dat de neuropotentie van MAPC-achtige cellen lager was dan deze 
van NSC. Bovendien geven onze resultaten aan dat, in analogie met andere recente studies, de inductie van 
een neuronale morfologie en de expressie van neurale merkers een aspecifiek fenomeen kan zijn in plaats van 
een bewijs voor neuropotentie. Aan de hand van de resultaten van deze in vitro experimenten verkozen we 
adulte NSC te gebruiken in de neurotransplantatie experimenten. 
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Studies hebben aangetoond dat celtransplantatie in verschillende diermodellen voor TLE kan leiden tot een 
gedeeltelijke omkering van pathologische veranderingen en een verlaging van de exciteerbaarheid. Maar 
vooraleer extrapolaties kunnen gemaakt worden naar TLE patiënten zijn meer uitgebreide en lange-termijn 
studies in chronische modellen voor TLE noodzakelijk. Het intrahippocampaal kainaat (KA) model is een 
chronisch, post-status epilepticus (SE) model voor TLE. Dit rat model vertoont typische hippocampale sclerose 
en spontane epileptische aanvallen die meestal beginnen in de hippocampus aan dezelfde kant van de KA 
laesie. De focale aard van de initiële schade en het aanvalsbegin maakt dit model zeer geschikt voor de 
evaluatie van lokale celtransplantatie. Tot nog toe werden de spontane aanvallen in dit model nog niet 
gekarakteriseerd. Wij volgden het intrahippocampaal KA model tot 42 weken na KA inspuiting met behulp van 
video-EEG monitoring om kenmerken zoals de duur, de ernst en de frequentie van de spontane aanvallen te 
bepalen. Over het algemeen vonden we dat de aanvalskarakteristieken vergelijkbaar waren met andere post-
SE modellen. Intrahippocampale KA injectie was zeer efficiënt aangezien alle behandelde ratten een SE en 
daaropvolgende spontane aanvallen ontwikkelden. In 87% van de ratten werd een eerste aanval gedetecteerd 
in de eerste acht weken na SE. De epileptische aanvallen duurden gemiddeld ongeveer één minuut en 34% van 
de aanvallen waren partieel zonder een duidelijke gedragscomponent. De aanvallen volgden een circadiaan 
patroon met meer aanvallen overdag. De aanvalsfrequentie was eerder laag en sterk variabel tussen de ratten 
onderling maar nam toe met de tijd. Dit model zou gebruikt kunnen worden om het effect van 
celtransplantatie op spontane aanvallen uit te testen op voorwaarde dat een groot aantal ratten op een 
uitgebreide manier gevolgd wordt met behulp van video en EEG.  
Neurale stamcellen werden geïsoleerd van de SVZ van volwassen “green fluorescent protein (GFP)”-reporter 
muizen en getransplanteerd in de sclerotische hippocampus van het intrahippocampaal KA model, drie dagen 
en drie weken na KA injectie. Drie en zes weken na transplantatie werden de overleving, de dispersie en de 
differentiatie van de getransplanteerde NSC geëvalueerd. Om het effect van de laesie op deze 
uitkomstparameters te bepalen werden de cellen ook getransplanteerd in de intacte hippocampus van niet-
epileptische ratten. Drie weken na transplantatie werd een klein deel van de getransplanteerde cellen 
(ongeveer 1%) teruggevonden in de hersenen van de gastheer. Dit percentage gedetecteerde cellen bleef 
stabiel voor minstens zes weken na transplantatie. De aanwezigheid van de laesie had geen duidelijke invloed 
op de overleving van de getransplanteerde cellen, maar we vonden wel dat de overleving significant hoger was 
indien cellen getransplanteerd werden drie dagen in plaats van drie weken na de KA laesie. In de sclerotische 
hippocampus bleven de cellen in dichte clusters terwijl in de intacte hippocampus de cellen meer verspreid de 
scheidingsvlakken van de hippocampus aflijnden. Zowel in de intacte als in de sclerotische hippocampus 
differentieerden de getransplanteerde NSC vooral naar astrocyten. De astrocytaire differentiatie was duidelijk 
gestimuleerd na transplantatie in de sclerotische hippocampus, wat erop wijst dat NSC bijdragen tot de 
gliotische respons. Hoewel een klein deel van de getransplanteerde NSC differentieerde naar neuronale cellen 
was er geen indicatie dat afgestorven neuronen vervangen werden of dat beschadigde netwerken hersteld 
werden.  
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Een tweede mogelijke celtherapie strategie voor TLE bestaat erin de endogene neurogenese te moduleren. In 
de dentate gyrus van de hippocampus worden doorheen het leven voortdurend nieuwe korrelcellen gevormd. 
In verschillende diermodellen voor TLE is korrelcel neurogenese sterk beïnvloed tijdens de epileptogenese. Het 
aantal nieuwgeboren korrelcellen is drie tot tien keer hoger na epileptische aanvallen. Een deel van deze jonge 
neuronen vormt abnormale synaptische connecties en integreert op abnormale (ectopische) locaties. Enkele 
van deze ectopische korrelcellen lijken geïncorporeerd te zijn in epileptische netwerken en vertonen 
epileptische ontladingsactiviteit. Op basis van deze bevindingen werd door verschillende auteurs verondersteld 
dat neurogenese bijdraagt tot epileptogenese. Om verder de rol van abnormale neurogenese in respons op 
epileptische aanvallen te onderzoeken, stelden we de hersenen van ratten bloot aan een lage dosis bestraling 
om zo de vorming van nieuwe neuronen te verhinderen tijdens epileptogenese in het kindling model voor TLE. 
Hoewel de productie van nieuwe neuronen in de hippocampus zeer sterk onderdrukt was tijdens het kindling 
proces, verhinderde dit niet dat de bestraalde ratten volledig gekindeld raakten. Meer nog, de drempel om een 
aanval uit te lokken was lager en de kindling snelheid hoger na bestraling. Verder onderzoek is echter nodig om 
uit te zoeken of deze verhoogde exciteerbaarheid het gevolg is van de onderdrukking van aanvalsgeïnduceerde 
neurogenese of een aspecifiek neveneffect van de bestraling. Deze studie geeft echter wel aan dat 
aanvalsgeïnduceerde neurogenese geen cruciale rol speelt in epileptogenese. Bijgevolg zal de onderdrukking 
van aanvalsgeïnduceerde neurogenese hoogstwaarschijnlijk geen celtherapie worden voor TLE. 
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RÉSUMÉ 
L’épilepsie est traitée de façon classique avec des médicaments antiépileptiques. Néanmoins, chez une grande 
partie des patients souffrant d’une sclérose du lobe temporal, se manifeste  une fréquence élevée de crises 
épileptiques. La sclérose de l’hippocampe est considérée comme la base pathologique de l’épilepsie temporale. 
C’est pourquoi la résection chirurgicale de ce tissu sclérotique reste, jusqu’à présent, le traitement alternatif 
avec le plus grand pourcentage de réussite. Cependant, une partie des patients ne peut pas être opérée, pour 
différentes raisons: il se peut que la localisation du foyer épileptique soit insuffisante, ou que l’intervention 
implique un risque de perte de fonctions cognitives importantes. En outre, une partie des patients récidive 
après une intervention chirurgicale. Pour tous ces patients, le développement de nouveaux traitements 
thérapeutiques valables peut avoir une signification clinique importante. Une possibilité du sujet de recherche 
intensive est la thérapie cellulaire. Le sujet de cette dissertation comprend l’évaluation de deux types de 
thérapies cellulaires: la transplantation cellulaire et la modulation de la neurogénèse endogène. 
Jusqu’à présent, des cellules ont été transplantées dans différents modèles animaux d’épilepsie temporale avec 
des buts différents. La restauration des circuits épileptiques neuronaux et la délivrance de substances 
antiépileptiques de façon locale étaient les points d’intérêts les plus importants. Dans ces deux derniers cas, les 
cellules fœtales sont les plus fréquemment utilisées comme source de cellules. Dû aux contraintes éthiques et 
pratiques, il s’avérait nécessaire de trouver d’autres ressources de cellules, n’ayant pas les mêmes contraintes 
que les cellules fœtales. Dans ce contexte, les cellules souches capables de générer des cellules neuronales 
peuvent être des candidats excellents pour des transplantions neurales dans les maladies neurodégénératives, 
car elles ont de très bonnes capacités d’expansion et peuvent se développer en phénotypes neuronaux 
différents. Les cellules souches dérivées des tissus adultes forment une source très intéressante, car elles 
peuvent amener au développement des stratégies de transplantation neuronales autologues. De cette façon, 
des problèmes éthiques et des réactions immunitaires sont évités. 
Au Laboratoire de Neurophysiologie Clinique et Expérimentale (LNCE) de l’hôpital universitaire de Gand, deux 
types de cellules souches, provenant du tissu adulte du rat, ont été isolées et mises en culture. D’une part, des 
cellules souches neuronales (NSC) ont été dérivées de la zone subventriculaire (SVZ) du cerveau, d’autre part 
des cellules qui ressemblent aux cellules progénitrices adultes multipotentes (MAPC-like) ont été isolées de la 
moelle de rats adultes. Les deux types de cellules ont été exposés à trois protocoles de différentiation 
neuronale différents. Ensuite, leur capacité de générer des cellules avec un phénotype neuronal a été évaluée. 
On a comparé la morphologie des cellules et l’expression des marqueurs neuronaux (beta3-tubuline, NF-200 et 
tau), du marqueur astrocytaire (GFAP) et des marqueurs oligodendodrocytaires (RIP, MBP) a été identifiée à 
l’aide de RT-PCR et d’immunocytochimie avant et après l’exposition au protocole spécifique. Quant aux NSC, 
les trois protocoles de différentiation ont généré des cellules avec les caractéristiques morphologiques de 
neurones ou de cellules gliales. En prime, l’expression de tous les gènes et antigènes neuronaux était élevée en 
conséquence de la différentiation. Les cellules MAPC-like développaient une morphologie semblable aux 
neurones dans seulement un des trois protocoles de différentiation. En plus, ces cellules exprimaient 
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seulement deux marqueurs neuronaux (beta3-tubuline et NF-200) et ne montraient pas d’expression 
augmentée après la différentiation. En outre, l’expression du marqueur neuronal (tau) et des marqueurs gliaux 
(GFAP, RIP et MPB) n’était pas détectée. L’incapacité de fournir des cellules neurales de façon reproductible 
nous a amené à conclure que les cellules MAPC-like sont inférieures aux NSC dans leur capacité de produire des 
cellules neurales adultes. En outre, ces résultats sont cohérents avec d’autres résultats scientifiques dans ce 
domaine, montrant que l’adoption d’une morphologie semblable aux neurones et l’expression de marqueurs 
neuraux pourraient plutôt être un phénomène aspécifique qu’un témoignage du développement neuronal. 
Basé sur ces résultats in vitro, nous avons choisi de continuer nos expériences de transplantation avec des NSC 
adultes d’origine cérébrale. 
Précédemment, des expériences scientifiques de transplantation cellulaire ont paru un succès, car il s’est avéré 
que dans quelques modèles d’épilepsie temporale certains changements pathologiques ont été partiellement 
rétablis. En plus, dans d’autres modèles, tels que des modèles de crises épileptiques évoquées, l’excitabilité 
neurale était réduite. Cependant, avant que des extrapolations à la situation humaine puissent être faites, 
l'effet à long terme de la transplantation sur des crises spontanées doit être étudié plus à fond dans les 
modèles chroniques de TLE. 
Le modèle de kainate (KA) intrahippocampal est un modèle post état-de-mal (SE) de l’épilepsie du lobe 
temporal. Ce modèle montre la sclérose hippocampale typique et les crises épileptiques spontanées, provenant 
la plupart du temps de l’hippocampe ipsilateral à la lésion de KA. En raison de la nature focale du dommage 
initial et de l’origine des crises épileptiques, le modèle de KA intrahippocampal est très intéressant pour 
évaluer la transplantation locale des cellules. Jusqu'ici, la caractérisation des crises spontanées dans ce modèle 
n'avait pas encore été réalisée. Dans cette étude, nous avons surveillé le modèle de KA intrahippocampal 
pendant 42 semaines avec l'enregistrement de vidéo et d’EEG pour déterminer des paramètres habituels de 
crises spontanées tels que la durée, la sévérité et la fréquence des crises. Nous avons constaté que les 
caractéristiques des crises spontanées étaient comparables à d'autres modèles post-SE. L' injection de KA 
intrahippocampal était très efficace alors que tous les rats traités ont développé SE et des crises spontanées 
ultérieures. Chez 87 % des rats, la première crise spontanée a été détectée pendant les huit premières 
semaines après l’injection de KA. La crise dure en moyenne environ 1 minute et  34 % de toutes les crises 
épileptiques étaient partielles sans généralisation secondaire. Les crises se sont produites dans un modèle 
circadien avec l'occurrence maximale pendant la journée. Généralement, la fréquence des crises épileptiques 
était plutôt basse et fortement variable parmi les rats. Seulement une petite fraction des rats (3 sur 15, 20 %) a 
montrée plus de trois crises en moyenne par jour. Avec le temps, une augmentation générale de la fréquence 
des crises a été observée. Ce modèle pourrait être employé pour examiner l'effet de la transplantation de 
cellules sur la suppression des crises spontanées, bien que la surveillance étendue et un nombre élevé de rats 
soient exigés.  
Des NSC, dérivées du SVZ de souris protéine fluorescente verte (GFP) transgéniques adultes, ont été 
transplantées dans l’hippocampe sclérotique du modèle de KA intrahippocampal, à trois jours et à trois 
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semaines après l’injection de KA. La survie, la dispersion et la différentiation du NSC ont été évaluées trois et six 
semaines après leur transplantation. Pour déterminer l'effet de la lésion de KA sur les paramètres observés, des 
NSC ont également été transplantées dans l’hippocampe normal des rats non-épileptiques. Trois semaines 
après la transplantation, une petite fraction (environ 1 %) des cellules transplantées a été détectée dans le 
cerveau. Cette fraction n'a pas changé de manière significative pendant au moins six semaines. La présence de 
la lésion n'a eu aucune influence principale sur la survie des cellules transplantées. Néanmoins, nous avons 
constaté qu'un retard de trois jours entre la lésion et la transplantation a favorisé de manière significative la 
survie en comparaison d’un retard de trois semaines. Dans l’hippocampe sclérotique, les NSC sont demeurées 
dans des faisceaux plutôt denses contrairement à l’hippocampe intact, où les cellules sont alignées le long des 
plans de rupture hippocampals. Les NSC s’étaient différenciées principalement vers des astrocytes et cette 
différentiation astrocytique a été clairement stimulée par la transplantation dans l’hippocampe sclérotique, 
indiquant que les NSC contribuent à la réponse gliale. Bien qu'une petite fraction des cellules transplantées ait 
exprimé les marqueurs neuronaux, il n'y avait aucune indication pour le remplacement ou la réparation 
neuronale des circuits endommagés. Basé sur leur survie stable, les NSC pourraient être employées pour la 
délivrance locale des substances supprimant les crises épileptiques dans l’hippocampe sclérotique. 
Une deuxième approche potentielle de thérapie cellulaire pour TLE consiste à moduler la neurogénèse 
endogène. Dans le gyrus denté de l’hippocampe, les cellules granulaires sont produites sans interruption 
durant toute la vie. Dans différents modèles pour TLE, la neurogénèse de cellules granulaires est fortement 
affectée pendant l'épileptogénèse. Le nombre de neurones granulaires nouveau-nés est augmenté de 3 à 10 
fois. Une proportion des neurones immatures montre la connectivité synaptique inadéquate et ils 
s’incorporent aux endroits ectopiques. Certains de ces cellules granulaires ectopiques semblent être 
incorporées dans les réseaux épileptiques. Basé sur ces observations, plusieurs auteurs ont supposé que la 
neurogénèse contribue à l'épileptogénèse. Pour explorer de plus le rôle de la neurogénèse anormale en 
réponse aux crises, nous avons utilisé une dose d’irradiation basse pour supprimer la génération de nouveaux 
neurones granulaires pendant l'épileptogénèse dans le modèle de kindling pour TLE. Bien que la formation de 
nouveaux neurones dans l’hippocampe ait été nettement supprimée pendant le kindling de rats irradiés, ce fait 
n'a pas empêché les rats de devenir entièrement épileptiques. En fait, le seuil pour évoquer une crise a été 
diminué et le taux de kindling a été augmenté chez les rats irradiés. Il reste à déterminer si cette excitabilité 
accrue est le résultat de la suppression de la neurogénèse ou un effet secondaire et non spécifique de 
l’irradiation. Cette étude a indiqué que la neurogénèse induite par les crises ne joue aucun rôle principal dans 
l'épileptogénèse. Ainsi, le blocage de la génération des neurones induits par les crises a peu de chance de 
devenir une option de thérapie cellulaire pour TLE.  
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